‫תשע"א‬/'‫ז‬
4/2011
‫רשומות‬
ISRAEL STATE RECORDS
‫כ"ד בניסן התשע"א‬
April 28 ,1122
‫יומן הפטנטים והמדגמים‬
PATENTS AND DESIGNS JOURNAL
Page/‫עמוד‬
Patents
Applications filed
Applications accepted
Patents granted
Patents renewed
Patents not in force
Patents renewed for 20 years
Changes in particulars entered in
register
Corrections
Country codes
Indices of applications accepted
Designs
Designs registered
Designs canceled
1
4
251
933
411
412
419
414
804
494
415
413
419
‫פטנטים‬
‫בקשות שהוגשו‬
‫בקשות שקובלו‬
‫פטנטים שניתנו‬
‫פטנטים שחודשו‬
‫פטנטים שתוקפם פקע‬
‫פטנטים שחודשו לעשרים שנה‬
‫שינויים בפרטים רשומים בפנקס‬
‫תיקונים‬
‫קודים למדינות‬
‫מפתחות לבקשות שהתקבלו‬
‫מדגמים‬
‫מדגמים שנרשמו‬
‫מדגמים שבוטלו‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫ידיעות כלליות‬
:‫ וכו' בענייני פטנטים ומדגמים יש לשלוח אל‬,‫ מסמכים‬,‫מכתבים‬
.‫ ירושלים‬,‫ מלחה‬5 ‫ בנין‬,‫ גנים טכנולוגיים ירושלים‬,‫רשם הפטנטים והמדגמים‬
'‫אגרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הרשות בבנק הדואר מס‬
‫ יש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה‬.0-54145-5
.‫שולמה‬
GENERAL INFORMATION
Letters, documents, etc. concerning Patents and Designs should be addressed to:
The Patent Authority, Jerusalem Technology Park, Building5, Malcha., Jerusalem.
Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the
Authority, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office
together with the application for the action for which the fee has been paid.
Copyright by the State of Israel. No
Extracts may be published except with the
permission of the Patent Office.
2
‫זכות היוצרים בתקצירים אלה שמורה למדינת‬
‫ אין להעתיק מתקצירים אלה אלא‬,‫ישראל‬
.‫ברשות לשכת הפטנטים‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
PATENTS
NOTICE UNDER SECTION 16 OF THE
PATENTS LAW, 5727-1967
In the following there are listed new
applications complying with the provisions
of rule 32(a) of the Patent Regulations, 57281968:
Particulars of the applications are given in
the following order:
Number and date of application and the first
four symbols of the International
Classification.
Title of invention (as proposed by applicant)
Applicant
Priority right:
Convention countryNumber and date of
Foreign application
International Application Number
International Publication Number
3
‫פטנטים‬
-‫ תשכ"ז‬,‫ לחוק הפטנטים‬11 ‫הודעה לפי סעיף‬
1611
‫להלן רשימת בקשות חדשות הממלאות אחר‬
‫(א) לתקנות‬25 ‫הדרישות שנקבעו בתקנה‬
:1611-‫ תשכ"ח‬,‫הפטנטים‬
:‫פרטי הבקשות מובאים לפי סדר זה‬
‫מספר הבקשה – ותאריך הגשתה וארבעה‬
‫הסמנים הראשונים של הסיווג הבינלאומי‬
)‫שם האמצאה (כפי שהוצע ע"י המבקש‬
‫המבקש‬
– ‫מדינת האיגוד‬
:‫דין קדימה‬
‫תאריך ומספר‬
‫בקשת החוץ‬
‫מספר בקשה בינלאומית‬
‫מספר פרסום בינלאומי‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
20/1//0121
501651
OPTICAL ECM TECHNIQUE
GENERATOR
RABINOVICH ROMAN
02/1//0121
‫מחולל טכניקות לוחמה אלקטרונית אופטי‬
‫רומן רבינוביץ‬
501155
501111
SYSTEM AND METHOD FOR VIDEO ASSISTED IDENTIFICATION OF
MOBILE PHONE USERS
VERINT SYSTEMS LTD.
01/1//0121
SWITCHED APPLICATION
PROCESSOR APPARATUS FOR
CELLULAR DEVICES
ELTA SYSTEMS LTD.
4
H01Q )5010.01(
‫מערך אנטנה הניתן לפריסה‬
‫אלתא מערכות בע"מ‬
DEPLOYABLE ANTENNA ARRAY
ELTA SYSTEMS LTD.
01/1//0121
G01R )5010.01(
H04W )5010.01(
‫מערכת ושיטה לזיהוי משתמשים של‬
‫טלפונים ניידים בעזרת מידע חוזי‬
‫ורינט מערכות בע"מ‬
501110
H04M )5010.01(
‫מערכת למיתוג מעבדי יישומים במערכות‬
‫תאיות‬
‫אלתא מערכות בע"מ‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
01/1//0121
501521
‫מגן לעמדת מקלען‬
‫פלסן סאסא בע"מ‬
GUNNER PLATFORM PROTECTOR
PLASAN SASA LTD.
01/1//0121
501521
501554
METHOD AND SYSTEM OF
MEASURING A DISTANCE
GADI TIVON
21/1//0121
G01S )5010.01(
‫שיטה ומערכת למדידות טווח‬
‫גדי טיבון‬
501152
A SENSOR FOR TAUT WIRE FENCES
MAGAL SECURITY SYSTEMS LTD.
5
E06B )5010.01(
‫מנגנון לדלת‬
‫פלסן סאסא בע"מ‬
DOOR MECHANISM
PLASAN SASA LTD.
20/1//0121
F41H )5010.01(
G08B )5010.01(
‫חיישן לגדרות תיל מתוח‬
‫מגל מערכות בטחון בע"מ‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
01/1//0121
501121
IMPROVED PROCESS AND SYSTEM
FOR LOADING FIRMWARE
ELTAM EIN HASHOFET
01/1//0121
‫תהליך משופר ומערכת לטעינת קושחה‬
‫השופט‬-‫אלתם עין‬
501110
RAPID RESCTION PROTECTION
SYSTEM FOR BUILDINGS, VESSELS
AND VEHICLES
DAVID COHEN
01/21/0121
‫דוד כהן‬
501151
A63F )5010.01(
–‫חפיסת קלפים מיוחדת למשחק רמי‬
‫אבנים‬
‫יוסף נוריאל‬
YOSEF NURIEL
506114
DESIGNS AND PROCESSES FOR
THERMALLY STABILIZING A
VERTICAL CAVITY SURFACE
EMITTING LASER (VCSEL) IN A
CHIP-SCALE ATOMIC CLOCK
HONEYWELL INTERNATIONAL INC.
US
61/301497
04/02/2010
20//////1
2//11/0121
US
6
F41H )5010.01(
‫ כליי שייט‬,‫מערכת מיגון מהירה לבנינים‬
‫וכליי רכב‬
‫אאאאאאאאאאאאאאאאאאאאאאא‬
1//22/0121
G06F )5010.01(
G02F )5010.01(
‫תרשימים ותהליכים לייצוב תרמי של‬
‫משטח חלל אנכי של לייזר פליטה בשעון‬
‫אטומי עם סקלה שביבית‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
22/22/0121
506556
DLP LINK SYSTEM WITH MULTIPLE
PROJECTORS AND INTEGRATED
SERVER
XPAND, INC.
US
61/261663
16/11/2009
01/11/0111
‫ עם מטול כפול ושרת‬DLP ‫מערכת קישור‬
‫מוכלל‬
506145
PROPELLANT CHARGE
DIEHL BGT DEFENCE GMBH & CO. KG
DE
102008026645.0 03/06/2008
PCT/EP/2009/003695
WO/2009/146808
10/20/0121
506144
HOUSEHOLD APPLIANCE
SEVERIN ELEKTROGERATE GMBH
DE
102009059175.3 17/12/2009
10/20/0121
506145
ELECTRICAL HOUSEHOLD APPLIANCE
SEVERIN ELEKTROGERATE GMBH
DE
102009059181.8 17/12/2009
7
F41A )5010.01(
F41A )5010.01(
‫מטען דחף‬
A47J )5010.01(
‫מתקן של משק בית‬
A47J )5010.01(
‫מתקן חשמלי של משק בית‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
11/20/0121
506110
FILL SUFFICIENCY METHOD AND
SYSTEM
LIFESCAN SCOTLAND LTD.
US
61/285916
11/12/2009
11/20/0121
506111
ACTIVE 3D GLASSES WITH OLED
SHUTTERS
XPAND, INC.
US
61/285048
09/12/2009
11/20/0121
506115
SOLAR POWERE 3D GLASSES
XPAND, INC.
US
61/285071
09/12/2009
1//11/0111
506112
PROBE DETECTION SYSTEM
INFINITESIMA LTD
GB
0810389.7
06/06/2008
1/001118/
21/20/011/
GB
PCT/GB/2009/050637
WO/2009/147450
8
G08B )5010.01(
‫מערכת ושיטה למדידת מילוי מספק‬
G02B )5010.01(
‫זכוכית לצפיה תלת מימדית עם מחיצות‬
OLED ‫נעילה מסוג‬
G02C )5010.01(
‫משקפי תלת – מימד המונעים סולרית‬
G12B )5010.01(
‫גשש מערכת גילוי‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
1//20/0121
506155
EDIBLE RECEPTACLES FOR FROZEN
CONFECTIONS
UNILEVER PLC,
EP
09180347.8 22/12/2009
1//20/0121
506125
ROTATING HARDWARE AND
PROCESS THEREFOR
GENERAL ELECTRIC COMPANY
US
12/644068
22/12/2009
00/1//0111
510165
METHOD AND AND SYSTEM FOR
DENTAL IMPLANTATION
DR. PINCHAS KFIR
US
61083196
24/07/2008
PCT/IL/2009/000717
WO/2010/010558
01/1//0111
510162
SYSTEM AND METHOD FOR
CHEMICAL POTENTIAL ENERGY
PRODUCTION
YEDA RESEARCH AND
DEVELOPMENT CO. LTD.
US
61/129913
29/07/2008
PCT/IL/2009/000743
WO/2010/013244
9
B65D )5010.01(
‫כלי קיבול אכילים עבור רקיחות קפואות‬
G06F )5010.01(
‫חומרה מסתובבת ותהליך עבורה‬
A61C )5010.01(
‫מערכת ושיטה להשתלה דנטלית‬
‫ד"ר פנחס כפיר‬
C01B )5010.01(
‫מערכת ושיטה ליצירת אנרגיה‬
‫פוטנציאלית כימית‬
‫ידע חברה למחקר ופיתוח בע"מ‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
0//1//0111
510164
BIOPARTICLE CAPTURE DEVICE,
AND USE THEREOF
BASTIEN KARKOUCHE
FR
0855210
29/07/2008
PCT/FR/2009/051497
WO/2010/012941
0//1//0111
‫התקן ללכידת חלקיקים ביולוגיים ושימושיו‬
510165
PYRIPYROPENE A BIOSYNTHETIC
GENE
MEIJI SEIKA KAISHA, LTD.
2008JP
24/07/2008
190862
011/-0/101/ 01/21/011/
JP
0111-101112 01/12/0111
JP
PCT/JP/2009/063293
WO/2010/010955
1//1//0111
510161
VARIABLE COHERENCE
INTEGRATION FOR THE LOCATION
OF WEAK SIGNALS
TRUEPOSITION, INC.
US
12/192842
15/08/2008
PCT/US/2009/053178
WO/2010/019477
01/1//0111
EARTH-BORING BITS AND OTHER
PARTS INCLUDING CEMENTED
CARBIDE
10
G01N )5010.01(
510161
C12N )5010.01(
‫ גן ביוסינתטי‬A ‫פיריפרופן‬
H04W )5010.01(
‫אינטגרציה קוהרנטית משתנה למציאת‬
‫אותות חלשים‬
E21B )5010.01(
‫חפצים לקידוח באדמה וחלקים אחרים‬
‫המכילים קרביד מבוטן‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
TDY INDUSTRIES, INC.
US
12/196815
PCT/US/2009/051126
WO/2010/021802
00/11/0111
22/08/2008
510161
COMPENSATING FOR ANTICIPATED
MOVEMENT OF A DEVICE
MICROSOFT CORPORATION
US
12/239277
26/09/2008
PCT/US/2009/057921
WO/2010/036664
01/11/0111
‫פיצוי לתזוזה צפויה של התקן‬
510166
510100
METHOD FOR MANUFACTURING A
THERMOPLASTIC POLYMER
MATRIX
11
H05H )5010.01(
‫מייצר חלקיקים נייטרלים‬
NEUTRAL PARTICLE GENERATOR
JIDDTEK PTY LTD
AU
2008903924 31/07/2008
12/1/101/
02/1//011/
US
PCT/AU/2009/000800
WO/2010/012021
01/1//0111
C07K )5010.01(
‫די–פפטידים דמויי פרולין‬
PSEUDOPROLINE DIPEPTIDES
F. HOFFMANN-LA ROCHE AG
EP
08165968.2 07/10/2008
PCT/EP/2009/062568
WO/2010/040660
00/11/0111
G06F )5010.01(
510101
C08K )5010.01(
‫שיטה ליצור מטריצת פולימר תרמופלסטי‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
RHODIA POLIAMIDA E
ESPECIALIDADES LTDA
FR
08/4335
PCT/IB/2009/006298
WO/2010/013107
30/07/2008
510105
20/1//0111
PURIN DERIVATIVES FOR USE IN THE
TREATMENT OF FAB-RELATED
DISEASES
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
PCT/EP08/060740 15/08/2008
1121101081
1//12/0111
EP
112111/080
21/11/0111
EP
PCT/EP/2009/060521
WO/2010/018217
1//1//0111
510102
PURINE DERIVATIVES FOR USE IN
THE TREATMENT OF ALLERGIC,
INFLAMMATORY AND INFECTIOUS
DISEASES
GLAXOSMITHKLINE LLC
US
61/087790
11/08/2008
PCT/EP/2009/060263
WO/2010/018131
00/1//0111
510104
DEACETYLASE INHIBITORS AND
USES THEREOF
PRESIDENT AND FELLOWS OF
HARVARD COLLEGE
US
61/082899
23/07/2008
PCT/US/2009/004235
WO/2010/011296
12
A61K )5010.01(
‫תולדות פורין לשימוש בטיפול‬
FAB–‫במחלות הקשורות ל‬
C07D )5010.01(
‫תולדות פורין לשימוש בטיפול במחלות‬
‫ דלקתיות וזיהומיות‬,‫אלרגיות‬
C07C )5010.01(
‫מעכבי דאצטילאז ושימושים בהם‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
0//1//0111
510105
GLYPHOSATE APPLICATIONS IN
AQUACULTURE
AURORA BIOFUELS, INC.
US
12/220688
24/07/2008
PCT/US/2009/004296
WO/2010/011335
02/1//0111
510101
ELECTRICAL CONNECTOR
3M INNOVATIVE PROPERTIES
COMPANY
US
61/083296
24/07/2008
20/00/00/
20/20/011/
US
PCT/US/2009/051191
WO/2010/011617
2//1//0111
510101
ELECTRICAL CONNECTOR
3M INNOVATIVE PROPERTIES
COMPANY
US
61/083283
24/07/2008
20/00/012
20/20/011/
US
PCT/US/2009/050455
WO/2010/011525
00/12/0122
SYSTEM AND METHOD FOR
TREATMENT OF LIQUID
WADIS LTD
13
510101
A01N )5010.01(
‫יישומי גליפוסאט בתנאי גידול מימיים‬
H01R )5010.01(
‫מחבר חשמלי‬
H01R )5010.01(
‫מחבר חשמלי‬
B08B )5010.01(
‫מערכת ושיטה לטיפול בנוזלים‬
‫וודיס בע"מ‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
00/1//0111
510106
A METHOD CIRCUIT DEVICE
ASSEMBLY AND SYSTEM FOR
CONVERTING SOLAR RADIATION
INTO ELECTRIC CURRENT
SOLECTA LTD
US
61/082832
23/07/2008
PCT/IB/2009/053211
WO/2010/010530
0//1//0111
‫שיטה מעגל חשמלי מתקן התקן להפיכת‬
‫קרינה סולרית לזרם חשמלי‬
510110
COMPOSITIONS FOR THE
TREATMENT OF PAIN AND/OR
INFLAMTION
DIVERDRUGS, S.L.
ES
P200802210 24/07/2008
PCT/EP/2009/005381
WO/2010/009892
00/12/0122
510111
TRAVEL SHARING SYSTEM AND
METHOD
YOSSEFF GELEM
14
‫סולקטה בע"מ‬
A61K )5010.01(
‫או דלקת‬/‫תכשירים לטיפול בכאב ו‬
E05B )5010.01(
‫מנעול חבוי בעל בריח מת ולשון מנעול‬
‫מגנטי‬
‫אלבא בע"מ‬
MORTISE LOCK WITH DEADBOLT
AND MAGNETIC LATCH
ALBA LTD.
00/12/0122
H01L )5010.01(
510115
G06F )5010.01(
‫מערכת ושיטה לשיתוף בנסיעות‬
‫יוסף גלם‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
00/1//0111
510112
METHODS OF ADMINISTERING
TOPICAL ANTIFUNGAL
FORMULATIONS FOR THE
TREATMENT OF FUNGAL
INFECTIONS
TDT, LTD
US
61/083115
23/07/2008
12/210222
10/21/011/
US
12/2112//
11/10/0111
US
12/21/200
11/1//0111
US
PCT/IB/2009/006742
WO/2010/010470
1//11/0111
‫שיטה למתן פורמולציות לעור נגד פטריות‬
‫לטיפול בדלקת פיטריות‬
510114
SYSTEM AND METHOD FOR
CONVERTING SOLIDS INTO FUEL
MAHJOOB, A. LATIF
US
12/178516
23/07/2008
PCT/US/2009/046612
WO/2010/011432
00/1//0111
510115
RETAINER FOR PRINTED CIRCUIT
BOARDS
PENTAIR ELECTRONIC PACKAGING
COMPANY
US
12/178533
23/07/2008
PCT/US/2009/051458
WO/2010/011788
15
A61K )5010.01(
C07C )5010.01(
‫מערכת ושיטה להמרת מוצקים לדלק‬
H01R )5010.01(
‫מעגן עבור לוחות מעגלים מודפסים‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
0//11/0111
510111
METHODS AND COMPOSITIONS FOR
REGULATING BIOFILM
DEVELOPMENT
ENVIRONMENTAL
BIOTECHNOLOGY CRC PTY LIMITED
AU
2005902660 24/05/2005
PCT/AU/2006/000693
WO/2006/125262
00/1//0111
510111
AMPLIFIED ELECTROKINETIC FLUID
PUMPING SWITCHING AND
DESALTING
MASSACHUSETTS INSTITUTE OF
TECHNOLOGY
US
61/129819
22/07/2008
12/1//1/2
01/1//011/
US
PCT/US/2009/051420
WO/2010/011760
21/1//0111
510111
GEMSTONE VIEWER
DE BEERS CENTENARY AG
GB
0813654.1
25/07/2008
PCT/GB/2009/050862
WO/2010/010375
01/1//0111
510116
SOLID PHARMACEUTICAL
COMPOSITION
TAKEDA PHARMACEUTICAL
COMPANY LIMITED
US
61/085201
31/07/2008
12/1/110/
12/1//011/
US
16
C12N )5010.01(
‫שיטות והרכבים לשם וויסות פיתוח‬
‫ביופילם‬
B01D )5010.01(
‫ החלפה והתפלה מוגברות של‬,‫שאיבה‬
‫נוזל אלקטרוקינטי‬
G01N )5010.01(
‫צופה מרגליות‬
C07D )5010.01(
‫תרכובת פרמצבטית מוצק‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
PCT/JP/2009/063833
WO/2010/013835
21/1//0111
510150
‫תכשירים נגד דלקת לטיפול מקומי‬
‫ושימושים בהם‬
TOPICAL ANTI-INFLAMMATORY
COMPOSITIONS AND USES THEREOF
IZUN PHARMACEUTICALS
CORPORATION
US
61/082613
22/07/2008
PCT/US/2009/050661
WO/2010/011541
00/1//0111
510151
PYRAZOLOPYRIDINE KINASE
INHIBITOR COMPOUNDS,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
VERTEX PHARMACEUTICALS
INCORPORATED
US
61/082929
23/07/2008
12/2/1212
00/20/011/
US
12/2102/1
01/10/0111
US
PCT/US/2009/051413
WO/2010/011756
00/1//0111
17
C07D )5010.01(
,‫תרכובות פיראזולופירידין מדכאי קינאז‬
‫תכשירים המכילים אותם ושימושים בהם‬
510155
TRI-CYCLIC PYRAZOLOPYRIDINE
KINASE INHIBITOR COMPOUNDS,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
VERTEX PHARMACEUTICALS
INCORPORATED
US
61/082919
23/07/2008
12/221100
21/22/011/
US
12/2/1211
00/20/011/
US
12/210210
01/10/0111
US
PCT/US/2009/051437
A61K )5010.01(
C07D )5010.01(
,‫תרכובות פיראזולופירידין טריציקליות‬
‫ תכשירים המכילים אותם‬,‫מדכאי קיאנז‬
‫ושימושים בהם‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
WO/2010/011772
10/11/0110
510152
[1,2,4] TRIAZOLO [4,3-a] PYRIDINE
DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
COMPRISING THE SAME
BRISTOL-MYERS SQUIBB COMPANY
US
60/408099
04/09/2002
11//121/1
02/1//0110
US
PCT/US/2003/027513
WO/2004/021984
10/11/0110
a–4,2[ [ ‫] פירידין‬1,5,4[ ‫תולדות טריאזולו‬
‫ותכשירי רוקחות המכילים אותן‬
510154
[1,2,4] TRIAZOLO [4,3-a] PYRIDINE
DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
COMPRISING THE SAME
BRISTOL-MYERS SQUIBB COMPANY
US
60/408099
04/09/2002
11//121/1
02/1//0110
US
PCT/US/2003/027513
WO/2004/021984
21/1//0111
18
C07D )5010.01(
a–4,2[ [ ‫] פירידין‬1,5,4[ ‫תולדות טריאזולו‬
‫ותכשירי רוקחות המכילים אותן‬
510155
METHOD FOR PRODUCING CARRIER
ON WHICH MICROORGANISMS
CAPABLE OF CONDUCTING
MULTIPLE PARALLEL
MINERALIZATION ARE
IMMOBILIZED, COLUMN REACTOR
AND SOLID MEDIUM FOR
CULTIVATING PLANTS
Incorporated Administrative Agency,
National Agriculture and Food Research
Organization
C07D )5010.01(
C12N )5010.01(
–‫שיטה לייצור נשא אליו מרותקים מיקרו‬
‫אורגניזמים היכולים לבצע מינרליזציות‬
‫ וחומר מוצק‬,‫ מגיב טורי‬,‫מקבילות מרובות‬
‫לטיפוח צמחים‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
2008262385
PCT/JP/2009/062868
WO/2010/041502
JP
21/1//0111
09/10/2008
510151
METHOD FOR PRODUCTING OF
INOCULUM OF MICROORGANISMS
OPTIMIZED AS CATALYST FOR
MULTIPLE PARALLEL
MINERALIZATION
Incorporated Administrative Agency,
National Agriculture and Food Research
Organization
2008JP
09/10/2008
262390
PCT/JP/2009/062870
WO/2010/041503
01/1//0111
‫שיטה לייצור תרכיב של מיקרו–אורגניזמים‬
‫היעיל כזרז למינרליזציות מרובות מקבילות‬
510151
PYRROLIDINYL-ALKYL-AMIDE
DERIVATIVES THEIR PREPARATION
AND THEIR THERAPEUTIC
APPLICATION AS CCR3 RECEPTOR
LIGANDS
SANOFI AVENTIS
HU
P0800478
31/07/2008
PCT/HU/2009/000067
WO/2010/013078
0//12/0122
SWITCH-SAFE
ABRAHAM COHEN
19
C12N )5010.01(
510120
C07D )5010.01(
‫ הכנתן‬,‫נגזרות פירולידיניל–אלקיל–אמיד‬
‫ושימוש רפואי שלהן כליגנדים לרצפטור‬
CCR2
F02N )5010.01(
‫טוויטש –סייף‬
‫אברהם כהן‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
11/1//0111
510124
CYCLOHEXYL AMIDE DERIVATIVES
AND THEIR USE AS CRF-1 RECEPTOR
ANTAGONISTS
NOVARTIS AG
EP
08162006.4 07/08/2008
112111/08/
2//12/0111
EP
12/011201
2//12/0111
US
PCT/EP/2009/060150
WO/2010/015655
21/1//0111
‫תולדות ציקלוהקסיל אמיד ושימושן‬
CRF–1–‫כאנטאגוניסטים של רצפטור ל‬
510125
PROCESSES FOR THE PREPARATION
OF 4-OXO-OCTAHYDRO-INDOLE-1CARBOXYLIC ACID METHYL ESTER
AND DERIVATIVES THEREOF
NOVARTIS AG
US
61/088156
12/08/2008
PCT/EP/2009/060351
WO/2010/018154
10/1//0111
ORGANIC COMPOUNDS
NOVARTIS AG
EP
08161765.6
12/21210/
US
PCT/EP/2009/060061
WO/2010/015613
00/1//0111
C07D )5010.01(
‫תהליכים להכנת מתיל אסטר של חומצה‬
–1–‫–אוקסו–אוקטאהידרו–אינדול‬4
‫קרבוקסילית ותולדות שלו‬
510121
C07C )5010.01(
‫תרכובות אורגניות‬
04/08/2008
21/10/0111
510121
DEVICE AND METHOD FOR DRINKING
WATER PURIFICATION
AQUA LIVING GMBH & CO. KG
20
C07C )5010.01(
C02F )5010.01(
‫התקן ושיטה לטיהור מי שתייה‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
102008034588.14
PCT/EP/2009/005367
WO/2010/009888
DE
20/22/011/
25/07/2008
510121
PROCESS FOR PRODUCING
THIAZOLE DERIVATIVE
DAIICHI SANKYO COMPANY,
LIMITED
2003JP
12/11/2003
382382
0110-0/00/0 20/22/0110
JP
0110-0/00// 20/22/0110
JP
PCT/JP/2004/016874
WO/2005/047296
01/1//0111
510126
METHOD FOR MEASURING
INTRACRANIAL ELASTICITY
ARTHUR RAPPAPORT
US
61/084827
30/07/2008
PCT/US/2009/052263
WO/2010/014815
0//1//0111
510140
METHODS AND COMPOSITIONS FOR
TREATING AND PREVENTING
AUTOIMMUNE DISEASES
THE JOHNS HOPKINS UNIVERSITY
US
61/083607
25/07/2008
PCT/US/2009/051618
WO/2010/011879
21
C07D )5010.01(
‫תהליך עבור הייצור של נגזרת ת'יאזול‬
A61B )5010.01(
‫שיטה למדידת גמישות תוך–גולגליתית‬
A61K )5010.01(
‫שיטות ותרכובות לטיפול ומניעה של‬
‫מחלות אוטואימוניות‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
21/1//0111
510141
‫דנדרימרים ארוכי טווח של די–אנ–איי‬
‫ושיטות לשימושם‬
LONG-ACTING DNA DENDRIMERS
AND METHODS THEREOF
GENISPHERE, LLC
US
61/188318
08/08/2008
PCT/US/2009/053264
WO/2010/017544
22/1//0111
510145
METHODS AND COMPOSITIONS FOR
ORAL ADMINISTRATION OF
PROTEINS
ORAMED LTD
US
61/089812
18/08/2008
PCT/IL/2009/000786
WO/2010/020978
1//1//0111
01/1//0111
22
‫אורמד בע"מ‬
A61K )5010.01(
‫–מונואוקסיג'נס‬2–‫מעקבי קינוראינינים‬
,‫ ותכשירי רוקחות המכילים אותם‬,‫מסוימים‬
‫ושיטות לשימוש שלהם‬
510144
HETEROGENEOUS HYDROGENCATALYST REACTOR
BLACK LIGHT POWER INC.
US
61/084923
30/07/2008
12/1/1021
11/1//011/
US
12/1///10
20/1//011/
US
12/11/120
11/11/011/
US
A61K )5010.01(
‫שיטות ותכשירים למתן חלבונים דרך הפה‬
510142
CERTAIN KYNURENINE-3MONOOXYGENASE INHIBITORS,
PHARMACEUTICAL COMPOSITIONS,
AND METHODS OF USE THEREOF
CHDI, INC.
US
61/086090
04/08/2008
PCT/US/2009/052667
WO/2010/017179
A61K )5010.01(
C01B )5010.01(
‫כור קטליזטור–מימן הטרוגני‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
12/11/12/
US
12/210/11
US
12/21/10/
US
12/211111
US
12/211100
US
12/2111//
US
12/221010
US
12/220/12
US
12/22//01
US
12/2101/0
US
12/201010
US
12/2/1100
US
12/2/1110
US
12/2111/2
US
12/210111
US
12/21100/
US
12/21/010
US
12/2112/1
US
12/21/212
US
12/211/11
US
12/2/1/2/
US
12/2//0/1
US
12/2/11/1
US
12/2///11
US
12/2/1/11
US
12/2/0/1/
US
12/2/1111
US
12/02///2
US
12/001122
US
12/000/02
US
12/0011/2
US
PCT/US/2009/052072
WO/2010/014684
0//1//0111
21/11/011/
10/21/011/
21/21/011/
21/21/011/
01/21/011/
0//21/011/
02/21/011/
1//22/011/
2//22/011/
11/20/011/
21/20/011/
21/12/0111
00/12/0111
11/10/0111
20/10/0111
0//10/0111
11/10/0111
20/10/0111
0//10/0111
10/1//0111
2//1//0111
01/1//0111
1//11/0111
21/11/0111
00/11/0111
01/11/0111
20/11/0111
21/11/0111
01/11/0111
10/1//0111
2//1//0111
510145
CLOSTRIDAL NEUROTOXINS WITH
ALTERED PERSISTENCY
MERZ PHARMA GMBH & CO. KGaA
EP
08015287.9 29/08/2008
12/21111/
01/1//011/
US
PCT/EP/2009/006272
WO/2010/022979
23
C07K )5010.01(
‫רעלנים עצבים של קלוסטרידיום עם‬
‫עקשנות שנתה‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
0//1//0111
510141
METHOD FOR DETECTING
CHROMOSOMAL ABNORMALITIES
UNIVERSITE PARIS DESCARTES
FR
0855114
25/07/2008
PCT/FR/2009/051499
WO/2010/010312
02/1//0111
‫שיטה לזיהוי אי–תקינות כרומוזומאלית‬
510141
DEVICE SUITABLE FOR TREATING A
FLUID, AS WELL AS A METHOD
SUITABLE FOR MANUFACTURING
SUCH A DEVICE
AKA HOLDING B.V.
NL
1035752
25/07/2008
PCT/NL/2009/050449
WO/2010/011138
01/12/0122
510141
G09B )5010.01(
‫מחיטיקט‬
‫דוד גנון‬
510150
BOTTLE FOR PACKAGING LIQUID
THAT IS TO BE DISPENSED DROP BY
DROP, WITH ANTIBACTERIAL
PROTECTION
LABORATOIRES THEA
FR
08/04420
31/07/2008
PCT/IB/2009/006420
24
B01D )5010.01(
‫מתקן המתאים לטיפול בנוזל ושיטה‬
‫המתאימה לייצור המתקן‬
MAHITICKET
DAVID GANON
02/1//0111
C12Q )5010.01(
B65D )5010.01(
‫בקבוק עבור אריזת נוזל שיינתן טיפה אחר‬
‫ עם הגנה נגד חיידקים‬,‫טיפה‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
WO/2010/013131
21/11/011/
510151
PHARMACEUTICAL FORMULATION
FOR CONTRACEPTION AND
HORMONE-REPLACEMENT
THERAPY
JOHN CLAUDE SAVOIR
US
60/477939
13/06/2003
PCT/IB/2004/001930
WO/2004/110408
02/1//0111
‫פורמולציה רוקחית למניעת הריון וטיפול‬
‫החלפת הורמון‬
510155
510152
COMPOUNDS WHICH SELECTIVELY
MODULATE THE CB2 RECEPTOR
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
US
61/100077
25/09/2008
PCT/US/2009/057777
WO/2010/036631
1//11/0111
25
C07K )5010.01(
‫ אנושיים המיוצרים‬IX–‫ ו‬VIII ‫פקטורים‬
‫באופן רקומביננטי‬
RECOMBINANTLY PRODUCED
HUMAN FACTOR VIII AND IX
OCTAPHARMA AG
EP
61/136250
21/08/2008
1/210/1181
02/1//011/
US
PCT/EP/2009/060829
WO/2010/020690
00/11/0111
A61K )5010.01(
C07D )5010.01(
‫תרכובות אשר באופן בררני מאפננות את‬
CB5 ‫קולטן‬
510154
C07D )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
PYRAZOLOPYRIMIDINES AND
THEIR USE FOR THE TREATMENMT
OF CNS DISORDERS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
08163879.3 08/09/2008
1121/1/181
20/1//0111
EP
PCT/EP/2009/061455
WO/2010/026214
1//1//0111
‫פיראזולופירימידינים ושימוש בהם לטיפול‬
‫באי סדרים של מערכת העצבים המרכזית‬
510155
NOVEL ADENINE DERIVATIVES
GLAXOSMITHKLINE LLC
US
61/087773
11/08/2008
PCT/EP/2009/060267
WO/2010/018134
1//11/0111
510151
COMBINATION THERAPY FOR THE
TREATMENT OF DIABETES AND
RELATED CONDITIONS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
08105293.8 10/09/2008
PCT/EP/2009/061659
WO/2010/029089
00/11/0111
510151
AZAINDAZOLE COMPOUNDS AS
CCR1 RECEPTOR ANTAGONISTS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
US
61/100401
26/09/2008
PCT/US/2009/057778
WO/2010/036632
26
A61K )5010.01(
‫תולדות חדשות של אדנין‬
A61K )5010.01(
‫טיפול משולב לטיפול בסכרת ומצבים‬
‫הקשורים בכך‬
C07D )5010.01(
‫תרכובות אזאינדאזול כאטגוניסטים של‬
CCRI ‫קולטן‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
1//1//0111
510151
MACHINE-READABLE FORM
CONFIGURATION AND SYSTEM AND
METHOD FOR BETTING
INTRALOT S.A.- INTEGRATED
LOTTERY SYSTEMS AND SERVICES
US
61/087864
11/08/2008
PCT/IB/2009/006653
WO/2010/018456
01/12/0122
01/12/0122
27
A01M )5010.01(
‫מחבט זבובים לאפריקה לשימוש‬
‫ משופר מבחינה ארכיטקטונית‬,‫אינטנסיבי‬
‫ מוצע בחינם לבתי ספר במדיניות‬,‫ומבנית‬
‫ שיטות הפצה‬,‫עניות‬
‫דב אפשטיין‬
510110
ELECTRONIC ENHANCEMENT OF
FUEL CELL PERFORMANCE
OFEK ESHKOLOT RESEARCH AND
DEVELOPMENT LTD.
US
US
08/09/2010
61/402927
01/1//0111
‫תצורת מכונה בצורה קריאה ומערכת‬
‫ושיטה להימור‬
510156
FLY SWATTER FOR AFRICA FOR
INTENSIVE USE,
ARCHITECTURALLY ENHANCED
AND STRUCTURALLY REINFORCED,
FREELY OFFERED TO SCHOOLS OF
POOR COUNTRIES, METHODS OF
DISTRIBUTION AND USE
DOV EPSTEIN
G07F )5010.01(
B05B )5010.01(
‫הגברה אלקטרונית לביצועים של תא דלק‬
510111
‫אופק אשכולות מחקר ופיתוח בע"מ‬
C12N )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
MELK EPITOPE PEPTIDES AND
VACCINES CONTAINING THE SAME
ONCOTHERAPY SCIENCE, INC.
US
61/085663
01/08/2008
PCT/JP/2009/003630
WO/2010/013485
02/1//0111
‫ וחיסונים המכילים‬MELK ‫פפטידי אפיטופ‬
‫אותם‬
510115
SOLAR RECEIVER SYSTEM
YEDA RESEARCH AND
DEVELOPMENT CO. LTD.
US
61/093325
31/08/2008
PCT/IL/2009/000836
WO/2010/023672
01/1//0111
510112
BENZOIMIDAZOLE DERIVATIVES
AND GLYCOGEN SYNTHASE
KINASE-3 BETA INHIBITORS
CONTAINING THE SAME
ONCOTHERAPY SCIENCE, INC.
US
61/084770
30/07/2008
PCT/US/2009/052225
WO/2010/014794
22/1//0111
510114
DATE KERNEL PREPARATION
GREEN LIFE CAFE LTD
US
61/136055
11/08/2008
PCT/IL/2009/000780
WO/2010/018572
2//1//0111
28
510115
F24J )5010.01(
‫מערכת קליטה סולרית‬
‫ידע חברה למחקר ופיתוח בע"מ‬
A01N )5010.01(
‫תולדות בנזואימידאזול ומעכבי גליקולן‬
‫ בתא המכילים אותן‬2–‫סינטאז קינאז‬
A23L )5010.01(
‫הכנה המבוססת על גרעיני תמר‬
‫גרין לייף קפה בע"מ‬
C12Q )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
METHODS AND SYSTEMS FOR
PREDICTING REPSONSE OF CELLS
TO A THERAPEUTIC AGENT
MERRIMACK PHARMACEUTICALS,
INC.
US
61/189053
15/08/2008
12/21//10
01/11/011/
US
12/01/011
01/10/0111
US
12/2/101/
2//1//0111
US
PCT/US/2009/054051
WO/2010/019952
01/1//0111
510111
ANTIBODIES DIRECTED AGAINST
PYROGLUTAMATE MONOCYTE
CHEMOATTRACTANT PROTEIN-1
(MCP-1 N1PE)
PROBIODRUG AG
US
61/090264
20/08/2008
PCT/EP/2009/060757
WO/2010/020669
2//1//0111
510111
ARRANGEMENT AND METHOD FOR
COMMUNICATING AUDIO AND DC
SIGNALS
SIEMENS INDUSTRY, INC.
US
61/090350
20/08/2008
20/1/2111
2//1//0111
US
PCT/US/2009/053976
WO/2010/021958
0//1//0111
510111
NITROGENATED DERIVATIVES OF
PANCRATISTATIN
PIERRE FABRE MEDICAMENT
FR
0855161
28/07/2008
29
‫שיטות ומערכות לחיזוי תגובת תאים‬
‫לגורם טיפולי‬
C07K )5010.01(
–1 ‫נוגדנים המכוונים נגד פירוגלוטמאט‬
)MCP (PE1N 1–MCP
G08B )5010.01(
‫ ואודיו‬DC ‫סידור ושיטה לתקשר אותות‬
C07D )5010.01(
‫נגזרות חנקניות של פאנקרטיסטאטין‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
PCT/EP/2009/059715
WO/2010/012714
12/1//0111
510116
IMIDAZOTHIADIAZOLES
DERIVATIVES
MERCK PATENT GMBH
EP
08013574.2 29/07/2008
PCT/EP/2009/004753
WO/2010/012345
01/11/0111
‫נגזרות של אימידזותיאדיאזולים‬
510110
METHOD OF DETERMINATION OF
RECEPTOR BINDING SATURATION
EFFECTED BY MONOCLONAL
ANTIBODIES
MERCK PATENT GMBH
EP
08013415.8 25/07/2008
PCT/EP/2009/004615
WO/2010/009794
12/11/0111
SIGNAL ACQUISITION IN A
WIRELESS COMMUNICATION
SYSTEM
30
G01N )5010.01(
‫שיטה לקביעת מידת הרוויה של קישור‬
‫רצפטור על ידי נוגדנים חד–שבטיים‬
510111
ROLLER MILL FOR GRINDING
PARTICULATE MATERIAL
FLSMIDTH A/S
DK
PA200801048 30/07/2008
PCT/EP/2009/056694
WO/2010/012527
2//11/0111
C07D )5010.01(
B02C )5010.01(
‫ריחיים מכבש לטחינת חימר חלקיקי‬
510112
H04B )5010.01(
‫תפיסת אות במערכת תקשורת אלחוטית‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
QUALCOMM INCORPORATED
US
60/580809
18/06/2004
22/100121
00/20/011/
US
PCT/US/2005/021051
WO/2006/009711
01/1//0111
510115
PROCESSES AND INTERMEDIATES
FOR MAKING SWEET TASTE
ENHANCERS
SENOMYX, INC.
US
61/085206
31/07/2008
12/21/11/
1//1//0111
US
PCT/US/2009/052048
WO/2010/014666
02/21/0111
‫תהליכים וחומרי ביניים להכנת מחזקי‬
‫טעם מתוק‬
510111
METHODS AND COMPOSITIONS FOR
DIAGNOSING ANKYLOSING
SPONDYLITIS USING BIOMARKERS
C07D )5010.01(
G01N )5010.01(
‫שיטות ותכשירים לאבחון דלקת חוליות‬
,‫עמוד השדרה הנגרמת כתוצאה מקשחת‬
‫ע"י שימוש בסמנים ביולוגיים‬
ABBOTT BIOTECHNOLOGY LTD.
US
60/732444
01/11/2005
PCT/US/2006/042564
WO/2007/089303
2//1//0111
510111
STEREOTACTIC DRIVE SYSTEM
MONTERIS MEDICAL, INC.
US
61/088969
14/08/2008
PCT/CA/2009/001138
WO/2010/017642
2//1//0111
31
510111
G05G )5010.01(
‫מערכת הנעה סטראוטקטית‬
A61B )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫מנחה מסלול‬
TRAJECTORY GUIDE
MONTERIS MEDICAL, INC.
US
61/089224
15/08/2008
12/2/1/11
01/1//0111
US
PCT/CA/2009/001137
WO/2010/017641
01/12/0122
510116
DENTAL IMPLANT HOUSING WITH
ONE PAGE OF DRAWING
BETZALEL MESSINGER
01/12/0122
‫מבנה שתיל דנטלי‬
‫מיסינגר בצלאל‬
510111
A DEVICE CONNECTED TO
DRINKING BOTTLE CORK, WHICH
ENABLES CONTROLLED
EXTRACTING THE FLUID IN
HORIZONTAL POSITION OF THE
BOTTLE
ITAMAR MAROM
1//1//0111
B67B )5010.01(
,‫התקן שמתחבר לפקק של בקבוק שתייה‬
‫שמאפשר הוצאה מבוקרת של הנוזל‬
‫במצב אופקי של הבקבוק‬
‫איתמר מרום‬
510112
DRUG DELIVERY SYSTEM AND
METHOD OF MUNUFACTURING
THEREOF
EXOGENESIS CORPORATION
US
61/086981
07/08/2008
PCT/US/2009/053113
WO/2010/017456
32
A61B )5010.01(
A61L )5010.01(
‫מערכת לשחרור תרופה ושיטות לייצורה‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
0//1//0111
510114
METHOD AND SYSTEM FOR
CONTROLLING PATH REDUNDANCY
IN THE ACQUISITION OF UTILITY
METERING DATA
MILTEL COMMUNICATIONS LTD
US
12/182269
30/07/2008
PCT/US/2009/051796
WO/2010/014522
00/11/0111
510115
PHOTOVOLTAIC SOLAR POWER
GENERATION SYSTEM
SOLARIS SYNERGY LTD
US
61/084630
30/07/2008
PCT/US/2009/048279
WO/2010/014310
01/12/0122
510111
510111
STRUCTURAL SUPPORT AND
TRACKING SYSTEM
DROR EYAL
US
61/129980
04/08/2008
12/201120
22/11/011/
US
PCT/IL/2009/000759
WO/2010/016060
33
‫שיטה ומערכת לשליטה ביתירות נתיב‬
‫בקריאת מידע ממכשירי מדידה‬
‫מילטל תקשורת בע"מ‬
B60K )5010.01(
‫מערכת פוטו–וולטאית לייצור כוח‬
‫מאנרגיית השמש‬
‫סולריס סינרג'י (ישראל) בע"מ‬
B23Q )5010.01(
‫מכונת גילוח‬
‫קטריבס יצחק ניסים‬
A SHAVING MACHINE
KATARIBAS ITZHAK NISSIM
1//1//0111
G08C )5010.01(
F24J )5010.01(
‫מערכת תמיכה ועקיבה‬
‫אייל דרור‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
01/1//0111
510161
ESTIMATING STATES OF A
PLURALITY OF TARGETS TRACKED
BY A PLURALITY OF SENSORS
BAE SYSTEMS PLC
GB
0813958.6
30/07/2008
1/0101/181
01/1//011/
EP
PCT/GB/2009/050944
WO/2010/013051
0//1//0111
‫הערכת מצבים של מגוון מטרות הנעקבות‬
‫באמצעות מגוון חיישנים‬
510165
USE OF AZOLES FOR INCREASING
THE ABIOTIC STRESS RESISTANCE
OF PLANTS OR PLANTS PARTS
BAYER CROPSCIENCE AG
EP
08013890.2 02/08/2008
PCT/EP/2009/005376
WO/2010/015337
01/12/0122
510162
510164
IMPROVED DATA ENTRY SYSTEMS
BENJAMIN FIROOZ GHASSABIAN
34
A01N )5010.01(
‫שימוש באזולים להגברת העמידות של‬
‫צמחים או חלקי צמחים ללחץ אביוטי‬
B23C )5010.01(
‫כלי חיתוך‬
‫ישקר בע"מ‬
CUTTING TOOL
ISCAR LTD.
01/12/0122
F24J )5010.01(
G06F )5010.01(
‫שיטות משופרות להכנסת נתונים‬
‫בנימין פירוז גסביאן‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
0//12/0122
510161
DEVICE FOR LOCKIING AND
CUTTING CABLE TIES
ARTHUR ANCHIPOLOVSKY
0//12/0122
‫אביזר לנעילה וחיתוך של אזיקונים‬
‫ארתור אנצ'יפולובסקי‬
510161
SYSTEM AND METHOD FOR
SELECTIVE MONITORING OF
MOBILE COMMUNICATION
TERMINALS BASED ON SPEECH
KEY-PHRASES
VERINT SYSTEMS LTD.
0//12/0122
SYSTEM AND METHOD FOR
DECODING TRAFFIC OVER PROXY
SERVERS
VERINT SYSTEMS LTD.
35
H04M )5010.01(
‫מערכת ושיטה לניהול טבלת זרמי‬
‫תעבורה‬
‫ורינט מערכות בע"מ‬
SYSTEM AND METHOD FOR FLOW
TABLE MANAGEMENT
VERINT SYSTEMS LTD.
0//12/0122
B23B )5010.01(
510161
H04M )5010.01(
‫מערכת ושיטה לניטור סלקטיבי של מסופי‬
‫תקשורת ניידים בהתבסס על ביטויי דיבור‬
‫ורינט מערכות בע"מ‬
510166
H04L )5010.01(
‫מערכת ושיטה לפענות תעבורה על פני‬
‫שרתי פרוקסי‬
‫ורינט מערכות בע"מ‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
0//12/0122
510600
SYSTEM AND METHOD FOR
EFFICIENT CLASSIFICATION AND
PROCESSING OF NETWORK TRAFFIC
VERINT SYSTEMS LTD.
0//12/0122
510601
510605
‫ורינט מערכות בע"מ‬
G09B )5010.01(
B62H )5010.01(
‫אופניים קלות‬
‫ג'יג'י סימוביץ‬
LIGHTWEIGHT BICYCLE
GIGI SIMOVICH
2//1//0111
‫מערכת ושיטה לסיווג ועיבוד יעילים של‬
‫תעבורת רשת‬
‫כיסוי גוף חד פעמי‬
‫דנה רוזנשטין ניר‬
DISPOSABLE BODY COVER
DANA ROSEHSTEIN-NIR
0//12/0122
H04L )5010.01(
510602
ANIT-IL-12/IL-23 ANTIBODIES
C07K )5010.01(
IL/ 23–IL–15 – ‫נוגדני אנטי‬
CEPHALON AUSTRALIA PTY LTD
AU
2008904178 14/08/2008
12/1/110/
2//1//011/
US
36
April 28, 2011-‫כ"ד בניסן התשע"א‬
PCT/AU/2009/001047
WO/2010/017598
01/1//0111
510604
SYSTEM AND METHOD FOR
ENHANCED MANEUVERABILITY
G.I. VIEW LTD
US
61/137509
30/07/2008
PCT/IL/2009/000748
WO/2010/013247
0//1//0111
‫מערכת ושיטה עבור יכולת תמרון מוגברת‬
510605
EXTRACTION OF URANIUM FROM
WET-PROCESS PHOSPHORIC ACID
URTEK, LLC
US
61/085177
31/07/2008
12/212200
2//10/0111
US
PCT/US/2009/051886
WO/2010/014562
20/1//0111
510601
METHOD FOR PROVIDING A
SLURRY
UNITED STATES GYPSUM COMPANY
US
10/846131
14/05/2004
PCT/US/2005/012003
WO/2005/114014
0//1//0111
37
A61B )5010.01(
510601
GI VIEW LTD
C22B )5010.01(
‫מיצוי אורניום מתהליך רטוב של חומצה‬
‫פוספורית‬
F16K )5010.01(
‫שיטה להכנת תערובת מימית‬
C07C )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
PROCESS OF ISOLATING
ENANTIOMER COMPONENTS FROM
ENANTIOMER COMPONENTS FROM
ENANTIOMER MIXTURES BY
PARTICLE-SIZE -CONTROLLED
CRYSTALLIZATION
POXEL SAS
EP
08013586.6 29/07/2008
PCT/EP/2009/059769
WO/2010/012746
0//1//0111
510601
COMBINATION OF TWO GENETIC
ELEMENTS FOR CONTROLLING THE
FLORAL DEVELOPMENT OF A
DICOTYLEDONOUS PLANT, AND
USE IN DETECTION AND SELECTION
METHODS
INSTITUT NATIONAL DE LA
RECHERCHE AGRONOMIQUE
FR
0855146
28/07/2008
PCT/FR/2009/051510
WO/2010/012948
02/1//0111
‫תהליך לבידוד רכיבי אננטיומר מתערובות‬
‫אננטיומר באמצעות גיבוש המבוקר לפי‬
‫גודל חלקיק‬
‫שילוב של שני רכיבים גנטיים לשליטה על‬
,‫התפתחות פרחים של צמח דו–פסיגי‬
‫ושימוש בשיטות גילוי ובחירה‬
510606
SYSTEM FOR METHOD OF REMOTE
SECURE BACKUP
KOOLSPAN, INC.
US
61/085277
31/07/2008
PCT/US/2009/052458
WO/2010/014934
02/1//0111
UNIVERSAL PATIENT LIFTING
FRAME
LIFE LIFT (MEDICAL PRODUCTS)
LIMITED
38
C12N )5010.01(
510610
G06F )5010.01(
‫מערכת ושיטה לגיבוי מאובטח מרחוק‬
A61G )5010.01(
‫מבנה להרמת חולה אוניברסלי‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
GB
0813956.0
1112/1/82
GB
PCT/GB/2009/001873
WO/2010/013005
2//1//011/
31/07/2008
01/12/0111
510615
METHODS FOR REMOVING A
CONTAMINANT USING INDIGENOUS
PROTEIN DISPLACEMENT ION
EXCHANGE MEMBRANE
CHROMATOGRAPHY
GENENTECH, INC.
C07K )5010.01(
‫שיטות להסרת חומר מזהם באמצעות‬
‫העתקת חלבון טבעי בכרומטוגפית‬
‫ממברנה לחילוף יונים‬
PCT/US/2008/073179
WO/2010/019148
11/1//0111
510612
PHOSPHATE BINDING MATERIALS
AND THEIR USES
MEDICAL RESEARCH COUNCIL
GB
0814326.5
05/08/2008
12/1/10//
11/1//011/
US
PCT/GB/2009/001931
WO/2010/015827
1//1//0111
510614
FGFR EXTRACELLULAR DOMAN
ACIDIC REGION MUTEINS
FIVE PRIME THERAPEUTICS, INC.
US
61/086121
04/08/2008
PCT/US/2009/052704
WO/2010/017198
39
A61K )5010.01(
‫חומרים קושרי פוספט ושימושים בהם‬
‫המועצה למחקר רפואי‬
C12N )5010.01(
‫מוטאינים מאזור חומצי לתחום חוץ–תאי‬
FGFR ‫של‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
2//11/0111
510611
TREATING INFLAMMATION AND
INFLAMMATORY PAIN PAIN
MUCOSA USING MUCOSAL
PROLONGED RELEASE
BIOADHESIVE THERAPEUTIC
CARRIERS
BIOALLIANCE PHARMA
EP
08164648.1 18/09/2008
12/11/110
2//11/011/
US
PCT/EP/2009/062068
WO/2010/031819
0//12/0122
‫טיפול בדלקת וכאב דלקת ברירית ע"י‬
‫שימוש בנשאים טיפוליים דביקים ביולוגית‬
‫בעלי שחרור ממושך ברירית‬
510611
IMPROVED INTERFACE FOR A
COMPUTER
JBIP LTD
0//12/0122
‫ג'יי בי איי פי בע"מ‬
510616
G06F )5010.01(
‫שיטה להזמנת שירות הסעה בין עירוני‬
‫במחיר מוזל‬
‫מרדכי עובדיה‬
510650
FILM-FORMING LIQUID
FORMULATIONS FOR DRUG
RELEASE TO HAIR AND SCALP
POLICHEM SA
EP
08161757.3 04/08/2008
40
G06F )5010.01(
‫ממשק מופשט משופר למחשב‬
METHOD FOR ORDERING TRANSIT
SERVICE FOR LONG DISTANCE
DRIVE, FOR A DISCOUNTED FEE
MORDECHAI OVADIA
01/1//0111
A61K )5010.01(
A61K )5010.01(
‫תכשירים נוזליים יוצרי–פילם לשחרור‬
‫תרופה לשיער ולקרקפת‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
PCT/EP/2009/059807
WO/2010/015556
01/1//0111
510651
SYNTHESIS AND FORMULATIONS
OF SALTS OF ISOPHOSPHORAMIDE
MUSTARD AND ANALOGS THEREOF
ZIOPHARM ONCOLOGY, INC.
US
61/137538
31/07/2008
PCT/US/2009/052295
WO/2010/014841
22/1//0111
‫סינטזה ופורמולציות של מלחים של חרדל‬
‫איזופוספוראמיד ואנאלוגים שלהם‬
510655
TREATMENT OF PULMONARY
ARTERIAL HYPERTENSION
NOVARTIS AG
US
61/088382
13/08/2008
12/21/112
01/10/0111
US
PCT/US/2009/053358
WO/2010/019540
22/1//0111
22/1//0111
41
A61K )5010.01(
‫טיפול ביתר לחץ דם של עורקי הריאות‬
510652
A CRYSTALLINE FORM OF 4-(5-{(IR)1-[5-(3-CHLOROPHENYL) ISOXAZOL3-YL]ETHOXY}-4-METHYL-4H-1,2,4,TRIAZOL-3-YL)PYRIDINE
ASTRAZENECA AB
US
61/088053
12/08/2008
PCT/SE/2009/050928
WO/2010/019101
A61K )5010.01(
C07D )5010.01(
–IR)–1–[5–(3({–5(–4 ‫צורת קריסטל של‬
–4–}‫–יל]אתוקסי‬2–‫כלורופניל)איזוקסאזול‬
‫–יל)פירידין‬2–‫–טריאזול‬H4 ,2,1–4–‫מתיל‬
510654
A61K )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
A NEW CRYSTALLINE FORM OF 4-(5{(IR)-1-[5-(3-CHLOROPHENYL)
ISOXAZOL-3-YL]ETHOXY}-4METHYL-4H-1,2,4-TRIAZOL-3YL)PYRIDINE
ASTRAZENECA AB
US
61/088049
12/08/2008
PCT/SE/2009/050927
WO/2010/019100
00/1//011/
510655
APODIZED DIFFRACTIVE IOL WITH
FRUSTRATED DIFFRACTIVE REGION
ALCON MANUFACTURING, LTD.
US
11/497594
02/08/2006
00/1//011/
42
A61F )5010.01(
‫עדשה חלקה בעלת דיפרקציה להשתלה‬
‫בעין עם אזור שמשנה את הדיפרקציה‬
510651
6-SUBSTITUTED BENZOXAZINES AS
5-HT-5A RECEPTOR ANTAGONISTS
F. HOFFMANN-LA ROCHE AG
EP
08163833.0 08/09/2008
PCT/EP/2009/061152
WO/2010/026110
A61F )5010.01(
‫עדשה חלקה בעלת דיפרקציה להשתלה‬
‫בעין עם אזור שמשנה את הדיפרקציה‬
510651
APODIZED DIFFRACTIVE IOL WITH
FRUSTRATED DIFFRACTIVE REGION
ALCON MANUFACTURING, LTD.
US
11/497594
02/08/2006
0//1//0111
–IR)–1–[5–(3({–5(–4 ‫צורת קריסטל של‬
–4–}‫–יל]אתוקסי‬2–‫כלורופניל)איזוקסאזול‬
‫–יל)פירידין‬2–‫–טריאזול‬H4 ,2,1–4–‫מתיל‬
C07D )5010.01(
1 ‫בנזוקסזינים מותמרים בעמדה‬
A5–HT–5 ‫כאנטגוניסטים של קולטן‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
12/1//0110
510651
ANTIBODIES SPECIFIC FOR 238P1B2
AND USES THEREOF
AGENSYS, INC.
A61K )5010.01(
‫ ושימושים‬B1P2385 ‫נוגדנים ספציפים ל‬
‫בהם‬
PCT/US/2002/000101
WO/2003/085081
00/11/011/
510656
CONDENSING SKELETAL IMPLANT
THAT FACILITATE INSERTION
OPHIR FROMOVICH
IL
156033
21/05/2003
PCT/IL/2004/000438
WO/2004/103202
00/11/011/
510620
CONDENSING SKELETAL IMPLANT
THAT FACILITATE INSERTION
OPHIR FROMOVICH
IL
156033
21/05/2003
PCT/IL/2004/000438
WO/2004/103202
0//1//0111
510621
BREATH TEST DEVICE AND
METHOD
EXALENZ BIOSCIENCE LTD
US
12/219824
29/07/2008
PCT/IL/2009/000730
WO/2010/013235
43
A61C )5010.01(
‫עיבוי שתל שלדי המסייע להחדרה‬
‫אופיר פרומוביץ‬
A61C )5010.01(
‫עיבוי שתל שלדי המסייע להחדרה‬
‫אופיר פרומוביץ‬
A61B )5010.01(
‫בדיקת נשימה מכשיר ושיטה‬
‫אקסלנז ביוסיינס בע"מ‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
0//1//0111
510625
MICROFLUIDIC SYSTEM AND
METHOD FOR MANUFACTURING
THE SAME
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD.
US
61/084089
28/07/2008
12/11111/
02/1//011/
US
20//10/22
01/11/0111
US
PCT/IL/2009/000734
WO/2010/013238
01/1//0111
510622
COMPOSITIONS AND METHODS FOR
TREATING INFLAMMATORY
DISORDERS
DEKEL PHARMACEUTICALS LTD
US
61/085008
31/07/2008
12/11//10
00/11/011/
US
PCT/IL/2009/000739
WO/2010/013240
00/11/0111
510624
NAVIGATIONAL AID FOR DIVER
ALBERT R. BASILICO
US
11/158678
22/06/2005
PCT/US/2006/024234
WO/2007/002246
0//12/0122
510621
METAL AND PLASTIC CONTAINER
THE STANLEY WORKS ISRAEL LTD
US
61/299239
28/01/2010
44
B01L )5010.01(
‫מערכת מיקרופלואידית ושיטה לייצורה‬
‫מוסד הטכניון למחקר ופתוח בע"מ‬
A01N )5010.01(
‫תכשירים ושיטות לטיפול במחלות‬
‫דלקתיות‬
‫דקל פארמסוטיקלס בע"מ‬
G12B )5010.01(
‫עזרה בניווט לצוללן‬
B65D )5010.01(
‫מיכל העשוי ממתכת ופלסטיק‬
‫דה סטנלי וורקס ישראל בע"מ‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
US
0//1//0111
20/12/210
01/12/0122
510621
NOVEL PHENYLAMINO
ISONICOTINAMIDE COMPOUNDS
MERCK PATENT GMBH
US
61/137858
04/08/2008
PCT/US/2009/051817
WO/2010/017051
02/1//0111
510621
KIT FOR THE TREATMENT OF
ONYCHOMYCOSIS
PIERRE FABRE DERMOCOSMETIQUE
FR
0855350
01/08/2008
PCT/EP/2009/059933
WO/2010/012824
02/1//0111
510626
SUPER BAINITE STEELS AND
METHODS OF MANUFACTURE
THEREOF
THE SECRETARY OF STATE FOR
DEFENCE
GB
0814003.0
31/07/2008
1/012//81
11/22/011/
GB
1/0101280
11/22/011/
GB
1/0102081
11/22/011/
GB
1/0011281
2//20/011/
GB
PCT/GB/2009/050947
WO/2010/013054
45
C07D )5010.01(
‫תרכובות חדשות של פניל–אמינו‬
‫איזוניקוטינאמיד‬
A61F )5010.01(
‫ערכה לטיפול באוניקומיקוזיס‬
C22C )5010.01(
‫פלדות סופר–ביניט ושיטות לייצורן‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
01/1//0111
510640
‫מלחי פירידוקסין–לקטם קרבוקסילאט‬
‫מותמרים‬
‫אלקוברה בע"מ‬
SUBSTITUTED PYRIDOXINELACTAM CARBOXYLATE SALTS
ALCOBRA LTD
US
61/084514
29/07/2008
PCT/IL/2009/000741
WO/2010/013242
00/1//0111
510641
SOLAR LIGHT COLLECTING
METHOD IN MULTI-TOWER BEAMDOWN LIGHT COLLECTONG
SYSTEM
COSMO OIL CO., LTD
2008JP
31/07/2008
197955
PCT/JP/2009/063154
WO/2010/013632
0//1//0111
46
F24J )5010.01(
‫שיטה לאיסוף אור השמש במערכת איסוף‬
‫אור רבת מגדלים עם קרן למטה‬
510645
CROSS-REACTIVE AND BISPECIFIC
ANTI-IL 17A/F ANTIBODIES
GENENTECH, INC.
US
61/093212
29/08/2008
12/2201//
1//22/011/
US
12/21//11
01/10/0111
US
PCT/US/2009/055420
WO/2010/025400
01/1//0111
A61P )5010.01(
510642
C07K )5010.01(
‫ ביספיציפיים‬F/A17 IL–‫נוגדנים אנטי‬
‫ופעילים נגד‬
C07C )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
DIRECT AND SELECTIVE
PRODUCTION OF ETHYL ACETATE
FROM ACETIC SCID UTILIZING A
BIMETAL SUPPORTED CATALYST
CELANESE INTERNATIONAL
CORPORATION
US
12/221209
31/07/2008
PCT/US/2009/004186
WO/2010/014145
02/1//0111
‫ייצור ישיר וסלקטיבי של אתיל אצטט‬
‫מחומצה אצטית ע"י שימוש בזרז בימתכתי‬
510644
COMPOSITIONS COMPRISING
THERMOPLASTIC STARCH
TRISTANO PTY LTD
AU
2008903922 31/07/2008
PCT/AU/2009/000979
WO/2010/012041
01/1//0111
01/1//0111
C07C )5010.01(
‫ייצור ישיר וסלקטיבי של אתנול מחומצה‬
‫בדיל‬/‫אצטית ע"י שימוש בזרז פלטינה‬
510641
ETHANOL PRODUCTION FROM
ACETIC ACID UTILIZING A COBALT
CATALYST
CELANESE INTERNATIONAL
CORPORATION
US
12/221239
31/07/2008
PCT/US/2009/004197
47
‫תכשירים המכילים עמילן תרמופלסטי‬
510645
DIRECT AND SELECTIVE
PRODUCTION OF ETHANOL FROM
ACETIC ACID UTILIZING A
PLATINUM/TIN CATALYST
CELANESE INTERNATIONAL
CORPORATION
US
12/221141
31/07/2008
PCT/US/2009/004195
WO/2010/014151
C08L )5010.01(
C07C )5010.01(
‫ייצור אתנול מחומצה אצטית ע"י שימוש‬
‫בזרז קובלט‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
WO/2010/014153
01/1//0111
510641
DIRECT AND SELECTIVE
PRODUCTION OF ACETALDEHYDE
FROM ACETIC ACID UTILIZING A
SUPPORTED METAL CATALYST
CELANESE INTERNATIONAL
CORPORATION
US
12/221135
31/07/2008
PCT/US/2009/004187
WO/2010/014146
0//1//0111
01/12/0122
A RETRACTABLE-CORD
HEADPHONES APPARATUS
SIMONA SHITRIT
48
‫ייצור ישיר וסלקטיבי של אצטאלדהיד‬
‫מחומצה אצטית ע"י שימוש בזרז מתכתי‬
‫נתמך‬
510641
INTRACARDIAC DEVICE FOR
RESTORING THE FUNCTIONAL
ELASTICITY OF THE CARDIAC
STRUCTURES, HOLDING TOOL FOR
THE INTRACARDIAC DEVICE, AND
METHOD FOR IMPLANTATION OF
THE INTRACARDIAC DEVICE IN THE
HEART
CUBE S.R.L.
US
12/219883
30/07/2008
PCT/EP/2009/059765
WO/2010/012742
C07C )5010.01(
A61F )5010.01(
‫התקן תוך לבבי להשבת הגמישות‬
‫ כלי ידני להתקן‬,‫התפקודית של מבני הלב‬
‫ ושיטה ליישום של ההתקן התוך‬,‫תוך לבבי‬
‫לבבי בלב‬
510646
H04R )5010.01(
‫מכשיר אוזניות עם כבל נסוג‬
‫סימונה שטרית‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
01/1//0111
510650
6-SUBSTITUTED ISOFLAVONOID
COMPOUNDS AND USES THEREOF
NOVOGEN RESEARCH PTY LTD.
AU
2008903873 30/07/2008
PCT/AU/2009/000973
WO/2010/012037
01/1//0111
‫תרכובות איזופיבנואידים מותמרים בעמדה‬
‫ ושימושיהם‬1
510651
CHOLEST-4-EN-3-ONE OXIME
DERIVATIVES, COMPOSITIONS
COMPRISING THE SAME AND USES
THEREOF
TROPHOS
FR
08/04338
30/07/2008
PCT/FR/2009/000944
WO/2010/012904
0//1//0111
0//1//0111
49
C07J )5010.01(
,‫–און אוקסים‬2–‫–אן‬4–‫תולדות קולסט‬
‫תכשירים המכילים אותן ושימושים בהן‬
510655
METHODS AND COMPOSITIONS FOR
DETECTION OF A PATHOGEN,
DISEASE, MEDICAL CONDITION, OR
BIOMARKER THEREOF
ARAD DORIT
US
61/129887
28/07/2008
12/201211
20/1//011/
US
12/2012/0
2//1//011/
US
12/211//1
20/10/0111
US
PCT/IB/2009/006643
WO/2010/013138
C07D )5010.01(
C12Q )5010.01(
‫ מצב‬,‫ מחלות‬,‫שיטות והרכבים לגילוי פתוגן‬
‫ או סמן ביולוגי שלהם‬,‫רפואי‬
510652
‫דורית ארד‬
A61K )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
COMPOSITIONS FOR THE
PROPHYLAXIS AND TREATMENT OF
DERMATOLOGICAL/MUCOSAL
DISEASES, AND USES THEREOF
DESPHARMA EGESZSEGUGYI
SZOLGALTATO KORLATOLT
FELELOSSEGU TARSASAG
EP
08462004.6 28/07/2008
PCT/EP/2009/059727
WO/2010/012720
‫תכשירים למניעה ולטיפול במחלות‬
‫רירית ושימושים בהם‬/‫עור‬
510655
1//1//0111
METHOD FOR CHARACTERIZING. IN
PARTICULAR FOR QUANTIFYING,
MOLECULAR MARKERS THAT ARE
INTRACELLULARLY ABSORBED FROM
TISSUES BY BLOOD MACROPHAGES
THAT ARE RECIRCULATED FROM THE
TISSUES INTO CIRCULATORY SYSTEM
SYNMED RESEARCH GMBH
DE
102008036185.2 04/08/2008
PCT/EP/2009/060106
WO/2010/015633
02/1//0111
11/1//0111
RESPIRATORY DISEASE
TREATMENT
50
‫ של‬,‫ בפרט לצרכי כימות‬,‫שיטה לאפיון‬
‫מרקרים מולקולאריים הנספגים‬
‫ על–ידי‬,‫מרקמות בפנים התא‬
‫ החוזרים ומופצים‬,‫מקרופאג'ים דמיים‬
‫מהרקמות לתוך המערכת המחזורית‬
510651
METHIONINE ANALOGS AND
METHODS OF USING SAME
BIOXINESS PHARMACEUTICALS,
INC.
US
61/085556
01/08/2008
PCT/US/2009/052474
WO/2010/014943
G01N )5010.01(
C07C )5010.01(
‫אנלוגים של מתיונין ושיטות לשימוש בהם‬
510656
A61K )5010.01(
‫טיפול במחלה נשימתית‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
PULMAGEN THERAPEUTICS
(INFLAMMATION) LIMITED
GB
0814488.3
07/08/2008
1/0011/82
0//20/011/
GB
PCT/GB/2009/001920
WO/2010/015818
11/1//0111
510615
‫תרכובות טריפירידיל קארבוקסאמיד‬
‫כאנטאגוניסטים לקולטן אורקסין‬
TRIPYRIDYL CARBOXAMIDE
OREXIN RECEPTOR ANTAGONISTS
MERCK SHARP & DOHME CORP.
US
61/188203
07/08/2008
PCT/US/2009/052786
WO/2010/017260
01/1//0111
510612
SYSTEM FOR TRANSPORTING
GROSSLY ASYMMETRICAL OBJECTS
SUCH AS A CLUSTER OF GRAPES OR
OTHER FRUIT THROUGH A
PNEUMATIC TUBE
PICKER TECHNOLOGIES LLC
US
61/085271
31/07/2008
PCT/US/2009/052140
WO/2010/014737
02/12/0122
DEVICE FOR ELECTRICITY
PRODUCTION BY VEHICLES
MOVING OVER IT
ELCHANAN A. BAR-LEV
51
C07D )5010.01(
B65G )5010.01(
‫מערכת להסעת חפצים אסימטריים באופן‬
‫ניכר כמו אשכולות ענבים או פרי אחר דרך‬
‫שפופרת פנאומטית‬
510614
F03B )5010.01(
–‫מתקן ליצור חשמל באמצעות דריכת כלי‬
‫רכב עליו‬
‫אלחנן בר לב‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
02/12/0122
510611
TANGENTIAL CUTTING INSERT AND
MILLING CUTTER
ISCAR LTD.
02/12/0122
‫שימה טנגנצ'יאלית וכרסום‬
‫ישקר בע"מ‬
510611
METHOD AND SYSTEM FOR
AUTOMATIC AUTOMATIC REAL
TIME OPTIMAL MANAGEMENT OF
EMERGENCY ROOM RESOURCES
MAKOR ISSUES AND RIGHTS LTD
21/22/0111
PYRAZALONE DERIVATIVE
FOMULATIONS
TEIKOKU PHARMA USA, INC.
52
G06F )5010.01(
‫ בזמן‬,‫שיטה ומערכת אוטומטית לניהול‬
‫ של משאבי חדר מיון‬,‫אמת‬
‫מקור הנפקות וזכויות בע"מ‬
510611
INHALANT FORMULATIONS
COMPRISING A BISPHOSPHONATE
AND A PYRAZOLONE DERIVATIVE
AND METHODS FOR USING THE
SAME
TEIKOKU PHARMA USA, INC.
US
12/330749
09/12/2008
PCT/US/2009/063892
WO/2010/068358
2//22/0111
B23C )5010.01(
A61K )5010.01(
‫פורמולציות שאיפה הכוללות ביספוספונט‬
‫ונגזרת פיראזולון ושיטה לשימוש בהן‬
510616
A61K )5010.01(
‫פורמולציות של נגזרת פיראזלון‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
US
61/116564
PCT/US/2009/064990
WO/2010/059727
02/1//0111
20/11/2008
510610
TRANSDERMAL EXTENDEDDELIVERY DONEPEZIL
COMPOSITIONS AND METHODS FOR
USING THE SAME
TEIKOKU PHARMA USA, INC.
US
61/101412
30/09/2008
PCT/US/2009/055542
WO/2010/039381
0//1//0111
‫תכשירי דונפזיל למתן–ממושך דרך העור‬
‫ושיטות במשתמשות בהם‬
510611
510615
METHODS AND APPARATUS OF
ADAPTING NUMBER OF
ADVERTISED TRANSMIT ANTENNA
PORTS
QUALCOMM INCORPORATED
US
61/092450
28/08/2008
20/1///1/
01/1//0111
US
PCT/US/2009/055217
WO/2010/025268
53
H04L )5010.01(
‫ תחום תדירות‬PN ‫רצף‬
FREQUENCY DOMAIN PN SEQUENCE
QUALCOMM INCORPORATED
US
61/092200
27/08/2008
20/1120/0
21/1//0111
US
PCT/US/2009/055214
WO/2010/025265
0//1//0111
A61K )5010.01(
H04W )5010.01(
‫שיטות והתקנים להתאמת מספר ממשקי‬
‫משושט שידור מפורסמים‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
10/1//0111
510612
SYSTEM FOR AUTOMATIC
PRODUCTION OF LECTURES AND
PRESENTATIONS FOR LIVE OR ONDEMAND PUBLISHING AND
SHARING
LIOR FRIEDMAN
US
61/085882
04/08/2008
PCT/IL/2009/000757
WO/2010/016059
0//1//0111
‫שיטה לייצור אוטומטי של הרצאות ומצגות‬
‫עבור הפצה ושיתוף בזמן אמת או על פי‬
‫דרישה‬
510614
A METHOD OF MEASURING
OVERLAY ERROR AND A DEVICE
MANUFACTURING METHOD
ASML NETHERLANDS B.V.
US
61/090118
19/08/2008
PCT/EP/2009/005422
WO/2010/020331
1//1//0111
510615
ANTIFUNGAL AGENTS
MERCK SHARP & DOHME CORP.
US
61/136106
12/08/2008
PCT/US/2009/004557
WO/2010/019203
1//11/0111
ORGANIC COMPOUNDS
NOVARTIS AG
EP
08164104.5
12/1111//
US
PCT/EP/2009/061644
WO/2010/029082
54
H04N )5010.01(
510611
‫ליאור פרידמן‬
G03F )5010.01(
‫שיטה למדידת שגיאת חפיפה ושיטה‬
‫לייצור מכשיר מדידה‬
A01N )5010.01(
‫חומרים אנטיפטרייתיים‬
C07D )5010.01(
‫תרכובות אורגניות‬
10/09/2008
20/11/011/
April 28, 2011-‫כ"ד בניסן התשע"א‬
01/1//0111
510611
HPV ‫חיסון נגד‬
VACCINE AGAINST HPV
GLAXOSMITHKLINE BIOLOGICALS
S.A.
US
61/085101
31/07/2008
12/2/1112
1//11/0111
US
PCT/EP/2009/059820
WO/2010/012780
1//1//0111
510611
SMS TECHNOLOGY FOR
COMPUTERIZED DEVICES
MEDIAFRIENDS, INC.
US
61/137918
05/08/2008
12/21//11
01/10/0111
US
PCT/US/2009/052715
WO/2010/017204
0//1//0111
510610
510611
IMPROVED DATA ENTRY SYSTEMS
BENJAMIN FIROOZ GHASSABIAN
55
H04W )5010.01(
‫טכנולוגיית מסרונים להתקנים ממוחשבים‬
CUTTING INSERT AND MILLING
CUTTER PROVIDED WITH THE SAME
TAEGUTEC LTD.
10-2008KR
20/08/2008
0081322
PCT/KR/2009/004132
WO/2010/021463
02/12/0122
A61K )5010.01(
B23C )5010.01(
‫שתל חותך ומחתך מכרסם המצויד בו‬
G06F )5010.01(
‫שיטות משופרות להכנסת נתונים‬
‫בנימין פירוז גסביאן‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
11/1//0111
510615
PROCESS FOR PREPARING
AZACYTIDINE INTERMEDIATE
SICOR INC.
US
61/086606
06/08/2008
12/2/1220
02/12/0111
US
12/2//011
2//11/0111
US
PCT/US/2009/052983
WO/2010/017374
21/11/0110
‫תהליך להכנת חומר ביניים של אזאסיטידין‬
510612
METHOD FOR DIFINTEGRATING OF
POWDER FOR NULATION
MEDA PHARMA GMBH & CO.KG
DE
10129703.3 22/06/2001
PCT/EP/2002/006610
WO/2003/000325
22/10/011/
510614
PURIFICATION PROCESS
GLAXOSMITHKLINE BIOLOGICALS
S.A.
GB
0305791.6
13/03/2003
1011/108/
20/10/0110
GB
PCT/EP/2004/002641
WO/2004/081515
12/10/0122
MEDICAL DRILL SYSTEM AMD
METHOD FOR FABRICATION
THEREOF
DR. ELKANA ELYAV
56
C07H )5010.01(
510611
A61M )5010.01(
‫שיטה לפירור פורמולציה אבקתית‬
C07K )5010.01(
‫תהליך טיהור‬
A61C )5010.01(
‫מערכת לקידוח רפואי ושיטה לבניה‬
‫ד"ר אלקנה אליאב‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
1//1//0111
510611
MONOCLONAL ANTIBODIES
AGAINST TISSUE FACTOR
PATHWAY INHIBITOR (TFPI)
BAYER HEALTHCARE LLC
US
61/085980
04/08/2008
PCT/US/2009/052702
WO/2010/017196
10/11/011/
C07K )5010.01(
‫נוגדנים חד–שבטיים נגד מעכב נתיב גורם‬
)TFPI( ‫רקמה‬
510611
A01H )5010.01(
‫ עמידים‬MELO CUCMIS ‫צמחים מטיפוס‬
CVYV–‫ל‬
CVYV-RESISTANT PLANTS OF THE
SPECIES CUCUMIS MELO
ENZA ZADEN BEHEER B.V.
PCT/EP/2008/007214
WO/2010/025747
02/1//0111
510660
PIPERIDINE DERIVATIVES AS JAK3
INHIBITORS
JAN DARE HATLO
US
61/085705
01/08/2008
12/11/110
21/11/011/
US
PCT/US/2009/052449
WO/2010/014930
00/1//0111
TERMINATING CONNECTOR
57
510661
C07D )5010.01(
JAK2 ‫תולדות פיפרידין כמעכבי‬
H01R )5010.01(
‫מחבר סופי‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
3M INNOVATIVE PROPERTIES
COMPANY
2008JP
01/08/2008
200085
PCT/US/2009/051377
WO/2010/014470
0//1//0111
510665
IMPROVEMENTS RELATING TO
NANODISPERSE COMPOSITIONS
UNILEVER PLC,
GB
0814953.6
18/08/2008
PCT/EP/2009/059546
WO/2010/020518
12/10/0122
‫שיפורים הקשורים לתכשירים עם פיזור ננו‬
510662
COMPOSITION FOR TREATING
PSORIASIS, METHOD FOR
PREPARATION THEREOF AND
METHOD FOR TREATING PSORIASIS
THEREBY
Z.H.T. ENGINEERING EQUIPMENT
AND TECHNOLOGIES LTD.
10/1//0111
510664
SOLVENT TRANSFER PROCESS FOR
ORGANIC POLYMERS
DOW GLOBAL TECHNOLOGIES INC.
US
61/086217
05/08/2008
PCT/US/2009/052573
WO/2010/017134
58
A61K )5010.01(
A61K )5010.01(
‫הרכב לטיפול בספחת ושיטות להכנה‬
‫ ציוד הנדסה וטכנולוגיה בע"מ‬.‫ט‬.‫ה‬.‫צ‬
C08F )5010.01(
‫תהליך העברת ממס עבור פולימרים‬
‫אורגניים‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
01/1//0111
510665
METHODS AND COMPOSITIONS FOR
TREATING NEURONAL DAMAGE
AND MODULATING TRANSIENT
RECEPTOR POTENTIAL CHANNELS
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD
US
61/085920
04/08/2008
PCT/IB/2009/053292
WO/2010/015965
11/1//0111
01/1//0111
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים בע"מ‬
C12M )5010.01(
‫יצירת הרכבים ממוענים רב–ממדיים בעלי‬
‫צפיפות גבוהה‬
510661
COMPOSITIONS FOR THE
TREATMENT OF MRSA AND USES
THEREOF
ONDINE INTERNATIONAL LTD
US
61/085577
01/08/2008
12/2/111/
22/11/0111
US
PCT/US/2009/052059
WO/2010/014676
59
‫שיטות ותכשירים לטיפול בנזק נוירונלי‬
‫וויסות של תעלות התלויות במתח ארעי‬
‫של רצפטורים‬
510661
CREATION OF HIGH DENSITY
MULTIDIMENSIONAL
ADDRESSABLE ASSEMBLIES
INCITOR INCORPORATED
US
61/086633
06/08/2008
12/11011/
0//1//011/
US
12/1100/1
0//1//011/
US
PCT/US/2009/053048
WO/2010/017417
A61K )5010.01(
A61K )5010.01(
‫ ושימושים‬MRSA–‫תכשירים לטיפול ב‬
‫בהם‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
12/10/0122
510661
METHODS FOR THE SEPARATION OF
HCL FROM A CARBOHYDRATE AND
COMPOSITIONS PRODUCED
THEREBY
HCL CLEANTECH LTD.
US
61/302113
06/02/2010
12/10/0122
510666
METHODS FOR THE SEPARATION OF
HCL FROM A CHLORIDE SALT AND
COMPOSITIONS PRODUCED
THEREBY
HCL CLEANTECH LTD.
US
61/302114
06/02/2010
01/11/0111
511000
A MULTI-HEAT SOURCE POWER
PLANT
ORMAT TECHNOLOGIES INC.
US
12/164497
30/06/2008
20//2/1/2
01/10/0111
US
PCT/IB/2009/006091
WO/2010/001217
0//11/0111
511001
HIP AND KNEE ACTUATION
SYSTEMS FOR LOWER LIMB
ORTHOTIC DEVICES
BERKELEY BIONICS
US
61/099817
24/09/2008
PCT/US/2009/058199
60
C07B )5010.01(
‫תהליך להפרדת חומצה כלורית‬
‫מפחמימית ותכשירים שהוכנו על ידו‬
‫אייץ ס' אל קלינטג בע"מ‬
C07B )5010.01(
‫תהליך להפרדת חומצה כלורית ממלח‬
‫כלוריד ותכשירים שהוכנו על ידו‬
‫אייץ ס' אל קלינטג בע"מ‬
F03G )5010.01(
‫תחנת כח עם כמה מקורות חום‬
A61H )5010.01(
‫מערכות הפעלת מפרק הירך וברך‬
‫להתקנים אורתוטיים לאברים תחתוניים‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
WO/2010/036791
12/10/0122
511005
A63G )5010.01(
‫ארגז חול‬
‫אברהם נידם‬
SANDBOX
AVRAHAM NIDAM
01/11/0111
511002
AMIDE DERIVATIVE, PEST
CONTROL AGENT CONTAINING THE
AMIDE DERIVATIVE AND PEST
CONTROLLING METHOD
MITSUI CHEMICALS AGRO, INC.
2008JP
01/08/2008
200114
PCT/JP/2009/061864
WO/2010/013567
00/1//0111
‫ גורם הדברת מזיקים הכולל‬,‫נגזרת אמיד‬
‫את נגזרת האמיד ושיטה להדברת מזיקים‬
511005
METHOD AND APPARATUS FOR
MANUFACTURE OF A POLYMER FILM,
WHICH IS ORIENTED UNDER AN ANGLE
TO ITS LONGITUDINAL DIRECTION
OLE-BENDT RASMUSSEN
GB
0814308.3
05/08/2008
EP
PCT/EP2009/050412 21/12/0111
PCT/EP/2009/059429
WO/2010/015512
2//1//0111
61
C07C )5010.01(
511001
B29C )5010.01(
,‫שיטה ומערכת לייצור סרט פולימרי‬
‫המכוון לזווית לכיוונו האורכי‬
F25J )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
SYSTEM FOR INCONDENSABLE
COMPONENT SEPARATION IN A
LIQUEFIED NATURAL GAS FACILITY
CONOCOPHILLIPS COMPANY
US
61/095189
08/09/2008
PCT/US/2009/053837
WO/2010/027629
01/1//0111
511001
SYSTEM FOR ENHANCED GAS
TURBINE PERFORMANCE IN A
LIQUEFIED NATURAL GAS FACILITY
CONOCOPHILLIPS COMPANY
US
61/095469
09/09/2008
PCT/US/2009/052026
WO/2010/030441
0//1//0111
‫מערכת להפרדת מרכיב שאינו מתעבה‬
‫במתקן של גז טבעי מנוזל‬
F25J )5010.01(
‫מערכת לביצועים משופרים של טורבינת‬
‫גז במתקן של גז טבעי מנוזל‬
511001
THIENOPYRIMIDINES FOR
PHARMACEUTICAL COMPOSITIONS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
08015049.3 26/08/2008
PCT/EP/2009/060876
WO/2010/023181
1//11/0111
511006
DELIVERY DEVICE FOR USE WITH A
THERAPEUTIC DRUG
F. HOFFMANN-LA ROCHE AG
US
61/095667
10/09/2008
PCT/EP/2009/061592
WO/2010/029054
62
C07D )5010.01(
‫תיאנו פירימידינים עבור תכשירי רוקחות‬
A61M )5010.01(
‫התקן נתינה לשימוש עם סם טיפולי‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
21/11/0111
511010
MONOCLONAL ANTIBODIES FOR
TREATMENT OF CANCER
JOHANNES GUTENBERGUNIVERSITAT MAINZ
EP
08016277.9 16/09/2008
12/11//10
21/11/011/
US
PCT/EP/2009/006704
WO/2010/031551
22/11/0111
511011
SIGNALING EXCHANGE FOR
HANDOVER CONTROL FOR
WIRELESS NETWORKS
NOKIA SIEMENS NETWORKS OY
US
61/096306
11/09/2008
PCT/EP/2009/061807
WO/2010/029148
01/1//0111
511015
7-(PIPERAZINE-1-YLMETHYL)-1HINDOLE-2-CARBOXYLIC ACID
(PHENYL)-AMIDE DERIVATIVES
AND ALLIED COMPOUNDS AS P38
MAP KINASE INHIBITORS FOR THE
TREATMENT OF RESPIRATORY
DISEASES
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
08163526.0 02/09/2008
PCT/EP/2009/061025
WO/2010/026096
1//1//0111
OVERLOAD RELAY
63
511012
C07K )5010.01(
‫נוגדנים חד–שבטיים לטיפול בסרטן‬
H04W )5010.01(
‫המרת איתות עבור בקרת העברה עבור‬
‫רשתות אלחוטיות‬
C07D )5010.01(
–H1–)‫–ילמתיל‬1–‫–(פיפראזין‬1 ‫תולדות‬
–)‫–חומצה קרבוקסילית (פניל‬5–‫אינדול‬
P 21 ‫אמיד ותרכובות קשורות כמעכבות‬
‫ קינאז לטיפול במחלות נשימתיות‬MAP
H02H )5010.01(
‫ממסר לעומס יתר‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
EATON INDUSTRIES
MANUFACTURING GMBH
GB
0814250.7
04/08/2008
PCT/GB/2009/001910
WO/2010/015811
511015
10/22/0111
METHOD FOR PRODUCING CHIRAL 8(3-AMINO-PIPERIDIN-1-YL)-XANTHINES
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
DE
102004054054.3 05/11/2004
PCT/EP/2005/055711
WO/2006/048427
11/1//0111
511011
PROSTATE CANCER METHYLATION
ASSAY
VERIDEX, LLC
US
61/086218
05/08/2008
PCT/US/2009/052861
WO/2010/017301
11/1//0111
511011
ORAL FORMULATIONS OF
CHEMOTHERAPEUTIC AGENTS
BIOALLIANCE PHARMA
EP
08305455.1 06/08/2008
PCT/EP/2009/060233
WO/2010/015688
1//11/0111
NOVEL INHIBITORS
64
511011
C07D )5010.01(
–1–‫–אמינו–פיפרידין‬2(–1 ‫שיטה ליצור‬
‫איל)–קסטינים קירליים‬
C12Q )5010.01(
‫בדיקת מתילציה בסרטן הערמונית‬
A61K )5010.01(
‫הרכבים פומיים של גורמים כמותרפיים‬
A61K )5010.01(
‫מעכבים חדשים‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
PROBIODRUG AG
US
61/094118
PCT/EP/2009/061453
WO/2010/026212
10/10/0122
04/09/2008
511016
A METHOD FOR THE SEPARATION
OF A NON-VOLATILE STRONG ACID
FROM A SALT THEREOF AND
COMPOSITIONS PRODUCED
THEREBY
EYAL RESEARCH CONSULTANTS
LTD.
10/10/0122
511050
A METHOD FOR TREATING A LIGNIN
STREAM
HCL CLEANTECH LTD.
10/10/0122
511051
A WATER DISPENSER WITH BAG IN
A BOX UNIT
NEVIOT NATURE GALILEE LTD
65
C07B )5010.01(
‫תהליך להפרדת חומצה חזקה לא–נדיף‬
‫ממלחו ותכשירים שהוכנו על ידו‬
‫אייל יועצי מחקר בע"מ‬
C08L )5010.01(
‫תהליך לטיפול בזרם ליגנין‬
‫אייץ ס' אל קלינטג בע"מ‬
B67D )5010.01(
‫מתקן מים הכולל יחידת שקית בקופסא‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
02/1//0111
CATHETER
ANGIOSLIDE LTD.
IL
161554
PCT/IL/2005/000420
WO/2005/102184
10/1//0111
BALLOON CATHETER
ANGIOSLIDE LTD
US
60/695868
11//01211
US
PCT/IL/2006/000770
WO/2007/004221
10/10/0122
511055
‫קטטר‬
‫אנג'יוסלייד בע"מ‬
22/04/2004
511052
05/07/2005
2//21/0111
511054
66
E05B )5010.01(
‫חלקי מפתח ומנעול‬
‫ ) תעשיות בע"מ‬01( ‫רב בריח‬
511055
ELECTROLYTIC COMBUSTIBLE GASPRODUCING APPARATUS
JOSE ANTONIO, MARTINEZ, CAO
ES
200802362
06/08/2008
PCT/EP/2009/059682
WO/2010/015542
02/1//0111
A61M )5010.01(
‫צנתר בלון‬
‫אנג'יוסלייד בע"מ‬
KEY AND LOCK ASSEMBLIES
RAV BARIACH (08) INDUSTRIES LTD
US
61/329121
09/04/2010
0//1//0111
A61B )5010.01(
C25B )5010.01(
‫מתקן אלקטרוליטי לייצור גז דליק‬
511051
B29C )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
A PIPE WITH INTEGRAL MALE AND
FEMALE ENDS, A JOINT MADE USING
THE SAME PIPE, AND PROCESSES OF
MAKING THE PIPE AND THE JOINT
JAIN IRRIGATION SYSTEMS LIMITED
IN
1675/MUM/2008 06/08/2008
PCT/IB/2009/053336
WO/2010/015975
0//11/0111
‫צינור עם סיומות זכר ונקבה‬
‫ מחבר המיוצר עם אותו‬,‫אינטגרליות‬
‫ ושיטות לייצור הצינור‬,‫צינור‬
511051
METHOD OF PASSIVATING AND
ENCAPSULATING CDTE AND CZT
SEGMENTED DETECTORS
REDLEN TECHNOLOGIES, INC.
US
12/188501
08/08/2008
PCT/US/2009/048416
WO/2010/016975
2//1//0111
01/11/011/
‫שיטה לפסיבציה ואנקפסולציה של גלאי‬
CZT–‫ ו‬CDTE
511051
LINACLOTIDE-CONTAINING
FORMULATIONS FOR ORAL
ADMINISTRATION
IRONWOOD PHARMACEUTICALS,
INC.
US
61/089422
15/08/2008
12/0/0000
10/1//0111
US
12/002/01
11/1//0111
US
PCT/US/2009/004675
WO/2010/019266
A61K )5010.01(
‫תכשירים מכילי לינקלוטייד למתן אוראלי‬
511056
EFFICIENT INKJET NOZZLE
ASSEMBLY
SILVERBROOK RESEARCH PTY LTD
H01L )5010.01(
B41J )5010.01(
‫התקן זרבובית להזרקת דיו יעילה‬
PCT/AU/2008/001429
WO/2010/034050
67
April 28, 2011-‫כ"ד בניסן התשע"א‬
1//1//0111
511020
PYRAZOLO [5,1-B] OXAZOLE
DERIVATIVES AS CRF1
ANTAGONISTS
NOVARTIS AG
EP
08161930.6 06/08/2008
112111108/
2//12/0111
EP
12/011111
2//12/0111
US
PCT/EP/2009/060094
WO/2010/015628
01/11/0111
511021
T CELL ADHESION MOLECULE,
GENE THEREOF AND METHODS
EMPLOYING THE SAME
EISAI R&D MANAGEMENT CO., LTD.
2005JP
29/09/2005
285194
PCT/JP/2006/319576
WO/2007/037430
0//1//0111
511025
SPRINKLER
NAANDAN JAIN IRRIGATION C.S.
LTD.
US
61/129972
04/08/2008
PCT/IL/2009/000733
WO/2010/016053
1//11/011/
68
511022
C07D )5010.01(
‫] אוקסאזול‬B–1,5[ ‫תולדות פיראזולו‬
CRF1 ‫כאנטאגוניסטים של‬
C12N )5010.01(
‫ גן המקודד‬,T ‫מולקולת אדהסיה של תאי‬
‫לה ושיטות העושות שימוש בה‬
A01G )5010.01(
‫ממטרה‬
‫ אגודה שיתופית‬- ‫דן ג'יין השקייה‬-‫נען‬
‫חקלאית בע"מ‬
A61K )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
PEPTIDES AS DERIVATIVES FOR
COMPOUNDS FOR LABELED WITH
18F
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT
EP
06090166.7 08/09/2006
1/1111/181
00/1//011/
EP
PCT/EP/2007/008042
WO/2008/028688
1//1//0111
‫פפטידים כתולדות עבור תרכובות‬
F18 ‫המסומנות עם‬
511024
TREATMENT OF AUTOIMMUNE
AND INFLAMMATORY DISEASE
GLAXO GROUP LIMITED
US
61/087294
08/08/2008
12/211/12
21/1//0111
US
12/02/10/
21/11/0111
US
PCT/US/2009/053136
WO/2010/017468
‫טיפול במחלה אוטואימונית ודלקתית‬
511025
11/1//0111
511021
2-[1H-BENZIMIDAZOL-2(3H)YLIDENE-2-(PYRIMIDIN-2YL)ACETAMIDES AND 2[BENZOTHIAZOL-2(3H)-YLIDENE]-2(PYRIMIDIN-2-YL)ACETAMIDES AS
KINASE INHIBITORS
TELIK, INC.
US
61/100869
29/09/2008
PCT/US/2009/058345
69
B65D )5010.01(
‫מיכל בעל מכסה‬
CONTAINER HAVING A LID
MAUSER-WERKE GMBH & CO.KG
DE
102008036988.8 08/08/2008
PCT/EP/2009/005703
WO/2010/015403
01/11/0111
C07K )5010.01(
C07D )5010.01(
–5–]‫)–ילאידן‬H2(5–‫–בנזימידאזול‬H1[–5
–5‫–יל)אצטאמידים ו‬5–‫(פירימידין‬
–‫–(פירימידין‬5–]‫)–ילאידן‬H2(5–‫[בנזותיאזול‬
‫–יל)אצטאמידים כמעכבי קינאז‬5
April 28, 2011-‫כ"ד בניסן התשע"א‬
WO/2010/036873
02/12/0110
511021
A METHOD FOR IDENTIFICATION,
ISOLATION AND PRODUCTION OF
ANTIGENS TO A SPECIFIC
PATHOGEN
INTERCELL AG
AT
A 130/01
26/01/2001
PCT/EP/2002/000546
WO/2002/059148
02/12/0110
511021
A METHOD FOR IDENTIFICATION,
ISOLATION AND PRODUCTION OF
ANTIGENS TO A SPECIFIC
PATHOGEN
INTERCELL AG
AT
A 130/01
26/01/2001
PCT/EP/2002/000546
WO/2002/059148
1//1//0111
511026
FORMULATIONS OF
CANFOSFAMIDE AND THEIR
PREPARATION
TELIK, INC.
US
61/092580
28/08/2008
PCT/US/2009/052694
WO/2010/025011
10/11/0111
70
511040
C07K )5001.04(
‫ בידוד ויצור של אנטיגנים‬,‫שיטה לזיהוי‬
‫בררניים לפתוגן‬
C07K )5001.04(
‫ בידוד ויצור של אנטיגנים‬,‫שיטה לזיהוי‬
‫בררניים לפתוגן‬
A61K )5010.01(
‫הרכבים של קנפוסאמיד והכנתם‬
C07K )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
NOVEL MELANOMA ANTIGEN
PEPTIDE AND USES THEREOF
UNIVERSITE DE NANTES
EP
08305517.8 02/09/2008
PCT/EP/2009/061354
WO/2010/026165
1//11/011/
‫פפטיד אנטיגן מלנומה חדש ושימושים בו‬
511041
IMMUNOMODULATORY EXTRACTS
FROM LACTOBACILLUS BACTERIA
AND METHODS OF
MANUFACTURING AND USE
THEREOF
OM PHARMA
A61K )5010.01(
‫מיצויים לאפנון חיסוני מחיידק‬
‫ ושיטות לייצורם‬LACTOBACILLUS
‫והשימוש בהם‬
PCT/US/2008/010350
WO/2010/027344
1//1//0111
511045
IMIDAZOPYRIDIN-2-ONE
DERIVATIVES AND USES THEREOF
DAIICHI SANKYO COMPANY,
LIMITED
2008JP
05/08/2008
201670
0111-1//1/1 0//10/0111
JP
PCT/JP/2009/063807
WO/2010/016490
10/10/0122
511042
A METHOD FOR THE SEPARATION
OF A NON-VOLATILE STRONG ACID
FROM A SALT THEREOF AND
COMPOSITIONS PRODUCED
THEREBY
EYAL RESEARCH CONSULTANTS
LTD.
71
C07D )5010.01(
‫–און ושימושים‬5–‫תולדות אימידאזופירידין‬
‫בהן‬
C07B )5010.01(
‫תהליך להפרדת חומצה חזקה לא–נדיף‬
‫ממלחו ותכשירים שהוכנו על ידו‬
‫אשר ויטנר בע"מ‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
US
61/302116
27/02/2011
22/1//0111
511044
DESALINIZATION APPARATUS AND
METHOD
LYTESYDE, LLC
US
12/190878
13/08/2008
PCT/US/2009/053420
WO/2010/019585
10/10/0122
511045
INTERCHANGEABLE DISPLAY
DEVICE FOR PANES
YOUNG ENTREPRENEURS ISRAEL
(1998) LTD
10/10/0122
A42B )5010.01(
‫) בע"מ‬1661( ‫יזמים צעירים ישראל‬
511041
A61F )5010.01(
‫סד שקוף קומפקטי הניתן לגילגול‬
‫וויסמד בע"מ‬
511041
SHARED VIRTUAL AREA
COMMUNICATION ENVIRONMENT
BASED APPARATUS AND METHODS
72
‫התקן ושיטה להתפלת מים מלוחים‬
‫מתקן תצוגה מתחלפת לשמשות‬
ROLLABLE COMPACT
TRANSPARENT SPLINT
WAISMED LTD
10/1//0111
B01D )5010.01(
G06F )5010.01(
‫שיטות והתקנן המבוססים על סביבת‬
‫תקשורת שיתופית‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
SOCIAL COMMUNICATIONS
COMPANY
US
61/042714
05/04/2008
PCT/US/2009/039470
WO/2009/146130
00/11/211/
511041
LIQUID INTERFERON-?
FORMULATIONS
RENTSCHLER BIOTECHNOLOGIE
GMBH
EP
97116562.6 23/09/1997
PCT/EP/1998/006065
WO/1999/015193
11/1//0111
?–‫פורמולציות נוזליות של אינטרפרון‬
511046
SURFACE FUNCTIONALISED
NANOPARTICLES
NANOCO TECHNOLOGIES LIMITED
GB
0814458.6
07/08/2008
12/1//211
20/1//011/
US
PCT/GB/2009/001928
WO/2010/015824
11/1//0111
11/1//0111
73
C01G )5010.01(
‫ננו חלקיקים מותמרים לפני השטח‬
511050
INJECTABLE TAXANE
PHARMACEUTICAL COMPOSITION
GP PHARM S.A.
IS
P200802389 07/08/2008
PCT/EP/2009/005691
WO/2010/015400
A61K )5010.01(
A61K )5010.01(
‫תכשיר רוקחות של טקסן הניתן להזרקה‬
511051
C12N )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
CELL DISRUPTION OF PLANT AND
ANIMAL RAW MATERIALS BY A
COMBINATION OF ATOMIZATION
PROCESSES WITH DECOMPRESSION
PROCESSES FOR SELECTIVE
EXTRACTION AND SEPARATION OF
INTRACELLULAR VALUABLE
SUBSTANCES
UHDE HIGH PRESSURE TECHNOLOGIES
GMBH
DE
102008036723.0 07/08/2008
PCT/EP/2009/005689
WO/2010/015398
11/1//0111
‫שבירת תאים של חומרי גלם מצמחים‬
‫ובעלי חיים על ידי שילוב של תהליכי‬
‫אטומיזציה ותהליכי הפחתת לחץ‬
–‫למיצוי סלקטיבי והפרדת חומרים תוך‬
‫תאיים בעלי ערך‬
511055
C07K )5010.01(
SYNTHESIS OF GLATIRAMER
ACETATE
SCINOPHARM TAIWAN, LTD.
US
61/188216
07/08/2008
PCT/US/2009/052845
WO/2010/017292
‫סינטזה של גלטירמר אצטט‬
511052
21/11/011/
A PROCESS FOR PREPARATION OF
INSULIN COMPOUNDS
BIOCON LIMITED
IN
01904/CHE/2008 07/08/2008
PCT/IN/2008/000598
WO/2010/016069
11/1//0111
511054
A UNIVERSAL TEMPLATE
ENABLING DRILLING AND PLACING
A DENTEL IMPLANT INTO A
PATIENT'S JAW
BECK ISRAEL
US
61/087707
10/08/2008
74
C07K )5010.01(
‫תהליך להכנת תרכובות אינסולין‬
A61C )5010.01(
‫תבנית אוניברסלית לקידוח ומיקום שתל‬
‫דנטלי בלסת מטופל‬
‫ישראל בק‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
PCT/IL/2009/000771
WO/2010/018565
22/1//0111
511055
METHODS AND APPARATUSES FOR
PROCESSING MEASUREMENT GAPS
IN A WIRELESS COMMUNICATION
SYSTEM
QUALCOMM INCORPORATED
US
61/087930
11/08/2008
20/112121
21/1//0111
US
PCT/US/2009/053478
WO/2010/019621
2//1//0111
11/21/0111
A61K )5010.01(
‫–ניטרוגלוטתיון על בסיס‬S ‫מעכבי רדוקטז‬
‫פירול חדשים כגורמים רפואיים‬
511051
HIGH FLOWABLE HETEROPHASIC
POLYPROPYLENE
BOREALIS AG
EP
08017556.5 07/10/2008
PCT/EP/2009/007113
WO/2010/040492
75
‫שיטות והתקנים לעיבוד פערי מדידה‬
‫במערכת תקשורת אלחוטית‬
511051
NOVEL PYRROLE INHIBITORS OF SNITROSOGLUTATHIONE
REDUCTASE AS THERAPEUTIC
AGENTS
N30 PHARMACEUTICALS, LLC
US
61/089313
15/08/2008
12/2211/0
02/22/011/
US
PCT/US/2009/053931
WO/2010/019910
H04W )5010.01(
C08L )5010.01(
‫פוליפרופלן הטריפאזי עם זרימות גבוהה‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
511051
21/11/0111
AN INSERTER
BAYER OY
FI
20085870
011/1//2
FI
PCT/FI/2009/050738
WO/2010/031902
‫מחדיר‬
17/09/2008
2//11/011/
511056
2//11/0111
AN INSERTER
BAYER OY
FI
20080523
PCT/FI/2009/050735
WO/2010/031900
A61F )5010.01(
A61F )5010.01(
‫מחדיר‬
17/09/2008
10/1//0111
511011
METHODS OF TREATING
THALASSEMIA
TARGEGEN, INC.
US
60/086233
05/08/2008
PCT/US/2009/052544
WO/2010/017122
11/1//011/
PHARMACEUTICAL USES OF
LANOSTA-8,24-DIEN-3-OLS
AMAZONIA FITOMEDICAMENTOS
LTDA
A61K )5010.01(
‫שיטות לטיפול בתלסמיה‬
511015
A61K )5010.01(
–‫ דיאן‬54 ,1–‫שימושים רפואיים של לנוסטה‬
‫–אולים‬2
PCT/IB/2008/002051
WO/2010/015874
76
April 28, 2011-‫כ"ד בניסן התשע"א‬
11/1//0111
511012
USE OF BACTERIAL BETALACTAMASE FOR IN VITRO
DIAGNOSTICS AND IN VIVO
IMAGING, DIAGNOSTICS AND
THERAPEUTICS
THE TEXAS A&M UNIVERSITY
SYSTEM
US
61/188112
06/08/2008
12/010111
0//20/011/
US
PCT/US/2009/004503
WO/2010/016911
1//1//0111
511014
METHOD AND A SYSTEM FOR
REDUCING ARTIFACTS
HUMANEYES TECHNOLOGIES LTD.
US
61/085893
04/08/2008
PCT/IL/2009/000761
WO/2010/016061
10/1//0111
511015
METHOD AND SYSTEM FOR CAB
MANAGEMENT
LEVY AMNON
US
61/086169
05/08/2008
PCT/IB/2009/053353
WO/2010/015984
21/1//0111
511011
PROCESS FOR PREPARING AMINES
FROM ALCOHOLS AND AMMONIA
YEDA RESEARCH AND
DEVELOPMENT CO. LTD.
US
61/087708
10/08/2008
PCT/IL/2009/000778
77
G01N )5010.01(
‫שימוש בבטא–לקטמז בקטריאלי‬
‫ ולהדמיה‬VITRO–IN ‫לדיאגנוסטיקה‬
‫ודיאגנוסטיקה תוך גופית‬
H04N )5010.01(
‫שיטה ומערכת להורדת שינוי תוכן‬
‫יומנייז טכנולוגיות בע"מ‬
G06Q )5010.01(
‫שיטה ומערכת לניהול מונית‬
‫לוי אמנון‬
C07F )5010.01(
‫תהליך להכנת אמינים מכהלים ואמוניה‬
‫ידע חברה למחקר ופיתוח בע"מ‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
WO/2010/018570
11/1//0111
511011
C07K )5010.01(
‫הפרדה על זיקה על ידי אינטרקציית‬
‫קוהזין–דוקרין‬
AFFINITY PURIFICATION BY
COHESIN-DOCKERIN INTERACTION
YEDA RESEARCH AND
DEVELOPMENT CO. LTD.
US
61/086813
07/08/2008
12/1100/2
12/11/011/
US
PCT/IL/2009/000773
WO/2010/016067
0//22/0111
‫רמות ליד אוניברסיטת תל אביב בע"מ‬
511011
DETACHABLE CORNER WHEEL
DEVICE AND MOVABLE SUITCASE
HANGZHOU GEMA SUITCASES & BAGS
CO. LTD
CN
200910100175.9 02/07/2009
PCT/CN/2009/001309
WO/2010/139101
10/10/0122
511016
INVOKING DENIAL OF SERVICE IN
MUNIVERSAL MOBILE
TELECOMMUNICATIONS SYSTEM
(UMTS) NETWORKS
PERCELLO LTD
0//1//0111
78
B60B )5010.01(
‫התקן של גלגל פינתי הניתן–להתקה‬
‫ומזוודה ניידת‬
H04L )5010.01(
‫גרימת מניעת שירות ברשתות תקשורת‬
‫ניידת אוניברסלית‬
‫פרסלו בע"מ‬
511010
C07D )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
DIHYDROPYRIDOPHTHALAZINONE
INHIBITORS OF POLY(ADPRIBOSE)POLYMERASE
BIOMARIN PHARMACEUTICAL INC.
US
61/086687
06/08/2008
12/212101
11/10/0111
US
12/2/01//
0//1//0111
US
PCT/US/2009/051879
WO/2010/017055
10/10/0122
‫דיהידרופירידופתאלאזינון כמעקב של פולי‬
‫–ריבוז)פולימראז‬ADP(
511015
METHODS APPARATUS ANS
SYSTEMS FOR FACILITATING THE
SALE OF VENTURE RELATED
FINANCIAL INSTRUMENTS
JOHNATHAN ASSIA
US
61/300875
03/02/2010
21/1//0111
MIRROR
AGC GLASS EUROPE
EP
08162132.8
PCT/EP/2009/060344
WO/2010/018152
12/22/2111
‫ מכשור ושיטה המשמשים‬,‫מערכת‬
‫למכירה של כלים פיננסיים‬
‫יונתן אסיא‬
511014
G02B )5010.01(
‫מראה‬
11/08/2008
511015
MULTIPARTICULATE MODIFIED
RELEASE COMPOSITION
ELAN PHARMA INTERNATIONAL
LTD.
US
60/106726
02/11/1998
PCT/US/1999/025632
WO/2000/025752
79
A21D )5010.01(
A61K )5010.01(
‫תכשיר רב–מרכיבים עם שחרור לא סדיר‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
11/1//0111
511011
NOVEL METHYLENEDIOXY
PHENOLIC COMPOUNDS AND THEIR
USE TO TREAT DISEASE
THE OHIO STATE UNIVERSITY
RESEARCH FOUNDATION
US
61/086425
05/08/2008
PCT/US/2009/052893
WO/2010/017323
11/10/0122
511011
511011
ZONED TOPSHEET
THE PROCTER & GAMBLE
COMPANY
US
12/188493
08/08/2008
PCT/US/2009/052958
WO/2010/017360
11/1//0111
511016
ZONED TOPSHEET
THE PROCTER & GAMBLE
COMPANY
US
12/188527
08/08/2008
PCT/US/2009/052960
WO/2010/017362
80
‫תרכובות מתילנדיאוקסי פנולי חדשות‬
‫ושימוש שלהן לטיפול במחלה‬
B23H )5010.01(
‫מרסן בר–סיבוב‬
‫סופטוויל בע"מ‬
ROTATABLE DAMPER
SOFTWHEEL LTD
11/1//0111
C07D )5010.01(
A61F )5010.01(
‫יריעה עליונה המחולקת לאיזורים‬
A61F )5010.01(
‫יריעה עליונה המחולקת לאיזורים‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
21/1//0111
511010
CYLINDER LOCK WITH CYLINDER
HOUSING AND FLAT KEY FOR A
CYLIDER LOCK
EVVA SICHERHEITSTECHNOLOGIE
GMBH
AT
A1256/2008 12/08/2008
PCT/EP/2009/005786
WO/2010/017941
0//11/2111
11/1//0111
‫מנעול צילינדר עם בית צילינדר ומפתח‬
‫שטוח עבור מנעול צילינדר‬
511011
METHODS AND DEVICES FOR
PROVIDING PROLONGED DRUG
THERAPY
ALZA CORPORATION
US
60/087787
03/06/1998
11/010202/
21/10/2111
US
PCT/US/1999/011920
WO/1999/062496
SINGLE USE MODULE
TRANSMEDICS, INC.
81
A61K )5010.01(
‫שיטות ותכשירים לאספקת ריפוי תרופתי‬
‫מתמשך‬
511015
DENTAL RESTORATION
CONDITIONING APPARATUS AND
METHOD
NAYM 55 DENTAL TECHNOLOGIES
LTD
US
61/136012
06/08/2008
PCT/IL/2009/000769
WO/2010/016066
1//21/0111
E05B )5010.01(
511014
A61C )5010.01(
‫מערכת לשחזור דנטלי ושיטה‬
‫ טכנולוגיות בע"מ‬55 ‫נעים‬
A61N )5010.01(
‫יחידה לשימוש חד פעמי‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
US
60/616835
11/11/1/2
US
11//0121/
US
PCT/US/2005/036211
WO/2006/042138
1//21/0111
PERFUSION SOLUTION
TRANSMEDICS, INC.
US
60/616835
11/11/1/2
US
11//0121/
US
PCT/US/2005/036211
WO/2006/042138
1//1//0111
07/10/2004
0//11/0111
11/21/0111
511015
‫תמיסת פרפוזיה‬
07/10/2004
0//11/0111
11/21/0111
511011
CONTINUOUS CULTIVATION,
HARVESTING, AND OIL
EXTRACTION OF PHOTOSYNTHETIC
CULTURES
KAI BIOENERGY
US
61/086106
04/08/2008
PCT/US/2009/052762
WO/2010/017243
22/1//0111
C12M )5010.01(
‫ קציר ומיצוי שמן של תרביות‬,‫גידול רציף‬
‫פוטוסינתטיות‬
511011
ENGINEERED ANTI-IL-13
ANTIBODIES, COMPOSITIONS,
METHODS AND USES
CENTOCOR ORTHO BIOTECH INC.
US
61/090472
20/08/2008
12/11/000
21/11/011/
US
PCT/US/2009/053425
WO/2010/021874
82
A61N )5010.01(
A61K )5010.01(
,‫ תכשירים‬,‫ מהונדסים‬IL–12 ‫נוגדנים אנטי‬
‫שיטות ושימושים‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
0//1//0111
511011
‫אבחונים וטיפולים עבור גידולים בלתי‬
VEGF–‫תלויים ב‬
DIAGNOSTICS AND TREATMENTS
FOR VEGF-INDEPENDENT TUMPRS
GENENTECH, INC.
US
61/093161
29/08/2008
PCT/US/2009/055434
WO/2010/025414
11/1//0111
511060
511061
A UNIVERSAL TESTING PLATFORM
FOR MEDICAL DIAGNOSTICS AND
AN APPARATUS FOR READING
TESTING PLATFORMS
ALERE SWITZEREL AND GMBH
US
12/185901
05/08/2008
12/200121
21/20/011/
US
PCT/US/2009/052857
WO/2010/017299
1//1//0111
83
A61B )5010.01(
‫פלטפורמות בדיקה אוניברסלית לאבחונים‬
‫רפואיים והתקן לקיראת פלטפורמות‬
‫בדיקה‬
511065
POLISHING PAD AND METHOD FOR
MANUFACTURING THE SAME
KURARAY CO. LTD.
2008JP
08/08/2008
205981
PCT/JP/2009/063802
F24J )5010.01(
‫המרת אנרגיה סולארית‬
SOLAR ENERGY CONVERSION
BRIGHTPHASE ENERGY, INC
US
61/086618
06/08/2008
PCT/US/2009/053054
WO/2010/017422
11/1//0111
C12Q )5010.01(
B24B )5010.01(
‫כרית ליטוש ושיטה לייצורו‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
WO/2010/016486
11/10/0122
511062
A METHOD FOR PROCESSING A
LIGNOCELLULOSIC MATERIAL AND
FOR THE PRODUCTION OF A
CARBOHYDRATE COMPOSITION
HCL CLEANTECH LTD.
21/11/0111
‫תהליך לעיבוד חומר ליגנוצליולוזי ולהכנת‬
‫תכשיר פחמימית‬
511065
UV LIGHT THERAPY DELIVERY
APPARATUS
PEREZ THOMAS
US
12/186698
06/08/2008
PCT/US/2009/044182
WO/2010/016962
11/1//011/
C08L )5010.01(
511061
INTRADERMAL NEEDLE-LESS
INJECTION MECHANISM
PERF-ACTION TECHNOLOGIES LTD
‫אייץ ס' אל קלינטג בע"מ‬
A61N )5010.01(
‫מכשיר לטיפול באור אולטרא–סגול‬
A61M )5010.01(
‫מנגנון להזרקה תת–עורית ללא מחט‬
PCT/IL/2008/001077
WO/2010/016049
21/1//0111
MIRROR
AGC GLASS EUROPE
EP
08162133.6
PCT/EP/2009/060345
84
511061
F24J )5010.01(
‫מראה‬
11/08/2008
April 28, 2011-‫כ"ד בניסן התשע"א‬
WO/2010/018153
10/1//0111
511061
USE OF DRONEDARONE FOR THE
PREPARATION OF A MEDICAMENT
FOR THE PREVENTION OF STROKE
OR TRANSIENT ISCHEMIC ATTACK
SANOFI-AVENTIS
EP
08290761.9 07/08/2008
12/1///10
22/1//011/
US
PCT/IB/2009/006831
WO/2010/015939
02/1//0111
A61K )5010.01(
‫שימוש בדרונדרון להכנת תרופה למניעת‬
‫שבץ מוחי או התקפה איסכמית ארעית‬
511066
FORMULATION FOR ORAL
ADMINISTRATION OF PROTEINS
ALVINE PHARMACEUTICALS, INC.
US
61/090831
21/08/2008
PCT/US/2009/004791
WO/2010/021752
21/1//0111
11/1//0111
85
‫פורמולציה למתן פומי של חלבונים‬
511100
PROCESS FOR MAKING 5AZACYTOSINE NUCLEOSIDES AND
THEIR DERIVATIVES
SCINOPHARM TAIWAN, LTD.
US
61/188431
08/08/2008
PCT/US/2009/053276
WO/2010/017547
G01N )5010.01(
C07H )5010.01(
‫–אזציטוזין‬5 ‫תהליך לייצור נוקלאוזידים של‬
‫ונגזרותיהם‬
511101
A61K )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
SUSTAINED RELEASE COMPOSITIONS
COMPRISING GUMS AND SUGAR
ALCOHOLS
AVANTOR PERFORMANCE MATERIALS,
INC.
IN
1676/MUM/2008 07/08/2008
PCT/US/2009/052956
WO/2010/017358
11/10/0122
511105
IMPROVED DATA ENTRY SYSTEMS
BENJAMIN FIROOZ GHASSABIAN
02/1//0111
511102
QUINUCLIDINE CARBONATE
DERIVATIVES AND MEDICINAL
COMPOSITION THEREOF
CHIESI FARMACEUTICI S.P.A.
EP
08162066.8 08/08/2008
PCT/EP/2009/005272
WO/2010/015324
0//1//0111
511104
5-SUBSTITUTED BENZOXAZINES
F. HOFFMANN-LA ROCHE AG
EP
08163832.2 08/09/2008
PCT/EP/2009/061157
WO/2010/026112
0//1//0111
86
511105
‫תכשירים בעלי שחרור מושהה‬
‫המכילים שרפים וסוכרים אלכוהוליים‬
G06F )5010.01(
‫שיטות משופרות להכנסת נתונים‬
‫בנימין פירוז גסביאן‬
C07D )5010.01(
‫תולדות קווינוקלידין קרבונאט ותכשיר‬
‫תרופתי שלהן‬
C07D )5010.01(
5–‫בנזוקסאזינים מותמרים‬
C12N )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
CELL SURFACE DISPLAY OF
POLYPEPTIDE ISOFORMS BY STOP
CODON READTHROUGH
NOVARTIS AG
EP
08163161.6 28/08/2008
PCT/EP/2009/006246
WO/2010/022961
01/1//0111
511101
SUBSTITUTED TRICYCLIC ACID
DERIVATIVES AS S1P1 RECEPTOR
AGONISTS USEFUL IN THE
TREATMENT OF AUTOIMMUNE AND
INFLAMMATORY DISORDERS
ARENA PHARMACEUTICALS, INC.
US
61/190311
27/08/2008
12/011121
0//11/0111
US
PCT/US/2009/004851
WO/2010/027431
0//1//0111
87
H04W )5010.01(
‫תמיכת טכנולוגיות גישות מרובות בסביבה‬
‫אלחוטית‬
511106
METHOD AND APPARATUS FOR
DERMATOLOGICAL
HYPOPIGMENTATION
THE GENERAL HOSPITAL
CORPORATION
US
61/087036
07/08/2008
C07D )5010.01(
‫נגזרות חומצה טריצקלית מותמרות‬
‫ שימושיות‬P1 S 1 ‫כאגוניסטים לקולטן‬
‫בטיפול בהפרעות אוטואימוניות ודלקתיות‬
511101
SUPPORTING MULTIPLE ACCESS
TECHNOLOGIES IN A WIRELESS
ENVIRONMENT
QUALCOMM INCORPORATED
US
61/092456
28/08/2008
20/1//1/1
01/1//0111
US
PCT/US/2009/055228
WO/2010/025279
1//1//0111
‫הצגת איזופורמים של פוליפפטידים על פני‬
‫שטח תא על ידי בחינת קודון עצירה‬
A61F )5010.01(
‫שיטה ומכשיר להיפו–פגמנטציה‬
‫דרמטולוגית‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
PCT/US/2009/053153
WO/2010/017477
2//1//0111
511110
ANTIBODY MODULATING THE
DIFFERENTIATION AND FUNCTION
OF DENDRITIC CELLS VIA BINDING
INTERCELULAR ADHESION
MOLECULE-1 AND USE THEREOF
DINONA INC.
US
61/087265
08/08/2008
PCT/KR/2009/002019
WO/2010/016652
11/1//0111
1//10/0122
‫נוגדן המווסת התמינות ופעילות של תאים‬
‫מסועפים באמצעות קשירה של מולקולה‬
‫ ושימוש שלו‬,‫ בין–תאית‬1–‫צמדנית‬
511111
SMALL MOLECULE INHIBITORS OF
RETROVIRAL ASSEMBLY AND
MATURATION
NEW YORK BLOOD CENTER, INC.
US
61/087574
08/08/2008
PCT/US/2009/052949
WO/2010/017355
CUTTING TOOL AND CUTTING
INSERT THEREFOR
88
A61K )5010.01(
‫חומרים המעכבים התכנסות והבשלה של‬
‫רטרו–וירוס‬
511115
TOY AND PROMOTIONAL ELEMENT
ITZHAK BAR YONA
1//10/0122
C07K )5010.01(
511112
G09F )5010.01(
‫אלמנט פרסום ומשחק‬
‫יצחק בר יונה‬
B23C )5010.01(
‫כלי חיתוך ושימה עבורו‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫ישקר בע"מ‬
ISCAR LTD.
11/11/0111
511114
PHARMACEUTICAL COMPOSITIONS
OF A NEUROACTIVE STEROID AND
USES THEREOF
EURO-CELTIQUE S.A.
US
60/688905
09/06/2005
PCT/EP/2006/005574
WO/2006/131392
01/1//0111
511115
NOVEL BENZAMIDES, PRODUCTION
THEREOF, AND USE THEREOF AS
MEDICAMENTS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
08163525.2 02/09/2008
PCT/EP/2009/061024
WO/2010/026095
11/1//0111
511111
METHOD AND DEVICE FOR
PRODUCING A COATING MATERIAL
PRIMIX CORPORATION
2008JP
11/08/2008
206851
PCT/JP/2009/063853
WO/2010/018771
89
A61K )5010.01(
‫הרכבים פרמצבטיים של סטרואיד‬
‫נוירואקטיבי ושימושים שלהם‬
C07D )5010.01(
‫ ייצורם ושימוש בהם‬,‫בנזאמידים חדשים‬
‫כתרופות‬
C09D )5010.01(
‫שיטה ומכשיר לייצור חומר ציפוי‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
2//1//0111
511111
HIG2 AND URLC10 EPITOPE PEPTIDE
AND VACCINES CONTAINING THE
SAME
ONCOTHERAPY SCIENCE, INC.
US
61/089972
19/08/2008
PCT/JP/2009/003897
WO/2010/021112
11/1//0111
‫ וחיסונים‬URLC10–‫ ו‬HIG5 ‫פפטידי אפיטופ‬
‫המכילים אותם‬
511111
ABSORBENT ARTICLE HAVING A
TUFTED TOPSHEET
THE PROCTER & GAMBLE
COMPANY
US
12/188543
08/08/2008
20/2//11/
1//1//011/
US
20//21211
02/10/0111
US
PCT/US/2009/052945
WO/2010/017353
1//11/0111
511116
LOAD SECURING SYSTEM
LOADHOG LIMITED
GB
0816753.8
12/09/2008
1/0012181
0//20/011/
GB
PCT/GB/2009/002125
WO/2010/029284
1//1//0111
511150
C7-FLUORO SUBSTITUTED
TERACYCLINE COMPOUNDS
TETRAPHASE PHARMACEUTICALS,
INC.
US
61/188307
08/08/2008
PCT/US/2009/053142
90
A61K )5010.01(
A61F )5010.01(
‫פריט סופג בעל יריעה עליונה עם ציצית‬
B65D )5010.01(
‫מערכת אבטחת עומס‬
C07C )5010.01(
‫תרכובות טטראציקלין מותמרות בעמדה‬
‫ עם פלואור‬C1
April 28, 2011-‫כ"ד בניסן התשע"א‬
WO/2010/017470
21/11/0111
511151
COMPOSITE ORGINIC COMPOUND
POWDER FOR MEDICAL USE,
METHOD FOR PRODUCING SAME
AND SUSPENSION OF SAME
ACTIVUS PHARMA CO, LTD
2008JP
19/09/2008
241855
PCT/JP/2009/004596
WO/2010/032434
21/1//0111
‫אבקת תרכובת אורגנית מרוכבת לשימוש‬
‫ שיטה לייצורה ותרחיף שלה‬,‫רפואי‬
511155
BIOMARKERS FOR ANTI-TNF
TREATMENT IN ULCERATIVE
COLITIS AND RELATED DISORDERS
CENTOCOR ORTHO BIOTECH INC.
US
61/091641
25/08/2008
PCT/US/2009/054287
WO/2010/044952
11/1//0111
A61K )5010.01(
TNF–‫סמנים ביולוגיים לטיפול אנטי‬
‫בדלקת כיב המעי הגס והפרעות קשורות‬
511152
SYSTEM AND METHOD FOR
MANAGING DIGITAL
INTERACTIONS
MICA TECHNOLOGIES, INC.
US
12/189135
08/08/2008
PCT/US/2009/052996
WO/2010/017385
1//11/0111
91
C12Q )5010.01(
511154
G06Q )5010.01(
‫שיטה ומערכת לניהול פעולות גומלין‬
‫דיגיטליות‬
B24D )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
ABRASIVE TOOLS HAVING A
CONTINUOUS METAL PHASE FOR
BONDING AN ABRASIVE
COMPONENT TO A CARRIER
Saint-Gobain ABRASIFS
US
61/087430
08/08/2008
PCT/US/2009/043356
WO/2010/016959
511155
21/1//0111
EQUIPMENT COOLING
BAE SYSTEMS PLC
GB
0814776.1
1/0/11//81
EP
PCT/GB/2009/050996
WO/2010/018398
‫כלי השחזה בעלי פאזת מתכת מתמשכת‬
‫להצמדה של רכיב השחזה לרכיב נושא‬
‫צינון של ציוד‬
13/08/2008
20/1//011/
511151
22/1//0111
CATALYST FOR DEGRADING LIGNIN,
CATALYST FOR DEGRADING AROMATIC
HYDROCARBON, AND PORPHYRIN
HIROFUMI FUKUTOME
JP
2008-238637
011/-0/0/11
JP
011/-0//00/
JP
JP
PCT/JP2009/058209
PCT/JP/2009/064201
WO/2010/018832
01/22/0111
B01J )5010.01(
‫ קטליסט‬,‫קטליסט לפירוק של ליגנין‬
‫לפירוק של פחמימן ארומטי‬
‫ופורפירין‬
11/08/2008
0//11/011/
2//21/011/
0//1//0111
511151
UNMANNED AIRCRAFT AND AERIAL
SURVEILLANCE SYSTEM FOR
UNMANNED AIRCRAFT
MITSUBISHI HEAVY INDUSTRIES,
LTD.
92
F28F )5010.01(
B64C )5010.01(
‫כלי טיס ללא טייס ומערכת פיקוח אווירית‬
‫עבור כלי טיס ללא טייס‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
2008309123
PCT/JP/2009/069723
WO/2010/064548
JP
20/1//0111
03/12/2008
511151
METHOD FOR PRODUCING AMIDE
DERIVATIVE
MITSUI CHEMICALS AGRO, INC.
2008JP
13/08/2008
208714
PCT/JP/2009/064295
WO/2010/018857
01/1//0111
511156
METHOD FOR IDENTIFYING AN
OBJECT IN A VIDEO ARCHIVE
EUROPEAN AERONAUTIC DEFENCE
AND SPACE COMPANY-EADS
FRANCE
FR
0855737
27/08/2008
PCT/EP/2009/060960
WO/2010/023213
1//11/011/
511120
DIGITAL VIDEO FILTER AND IMAGE
PROCESSING
NED M. AHDOOT
C07C )5010.01(
‫שיטה להכנת נגזרת אמיד‬
G06F )5010.01(
‫שיטה לזיהוי חפץ בארכיון וידאו‬
G09G )5010.01(
‫מסנן וידאו דיגיטלי ועיבוד תמונה‬
PCT/US/2008/010484
WO/2010/027348
2//1//0111
93
511121
C12N )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
INHBB EPITOPE AND VACCINES
CONTAINING THE SAME
ONCOTHERAPY SCIENCE, INC.
US
61/089973
19/08/2008
PCT/JP/2009/003894
WO/2010/021111
0//1//0111
‫ וחיסונים המכילים‬INHBB ‫פפטידי אפיטופ‬
‫אותם‬
511125
ANTI-IL-6 ANTIBODIES,
COMPOSITIONS, METHODS AND
USES
CENTOCOR ORTHO BIOTECH INC.
US
60/676498
29/04/2005
11/1//021
10/11/0111
US
PCT/US/2006/016457
WO/2006/119115
0//1//0111
2//1//0111
C07K )5010.01(
‫–נוגדני אנטי הרכבים שיטות ושימושם‬IL–1
511124
STABILISERS FOR INANIMATE
ORGANIC MATERIALS
BASF SE
EP
08163194.7 28/08/2008
PCT/EP/2009/060531
WO/2010/023115
94
‫ –נוגדני אנטי הרכבים שיטות‬IL –1
‫ושימושם‬
511122
ANTI-IL-6 ANTIBODIES,
COMPOSITIONS, METHODS AND
USES
CENTOCOR ORTHO BIOTECH INC.
US
60/676498
29/04/2005
11/1//021
10/11/0111
US
PCT/US/2006/016457
WO/2006/119115
C07K )5010.01(
C08K )5010.01(
‫מייצבים עבור חומרים אורגניים דוממים‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
1//11/0111
511125
PHARMACEUTICAL COMBINATION
OF 3-(3-DIMETHYLAMINO-1-ETHYL2-METHYL-PROPYL)-PHENOL AND
AN ANTIEPILEPTIC
GRUNENTHAL GMBH
EP
08015625.0 05/09/2008
PCT/EP/2009/006424
WO/2010/025931
1//11/0111
01/11/0111
–1–‫–דימתילאמינו‬2(–2 ‫שילוב רוקחי של‬
–‫–מתיל–פרופיל)–פנול וחומר אנטי‬5–‫אתיל‬
‫אפילפטי‬
511121
PYRIDO [5,4-D] PYRIMIDINES AS
CELL PROLIFERATION INHIBITORS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
08163897.5 08/09/2008
PCT/EP/2009/061656
WO/2010/026262
95
C07D )5010.01(
‫]פירימידינם כמעכבי התרבות‬D–4,5[‫פירידו‬
‫מהירה של תאים‬
511121
3H -IMIDAZO [4,5-B] PYRIDINE-6CARBOXAMIDES AS ANTIINFLAMMATORY AGENTS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
08165120.0 25/09/2008
12/1111//
01/11/011/
US
PCT/EP/2009/062425
WO/2010/034799
01/11/0111
A61P )5010.01(
511121
C07D )5010.01(
–1–‫] פירימידין‬B–5,4[ ‫–אימידאזו‬H2
‫קרבוקסאמידים כגורמים אנטי–דלקתיים‬
C07D )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
IH-BENZIMIDAZOLE-5CARBOXAMIDES AS ANTIINFLAMMATORY AGENTS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
08165120.0 25/09/2008
12/1111//
01/11/011/
US
PCT/EP/2009/062421
WO/2010/034796
22/1//0111
511126
LINER FOR TUBULAR BODY
PORTION AND APPARATUS AND
METHODS FOR APPLICATION
THEREOF
BINERIX MEDICAL LTD
US
61/136112
13/08/2008
12/201110
21/11/011/
US
PCT/IL/2009/000779
WO/2010/018571
22/1//0111
511140
METHOD OF IDENTIFYING DISEASE
RISK FACTOR
ZINFANDEL PHARMACEUTICALS,
INC.
US
61/088203
12/08/2008
12/2/11/0
20/11/0111
US
12/00/1//
21/1//0111
US
PCT/US/2009/053373
WO/2010/019550
20/1//0111
96
511141
‫–קרבוקסאמידים‬5–‫–בנזאימידאזול‬H1
‫כגורמים אנטי–דלקתיים‬
A61F )5010.01(
‫ריפוד לחלק גוף צינורי והתקנים ושיטות‬
‫ליישומו‬
‫בינריקס מדיקל בע"מ אצל גד טרליוק‬
G01N )5010.01(
‫שיטה לזיהוי גורמי סיכון למחלות‬
C07D )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
2-ALKYL-6-CYCLOAMINO-3(PYRIDIN-4-YL)IMIDAZO[1,2B]PYRIDAZINE DERIVATIVES,
PREPARATION THEREOF, AND
THERAPEUTIC APPLICATION
THEREOF
SANOFI-AVENTIS
FR
08/04573
12/08/2008
12/1//201
20/1//011/
US
PCT/FR/2009/001001
WO/2010/018327
–2–‫–ציקלואמינו‬1–‫–אלקיל‬5 ‫נגזרות‬
,‫]פירידאזין‬B–5,1[‫–איל)אימידאזו‬4–‫(פירידין‬
‫ ויישום רפואי שלהן‬,‫הכנתן‬
511142
20/1//0111
THERAPEUTIC COMPOSITIONS
CONTAINING MACITENTAN
ACTELION PHARMACEUTICALS LTD.
IB
PCT/IB08/053252 13/08/2008
PCT/IB/2009/053553
WO/2010/018549
22/1//0111
511144
LASER ASSEMBLY AND METHOD
AND SYSTEM FOR ITS OPERATION
X.D.M. LTD
US
61/087756
11/08/2008
PCT/IL/2009/000784
WO/2010/018574
00/22/011/
511145
MICRO-OPTIC SECURITY AND
IMAGE PRESENTATION SYSTEM
VISUAL PHYSICS, LLC
US
60/524281
21/11/2003
11/10/010
00/12/011/
US
11/10/00/
20/22/011/
US
PCT/US/2004/039315
97
A61K )5010.01(
‫תכשירים רפואיים המכילים‬
‫מסיטנטאן‬
H01S )5010.01(
‫הרכב לייזר ושיטה ומערכת להפעלתו‬
‫ אם בע"מ‬.‫ די‬.‫אקס‬
G02B )5010.01(
–‫מערכת להצגת דמות ואבטחה מיקרו‬
‫אופטית‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
WO/2005/052650
10/11/0111
511141
PENETRATION RESISTANT ARTICLE
TEIJIN ARAMID GMBH
EP
08164023.7 10/09/2008
PCT/EP/2009/061338
WO/2010/028993
01/11/0111
511141
1H-BENZIMIDAZOLE-5CARBOXAMIDES AS ANTIINFLAMMATORY AGENTS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
08165120.0 25/09/2008
12/1111//
01/11/011/
US
PCT/EP/2009/062422
WO/2010/034797
01/11/0111
511141
3H-IMIDAZO [4,5-C] PYRIDINE-6CARBOXAMIDES AS ANTIINFLAMMATORY AGENTS
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
US
61/099987
25/09/2008
1/212120181 01/11/011/
EP
PCT/EP/2009/062424
WO/2010/034798
02/1//0111
98
511146
F41H )5010.01(
‫מוצר עמיד לחדירה‬
C07D )5010.01(
‫–קרבוקסאמידים‬5–‫–בנזאימידאזול‬H1
‫כגורמים נוגדי דלקת‬
C07D )5010.01(
–1–‫]פירידין‬C–5,4[‫–אימידאזו‬H2
‫קרבוקסאמידים כגורמים נוגדי דלקת‬
C07D )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
TWO PHASE BIOACTIVE
FORMULATIONS
SOUTHWEST RESEARCH INSTITUTE
US
12/192400
15/08/2008
PCT/US/2009/052457
WO/2010/019398
0//1//0111
‫הרכבים פעילים ביולוגית בעלי שתי פאזות‬
511150
– ? ‫שיטה עבור ייצור תרכובת‬
‫הידרוקסיאסטר‬
METHOD FOR PRODUCING ?HYDROXYESTER COMPOUND
SUMITOMO CHEMICAL COMPANY,
LIMITED
2008JP
26/08/2008
216358
0111-120/10 00/12/0111
JP
PCT/JP/2009/065130
WO/2010/024419
21/10/0122
511155
COVER THE SIDA AND THE BACK
MIRRORS OF VARIOUS
TRANSPORTATION
LIMOR ARBEL
2//1//0111
B60J )5010.01(
‫חיפוי מראות הצדדיות והאחוריות של‬/‫כיסוי‬
‫כלי התחבורה למיניהם‬
‫ארבל לימור‬
511152
ORGANOARSENIC COMPOUNDS
AND METHODS FOR THE
TREATMENT OF CANCER
ZIOPHARM ONCOLOGY, INC.
US
61/189511
20/08/2008
PCT/US/2009/053858
WO/2010/021928
99
C07C )5010.01(
A61P )5010.01(
‫תרכובות אורגנוארסניות ושיטות לטיפול‬
‫בסרטן‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
0//1//0111
511154
MARKERS AND METHODS FOR
ASSESSING AND TREATING
ULCERATIVE COLITIS AND
RELATED DISORDERS USING A 20
GENE PANEL
CENTOCOR ORTHO BIOTECH INC.
US
61/092966
29/08/2008
PCT/US/2009/055323
WO/2010/025340
0//1//0111
511151
PHOTOSYNTHETIC
MICROORGANISMS ENRICHED IN
SELENIUM USING
SELENOHYDROXY ACID
COMPOUNDS, USES THEREOF IN
NUTRITION, COSMETICS AND
PHARMACY
ECO SOLUTION
FR
08/55827
29/08/2008
PCT/FR/2009/001044
WO/2010/023384
22/1//0111
511151
SOLID CORE MICROCAPSULAR
COMPOSITIONS AND USES THEREOF
BOTANOCAP LTD.
US
61/087755
11/08/2008
PCT/IL/2009/000789
WO/2010/018576
0//1//0111
100
511156
G01N )5010.01(
‫סמנים ושיטות להערכה וטיפול בדלקת‬
‫כיב המעי הגס ואי–סדרים קשורים‬
‫ גנים‬50 ‫באמצעות פנל‬
C12N )5010.01(
‫מיקרואורגניזמים פוטוסינטיים מועשרים‬
‫בסלניום באמצעות תרכובות חומצה‬
,‫סלנוהידרוקסי ושימושיהם בתזונה‬
‫קוסמטיקה ורוקחות‬
A01N )5010.01(
‫תכשירים המכילים מוצקים מקופסלים‬
‫ושימוש בהם‬
‫קאפ בע"מ‬-‫בוטנו‬
B28C )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
EFFICIENT WET STARCH
PREPARATION SYSTEM FOR
GYPSUM BOARD PRODUCTION
UNITED STATES GYPSUM COMPANY
US
12/205615
05/09/2008
PCT/US/2009/055383
WO/2010/027920
‫מערכת יעילה להכנת עמילן רטוב לייצור‬
‫לוח גבס‬
511110
02/1//0111
ENDOPROSTHESIS HAVING PLUG-IN
CONNECTION AND IMPROVED
ROTARY PROTECION
DERU GMBH
DE
202008011178.1 22/08/2008
PCT/EP/2009/006096
WO/2010/020429
21/1//0111
‫תותב פנימי בעל מחבר והגנה משופרת‬
‫מפני סיבוב‬
511111
METHOD AND DEVICE FOR THE
AUTOMATIC REGULATION OF
PLANT IRRIGATION
PLANTCARE AG.
SE
1425/08
05/09/2008
PCT/CH/2009/000274
WO/2010/025573
00/1//0111
101
A01G )5010.01(
‫שיטה ומכשיר לויסות אוטומטי של‬
‫השקיית צמחים‬
511115
MAINTAINING CIRCUIT SWITCHED
CONTINUITY IN AN ENHANCED
UNIVERSAL TERRESTRIAL RADIO
ACCESS NETWORK
INTERDIGITAL PATENT HOLDINGS,
INC.
US
61/088397
13/08/2008
PCT/US/2009/051492
WO/2010/019364
A61F )5010.01(
H04W )5010.01(
‫המשכיות ממותגת במעגל תחזוקה ברשת‬
‫גישת רדיו יבשתית אוניברסלית מוגברת‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
21/10/0122
511112
A METHOD FOR GENERATING A
RANDOMIZED DATA STRUCTURE
FOR REPRESENTING SETS, BASED
ON BLOOM FILTERS
BEN-GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
01/1//0111
‫שיטת ייצור מבנה נתונים אקראי לייצוג‬
BLOOM ‫ המתבססת על מסנני‬,‫מערכות‬
‫אוניברסיטת בן גוריון בנגב הרשות למחקר‬
‫ופיתוח‬
511114
PYRROLOPYRIMIDINE COMPOUNDS
AS CDK INHIBITORS
NOVARTIS AG
US
61/091037
22/08/2008
PCT/EP/2009/060793
WO/2010/020675
0//1//0111
102
C07K )5010.01(
IL, 17––55 ‫שימושים במשפחת ציטוקינים‬
‫ במחלות אוטואימוניות‬IL–1 –‫ו‬,IL
511111
PROCESS FOR PREPARING CERTAIN
CINNAMIDE COMPOUNDS
C07D )5010.01(
CDK ‫תרכובות פירולופירימידין כמעכבי‬
511115
USES OF IL-22, IL-17, AND IL-1
FAMILY CYTOKINES IN
AUTOIMMUNE DISEASES
WYETH LLC
US
61/092743
28/08/2008
12/2101//
0//21/011/
US
PCT/US/2009/055366
WO/2010/025369
01/1//0111
G06F )5010.01(
C07D )5010.01(
‫תהליך להכנת תרכובות סינאמיד מסוימות‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
EISAI R&D MANAGEMENT CO., LTD.
US
61/092262
27/08/2008
PCT/US/2009/055079
WO/2010/025197
1//11/0111
511111
SUBSTITUTED PYRROLIDINE-2CARBOXMIDES
F. HOFFMANN-LA ROCHE AG
US
61/097884
18/09/2008
12/001100
21/1//0111
US
PCT/EP/2009/061610
WO/2010/031713
0//1//0111
511116
ENHANCING THE REPRODUCTION
OF MULTIPLE AUDIO CHANNELS
DOLBY LABORATORIES LICENSING
CORPORATION
US
61/190963
03/09/2008
PCT/US/2009/055118
WO/2010/027882
2//1//0111
MIF MODULATORS
YALE UNIVERSITY
US
61/189327
PCT/US/2009/004704
WO/2010/021693
10/11/011/
ASPIRATION PUMP UNIT
MEDELA HOLDING AG
103
511110
A61K )5010.01(
‫–קרבוקסאמידים מותמרים‬5–‫פירולידינ‬
H04S )5010.01(
‫שיפור העתקה של ערוצי רדיו מרובים‬
C07D )5010.01(
MIF ‫מאפנני‬
18/08/2008
511111
A61M )5010.01(
‫יחידת משאבת שאיפה‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
CH
749/06
PCT/CH/2007/000220
WO/2007/128156
09/05/2006
02/11/0112
511115
OPTICAL MAGNETRON FOR HIGH
EFFICIENCY PRODUCTION OF
OPTICAL RADIATION, AND 1/2
LAMBDA INDUCED PI-MODE
OPERATION
RAYTHEON COMPANY
US
09/584887
01/06/2000
11//1/100
12/10/0112
US
PCT/US/2001/016622
WO/2001/097250
21/10/0122
‫מגנטרון אופטי להפקה של קרינה‬
‫אופטיתביעילות גבוהה והפעלת מצב פאי‬
‫ למבדה‬1/5–‫מושראתב‬
511112
A CLASP AND AN EARRING USING
THIS CLASP
GADOO LTD.
1//1//0111
104
A44B )5010.01(
‫סגר ועגיל נושא הסגר‬
‫גאדו בע"מ‬
511114
CHUTE WITH HEIGHT ADJUSTMENT
MEMBERS
ALIAXIS PARTICIPATIONS
FR
0804587
13/08/2008
PCT/FR/2009/051352
WO/2010/018331
22/1//0111
H01J )5010.01(
511111
E03F )5010.01(
‫מגלש בעל איברי כיוונון גובה‬
C12N )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
METHODS FOR THE PRODUCTION
OF IPS CELLS
CELLULAR DYNAMICS
INTERNATIONAL, INC.
US
61/088054
12/08/2008
PCT/US/2009/053403
WO/2010/019569
20/1//0111
511111
GENETIC VARIANTS USEFUL FOR
RISK ASSESSMENT OF THYROID
CANCER
DECODE GENETICS EHF
IS
8755
12/08/2008
//12
11/10/0111
IS
PCT/IS/2009/000010
WO/2010/018600
0//1//0111
105
C12Q )5010.01(
‫קישור בין פולימורפיזם של חלבון למחלות‬
‫לב בעורקים כליליים‬
511116
THERMALLY INSULATED DIE PLATE
ASSEMBLY FOR UNDERWATER
PELLETIZING AND THE LIKE
GALA INDUSTRIES, INC.
US
12/222669
13/08/2008
PCT/US/2009/053553
WO/2010/019667
C12Q )5010.01(
‫שימוש של ואריאנטים גנטים להערכת‬
)‫הסיכון של סרטן בלוטת התריס (תירואיד‬
511111
ASSOCIATION OF PROTEIN
POLYMORPHISMS WITH CORONARY
HEART DISEASE
SANOFI-AVENTIS DEUTSCHLAND
GMBH
EP
04021528.7 10/09/2004
PCT/EP/2005/009270
WO/2006/027128
20/1//0111
IPS ‫שיטות לייצור תאי‬
B29B )5010.01(
‫מכלול לוח תבנית מבודד תרמי עבור‬
‫יציקת תבליות התת המים וכדומה‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
22/1//0111
511110
MULTI-ARM POLYMERIC
ALKANOATE CONJUGATES,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
NEKTAR THERAPEUTICS
US
61/087826
11/08/2008
12/21110/
01/21/011/
US
12/22000/
22/22/011/
US
PCT/US/2009/004618
WO/2010/019233
20/1//0111
,‫מוצמדי פולימר אלקאנואט רב זרועי‬
‫ ושימושים בהם‬,‫תכשירים המכילים אותם‬
511111
SYSTEM AND METHOD FOR
SEGMENTING PRINTED MEDIA
PAGES INTO ARTICLES
GOOGLE INC.
US
12/191120
13/08/2008
PCT/US/2009/053757
WO/2010/019804
2//1//0111
511114
POLYVALENT VACCINE
THE UNIVERSITY OF ALABAMA AT
BIRMINGHAM RESEARCH
FOUNDATION
US
12/192015
14/08/2008
PCT/US/2009/004664
WO/2010/019262
20/1//0111
DATA ENTRY SYSTEM
KEYLESS SYSTEMS LTD
106
A61K )5010.01(
511115
G06K )5010.01(
‫מערכת ושיטה להפרדת דפי מדיה‬
‫מודפסים למאמרים‬
C07K )5010.01(
‫חיסון רב ערכי‬
G06F )5010.01(
‫מערכת הכנסת נתונים‬
‫קילס סיסטמס‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
US
61/136104
210111
IL
2101//
IL
210//1
IL
21/110
IL
21//1/
IL
21//02
IL
PCT/IL/2009/000790
WO/2010/018577
12/08/2008
2//1//011/
0//1//011/
0//1//011/
11/11/011/
20/21/011/
00/21/011/
511111
21/1//0111
AUTOMATIC COCKTAIL PREPARER
LIN BO
CN
200810045787.8 12/08/2008
PCT/CN/2009/073163
WO/2010/017757
21/10/0122
511111
THERAPEUTIC PAD
INCORPORATING A HEADREST
Victor Bochnik
0//1//0111
‫מכשיר אוטומטי להכנת קוקטיילים‬
A61K )5010.01(
‫משטח טיפולי המשלב תמיכת ראש‬
‫ויקטור בוכניק‬
511111
NEW BENZOFURANS SUITABLE AS
PRECURSORS TO COMPOUNDS
THAT ARE USEFUL FOR IMAGING
AMYLOID DEPOSITS
ASTRAZENECA AB
US
61/092851
29/08/2008
PCT/SE/2009/050972
WO/2010/024769
107
A47J )5010.01(
C07D )5010.01(
‫בנזופוראנים חדשים המתאימים‬
‫כפרקורסורים לתרכובות שיעילות‬
‫להדמיית מרבצי אמילואיד‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
2//1//0111
511116
‫תרכובות לטיפול במחלות עצבים‬
‫פריפריאליות‬
COMPOUNDS FOR THE TREATMENT
OF PERIPHERAL NEUROPATHIES
NOVARTIS AG
EP
08162517.0 18/08/2008
PCT/EP/2009/060611
WO/2010/020610
11/11/0111
511160
511161
A PROCESS FOR PREPARING[1S- [1ALPHA, 2-ALPHA, 3-BETA (1S*, 2R*) 5BETA]]-3-[7-[2-(3,4-DIFLUOROPHENYL)CYCLOPROPYLAMINO]-5(PROPYLTHIO)-3H-1, 2,3-TRIAZOLO [4,5D]PYRIMIDIN-3-YL]-5-(2HYDROXYETHOXY)CYCLOPENTANE1,2-DIOL AND TO ITS INTERMEDIATES
ASTRAZENECA AB
US
61/095341
PCT/SE/2009/050999
WO/2010/030224
00/1//011/
108
A61K )5010.01(
‫פורמולציות נוגדן חדשות‬
NOVEL ANTIBODY FORMULATION
F. HOFFMANN-LA ROCHE AG
EP
08164746.3 19/09/2008
PCT/EP/2009/061692
WO/2010/031720
1//11/0111
A61K )5010.01(
C07D )5010.01(
–5 ,‫–אלפא‬S1–[1[ ‫תהליך להכנת‬
–2–]]‫–בטא‬S1, *R2)5*( ‫–בטא‬2,‫אלפא‬
–)‫–דיפלואורופניל‬4,2(–5[–1[
–)‫–(פרופילתיאו‬5–]‫ציקלופרופילאמינו‬
–‫]פירימידינ‬D–5,4[ ‫–טריאזולו‬H3–3,2,1
–5(–5–]‫–יל‬2
–5,1–‫הידרוקסיאתוקסי)ציקלופנטאנ‬
‫דיאול ותוצרי ביניים שלו‬
09/09/2008
511165
C07C )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫תכשירים לטיפוח אישי המכילים‬
‫סולפאטים מסועפים‬
PERSONAL CARE COMPOSITIONS
COMPRISING BRANCHED SULFATES
RHODIA INC.
US
60/489314
22/07/2003
PCT/US/2004/023716
WO/2005/009385
511162
21/1//0111
BICYCLIC TRIAZOLE DERIVATIVES
FOR THE TREATMENT OF TUMOURS
MERCK PATENT GMBH
DE
102008037790.2 14/08/2008
PCT/EP/2009/005172
WO/2010/017870
01/11/211/
511164
SHEET FOR FABRICATING A STENT
MEDINOL LTD.
US
742422
30/10/1996
01/11/211/
STENT
MEDINOL LTD.
US
742422
1//1//011/
109
511165
A61K )5010.01(
‫נגזרות דו–ציקליות של טריאזול לטיפול‬
‫בגדלים‬
A61M )5010.01(
‫יריעה לייצור סטנט‬
‫מדינול בע"מ‬
A61M )5010.01(
‫סטנט‬
‫מדינול בע"מ‬
30/10/1996
511161
A01N )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
SYNERGISTIC PESTICIDAL
COMPOSITIONS COMPRISING AN
ACTIVE COMPOUND, AN
AMMONIUM SALT, AND A
NONIONIC SURFACTANT
DOW AGROSCIENCES LLC
US
61/088020
12/08/2008
PCT/US/2009/053065
WO/2010/019453
00/1//0111
511161
SELF-ACTUATING CLOSURE
MECHANISM FOR CLOSABLE
ARTICLES
MAGLID TECHNOLOGIES HOLDING
LTD
US
61/087814
11/08/2008
12/21/1/1
00/21/011/
US
12/2/2011
01/20/011/
US
PCT/IB/2009/006349
WO/2010/018431
20/1//0111
110
B65D )5010.01(
‫ לחפצים‬,‫מנגנון סגירה המפעיל את עצמו‬
‫הנסגרים‬
511161
A SYSTEM FOR ANESTHETIZING
WHILST ATTUNING THE
TEMPERATURE OF MAMMALS AND
METHODS THEREOF
ASPECT MAGNET TECHNOLOGIES
LTD
US
61/088011
12/08/2008
PCT/IL/2009/000792
WO/2010/018578
1//1//0111
‫תכשירים סינרגיסטיים להדברת מזיקים‬
,‫ מלח אמוניום‬,‫המכילים תרכובת פעילה‬
‫וחומר פעיל שטח לא–יוני‬
A61N )5010.01(
‫מערכת להרדמה בזמן ויסות הטמפרטורה‬
‫של יונקים ושיטה בעבור כך‬
511166
‫אספקט טכנולוגיות מגנטים בע"מ‬
F03D )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
DEEP OFFSHORE FLOATING WIND
TURBINE AND METHOD OF DEEP
OFFSHORE FLOATING WIND
TURBINE ASSEMBLY,
TRANSPORTATION, INSTALLATION
AND OPERATION
YOEL ROZNITSKY
US
61/189237
18/08/2008
12/0211/0
01/11/0111
US
12/01/0/0
20/11/0111
US
PCT/US/2009/004465
WO/2010/021655
20/10/0122
‫טורבינת רוח הצפה בעומק רחוק מהחוף‬
‫ התקנה והפעלה‬,‫ הובלה‬,‫ושיטה להרכבה‬
‫של הטורבינה זו‬
511501
ELECTRONIC SYSTEM AIMED FOR
DIRECD MARKETING
SHAI FADLON
20/10/0122
‫מערכת אלקטרונית לשיווק ישיר‬
‫שי פדלון‬
511505
EMPLOYMENT CANDIDETES
DATABASE CREATED BY HR
MANAGERS AND SPECIALIZED IN
RECRUITMENT USING INTERNET
PROFESSIONAL NETWORKS
MICHAL MAGEN
20/1//0111
G09B )5010.01(
‫מאגר מועמדים לעבודה שנבנה ע"י‬
‫ות משאבי האנוש והעוסקים בגיוס‬/‫מנהלי‬
‫באמצעות רשת מקצועית‬
‫מיכל מגן‬
511502
COMPOSITIONS COMPRISING SOLID
DISPERSIONS AND USES THEREOF
111
G07B )5010.01(
A61K )5010.01(
‫תכשירים המכילים תפזורות מוצקות‬
‫ושימושים בהם‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
VERTEX PHARMACEUTICALS
INCORPORATED
US
61/088704
13/08/2008
12/1///12
2//1//011/
US
12/111111
21/1//011/
US
12/2/1210
02/12/0111
US
12/2/210/
0//11/0111
US
12/2/00/1
10/11/0111
US
PCT/US/2009/004629
WO/2010/019239
2//1//0111
511504
MUCOADHERENTS COMPOSITIONS
AND THEIR USE
INCREMENTHA PD&I-PESQUISA,
DESENVOLVIMENTO E INOVACAO
DE FARMACOS E MEDICAMENTOS
LTDA.
PI0803568BR
14/08/2008
7
PCT/BR/2009/000255
WO/2010/017614
20/1//0111
112
‫הרכבים הנבדקים למוקוזה ושימושיהם‬
511505
PHOTOVOLTAIC CELLS WITH
PROCESSED SURFACES AND
RELATED APPLICATIONS
GREENFIELD SOLAR CORP
US
61/088921
14/08/2008
12/1//101
2//1//011/
US
12/1/10/1
21/1//011/
US
12/110102
0//1//011/
US
20/101110
11/1//0111
US
20/1011//
11/1//0111
US
20/101110
11/1//0111
US
20/1011/0
11/1//0111
US
PCT/US/2009/053576
WO/2010/019685
A61K )5010.01(
H01L )5010.01(
‫תאים חשמלוריים עם משטחים מעובדים‬
‫ויישומים קשורים‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
20/1//0111
511501
‫תכנית מעגל חשמלי הניתנת לאכילה‬
INGESTIBLE CIRCUITRY
PROTEUS BIOMEDICAL, INC.
US
61/088355
13/08/2008
PCT/US/2009/053721
WO/2010/019778
2//1//0111
511501
METHOD AND DEVICE FOR
REMOTELY CONTROLLING A
CAMERA ON BOARD A MOBILE
STATION
EUROPEAN AERONAUTIC DEFENCE
AND SPACE COMPANY-EADS
FRANCE
FR
0855644
20/08/2008
PCT/EP/2009/060650
WO/2010/020625
20/1//0111
113
G06T )5010.01(
‫שיטה והתקן לבקרה מרחוק של מצלמה‬
‫מותקנת בתחנה ניידת‬
511506
AZETIDINE POLYSUBSTITUTED
COMPOUNDS, PREPARATION
THEREOF, AND THERAPEUTIC
APPLICATION THEREOF
SANOFI-AVENTIS
FR
0804596
14/08/2008
PCT/FR/2009/001004
WO/2010/018329
20/1//0111
A61B )5010.01(
511510
C07D )5010.01(
,‫ הכנתן‬,‫תרכובות אזטידין רב–מותמרות‬
‫ויישום רפואי שלהן‬
C07D )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
AZETIDINE POLYSUBSTITUTED
COMPOUNDS, PREPARATION
THEREOF, AND THERAPEUTIC
APPLICATION THEREOF
SANOFI-AVENTIS
FR
0804595
14/08/2008
PCT/FR/2009/001003
WO/2010/018328
20/10/0122
,‫ הכנתן‬,‫תרכובות אזטידין רב–מותמרות‬
‫ויישום רפואי שלהן‬
511511
A MEMS DEVICE AND METHOD FOR
USING SAME
BTENDO LTD.
1//11/0111
20/1//0111
VALVE ASSEMBLIES
SIGMA-ALDRICH CO.
US
61/089730
PCT/US/2009/053587
WO/2010/021891
114
‫ ושיטה לשימוש בו‬MEMS ‫התקן‬
‫ביטנדו בע"מ‬
511515
PIPERAZINE DERIVATIVES FOR
BINDING AND IMAGING AMYLOID
PLAQUES AND THEIR USE
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT
EP
08164279.5 12/09/2008
PCT/EP/2009/006406
WO/2010/028776
B82B )5010.01(
C07D )5010.01(
‫תולדות פיפראזין לקישור ודימות של רובד‬
‫אמילואיד ושימושיהן‬
511512
F16K )5010.01(
‫הרכבי שסתום‬
18/08/2008
April 28, 2011-‫כ"ד בניסן התשע"א‬
2//1//0111
511514
PURIFIED MESENCHYMAL STEM
CELL COMPOSITIONS AND
METHODS OF PURIFYING
MESENCHYMAL STEM CELL
COMPOSITIONS
OSIRIS THERAPEUTICS, INC.
US
61/088898
14/08/2008
PCT/US/2009/053891
WO/2010/019886
2//1//0111
‫תכשירים טהורים של תאי גזע מזנכימלים‬
‫ושיטות לטיהור תכשירים של תאי גזע‬
‫מזנכימלים‬
511515
ULTRA CONCENTRATED LIQUID
LAUNDRY DETERGENT
MELALEUCA, INC.
US
61/088900
14/08/2008
PCT/US/2009/053811
WO/2010/019841
2//1//0111
511511
METHOD AND APPARATUS FOR
ESTIMATING BODY SHAPE
BROWN UNIVERSITY
US
61/189070
15/08/2008
12/2/122/
21/1//011/
US
12/21/221
02/21/011/
US
PCT/US/2009/053953
WO/2010/019925
20/1//0111
511511
METHODS FOR EVALUATING
CHROMATOGRAPHY COLUMN
PERFORMANCE
BIOGEN IDEC MA INC.
US
61/089351
15/08/2008
PCT/US/2009/053773
115
C12N )5010.01(
C11D )5010.01(
‫נוזל מרוכז לניקוי כביסה‬
G06T )5010.01(
‫שיטה ומערכת לאומדן צורת גוף‬
G01N )5010.01(
‫שיטות להערכת ביצוע כרומטוגרפית‬
‫קולונה‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
WO/2010/019814
20/1//0111
511511
N DEGREES-OF-FREEDOM (DOF)
LAPAROSCOPE MANEUVERABLE
SYSTEM
M.S.T. MEDICAL SURGERY
TECHNOLOGIES LTD
US
61/088765
14/08/2008
12/2/2//1
00/1//0111
US
PCT/IL/2009/000800
WO/2010/018582
21/11/0111
‫ דרגות‬n ‫מערכת להזזת לרינגוסקופ בעלות‬
‫חופש‬
‫ מדיקל סורג'רי טכנולוגיס בע"מ‬.‫טי‬.‫אס‬.‫אמ‬
511516
A CHAMBER FOR HOUSING
ANIMALS DURING ANAESTHETIC
PROCEDURES
ASPECT MAGNET TECHNOLOGIES
LTD
US
61/095642
10/09/2008
12/11111/
22/11/011/
US
12/20211/
22/20/011/
US
PCT/IL/2009/000884
WO/2010/029547
2//1//0111
511550
PROCESS FOR FORMING AND
DEVOLATILATILIZING
BROMINATED POLYBUTADIENE
POLYMER PARTICLES
DOW GLOBAL TECHNOLOGIES INC.
US
61/089711
18/08/2008
PCT/US/2009/054146
WO/2010/022041
116
A61B )5010.01(
B01L )5010.01(
‫תא להחזקת בעלי חיים במהלך הליכי‬
‫הרדמה‬
‫אספקט טכנולוגיות מגנטים בע"מ‬
C08J )5010.01(
‫תהליך ליצירה ועיבוי של חלקיקי פולימר‬
‫פולי–בוטדיאן שעברו ברומינציה‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
20/1//0111
511551
PROCESS FOR PREPARING
POLYMORPH OF 7-CHLORO-N,N,5TRIMETHYL-4-OXO-3-PHENYL-3,5DIHYDRO-4H-PYRIDAZINO [4,5-B]
INDOLE-1-ACETAMIDE
SANOFI-AVENTIS U.S. LLC
US
61/089648
18/08/2008
PCT/US/2009/053698
WO/2010/021905
21/21/011/
N,N, ‫–כלורו‬1 ‫תהליך להכנת פולימורף של‬
–5,2–‫–פניל‬2–‫–אוקסו‬4–‫–טרימתיל‬5
–‫]אינדול‬B–5,4[ ‫–מימן–פירידאזינו‬4–‫דיהידרו‬
‫–אצטמיד‬1
511555
HIGH SPEED MEDIA ACCESS
CONTROL AND DIRECT LINK
PROTOCOL
QUALCOMM INCORPORATED
US
60/511904
15/10/2003
11/122/11
21/21/0110
US
11/120001
02/21/0110
US
11/101011
12/20/0110
US
11/1010//
12/20/0110
US
11/100/12
00/20/0110
US
11/1/1110
2//10/011/
US
11/1/11/1
10/11/011/
US
11/1/1//2
1//1//011/
US
11/111111
22/1//011/
US
21/11/02/
20/21/011/
US
PCT/US/2004/034259
WO/2005/039105
21/21/011/
511552
HIGH SPEED MEDIA ACCESS
CONTROL AND DIRECT LINK
PROTOCOL
QUALCOMM INCORPORATED
US
60/511904
15/10/2003
11/122/11
21/21/0110
US
11/120001
02/21/0110
US
11/101011
12/20/0110
US
117
C07D )5010.01(
H04L )5010.01(
‫פרוטוקול מהיר לשליטה לגישה למדיה‬
‫וקשר ישיר‬
H04L )5010.01(
‫פרוטוקול מהיר לשליטה לגישה למדיה‬
‫וקשר ישיר‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
11/1010//
US
11/100/12
US
11/1/1110
US
11/1/11/1
US
11/1/1//2
US
11/111111
US
21/11/02/
US
PCT/US/2004/034259
WO/2005/039105
21/22/011/
12/20/0110
00/20/0110
2//10/011/
10/11/011/
1//1//011/
22/1//011/
20/21/011/
511554
ADJUSTING THE TRANSMIT POWER
LEVEL OF A CELLULAR
COMMUNICATION TERMINAL
CAPABLE OF PEER-TO-PEER
COMMUNICATIONS
QUALCOMM INCORPORATED
US
60/523989
21/11/2003
21/11///1
01/11/011/
US
PCT/US/2004/038817
WO/2005/053253
01/1//0111
2//1//0111
118
‫כוונון העברת רמת האנרגיה של מסוף‬
‫תקשורת סלולרי המסוגל להתחבר אל‬
‫חיבור של אמצעי תקשורת‬
511555
USE OF A COX-2 INHIBITOR FOR THE
TREATMENT OF A COX-2
DEPENDENT DISORDER IN A
PATIENT NOT CARRYING HLA
ALLELES ASSOCIATED WITH
HEPATOTOXICITY
NOVARTIS AG
US
61/091081
22/08/2008
12/02211/
10/1//0111
US
PCT/US/2009/054415
WO/2010/022211
H04L )5010.01(
C12Q )5010.01(
‫ לטיפול בהפרעה‬COX–5 ‫שימוש במעכב‬
‫ בחולה שאיננו בעל אללי‬COX–5 ‫תלויית‬
‫ הקשורים לרעלנות בכבד‬HLA
511551
C07D )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
DIOXA -BICYCLO [3.2.1]OCTANE2,3,4-TRIOL DERIVATIVES
PFIZER INC.
US
61/092470
28/08/2008
12/00/020
02/1//0111
US
PCT/IB/2009/053626
WO/2010/023594
21/10/0122
–‫]אוקטאנ‬1.5.2[ ‫תולדות דיאוקסא–ביציקלו‬
‫–טריאול‬4,2,5
511551
‫מגן שמש לרכב‬
‫ניצן דפנה‬
SUNSHADE FOR MOTOR VEHICLE
NITZAN DAPHNA
21/10/0122
511551
511556
TRANSLATION SYSTEM FOR
PRODUCING A PROTEIN
COMPRISING AN UNNATURAL
AMINO ACID
THE SCRIPPS RESEARCH INSTITUTE
US
60/622738
27/10/2004
PCT/US/2005/039210
WO/2006/110182
119
A44C )5010.01(
‫שעון צמיד עם חורים לחיבור סיכות‬
‫דקורטיביות‬
‫דגן זקס‬
BRACELET WATCH WITH HOLES
FOR DECORATIVE PINS
DAGAN ZAKS
0//21/0111
B60J )5010.01(
C12N )5010.01(
‫מערכת תרגום ליצור חלבון המכיל חומצת‬
‫אמינו לא–טבעית‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
01/1//0111
511520
ANTISENSE OLIGONUCLEOTIDES
DIRECTED AGAINST CONNECTIVE
TISSUE GROWTH FACTOR AND USES
THEREOF
ISIS PHARMACEUTICALS, INC.
US
61/190121
25/08/2008
PCT/US/2009/054973
WO/2010/042281
1//11/0111
‫אנטיסנס אוליגונוקליאוטידים המכוונים נגד‬
‫גורם גדילה של רקמה מחברת ושימושים‬
‫בהם‬
511521
SUSTAINED RELEASE
FORMULATIONS USING NONAQUEOUS CARRIERS
AMYLIN PHARMACEUTICALS, INC.
US
61/094381
04/09/2008
PCT/US/2009/056058
WO/2010/028257
02/1//0111
511525
HUMAN NOTCH3 BASED FUSION
PROTEINS AS DECOY INHIBITORS
OF NOTCH3 SIGNALING
THE TRUSTEES OF COLUMBIA
UNIVERSITY IN THE CITY OF NEW
YORK
US
61/189930
22/08/2008
PCT/US/2009/004765
WO/2010/021729
01/1//0111
511522
VACCINE
GLAXOSMITHKLINE BIOLOGICALS
S.A.
US
61/092582
28/08/2008
12/111///
21/21/011/
US
120
A61K )5010.01(
A61K )5010.01(
‫הרכבים בעלי שחרור מושהה עם נשאים‬
‫שאינם מימיים‬
A61K )5010.01(
‫ אנושיים‬NOTCH2 ‫חלבוני איחוי מבוססי‬
NOTCH2 ‫כמעכבי פיתוי של איתות‬
A61K )5010.01(
‫תרכיב‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
12/2111//
US
PCT/EP/2009/060967
WO/2010/023216
11/11/0111
12/1//0111
511524
COMPOSITIONS AND METHODS FOR
THE PREVENTION OF OXIDATIVE
DEGRADATION OF PROTEINS
GENENTECH, INC.
US
61/095878
10/09/2008
PCT/US/2009/056365
WO/2010/030670
1//10/0111
511525
SOLID STATE INETIAL SENSOR ON
CHIP
SURAL
US
61/089170
15/08/2008
PCT/US/2009/033075
WO/2010/019278
21/10/0122
511521
511521
DENTAL ANCHOR APPARATUS AND
METHOD
ZEST IP HOLDINGS, LLC
US
61/091982
26/08/2008
121
‫תכשירים ושיטות למניעה של חמצון‬
‫מכלה של חלבונים‬
G01P )5010.01(
‫חיישן אינרציה על שבב מצב–מוצק‬
B23B )5010.01(
‫כלי חיתוך מסובב‬
‫ וי יועצים בע"מ‬5 ‫אמ‬
ROTARY CUTTER
M2V CONSULTNTS LTD
22/1//0111
A61K )5010.01(
A61C )5010.01(
‫התקן ושיטה עבור עוגן דנטלי‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
12/20//2/
US
20/10//10
US
PCT/US/2009/053363
WO/2010/025034
22/1//0111
2//20/011/
1//1//0111
511521
METHOD AND APPARATUS FOR
LOW-COMPLEXITY INTERFERENCE
CANCELLATION IN
COMMUNICATION SIGNAL
PROCESSING
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL)
US
12/201303
29/08/2008
PCT/EP/2009/060390
WO/2010/023100
01/1//0111
511526
METHOD FOR THE DESALINATION
OR PURIFICATION OF WATER BY
DISTILLATION OF A SPRAY (SPRAY
PUMP)
UGOLIN, NICOLAS
FR
0804656
20/08/2008
111101/
02/12/0111
FR
PCT/FR/2009/001019
WO/2010/020723
20/1//0111
511540
METHOD FOR PRODUCING A
GETTER DEVICE
ALVATEC ALKALI VACUUM
TECHNOLOGIES GMBH
AT
A1283/2008 18/08/2008
PCT/AT/2009/000311
WO/2010/019977
122
H04L )5010.01(
‫שיטה והתקן לביטול הפרעות מורכבות‬
‫נמוכה בעיבוד אותות תקשורת‬
B01D )5010.01(
‫שיטה להתפלה או טיהור של מים על ידי‬
‫זיקוק של רסס‬
H01J )5010.01(
‫שיטה לייצור מכשיר איסוף‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
511541
21/1//0111
7-AZAINDOLE DERIVATIVES
MERCK PATENT GMBH
DE
102008038221.3 18/08/2008
PCT/EP/2009/005024
WO/2010/020308
0//1//0111
511545
SYSTEMS AND METHODS FOR
SEMANTIC CONCEPT DEFINITION
AND SEMANTIC CONCEPT
RELATIONSHIP SYNTHESIS
UTILIZING EXISTING DOMAIN
DEFINITIONS
PRIMAL FUSION INC
US
61/092973
29/08/2008
PCT/CA/2009/001185
WO/2010/022505
21/1//0111
511542
REGULATION OF INTEGRIN
SURFACE EXPRESSION
NEW YORK BLOOD CENTER, INC.
US
61/090488
20/08/2008
PCT/US/2009/054291
WO/2010/022139
01/1//0111
123
511544
C07D )5010.01(
‫–אזאינדול‬1 ‫נגזרות של‬
G06F )5010.01(
‫מערכות ושיטות להגדרת מושג סמנטי‬
‫וסינתזה של יחס מושג סמנטי תוך כדי‬
‫ניצול הגדרות תחום קיימות‬
G01N )5010.01(
‫בקרת ביטוי של אינטגרין על פני התא‬
G01N )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
HIGH THROUGHPUT SYSTEM FOR
CFU ASSAY BY THE USE OF HIGH
RESOLUTION DIGITAL IMAGING,
DIFFERENTIAL STAINING AND
AUTOMATED LABORATORY
SYSTEM
NEW YORK BLOOD CENTER, INC.
US
61/090491
20/08/2008
PCT/US/2009/054545
WO/2010/022288
21/21/0111
‫ תוך שימוש‬CFU ‫מערכת סריקה רחבה ל‬
‫ צביעה‬,‫במערכת הדמיה ברזולוציה גבוהה‬
‫מבדילה ומערכת מעבדה אוטומטית‬
511545
APPARATUS AND METHOD FOR
IMAGING THE EYE
VERDOONER STEVEN
US
61/105901
16/10/2008
PCT/US/2009/061016
WO/2010/045564
21/1//0111
‫מכשיר ושיטה לדימות העין‬
511541
PROVISIONING VIRTUAL
RESOURCES USING NAME
RESOLUTION
IBM CORPORATION
US
12/197363
25/08/2008
PCT/EP/2009/060717
WO/2010/023139
0//11/0121
124
G06F )5010.01(
‫אספקת משאבים וירטואליים ע"י תרגום‬
‫שמות‬
511541
STATISTICAL ANALYSIS OF DATA
RECORDS FOR AUTOMATIC
DETERMINATION OF SOCIAL
REFERENCE GROUPS
IBM CORPORATION
US
12/494314
30/06/2009
PCT/EP/2010/058991
WO/2011/000770
A61B )5010.01(
G06Q )5010.01(
‫אנליזה סטטיסטית של רשומות נתונים‬
‫להגדרה אוטומטית של קבוצות התייחסות‬
‫חברתיות‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
21/10/0122
511541
DISPOSABLE DISPENSER FOR
DISPOSABLE CUPS HUNG ANY
SURFACE
ITAY HADAD
21/10/0122
‫דיספנסר חד פעמי לכוסות חד פעמיות‬
‫הנתלה בכל משטח‬
‫איתי חדד‬
511546
DISPOSABLE DISPENSER
CONTAINING PAPER NAPKINS AND
TOOTHPICKS
ITAY HADAD
2//10/0122
511551
METHOD AND APPARATUS FOR
BABY BOTTLE
SHOSI SARAF
125
B65D )5010.01(
‫דיספנסר חד פעמי המכיל מפיות נייר‬
‫וקיסמי שיניים‬
‫איתי חדד‬
F21V )5010.01(
‫מחזיק נר‬
‫פתרונות עדכניים חדשניים‬-‫חברת פענח‬
‫בע"מ‬
CANDLE HOLDER
2//10/0122
B65D )5010.01(
511555
A61J )5010.01(
‫ ומתקן לבקבוקי תינוקות‬,‫שיטה‬
‫שושי שרף‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
2//10/0122
511552
METHOD SYSTEM AND DEVICE FOR
CHECKS PAYMENTS
FITOUSSI ANDRE NISSIM
2//10/0122
‫ מערכת ומתקן לתשלום בצ'קים‬,‫שיטה‬
‫פיטוסי אנדרי ניסים‬
511554
B01D )5010.01(
‫שיטה‬
‫רום רז‬
METHOD
ROM RAZ
2//21/011/
G06F )5010.01(
511555
COP1 MOLECULES AND USES
THEREOF
GENENTECH, INC.
G01N )5010.01(
‫ והשימוש בהם‬COP1 ‫פרודות‬
PCT/US/2004/034174
WO/2006/043938
01/11/0111
511551
METHOD FOR FORMATION OF AN
ENERGIZED OPHTHALMIC DEVICE
JOHNSON & JOHNSON VISION CARE,
INC.
US
61/100988
29/09/2008
20/11/101
00/11/0111
US
PCT/US/2009/058380
126
B29D )5010.01(
‫שיטה ליצור התקן אופטלמי טעון באנרגיה‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
WO/2010/036893
01/11/0111
511551
METHOD OF FORMING AN
OPHTALMIC LENS WITH AN
ENERGY SOURCE AND A CURRENT
DRAWING COMPONENT
JOHNSON & JOHNSON VISION CARE,
INC.
US
61/101282
30/09/2008
20/111/1/
00/11/0111
US
PCT/US/2009/058382
WO/2010/039610
0//11/0111
B29D )5010.01(
‫שיטה ליצירת עדשות עיניות עם מקור‬
‫אנרגיה ורכיב מתווה זרם‬
511551
METHOD AND APPARATUS FOR
FORMING A VARIABLE FOCUS
OPTHALMIC DEVICE
JOHNSON & JOHNSON VISION CARE,
INC.
US
61/101479
30/09/2008
20/11/1/1
01/11/0111
US
PCT/US/2009/058589
WO/2010/039645
10/11/0111
‫שיטה והתקן ליצירת התקן מיקוד‬
‫אופטלמי משתנה‬
511556
METHOD AND SYSTEM FOR PUNCTUAL
FASTENING A WATERPROOFING
MEMBRANE TO HYDRAULIC WORKS
CARPI TECH B.V. AMSTERDAM,
BALERNA BRANCH
IT
MI2008A001624 11/09/2008
PCT/EP/2009/006344
WO/2010/028766
127
B29D )5010.01(
E02B )5010.01(
‫שיטה ומערכת להידוק דייקן של קרום‬
‫אטום בפני מים לעבודות הידראוליות‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
2//1//0111
511510
METHOD AND FORMULATION FOR
TREATING ADVERSE BIOLOGICAL
CONDITIONS
LIVIONEX, INC.
US
61/189060
15/08/2008
PCT/US/2009/004709
WO/2010/019276
21/11/0111
‫שיטה והרכב לטיפול בתנאים ביולוגיים‬
‫מנוגדים‬
511511
METHOD AND APPARATUS FOR
MANAGING A NEW DATA
INDICATOR IN A WIRELESS
COMMUNICATION SYSTEM
QUALCOMM INCORPORATED
US
61/095676
10/09/2008
20/111/11
1//11/0111
US
PCT/US/2009/056547
WO/2010/030806
21/12/0111
N-SULFONAMIDO POLYCYCLIC
PYRAZOLYL COMPOUNDS
ELAN PHARMACEUTICALS, INC
128
H04L )5010.01(
‫שיטה והתקן לניהול אינדיקטור לנתונים‬
‫חדשים במערכת תקשורת אלחוטית‬
511515
A METHOD AND APPARATUS FOR
SIGNALING TO A MOBILE DEVICE WHICE
SET OF TRAINING SEQUENCE CODES TO
USE FOR A COMMUNICATION LINK
QUALCOMM INCORPORATED
US
PCT/US2008/076312 12/09/2008
12/211100
20/21/011/
US
PCT/US/2009/031393
WO/2010/030399
1//11/0111
A61K )5010.01(
511512
H04L )5010.01(
‫שיטה והתקן לאיתות להתקן נייד‬
‫באיזו מערכת קודי רצף אימון‬
‫להשתמש עבור קישור תקשורת‬
C07D )5010.01(
‫–סולפונאמידו פיראזול‬N ‫תרכובות‬
‫פוליציקלי‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
US
61/094799
12/1110/2
US
12/2/00//
US
12/001100
US
PCT/US/2009/055987
WO/2010/028213
2//1//0111
05/09/2008
00/11/011/
0//1//0111
2//1//0111
511514
STRONTIUM-82/RUBIDIUM-82
GENERATOR, METHOD FOR
PRODUCING A RUBIDIUM-82
COMPRISING DIAGNOSTIC AGENT
SAID DIAGNOTIC AGENT AND ITS
USE IN MEDICINE
STICHTING JEROEN BOSCH
ZIEKENHUIS
EP
08075710.7 18/08/2008
PCT/EP/2009/060584
WO/2010/020596
01/1//0111
1//1//0111
129
‫ שיטה‬,15 ‫רובידיום‬/15 ‫מחולל סטרונציום‬
,15 ‫לייצור חומר מאבחן המכיל רובידיום‬
‫ והשימוש בו ברפואה‬,‫החומר המאבחן‬
511515
[4-(5-AMINOMETHYL-2-FLUOROPHENYL)-PIPERIDIN-1-YL]-[7FLUORO-1(2-METHOXY-ETHYL)-4TRIFLUOROMETHOXY-1H-INDOL-3YL]-METHANONE AS AN INHIBITOR
OF MAST CELL TRYPTASE
SANOFI AVENTIS
US
61/091011
22/08/2008
12/11212/
00/1//011/
US
PCT/US/2009/054381
WO/2010/022196
G21G )5010.01(
C07D )5010.01(
–‫ פלורו–פניל) פיפרידין‬5–‫ אמינומתיל‬5(–4[
4 )‫ מתוקסי–אתיל‬5(–1–‫–פלורו‬1[–]‫–איל‬1
–]‫–איל‬2–‫ אינדול‬H1 –‫טריפלורומתוקסי‬
‫מטאנון כמעכבים עבור טריפטאז של תאי‬
‫מאסט‬
511511
C07C )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
IMPROVED PROCESS FOR THE
ADDITION OF THIOLATES TO ALFA,
BETA-UNSATURATED CARBONYL
OR SULFONYL COMPOUNDS
DOW AGROSCIENCES LLC
US
61/090045
19/08/2008
PCT/US/2009/053061
WO/2010/021855
‫תהליך משופר להוספת תיולטים‬
‫ בטא בלתי רוויות של‬,‫לתרכובות אלפא‬
‫קרבוניל או סולפוניל‬
511511
11/1//0111
‫נגזרות של אוקסאדיאזול לטיפול‬
‫בסוכרת‬
OXADIAZOLE DERIVATIVES FOR THE
TREATMENT OF DIABETES
MERCK PATENT GMBH
DE
102008038220.5 18/08/2008
PCT/EP/2009/004992
WO/2010/020305
21/1//0111
511511
NEW (POLY)
AMINOALKYLAMINOALKYLAMIDE,
ALKYL-UREA, OR ALKYLSULFONAMIDE DERIVATIVES OF
EPIPODOPHYLLOTOXIN, A PROCESS
FOR PREPARING THEM, AND
APPLICATION THEREOF IN
THERAPY AS ANTICANCER AGENTS
PIERRE FABRE MEDICAMENT
FR
0855629
19/08/2008
PCT/EP/2009/060739
WO/2010/020663
2//1//0111
POLYMORPHIC FORM OF
GRANISETRON HYDROCHLORIDE
AND METHODS OF MAKING THE
SAME
130
C07D )5010.01(
C07D )5010.01(
–‫נגזרות חדשות של (פולי) אמינו–אלקיל‬
‫ או‬,‫ אלקיל–אוריה‬,‫אמינו–אלקיל–אמיד‬
,‫אלקיל–סולפונאמיד לאפיפודופילוטוקסין‬
‫ ושימוש בהן בטרפיה‬,‫תהליך להכנתן‬
‫כחומרים נגד סרטן‬
511516
A61K )5010.01(
‫צורה פולימרפית של גרניסטרון‬
‫הידרוכלוריד ושיטות לייצורה‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
SCINOPHARM TAIWAN, LTD.
US
61/189421
19/08/2008
PCT/US/2009/054164
WO/2010/022052
21/1//0111
511510
ISOLATED MULTI-NETWORK
COMPUTER SYSTEM AND
APPARATUS
HIGH SEC LABS LTD
US
61/089945
19/08/2008
PCT/IL/2009/000815
WO/2010/020991
2//10/0122
01/1//0111
‫הי סק מעבדות בע"מ‬
B62D )5010.01(
‫התקן למדידת וכוונון פרמטרים גיאומטריים‬
‫של תושבת כלי – רכב‬
511515
IMPROVED CELL COMPOSITION
AND METHODS OF MAKING THE
SAME
ANTHROGENESIS CORPORATION
US
61/090577
20/08/2008
PCT/US/2009/004740
WO/2010/021714
131
‫מערכת והתקן לבידוד רשתות מחשב‬
511511
APPARATUS FOR MEASURING AND
ADJUSTING PARAMETERS OF THE
GEOMETRY OF THE WHEELED
VEHICLE CHASSIS
MYKHAYLO LOKSHYN
H04L )5010.01(
A01N )5010.01(
‫הרכב משופר של תאים ושיטות להכנתו‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
0//1//0111
511512
METHODS AND COMPOSITIONS FOR
TREATMENT OF BONE DEFECTS
WITH PLACENTAL CELL
POPULATIONS
ANTHROGENESIS CORPORATION
US
61/090897
22/08/2008
12/111/1/
00/1//011/
US
PCT/US/2009/004801
WO/2010/021756
11/11/0111
‫שיטות והרכבים לטיפול בפגמי עצמות על‬
‫ידי אוכלוסיות של תאי השליה‬
511514
PHASE COMPENSATION FOR MULTISTIMULUS CONTROLLER
APPLE INC.
US
12/283435
10/09/2008
PCT/US/2009/056413
WO/2010/030709
2//11/0111
511515
ENERGIZED OPHTHALMIC LENS
JOHNSON & JOHNSON VISION CARE,
INC.
US
61/192765
22/09/2008
20/11/2121
21/11/0111
US
PCT/US/2009/057284
WO/2010/033679
0//1//0111
N-(2-AMINOPHENYL)-4-[N(PYRIDINE-3-YL)METHOXYCARBONYLAMINOMETHYL]-BENZAMIDE (MS275) POLYMORPH B
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT
132
A61K )5010.01(
511511
G06F )5010.01(
‫פיצוי פאזה עבור בקר רב–תמריצים‬
B29D )5010.01(
‫עדשות עיניות עם ספק אנרגיה‬
C07D )5010.01(
–)‫–יל‬2–‫–(פירידין‬N[–4–)‫–אמינופניל‬N–(2
‫מתוקסיקרבוניל–אמינומתיל]–בנזאמיד‬
B ‫) פולימורף‬MS–515(
April 28, 2011-‫כ"ד בניסן התשע"א‬
EP
08163274.7
12/1101/1
US
PCT/EP/2009/006381
WO/2010/022988
21/11/0111
29/08/2008
01/1//011/
511511
NOVEL IMIDAZOLIDINE COMPOUNS
AS ANDROGEN RECEPTOR
MODULATORS
GALAPAGOS NV
US
61/191918
11/09/2008
111100081
11/12/0111
GB
PCT/EP/2009/061733
WO/2010/029119
2//1//0111
‫תרכובות אימידאזולידין חדשות כמאפננות‬
‫קולטן אנדרוגן‬
511511
DRUG INFUSION SYSTEM WITH
REUSABLE AND DISPOSABLE
COMPONENTS
CALIBRA MEDICAL, INC.
US
61/089749
18/08/2008
12/00/21/
02/1//0111
US
PCT/US/2009/054186
WO/2010/022069
21/11/0111
511516
METHODS FOR INHIBITING OCULAR
ANGIOGENSIS
GENENTECH, INC.
US
61/095757
10/09/2008
12/210110
1//21/011/
US
12/00/121
2//1//0111
US
PCT/US/2009/056557
WO/2010/030813
133
C07D )5010.01(
A61M )5010.01(
‫מערכת לעירוי תרופות עם רכיבים‬
‫לשימוש חוזר ולשימוש חד–פעמי‬
C07K )5010.01(
‫שיטות לעיכוב שגשוג כלי דם עיניים‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
01/1//0111
511510
DATA PACKET GENERATOR FOR
GENERATING PASSCODE
ESTHER FINALE LLC
US
61/090461
20/08/2008
12/211010
2//21/011/
US
12/20/011
2//20/011/
US
PCT/US/2009/054520
WO/2010/022274
10/11/0110
‫מייצר חבילות מידע ליצירת סיסמאות‬
511511
[1,2,4] TRIAZOLO [4,3-a] PYRIDINE
DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
COMPRISING THE SAME
BRISTOL-MYERS SQUIBB COMPANY
US
60/408099
04/09/2002
11//121/1
02/1//0110
US
PCT/US/2003/027513
WO/2004/021984
21/11/0111
21/11/0111
134
C07D )5010.01(
]a–4,3[ ‫] פירידין‬1,5,4[ ‫תולדות טריאזולו‬
‫ותכשירי רוקחות המכילים אותן‬
511515
COMPOSITIONS AND USE THEREOF
FOR TREATING S. PNEUMONIAE
INFECTION
BEN-GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
US
61/136516
11/09/2008
PCT/IL/2009/000883
WO/2010/029546
G06F )5010.01(
A61K )5010.01(
‫תכשירים ושימוש בהם לטיפול דלקת מ‬
PNEUMONIAE .S
‫אוניברסיטת בן גוריון בנגב הרשות למחקר‬
‫ופיתוח‬
511512
A61K )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
COMPOSITIONS AND USE THEREOF
FOR TREATING S. PNEUMONIAE
INFECTION
BEN-GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
US
61/136517
11/09/2008
PCT/IL/2009/000882
WO/2010/029545
2//1//0111
‫תכשירים ושימוש בהם לטיפול דלקת‬
.PNEUMONIAE S‫מ‬
‫אוניברסיטת בן גוריון בנגב הרשות למחקר‬
‫ופיתוח‬
511514
ANTIBODIES BINDING CCR2,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
PFIZER INC.
US
61/189357
18/08/2008
PCT/US/2009/004711
WO/2010/021697
02/1//0111
FILTER TOP ASSEMBLY
LAB PRODUCTS, INC.
US
61/090783
PCT/US/2009/004780
WO/2010/021742
11/1//0111
‫ תכשירים‬,CCR5–‫נוגדים הנקשרים ל‬
‫המכילים אותם ושימושים בהם‬
511515
A01K )5010.01(
‫מכלול ראש מסנן‬
21/08/2008
511511
METHOD FOR PRODUCING A LENS
QIOPTIC PHOTONICS GMBH & CO. KG
DE
102008038245.0 18/08/2008
PCT/EP/2009/005692
WO/2010/020347
135
C07K )5010.01(
G02B )5010.01(
‫שיטה ליצור עדשה‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
0//1//0111
511511
EQUIPMENT AND METHOD FOR
PHYSICAL VAPOR DEPOSITION
KENNAMETAL INC.
US
12/194866
20/08/2008
PCT/US/2009/051806
WO/2010/021811
0//21/0110
2//10/0122
H04Q )5010.01(
‫מערכת לוידוי זהות המשתמש באמצעות‬
‫דינמיקת עכבר מחשב‬
‫אוניברסיטת בן גוריון בנגב הרשות למחקר‬
‫ופיתוח‬
511560
NEW 2-AMIDOTHIADIAZOLE
DERIVATIVES
ALMIRALL, S.A.
EP
08382042.3 14/10/2008
PCT/EP/2009/007348
136
A61K )5010.01(
‫חומרים נוגדי הפרעות קצב הניתנים באופן‬
‫ואגינלי לטיפול בכאב באגן ובחוסר פריון‬
511516
SYSTEM FOR VERIFYING USER
IDENTITY VIA MOUSE DYNAMICS
BEN-GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
20/21/0111
)PVD( ‫ציוד ושיטה לשיקוע אדים פיזי‬
511511
VAGINALLY ADMINISTERED ANTIDYSRHYTHMIC AGENTS FOR
TREATING PELVIC PAIN AND
INFERTILITY
COLUMBIA LABORATORIES
(BERMUDA) LIMITED
US
60/330684
29/10/2001
21/0//120
0//21/0110
US
PCT/EP/2002/012042
WO/2003/037381
C23C )5010.01(
C07D )5010.01(
‫–אמידותיאדיאזול חדשות‬5 ‫תולדות‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
WO/2010/043377
02/1//0111
511561
PICOLINAMIDE DERIVATIVES AS
KINASE INHIBITORS
NOVARTIS AG
US
61/093666
02/09/2008
12/001111
21/1//0111
US
PCT/EP/2009/061205
WO/2010/026124
01/11/0111
511565
THIAZOLYL-PYRAZOLOPYRIMIDINE
COMPOUNDS AS SYNTHETIC
INTERMEDIATES
ELI LILLY AND COMPANY
US
61/102153
02/10/2008
PCT/US/2009/058722
WO/2010/039678
02/1//0111
511562
COMBINATION THERAPY FOR
TUBERCULOSIS
THE JOHN HOPKINS UNIVERSITY
US
61/093879
03/09/2008
PCT/IB/2009/053796
WO/2010/026526
02/21/0111
DETERMINATION OF
IMMUNOGLOBULIN ENCODING
NUCLEIC ACID
F. HOFFMANN-LA ROCHE AG
137
511564
C07D )5010.01(
‫תולדות פיקולינאמיד כמעכבי קינאז‬
C07D )5010.01(
‫תרכובות טיאזוליל–פיראזולופירימידין‬
‫כתוצרי ביניים סינטטיים‬
A61K )5010.01(
‫תרפיית קומבינציה לשחפת‬
C12Q )5010.01(
‫הגדרת חומצת גרעין המקודדת‬
‫לאימונוגלובולין‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
EP
08018698.4
PCT/EP/2009/007521
WO/2010/046094
2//11/0111
23/10/2008
511565
STABLE LIQUID ANTIBODY
FORMULATION
PFIZER INC.
US
61/098305
19/09/2008
PCT/IB/2009/054111
WO/2010/032220
2//10/0122
511561
INDICATOR POSITION DETECTING
DEVICE AND INDICATOR POSITION
DETECTING METHOD
WACOM CO., LTD.
2010JP
30/03/2010
077141
01/1//0111
511561
COMPOSITIONS OF PD-1
ANTAGONISTS AND METHODS OF
USE
AMPLIMMUNE, INC.
US
61/091709
25/08/2008
12/11211/
01/1//011/
US
12/112/11
01/1//011/
US
12/02211/
10/1//0111
US
PCT/US/2009/004825
WO/2010/027423
138
A61K )5010.01(
‫פורמולציית נוגדן נוזלית יציבה‬
G08B )5010.01(
‫התקן ושיטה לאיתור אינדיקטור מיקום‬
C07K )5010.01(
PD–1 ‫תרכובות של אנטאגוניסטים של‬
‫ושיטות לשימוש‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
01/1//0111
511566
PD-1 ANTAGONISTS AND METHODS
OF USE THEREOF
AMPLIMMUNE, INC
US
61/091705
25/08/2008
12/11211/
01/1//011/
US
12/112/11
01/1//011/
US
12/112110
01/1//011/
US
12/2/01//
11/12/0111
US
12/211110
12/1//0111
US
PCT/US/2009/054971
WO/2010/027828
02/1//0111
511200
PROCESSES FOR THE PREPARATION
OF SGLT2 INHIBITORS
THERACOS, INC
US
61/091248
22/08/2008
PCT/US/2009/054585
WO/2010/022313
2//10/0122
511201
ACCOMMODATING APPARATUS
CONNECTING TO FAUCET
ALBERT ZERBIB SALOMON
01/1//0111
‫ ושיטות‬PD–1 ‫אנטאגוניסטים של‬
‫לשימושם‬
C07D )5010.01(
SGLT5 ‫תהליכים להכנת מעכבי‬
E03C )5010.01(
‫מתקן אכסון המתחבר לברז‬
‫אלברט זרביב סלומון‬
511205
A METHOD AND APPARATUS FOR
PERSONAL SKIN TREATMENT
SYNERON MEDICAL LTD
US
61/098774
21/09/2008
12/2/1112
01/11/0111
US
139
C07K )5010.01(
A61B )5010.01(
‫מכשיר ושיטה לטיפול אישי בעור‬
‫סינרון מדיקל בע"מ‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
PCT/IL/2009/000817
WO/2010/032235
01/10/0122
511202
A CAN AND METHOD FOR USING
THEREOF
OFIR MAGOR
01/10/0122
‫קופסת שימורים ושיטה לשימוש בה‬
‫אופיר מגור‬
511204
IMPROVEMENTS IN FUR HAT
PRODUCTION
BRIZEL ISRAEL
0//11/011/
PH-DEPENDENT CONTROLLED
RELEASE PHARMACEUTICAL
COMPOSITION FOR NON-OPIOIDS
WITH RESISTANCE AGAINST THE
INFLUENCE OF ETHANOL
EVONIK ROHM GMBH
B05C )5010.01(
A42C )5010.01(
‫שכלולים בייצור כובעי פרווה‬
‫בריזל ישראל‬
511205
A61K )5010.01(
‫תכשיר רוקחות בעל שחרור מבוקר התלוי‬
‫ עבור חומרים שאינם אופיאוידים עם‬PH–‫ב‬
‫עמידות בפני השפעת אתנול‬
PCT/EP/2008/062767
WO/2010/034344
0//11/011/
140
511201
A61K )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
PH-DEPENDENT CONTROLLED
RELEASE PHARMACEUTICAL
OPIOID COMPOSITION WITH
RESISTANCE AGAINST THE
INFLUENCE OF ETHANOL
EVONIK ROHM GMBH
‫תכשיר אופיאויד רוקחי בעל שחרור מבוקר‬
‫ עם עמידות להשפעת אתנול‬PH–‫התלוי ב‬
PCT/EP/2008/062761
WO/2010/034342
21/21/0111
511201
PROCESS FOR PREPARING
CINACALCET
ZACH SYSTEM S.P.A.
EP
08167762.7 28/10/2008
PCT/EP/2009/063603
WO/2010/049293
01/1//011/
511201
C07C )5010.01(
‫תהליך להכנת סינאכאלצט‬
F03B )5010.01(
‫יחידת כוח גלית‬
A WAVE-POWER UNIT
SEABASED AB
PCT/SE/2008/050963
WO/2010/024740
2//11/0111
511206
BINDER OF ENERGIZED
COMPONENTS IN AN OPHTHALMIC
LENS
JOHNSON & JOHNSON VISION CARE,
INC.
US
61/192765
22/09/2008
20/11/121
21/11/0111
US
20/11/1/1
21/11/0111
US
PCT/US/2009/057289
WO/2010/033683
141
B29D )5010.01(
‫כורכן של רכיבים עם מקור אנרגיה‬
‫בעדשות עיניות‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
02/1//0111
511210
METHOD FOR PRODUCING DOUBLECROSSLINKED COLLAGEN
FIBROGEN, INC.
US
61/189988
22/08/2008
PCT/US/2009/004774
WO/2010/021738
01/1//0111
511211
PYRROLO [1,2-B] PYRIDAZINE
DERIVATIVES AND THEIR USE AS
HIF MODULATORS
FIBROGEN, INC.
US
61/090468
20/08/2008
PCT/US/2009/054473
WO/2010/022240
01/1//0111
511215
TREATMENT OF STROKE USING
ISOLATED PLACENTAL CELLS
ANTHROGENESIS CORPORATION
US
61/090565
20/08/2008
PCT/US/2009/004741
WO/2010/021715
01/11/0111
511212
COMPOUNDS, COMPOSITIONS AND
METHODS FOR THE TREATMENT OF
?-AMYLOID DISEASES AND
SYNUCLEINOPATHIES
PROTEOTECH, INC.
US
12/244968
03/10/2008
142
C07K )5010.01(
‫שיטה לייצור קולגן מצולב‬
C07D )5010.01(
‫] פירידאזין ושימוש‬B–5,1[ ‫תולדות פירולו‬
HIF ‫בהן כמאפננות‬
C12N )5010.01(
‫טיפול בשבץ על ידי שימוש בתאים‬
‫מבודדים של השליה‬
A01N )5010.01(
‫ הרכבים ושיטות לטיפול‬,‫תרכובות‬
‫במחלות הקשורות לבטא–אמילויד‬
‫ובסינוקלינופאטיס‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
PCT/US/2009/048855
WO/2010/039308
2//11/0111
511214
PHARMACEUTICAL DOSAGE FORMS
COMPRISING POLY (?CAPROLACTONE)
PURDUE PHARMA L.P.
US
61/098089
18/09/2008
12/000/1/
1//1//0111
US
PCT/IB/2009/006917
WO/2010/032128
2//11/0111
A61K )5010.01(
‫תכשירי מינון פרמצבטיים המכילים פולי‬
)‫(?–קפרוקטון‬
511216
‫בורג דחיסה אורתופדי‬
ORTHOPEDIC COMPRESSION SCREW
ORTHOHELIX SURGICAL DESIGNS,
INC.
US
12/283777
16/09/2008
PCT/US/2009/005140
WO/2010/033172
21/11/0111
511250
TET SYSTEM FOR IMPLANTED
MEDICAL DEVICE
HEARTWARE, INC.
US
61/191595
10/09/2008
PCT/US/2009/005108
WO/2010/030378
02/1//0111
143
A61B )5010.01(
A61N )5010.01(
‫ להתקן רפואי מושתל‬TET ‫מערכת‬
511251
H04L )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
METHOD AND SYSTEM FOR
INTEGRATING PLURALITY OF
BUILDING MANAGEMENT SERVICES
AND HOME AUTOMATION SERVICES
WITH PLURALITY OF MULTI-PLAY
SERVICES ON NEUTRAL ACCESS
NETWORK OPERATION BASIS
HARI, SHANKER SINGH
IN
2046/DEL/2008 29/08/2008
PCT/IN/2009/000475
WO/2010/035280
01/10/0122
511255
DEVICE FOR EMULATING REMOTE
CONTROL FOR A VEHICLE
BOAZ FEMSON
0//1//0111
‫בועז פמסון‬
511252
511254
INFLUENZA VIRAL VECTOR
CONTAINING INCORPORATION
SEQUENCES
WISCONSIN ALUMNI RESEARCH
FOUNDATION
US
60/356538
13/02/2002
11///01/1
1//12/0110
US
PCT/US/2003/004233
144
G08C )5010.01(
‫התקן להעתקת שלט רחוק לכלי רכב‬
RUBBERIZED ASPHALT PELLETS
BILLIAN I.P. LIMITED
US
61/093193
29/08/2008
20/1//210
01/1//0111
US
PCT/US/2009/055129
WO/2010/025212
20/10/0110
‫שיטה ומערכת לשילוב ריבוי שירותי‬
‫ניהול בניה ושירותי מיכון ביתי עם ריבוי‬
‫שירותים רבי–משתמשים על פעולת‬
‫רשת בעלת נגישות נייטרלית‬
C08L )5010.01(
‫כדורי אספלט העשויים מגומי‬
C12N )5010.01(
‫וקטור נגיפי המכיל רצפי הכללה‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
WO/2003/068923
02/10/0122
511255
‫מחזיק ספר בישול למטבח‬
‫שחר דוידזון‬
COOK BOOK HOLDER
SHAHAR DAVIDSON
02/10/0122
511251
CUTTING TOOL AND CUTTING
INSET THEREFOR
ISCAR LTD.
02/10/0122
IMPROVEMENTS IN THE
ABSORPTION OF THERAPEUTIC
AGENTS ACROSS MUCOSAL
MEMBRANES OR THE SKIN
CRITICAL PHARMACEUTICALS
LIMITED
145
B23C )5010.01(
‫כלי חיתוך ושימת חיתוך עבורו‬
‫ישקר בע"מ‬
511251
A METHOD OF REMOVING DENTAL
CEMENT FROM DENTAL
RESTORATIONS
JOSEPH FISH
2//11/0111
B42D )5010.01(
511251
A61K )5010.01(
‫שיטה להסרת צמנט דנטלי משחזורים‬
‫דנטליים‬
‫יוסף פיש‬
A61K )5010.01(
‫שיפורים בספיגת חומרים טיפוליים דרך‬
‫קרומים ריריים או העור‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
GB
0816642.3
1/01/1181
GB
PCT/GB/2009/051188
WO/2010/029374
01/1//0111
12/09/2008
20/22/011/
511256
MODULAR DIGITAL TELEVISION
DECODER
NOVABASE DIGITAL TV
TECHNOLOGIES GMBH
EP
08015137.6 27/08/2008
PCT/EP/2009/006191
WO/2010/022935
‫מפענח מודולרי לטלויזיה דיגיטלית‬
511220
10/11/0111
LABEL, ESPECIALLY FOR A REUSABLE
CONTAINER
CCL LABEL MEERANE GMBH
DE
102008045547.4 03/09/2008
PCT/EP/2009/061351
WO/2010/026163
20/1//0111
146
C09J )5010.01(
‫ במיוחד למיכל בשימוש חוזר‬,‫תווית‬
511221
PROCESS FOR BROMINATING
UNSATURATED ORGANIC
COMPOUNDS USING A
QUATERNARY PHOSPHONIUM
TRIBROMIDE AS THE BROMINATING
AGENT
DOW GLOBAL TECHNOLOGIES INC.
US
61/090954
22/08/2008
PCT/US/2009/053699
WO/2010/021906
H04N )5010.01(
C08F )5010.01(
‫תהליך לברומינציה של תרכובות אורגניות‬
‫בלתי רוויות על–ידי שימוש בפוספוניום‬
‫ כגורם ברומינציה‬,‫ תלת–ברומידי‬,‫רביעוני‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
02/21/0111
511225
SYSTEMS AND METHODS FOR
CONTROL OF A VEHICLE
IROBOT CORPORATION
US
10/972082
22/10/2004
21/1/2/0/
00/21/011/
US
21/1/2/01
00/21/011/
US
21/1/01/2
00/21/011/
US
21/1/2/2/
00/21/011/
US
21/11/0111
511222
PROCESS FOR REMOVING
HYDROGEN CYANIDE FROM
ETHANEDINITRILE
LONZA AG
EP
08018429.4 22/10/2008
12/22/02/
20/22/011/
US
PCT/EP/2009/006658
WO/2010/046004
1//11/0111
511224
BOTTLE CAP
BIO CLINICAL DEVELOPMENT, INC
US
61/099328
23/09/2008
20///1//1
10/11/0111
US
PCT/US/2009/046211
WO/2010/036416
01/1//0111
PYRROLE COMPOUNDS
TAKEDA PHARMACEUTICAL
COMPANY LIMITED
147
511225
B60W )5010.01(
‫מערכות ושיטות לשליטה ברכב‬
C01C )5010.01(
‫שיטה לסילוק מימן ציאנידי‬
‫מאתאנדיניטריל‬
B65D )5010.01(
‫פקק לבקבוק‬
C07D )5010.01(
‫תתרכובות פירול‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
2008218851
011/-011111
JP
PCT/JP/2009/065279
WO/2010/024451
JP
21/11/011/
27/08/2008
2//21/011/
511221
OXYGEN SCAVENGER FOR LOW
MOISTURE ENVIRONMENT AND
METHODS OF USING THE SAME
MULTISORB TECHNOLOGIES, INC.
US
10/677582
02/10/2003
PCT/US/2004/015823
WO/2005/040304
02/1//0111
‫מנקה לחמצן בסביבה בעלת לחות נמוכה‬
‫והשימוש בו‬
511221
INDEXING SYSTEM
MANGO MOON TRADING 1138 CC
ZA
2008/07257 21/08/2008
PCT/IB/2009/053690
WO/2010/020963
02/10/0122
511221
IMPROVED DATA ENTRY SYSTEMS
BENJAMIN FIROOZ GHASSABIAN
0//1//0111
148
C09K )5010.01(
511240
G06F )5010.01(
‫מערכת מפתוח‬
G06F )5010.01(
‫שיטות משופרות להכנסת נתונים‬
‫בנימין פירוז גסביאן‬
H05H )5010.01(
April 28, 2011-‫כ"ד בניסן התשע"א‬
SYSTEM FOR ENHANCING
PREIGNITION CONDITIONS OF
THERMONUCLEAR FUSION
REATIONS
ADVANCED FUSION SYSTEMS LLC
US
61/190435
28/08/2008
12/022//1
0//10/0111
US
PCT/US/2009/055448
WO/2010/047880
00/10/0122
‫מערכת לחיזוק תנאי הצתה מוקדמת של‬
‫ראקצית היתוך גרעיני‬
511245
A PEN DISPENSER AND METHOD
THEREFOR
GITTELMAN NAFTALI
1//10/011/
‫מנפק עטים ושיטה עבורו‬
‫גיטלמן נפתלי‬
511251
PON POLYPEPTIDES,
POLYNUCLEOTIDES ENCODING
SAME AND COMPOSITIONS AND
METHODS UTILIZING SAME
YEDA RESEARCH AND
DEVELOPMENT CO. LTD.
US
60/451267
04/03/2003
11/120101
00/21/0110
US
PCT/IL/2004/000216
WO/2004/078991
0//1//0111
C12N )5010.01(
PON ‫פולינוקלאוטידים ופוליפפטידים של‬
‫ותכשירים הכוללים אותם ושיטות‬
‫לשימושם‬
511214
DIRECTIONAL EXPANSION OF
INTRALUMINAL DEVICES
CARLOS VONDERWALDE
US
61/092561
28/08/2008
PCT/CA/2009/001198
149
B65D )5010.01(
‫ידע חברה למחקר ופיתוח בע"מ‬
A61F )5010.01(
– ‫הרחבה כיוונית של מכשירים פנים‬
‫חלליים‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
WO/2010/022516
11/10/0111
511215
VACCINE COMPRISING PROTEIN
NMB0964 FROM NEISSERIA
MENINGITIDIS
UTRECHT UNIVERSITY
GB
0816447.7
08/09/2008
PCT/EP/2009/052689
WO/2010/025964
2//11/0111
–‫ מ‬NMB0964 ‫חיסון המכיל חלבון‬
MENINGITIDIS NEISSERIA
511211
ANTI-CANCER DRUGS AND USES
RELATING THERETO FOR
METASTATIC MALIGNANT
MELANOMA AND OTHER CANCERS
KASINA LAILA INNOVA
PHARMACEUTICALS PRIVATE
LIMITED
IN
2230/CHE/08 15/09/2008
PCT/IN/2009/000504
WO/2010/029577
2//20/011/
150
C07D )5010.01(
‫תרופות נגד סרטן ושימושים הקשורים‬
‫אליהן עבור מלנומה ממאירה גרורתית‬
‫וסוגי סרטן אחרים‬
511211
AN ANTIBODY, A FRAGMENT
THEREOF, A METHOD OF
PREPARING THE SAME AND A USE
OF THE ANTIBODY
GENENTECH, INC.
US
60/531409
19/12/2003
PCT/US/2004/042619
WO/2005/063816
A61K )5010.01(
C07K )5010.01(
‫ שיטה להכנתו ושימושים‬,‫ חלקי נוגדן‬,‫נוגדן‬
‫של הנוגדן‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
21/11/0111
511211
‫תכשירים ושיטות לויסות אוסמו מולריות‬
‫של תא‬
COMPOSITIONS AND METHODS FOR
REGULATING CELL OSMOLARITY
GENENTECH, INC.
US
61/097149
15/09/2008
PCT/US/2009/057031
WO/2010/031074
00/11/0111
511216
LIGANDS FOR AGGREGATED TAU
MOLECULES
WISTA LABORATORIES LTD.
US
61/099,376
23/09/2008
PCT/GB/2009/002260
WO/2010/034982
21/21/0111
2//1//0111
A61K )5010.01(
‫טיפול בסכרת בחולים עם בקרה גליקמית‬
‫שאינה מספקת למרות טיפול עם תרופה‬
‫נגד סכרת אוראלית או שאינה אוראלית‬
511211
NON-LETHAL VARIABLE DISTANCE
ELECTRONIC TIMED PAYLOAD
PROJECTILE AMMUNITIONS
G01N )5010.01(
‫ליגדנים עבור צבר מוליקולות טאו‬
511210
TREATMENT FOR DIABETES IN
PATIENTS WITH INSUFFICIENT
GLYCEMIC CONTROL DESPTIE
THERAPY WITH AN ORAL OR NONORAL ANTIDIABETIC DRUG
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
08166829.5 16/10/2008
12/211121
21/21/011/
US
1121/01/81
11/1//0111
EP
PCT/EP/2009/063511
WO/2010/043688
C12N )5010.01(
B67D )5010.01(
‫תחמושת קליע עם מטען יעודי המתוזמן‬
–‫אלקטרונית עם מרחק משתנה בלתי‬
‫קטלנית‬
SAFARILAND, LLC
151
April 28, 2011-‫כ"ד בניסן התשע"א‬
US
61/190603
PCT/US/2009/054068
WO/2010/096085
29/08/2008
02/1//0111
511215
‫תבניות לבנים ושיטה‬
BLOCK MOULDS AND METHOD
BENEX TECHNOLOGIES PTY LTD.
AU
2008904457 29/08/2008
PCT/AU/2009/001129
WO/2010/022475
0//11/0111
511212
METHOD AND APPARATUS FOR
CONNECTING AC POWERED
SWITCHES, CURRENT SENSORS AND
CONTROL DEVICES VIA TWO IR,
FIBER OPTIC AND LIGHT GUIDE
CABLES
ELBEX VIDEO LTD
US
12/236656
24/09/2008
PCT/US/2009/048376
WO/2010/036431
00/10/0122
SYSTEM AND METHOD TO
INCREASE EFFICIENCY IN
MATCHING CANDIDATES TO JOB
OFFERS WHILE
SARUSI SHLOMIT
152
B28B )5010.01(
H04M )5010.01(
‫ חיישני זרם‬,‫שיטה ומכשיר לחיבור מתגים‬
‫ המופעלים בעזרת זרם‬,‫ומכשירי בקרה‬
‫ וכבלים‬,‫ דרך אינפרא–אדום דו כיווני‬,‫ישיר‬
‫ סיב אופטי ומובילי אור‬:‫מסוג‬
511211
‫אלבקס וידאו בע"מ‬
G06F )5010.01(
‫שיטה ומערכת להגדלת יעילות התאמת‬
‫מועמדים להצעות עבודה תוך שמירת‬
‫פרטיות המועמד‬
‫סרוסי שלומית‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
10/11/0111
511211
PHOTOELECTRIC STRUCTURE AND
METHOD OF MANUFACTURING
THEREOF
GADI GOLAN
US
61/190592
02/09/2008
PCT/IL/2009/000848
WO/2010/026576
21/22/0111
02/1//0111
‫מבנה פוטואלקטרי ושיטה ליצורו‬
‫גדי גולן‬
511216
RESISTANCE TO POST HARVEST
DETERIORATION IN CUCUMBER
RIJK ZWAAN ZAADTEELT EN
ZAADHANDEL B.V.
EP
08020156.9 19/11/2008
12/20210/
22/20/011/
US
PCT/EP/2009/065509
WO/2010/057960
QUANTUM DOTS, METHODS OF
MAKING QUANTUM DOTS, AND
METHODS OF USING QUANTUM
DOTS
EMORY UNIVERSITY
153
A01H )5010.01(
‫עמידות בפני קלקול של מלפפונים לאחר‬
‫קצירתם‬
511210
USE OF FUNGICIDAL COMPOUND
COMPOSITIONS FOR CONTROLLING
CERTAIN RUST FUNGI
BAYER CROPSCIENCE AG
EP
08163617.7 03/09/2008
1/21/0108/
1//22/011/
EP
PCT/EP/2009/006056
WO/2010/025832
10/11/0111
H01L )5010.01(
511211
A01N )5010.01(
‫שימוש בתכשירים של תרכובת קוטלת‬
‫פטריות לבקרת פטרית חילדון מסויימת‬
H01L )5010.01(
‫ שיטה ליצור נקודות‬,‫נקודות קוונטיות‬
‫קוונטיות ושיטות לשימוש בנקודות‬
‫קוונטיות‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
US
61/093801
PCT/US/2009/055831
WO/2010/028112
03/09/2008
511215
11/22/0111
PROCESS FOR THE PREPARATION
OF ETHANEDINITRILE
LONZA LTD.
EP
08019609.0 10/11/2008
12/220///
21/22/011/
US
PCT/EP/2009/007992
WO/2010/052017
511212
2//11/0111
VINYL ALCOHOL CO-POLYMER
CRYGELS, VINYL ALCOHOL COPOLYMERS, AND METHODS AND
PRODUCTS THEREOF
MARIA STROMME
US
61/096976
15/09/2008
PCT/IB/2009/054012
WO/2010/029517
511214
01/1//0111
A DENTAL BONE IMPLANT,
METHODS FOR IMPLANTING THE
DENTAL BONE IMPLANT AND
METHODS AND SYSTEMS FOR
MANUFACTURING DENTAL BONE
IMPLANTS
C01C )5010.01(
‫שיטה להכנת אתאן דיניטריל‬
C08F )5010.01(
,‫קריוגלים מקופולימר של ויניל אלכוהול‬
‫ ושיטות‬,‫קופולימרים של ויניל אלכוהול‬
‫ומוצרים שלהם‬
A61F )5010.01(
‫ שיטות להשתלת‬,‫שתל לעצם דנטלי‬
‫השתל לעצם דנטלי ושיטות ומערכות‬
‫לייצור שתלים לעצם דנטלי‬
‫ד"ר אנדי בויאנג'ו‬
US
61/136299
PCT/IL/2009/000826
WO/2010/023665
154
26/08/2008
April 28, 2011-‫כ"ד בניסן התשע"א‬
11/22/0110
511215
ANTI-CD33 ANTIBODIES OR
EPITOPE-BINDING FRAGMENTS
THEREOF AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THE
SAME
IMMUNOGEN, INC.
US
60/424332
07/11/2002
PCT/US/2003/032737
WO/2004/043344
0//10/0122
511211
DEVICE FOR PEOPLE RESCUE FROM
HIGH-RISE BUILDINGS
GOOTMAN PAVEL B.
0//10/0122
511216
511261
GREEN DENTAL WASTE RECYCLING
SYSTEM
ETAI BOGEM
155
‫ או קטעים מהם‬CD22 ‫נוגדנים נגד‬
‫המלכדים אפיטפים ותכשירי רוקחות‬
‫המכילים אותם‬
A62B )5010.01(
‫מבנה להצלת אנשים מבינינים של גובה‬
‫רב‬
.‫גוטמן פבל ב‬
F03D )5010.01(
‫הרוח מהעקיצה‬
‫רוסלן שבילסקי‬
WIND GYBE
VIKTOR KISLEV
0//10/0122
A61K )5010.01(
A61L )5010.01(
‫מערכת ירוקה למחזור פסולת דנטלית‬
‫איתי בוגן‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
0//10/0122
511261
RESERVOIR COVERING SYSTEM
DAVID YEKUTIELY
US
61/307457
24/02/2010
0//10/0122
511266
PROCESS AND METHOD OF
IMPLEMENTING RESERVOIR
COVERS
DAVID YEKUTIELY
US
61/307459
24/02/2010
00/21/011/
511405
METHODS OF SYNTHESIZING
HETEROMULTIMERIC
POLYPEPTIDES IN YEAST USING A
HAPLOID MATING STRATEGY
KECK GRADUATE INSTITUTE
US
60/513876
22/10/2003
PCT/US/2004/035302
WO/2005/040395
0//10/0122
A METHOD OF MAKING
AERODYNAMIC VALVES FOR
BREATHING MASKS AND ITS
IMPLEMENTATION
RUVIM LONDON
156
511452
B65D )5010.01(
‫מערכת כיסוי גוף מים‬
‫דוד יקותיאלי‬
H05K )5010.01(
‫תהליך ושיטה ליישום כיסויי גופי מים‬
‫דוד יקותיאלי‬
C12N )5010.01(
‫שיטות סינתזה של פוליפפטידים‬
‫הטרומולטימריים בשמרים המשתמשות‬
‫באסטרטגית זווג הפלואידי‬
F16K )5010.01(
‫שיטת יצור שסתום אארודינמי במסחות‬
‫רספירטוריות וביצועתה‬
‫אולג אבל‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫כ"ד בניסן התשע"א‪April 28, 2011-‬‬
‫‪157‬‬
NOTICE UNDER SECTION 26 OF THE
PATENTS LAW, 5727-1967
The applications, particulars of which are set
out below, have been accepted pursuant to
Section 17 of the Patents Law. Any person
wishing to oppose the grant of a patent on any
of the applications published here, may,
within three months from the date of this
journal, give to the Commissioner of Patents
notice under Section 30 of the Patents Law, in
the manner prescribed in regulations 57 et seq
of the Patents Regulations, 5728-1968
Particulars of the applications, where
applicable, are given in the following order:
[11] [21] Number of application
[54] Title of invention
[22] Application date
[31] [32] [33] Number and date of foreign
application – convention country.
*[51] Int.Cl.
[61] Application for patent of addition
[62] Divisional application
[71] Applicant
[72] Inventor
[87] International Publication Number
[74] Address for service
[57] Abridgement of invention (in the
language in which the specification is drawn
up)
*Note:, patent applications published in this
journal were classified according to the
International Classification version that was
in force when this journal was prepared.
158
- ‫ לחוק הפטנטים תשכ"ז‬51 ‫הודעה לפי סעיף‬
1611
‫הבקשות שפרטיהן מתפרסמים להלן קובלו‬
‫ כל המעונין‬.‫ לחוק הפטנטים‬11 ‫לפי סעיף‬
‫להתנגד למתן פטנט על פי בקשה מהבקשות‬
‫ תוך שלושה חדשים‬,‫המתפרסמות רשאי‬
‫ להגיש לרשם הפטנטים‬,‫מתאריך יומן זה‬
‫ לחוק‬20 ‫הודעת התנגדות לפי סעיף‬
‫ ואילך‬51 ‫הפטנטים בדרך הקבועה בתקנה‬
.1611 – ‫ תשכ"ח‬,‫לתקנות הפטנטים‬
‫פרטי הבקשות במידה ויישימים מובאים לפי‬
:‫סדר זה‬
‫מספר הבקשה‬
‫שם האמצאה‬
‫תאריך הבקשה‬
‫מספר ותאריך של בקשות החוץ – מדינת‬
‫האגוד‬
‫*סיווג בינלאומי‬
‫בקשה לפטנט מוסף‬
‫בקשת חלוקה‬
‫המבקש‬
‫הממציא‬
‫מס' פרסום של בקשה הבינלאומית‬
‫מען למסירת מסמכים‬
)‫תקציר האמצאה (בשפה בה ערוך הפירוט‬
‫ בקשות הפטנטים שפורסמו ביומן‬:‫**הערה‬
‫זה סווגו בהתאם לגרסת הסיווג הבינלאומי‬
‫שהייתה בתוקף בעת הכנת הבקשות‬
.‫לפרסום‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
561524
]54[
USE OF AN APO-2 LIGAND FOR
THE PREPARATION OF A
MEDICAMENT FOR THE
TREATMENT OF CANCER AND
IN-VITRO OR EX-VIVO
METHODS OF INDUCING
APOPTOSIS IN MAMMALIAN
CANCER CELLS USING SUCH
APO-2 LIGAND
]11[
]92[
]52[
]42[
]14[
]44[
08.01.1997
08/584031
]91[ 09.01.1996
]99[ US
Int. Cl.(2010.01) A61K 35//00, 38//19, 47//48, C07K 14//525, C12N 15//12, 15//28
GENENTECH, INC., U.S.A.
WO/1997/025428
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
31 AHAD HAAM STREET
21 ‫רחוב אחד העם‬
P.O. BOX 2499
‫תל אביב‬5466 .‫ד‬.‫ ת‬,
TEL AVIV 65202
A cytokine, designated Apo-2 ligand, which induces mammalian cell apoptosis is
provided. The Apo-2 ligand is believed to be a member of the TNF cytokine family.
Compositions including Apo-2 ligand chimeras, nucleic acid encoding Apo-2 ligand,
and antibodies to Apo-2 ligand are also provided. Methods of using Apo-2 ligand to
induce apoptosis and to treat pathological conditions such as cancer, are further
provided.
]54[
The applications for division
from this application have
not yet been published
‫ להכנת תרופה לטיפול‬Apo – 2 ‫שימוש בליגנד‬
‫ להשריית‬ex–vivo ‫ או‬in–vitro ‫בסרטן ושיטות‬
‫אפופטוזיס בתאי סרטן של יונק באמצעות‬
‫ כזה‬Apo – 2 ‫שימוש בליגנד‬
2210/10
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
]54[
159
POLYNUCLEOTIDES OF BREAST
CANCER RESISTANCE PROTEINS
(BCRP), NUCLEIC ACIDS,
PLASMIDS AND EXPRESSION
VECTORS ENCODING THE
137466
‫פולינוקלאוטידים של חלבונים עמידים לסרטן‬
‫השד‬
‫ פלסמידים ווקטורי‬,‫ חומצות גרעין‬,)BCRP(
‫ביטוי המקודדים אותם‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
SAME
]11[
]92[
]52[
]42[
]14[
]44[
]54[
05.02.1999
60/073763
]91[ 05.02.1998
]99[ US
Int. Cl.(2010.01) C12N 15//11, 15//12, 15//63
UNIVERSITY OF MARYLAND,
BALTIMORE, U.S.A.
WO/1999/040110
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The Breast Cancer Resistance Protein is described, as well as the cDNA encoding said
protein. This protein has been found to confer resistance to cancer chemotherapeutic
drugs.
__________________
]22[]12[
]54[
SCALE WITH MOBILE DISPLAY
]11[
]52[
]42[
]41[
]44[
26.02.2001
Int. Cl.(2008.04) G01G 21/28
RAZ-PAT LTD.
HAIM RAZ, ZEEV RAZ
RAZ-PAT LTD.,
P.O.B. 400, OMER
]54[
160
141640
‫משקל עם תצוגה ניידת‬
‫ עומר‬,‫פט בע"מ‬-‫רז‬
‫ זאב רז‬,‫חיים רז‬
,‫רז פט בע"מ‬
400 .‫ד‬.‫ת‬
‫עומר‬
A light, movable, inexpensive, household weighing scale comprising: (a) a housing
(2), at least part of the upper surface of said housing being a weighing platform (3),
weighing mechanism and a read out mechanism, at least the latter being operated by
electricity; are located in the housing; (b) characterized by having a compact display
(5) unit case, the display unit case being an integral part of the housing, the compact
unit case having an ordinary small display screen (6) and being electrically operated
and (c) whereby the weighing result is being transmitted from the housing to the
compact display unit case through transmission means located in the housing and in
the compact display unit case; and also (d) characterized by that the compact display
unit case is connected to the upper surface of the housing, both having attachment
means to be connected to each other with an option to be disconnected from each
other; and (e) the compact display unit case, being mobile and detachable and drawn
away from the housing's upper surface, but when not lifted, remains attached to the
April 28, 2011-‫כ"ד בניסן התשע"א‬
housing, and operates in such position and is an integral part of the housing.
__________________
]22[]12[
142393
–‫תהליך להכנת כוהל שעבר רזולוציה סטראו‬
‫איזומרית באמצעות הידרוליזה אנזימטית‬
‫סלקטיבית של התערובת הרצמית של האסטר‬
‫במערכת ממסים לא הומוגנית‬
]54[
PROCESS FOR THE
PREPARATION OF A
STEREOISOMERIC RESOLVED
ALCOHOL BY SELECTIVE
ENZYMATIC HYDROLYSIS OF A
RACEMIC ESTER MIXTIURE IN A
NON-HOMOGENEOUS SOLVENT
SYSTEM
]11[
]92[
]52[
]42[
08.10.1999
60/103804
]91[ 09.10.1998
]99[
Int. Cl.(2010.01) C07D 41/1/04, C12P 41//00
ALTUS PHARMACEUTICALS, INC.,
161
US
April 28, 2011-‫כ"ד בניסן התשע"א‬
]14[
]44[
]54[
U.S.A.
WO/2000/022157
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to a process for the biocatalyst-mediated enantioselective
conversion of enantiomeric mixtures of hydrophobic esters using a biphasic solvent
system. More particularly, the present invention relates to the enzyme-mediated
enantioselective synthesis of anti-viral compounds, such as 2-hydroxymethyl-5-(5fluorocytosin-1-yl)-1,3-oxathiolane (FTC) and its analogues, in a non-homogeneous
reaction system.
2022/01
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
]54[
USE OF AN ANTI CD11A
ANTIBODY IN THE
PREPARATION OF A
MEDICAMENT FOR TREATING
PSORIASIS
]11[
]92[
17.03.2000
60/125228
]91[ 19.03.1999
113215952
2331932333
133149149
2331932333
Int. Cl.(2010.01) A61K 39//395
GENENTECH, INC., U.S.A.
XOMA TECHNOLOGY, U.S.A.
]52[
]42[
145480
‫ בהכנת תרופה‬CD11a ‫שימוש בנוגדן כנגד‬
‫לטיפול פסוריאזיס‬
]99[
US
US
US
]14[
]44[
WO/2000/056363
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
A method is provided for reducing the occurrence of fever, headache, nausea and/or
vomiting associated with administration of a therapeutic compound to a mammal in
need therof, comprising administering to the mammal a first conditioning dose of a
non-target cell depleting compound which binds to a cell surface receptor on a target
mammalian cell; and administering a second therapeutic dose of the compound,
162
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
wherein the second dose is higher than the first dose.
__________________
]22[]12[
146674
‫מערכת מחשב עם משטח ממשק‬
]54[
COMPUTER SYSTEM
INTERFACE SURFACE
]11[
]92[
24.05.2000
PQ0559
]91[ 25.05.1999
]99[ AU
PQ1313
9131132333
AU
PQ3457
2532132333
AU
PQ4392
1232132333
AU
Int. Cl.(2010.01) B41J 29//00, G06F 03//03, 03//033, 03//048, 03//12
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2000/072110
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
'‫א‬51 ‫רחוב הברזל‬
26A HABARZEL ST.,
‫רמת החייל‬
RAMAT HACHAYAL 69710
]52[
]42[
]14[
]44[
]54[
163
A method and system for enabling user interaction with computer software running in
a computer system. The user interaction is via an interface, such as a sheet of paper
bearing information relating to the computer software and coded data indicative of an
interactive element relating to the computer software. A sensing device is placed in an
operative position relative to the interface surface, and senses indicating data indicative
of the interactive element. The sensing device also generates movement data indicative
of the sensing device's movement relative to the interface surface. The indicating and
movement data from the sensing device are received in a computer, and the interactive
element identified. The computer software is then operated at least partly in reliance on
the movement data, and in accordance with instructions associated with the interactive
element.
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
147093
–‫פפטיד רטרו–אינוורסו שנתקבלו מאינטרלויקין‬
3
]54[
RETRO-INVERSO PEPTIDE
DERIVED FROM INTERLEUKIN-3
]11[
]92[
]52[
]42[
]14[
]44[
16.06.2000
60/139688
]91[ 16.06.1999
]99[ US
Int. Cl.(2010.01) A61K 38//10, 38//20, A61P 25//00, C07K 05//00, 07//08, 14//54
MYELOS CORPORATION, U.S.A.
WO/2000/077028
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
Retro-inverso peptides derived from interleukin-3 (IL-3) having between 12 and about
40 amino acids and including the sequence shown in SEQ ID NO: 1. These peptides
have the same activity as native IL-3 and also have neurotrophic activity. Because of
the D-amino acid linkage in the peptides, they are less susceptible to proteolytic
degradation in vivo.
]54[
__________________
]22[]12[
]54[
164
RETRO-INVERSO PEPTIDES
DERIVED FROM INTERLEUKIN-6
147094
‫פפטידים רטרו–אינוורסו שנתקבלו‬
6–‫מאינטרלויקין‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]11[
]92[
]52[
]42[
]14[
]44[
]54[
16.06.2000
60/139687
]91[ 16.06.1999
]99[ US
Int. Cl.(2010.01) A61K 38//10, 38//20, A61P 25//00, C07K 07//02, 07//08, 14//54
MYELOS CORPORATION, U.S.A.
WO/2000/077033
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
Retro-inverso peptides derived from interleukin-6 (IL-6) having between 17 and about
40 amino acids and including the sequence shown in SEQ ID NO: 1. These peptides
have the same activity as native IL-6 and also have neurotrophic activity. Because of
the D-amino acid linkage in the peptides, they are less susceptible to proteolytic
degradation in vivo.
221110/
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
147902
‫אנטיגן לקטין טרנס ממברנה מטיפוס סי‬
‫המתבטא בסרטן בלוטת הערמונית בבני אדם‬
‫והשימוש בו‬
]54[
C-TYPE LECTIN
TRANSMEMBRANE ANTIGEN
EXPRESSED IN HUMAN
PROSTATE CANCER AND USES
THEREOF
]11[
]92[
]52[
11.08.2000
60/148935
]91[ 12.08.1999
]99[ US
Int. Cl.(2010.01) A61K 38//17, 39//395, 48//00, A61P 35//00, C07K 14//435, 14//705,
C12N 05//10, 15//12, 15//63, 15//70, C12Q 01//68, G01N 33//53
AGENSYS, INC., U.S.A.
WO/2001/012811
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]42[
]14[
]44[
]54[
165
A novel gene (designated PC-LECTIN) that is highly overexpressed in prostate cancer
and its encoded protein is described. PC-LECTIN in normal human tissues is restricted
to testis, but is highly expressed in prostate cancer. Consequently, PC-LECTIN
April 28, 2011-‫כ"ד בניסן התשע"א‬
provides a diagnostic and/or therapeutic target for prostate cancer.
221/1//
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
148153
‫ ותרכיב‬,‫שיטה לייצור תרכיב המכיל חלבוני לחץ‬
‫המיוצר ע"י השיטה הנ"ל‬
]54[
METHOD FOR PRODUCING A
VACCINE CONTAINING STRESSPROTEINS AND VACCINE
PRODUCED BY SAID METHOD
]11[
]92[
]52[
]42[
18.08.2000
9919734.5
]91[ 19.08.1999
]99[ GB
Int. Cl.(2010.01) A61K 39//00, 39//002, 39//005, 39//04, G01N 33//569
IMMUNOBIOLOGY LIMITED,
UNITED KINGDOM
WO/2001/013944
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]14[
]44[
]54[
The present invention relates to a method for producing and isolating specific
immunogenic endogenous heat shock proteins induced by the treatment of extracellular pathogens with stress inducing stimuli and vaccines prepared from such
proteins.
__________________
]22[]12[
]54[
METHODS FOR MAKING
RECOMBINANT PROTEINS
USING APOPTOSIS INHIBITORS
]11[
]92[
25.09.2000
60/156232
166
]91[
27.09.1999
148512
‫שיטות ליצור חלבונים רקומביננטיים באמצעות‬
‫מעכבי מוות תאי מתוכנן‬
]99[
US
April 28, 2011-‫כ"ד בניסן התשע"א‬
]52[
]42[
]14[
]44[
Int. Cl.(2010.01) C12N 15//67, C12P 21//02
GENENTECH, INC., U.S.A.
WO/2001/023592
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
The invention provides improved methods of making and producing recombinant
proteins in vitro cultures of host cells using apoptosis inhibitors. The use of one or
more apoptosis inhibitors in the methods can reduce apoptosis in the cell cultures and
markedly improve yield of the desired recombinant proteins.
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
150018
‫אנטיגנים סרפנטינים טרנסממברנליים‬
‫ שימושים‬,‫המבוטאים בסרטנים של הערמונית‬
‫בהם ושיטה לגילויים‬
]54[
SERPENTINE TRANSMEMBRANE
ANTIGENS EXPRESSED IN
HUMAN PROSTATE CANCERS,
THEIR USES AND AN ASSAY FOR
DETECTION THEREOF
]11[
]92[
]52[
06.12.2000
09/455486
]91[ 06.12.1999
]99[ US
Int. Cl.(2010.01) A61K 39//00, C07K 14//705, 16//28, C12N 05//18, 15//12, 15//13,
G01N 33//53
AGENSYS, INC., U.S.A.
WO/2001/040276
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]42[
]14[
]44[
]54[
167
Described is a novel family of cell surface serpentine transmembrane antigens. Two of
the proteins in this family are exclusively or predominantly expressed in the prostate,
as well as in prostate cancer, and thus members of this family have been termed
'STEAP' (Six Transmembrane Epithelial Antigen of the Prostate). Four particular
human STEAPs are described and characterized herein. The human STEAPs exhibit a
high degree of structural conservation among them but show no significant structural
homology to any known human proteins. The prototype member of the STEAP family,
STEAP-1, appears to be a type IIIa membrane protein expressed predominantly in
prostate cells in normal human tissues. Structurally, STEAP-1 is a 339 amino acid
protein characterized by a molecular topology of six transmembrane domains and
intracellular N- and C- termini, suggesting that it folds in a 'serpentine' manner into
April 28, 2011-‫כ"ד בניסן התשע"א‬
three extracellular and two intracellular loops. STEAP-1 protein expression is
maintained at high levels across various stages of prostate cancer. Moreover, STEAP-1
is highly over-expressed in certain other human cancers.
3
The applications for division
from this application have
not yet been published
22110/122111//
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
150984
‫ציטוקינים שעברו שינוי לשימוש בריפוי‬
‫סרטן‬
]54[
MODIFIED CYTOKINES FOR USE
IN CANCER THERAPY
]11[
]92[
]52[
13.02.2001
MI2000A000249 ]91[ 15.02.2000
]99[ IT
Int. Cl.(2010.01) A61K 47//48, 48//00, C07K 05//093, 07//06, 07//08, 14//525,
14//555, 14//57, 19//00, C12N 15//23, 15//28, 15//62, 15//63
FONDAZIONE CENTRO SAN
RAFFAELE DEL MONTE TABOR,
ITALY
WO/2001/061017
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]42[
]14[
]44[
]54[
Cytokine derivatives capable of homing the tumoral vessels and the antigen presenting
cells and the use thereof as antitumoral agents.
__________________
168
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
]54[
SPRINKLER OUTLET DEVICE
]11[
]52[
]42[
06.08.2002
Int. Cl.(2010.01) B05B 03//10
NAAN-DAN IRRIGATION
SYSTEMS LTD.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]44[
]54[
151105
‫התקן יציאה עבור ממטרה‬
‫דן מערכות השקייה בע"מ‬-‫נען‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A sprinkler comprising: a sprinkler body including a water inlet and a water outlet,
said water outlet (10) comprising: a water path portion (12) defining a water path
about a water path axis (14), said water path portion including a water inlet portion
(22) defining a water path inlet (24) and a water outlet portion (26), said water inlet
portion defining a water flow path from said water path inlet towards said water outlet
portion and a plurality of radially inwardly directed ribs (30) extending inwardly from
an inner facing surface (32) of said inlet portion, said radially inwardly directed ribs
having a non-uniform cross section selected such that the separation between the ribs
along the radial extent thereof is generally uniform.
1.
169
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
151568
‫ המותאמים להתמוסס‬,‫פילמים מוצקים אכילים‬
‫בפה המכילים לפחות פולימר מסיס במים‬
‫וקומפלקס ספיחה ושיטות להכנתם‬
]54[
ORALLY CONSUMABLE SOLID
FILMS ADAPTED TO DISSOLVE
IN THE MOUTH, COMPRISING
AT LEAST ONE WATER
SOLUBLE POLYMER AND AN
ADSORPTION COMPLEX AND
METHODS FOR THEIR
PREPARATION
]11[
]92[
]52[
]42[
23.01.2001
09/535005
]91[ 23.03.2000
]99[ US
Int. Cl.(2010.01) A61K 09//00, 09//20, 47//48
WARNER-LAMBERT COMPANY
LLC, U.S.A.
WO/2001/070194
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Physiologically acceptable films, including edible films, are disclosed. The films
include a water soluble film-forming polymer, such as pullulan, and a taste masked
pharmaceutically active agent, such as dextromethorphan. The taste masking agent is
preferably a sulfonated polymer ion exchange resin comprising polystyrene crosslinked with divinylbenzene, such as Amberlite 3Methods for producing the films are
also disclosed3
]14[
]44[
]54[
The applications for division
from this application have
not yet been published
2022//0
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
170
152325
April 28, 2011-‫כ"ד בניסן התשע"א‬
]54[
BIS-(N,N'-BIS-(2HALOETHYL)AMINO)
PHOSPHORAMIDATES AS
ANTITUMOR AGENTS
]11[
]92[
]52[
02.05.2001
09/563181
]91[ 02.05.2000
]99[ US
Int. Cl.(2010.01) A61K 31//664, 45//00, A61P 31//10, 33//00, 35//00, C07F 09//00,
09//24
TELIK, INC., U.S.A.
WO/2001/083496
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]42[
]14[
]44[
]54[
)‫–הלואתיל) אמינו‬2(–‫'–ביס‬N,N(–‫ביס‬
‫פוספוראמידטים כגורמי נוגדי גידול‬
The present invention relates to chemical compounds, methods of treatment,
pharmaceutical compositions, and processes for their preparation. The compounds
possess anti-tumor activities or are capable of being modified to have anti-tumor
activities, and therefore, this invention particularly relates to the use of the compounds
in methods for the treatment of tumors and especially for the treatment of cancer, as
well as to the processes for their preparation.
__________________
]22[]12[
153265
]54[
METHOD AND APPARATUS FOR
EFFICIENT MANAGEMENT OF
XML DOCUMENTS
]11[
]92[
]52[
]42[
01.06.2001
09/588195
]91[ 06.06.2000
]99[ US
Int. Cl.(2010.01) G06F 12//00, 17//22, 17//27, 17//30
MICROSOFT CORPORATION,
U.S.A.
WO/2001/095155
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]44[
]54[
171
XML ‫שיטה והתקן לניהול יעיל של מסמכי‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
An in-memory storage manager represents XML-compliant documents as a collection
of objects in memory. The collection of objects allows the storage manager to
manipulate the document, or parts of the document with a consistent interface and to
April 28, 2011-‫כ"ד בניסן התשע"א‬
provide for features that are not available in conventional XML documents, such as
element attributes with types other than text and documents that contain binary rather
than text information. In addition, in the storage manager, the XML-compliant
document is associated with a schema document which defines the arrangement of the
document elements and attibutes. The schema data associated with a document can
contain a mapping between document elements and program code to be associated
with each element. The storage manager further has methods for retrieving the code
from the element tag. The retrieved code can then be invoked using attributes and
content from the associated element and the element then acts like a conventional
object. Further, the storage manager allows real-time access by separate process
operating in different contexts. The objects that are used to represent the document are
constructed from common code found locally in each process. In addition, the data in
the objects is also stored in memory local to each process. The local memories are
synchronized by means of a distributed memory system that continually equates the
data copies of the same element in different processes. Client-specified collections are
managed by a separate collection manager. The collection manager maintains a data
structure called a 'waffle' that represents the XML data structures in tabular form. A
record set engine that is driven by user commands propagates a set of updates for a
collection to the collection manager. Based on those updates, the collection manager
updates index structures and may notify waffle users via the notification system.
__________________
]22[]12[
153464
‫תרופה הנתנת דרך הפה בצורת מינון לשחרור‬
‫מבוקר‬
]54[
CONTROLLED RELEASE ORAL
DRUG DOSAGE FORM
]11[
]92[
]52[
]42[
]14[
]44[
26.02.2001
598061
]91[ 20.06.2000
]99[ US
Int. Cl.(2010.01) A61K 09//00, 09//20, 09//22, 47//36, 47//38
DEPOMED, INC., U.S.A.
WO/2001/097783
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
172
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
April 28, 2011-‫כ"ד בניסן התשע"א‬
]54[
JERUSALEM 91013
The retention of oral drug dosage forms in the stomach is improved by using swellable
dosage forms that are shaped in a manner that will prevent them from inadvertently
passing through the pylorus as a result of being in a particular orientation. The planar
projection of the shape is one that has two orthogonal axes of different lengths, the
longer being short enough to permit easy swallowing prior to swelling while the
shorter is long enough within one-half hour of swelling to prevent passage through the
pylorus.
__________________
]22[]12[
154209
‫פרומוטר לביטוי של חלבונים הטרולוגיים ברמה‬
‫גבוהה‬
]54[
PROMOTER FOR HIGH LEVEL
EXPRESSION OF
HETEROLOGOUS PROTEINS
]11[
]92[
]52[
]42[
16.09.2001
138529
]91[ 18.09.2000
]99[ IL
Int. Cl.(2010.01) C12N 01//21, 09//02, 15//67, 15//74
YEDA RESEARCH AND
‫ רחובות‬,‫ידע חברה למחקר ופיתוח בע"מ‬
DEVELOPMENT CO. LTD.
‫ציונה‬-‫ נס‬,‫פרוכון בע"מ‬
PROCHON LTD.
MOSHE PERETZ, OREN BOGIN,
‫ יגאל‬,‫ אבנר יאיון‬,‫ אורן בוגין‬,‫משה פרץ‬
AVNER YAYON, YIGAL BURSTEIN
‫בורשטיין‬
WO/2002/022779
WEBB & CO.,
,'‫ד"ר וב ושות‬
2 PEKERIS ST., P.O.B. 2189,
5 ‫רח' פקריס‬
REHOVOT 76121
‫רחובות‬5116 .‫ד‬.‫ ת‬,
The present invention discloses the isolation and use of a specific bacterial promoter
region suitable for use in constructs for the high level production of heterologous
proteins. This promoter is derived from the bacterial gene encoding for alcohol
dehydrogenase, in particular the alcohol dehydrogenase genes isolated from the
thermophilic bacterial strain T. brockii and the mesophilic bacterial strain Clostridium
beijerinckii. It is now disclosed that using either the intact promoter region or certain
specific fragments consisting of at least a 88bp DNA sequence in the upstream
untranslated region of the bacterial alcohol dehydrogenase gene, operatively linked to
the nucleic acid sequences encoding a heterologous protein, and insertion into a DNA
plasmid or any other suitable vector system, hereologous genes can be expressed in
high levels in host cells. Heterologous proteins or peptides can be expessed
constitutively at high levels. The proteins are obtained in their active folded form.
]41[
]14[
]44[
]54[
173
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
155492
‫שיטה והתקן להדפסת תוכנית לעיבוד דמויות‬
‫ומידע של דמויות מועבד על גבי תמונות‬
]54[
METHOD AND APPARATUS FOR
PRINTING IMAGE PROCESSING
PROGRAM AND PROCESSED
IMAGE DATA ON
PHOTOGRAPHS
]11[
]92[
]52[
]42[
19.10.2001
09/693083
]91[ 20.10.2000
]99[ US
Int. Cl.(2010.01) H04N 01//21
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2002/035450
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A method of printing digital data onto a photograph using infrared ink and using an ink
jet printing process is disclosed. The data can store the details of an image taken by a
camera, which has been transformed by a proprietary image processing program,
loaded separately into the camera, along with a copy of the program, the data being
recorded in a fault tolerant form enabling the copying or recovery of the transformed
photograph or of the original thereof notwithstanding damage thereto.
]14[
]44[
]54[
__________________
174
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
155692
‫מערכת ושיטה ליצירת מבחן עם מגבלות‬
‫דינאמיות באנליזה סטטית‬
]54[
SYSTEM AND METHOD FOR
TEST GENERATION WITH
DYNAMIC CONSTRAINTS USING
STATIC ANALYSIS
]11[
]92[
31.10.2001
60/245146
]91[ 03.11.2000
]99[ US
133433111
1131931112
US
Int. Cl.(2010.01) G01R 31//3183, G06F 11//22, 17//50
VERISITY LTD.
AMOS NOY
]52[
]42[
]14[
]44[
]54[
‫ ראש העין‬,‫וריסיטי בע"מ‬
‫עמוס נוי‬
WO/2002/037340
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
A system and method for testing the quality of a simulation model for the DUT (device
under test) with dynamic constraint solving and test generation for the testing and
verification process. The present invention provides such dynamic constraint solving
through the creation of a sequence of instructions in a 'generator mini-language
(GML). These instructions are then executed in order to provide a correct random
solution to any given set of dynamic constraints. the process of execution is preferably
performed by a constraint resolution engine, optionally and more preferably
implimented as software, which manages the requirements imposed by the constraints
on the execution, while simultaneously enabling a random solution to the set of
constraints to be provided. Such a constraint resolution engine may optionally be
viewed as a type of state machine, in which the individual elements of the state
machine are more preferably represented by one or more dynamic graph(s).
__________________
175
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
156361
]54[
NON-AQUEOUS NSAID
FORMULATIONS COMPRISING
BIO-COMPATIBLE OIL CARRIER
INCLUDING A PHOSPHOLIPID
FOR PROTECTING THE
GASTROINTESTINAL TRACT
AND PROVIDING THERAPEUTIC
ACTIVITY AND METHOD FOR
PREPARATION THEREOF
]11[
]92[
]52[
]42[
19.12.2001
60/256711
]91[ 19.12.2000
]99[ US
Int. Cl.(2010.01) A61K 09//107, 31//167, 31//192, 31//616, 45//00, 47//24
THE BOARD OF REGENTS OF THE
UNIVERSITY OF TEXAS SYSTEM,
U.S.A.
LENARD LICHTENBERGER
WO/2002/085414
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
1 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
A novel pharmaceutical composition is provided by which nonsteroidal antiinflammatory drugs (NSAIDs) are added directly to phospholipid-containing oil such
as lecithin oils or to a bio-compatible oil to which an phospholipid has been added to
make a NSAID-containing formulation that possess low gastrointestinal (GI) toxicity
and enhanced therapeutic activity to treat or prevent inflammation, pain, fever, platelet
aggregation, tissue ulcerations and/or other tissue disorders. The composition of the
invention are in the form of a non-aqueous solution, paste, suspension, dispersion,
colloidal suspension or in the form of an aqueous emulsion or microemulstion for
internal, oral, direct or topical administration.
]41[
]14[
]44[
]54[
176
‫ לא מימיות בעלות פעילות‬NSAID ‫פורמולציות‬
‫רפואית והמכילות נשא ביו קומפטבילי שומני‬
‫הכולל פוספוליפיד להגנה על מערכת הקיבה‬
‫והמעיים ושיטות להכנתן‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
156376
‫מערכת חישה למיקום עם פד אינטגראלי‬
‫לאיתור ותצוגת מיקום‬
]54[
POSITION SENSING SYSTEM
WITH INTEGRAL LOCATION
PAD AND POSITION DISPLAY
]11[
]92[
]52[
]42[
]44[
10.06.2003
10/173298
]91[ 17.06.2002
]99[ US
Int. Cl.(2010.01) A61B 17//11
BIOSENSE WEBSTER INC., U.S.A.
D. KLIGLER I.P. SERVICES LTD.,
,‫ קליגלר שירותי קניין רוחני בע"מ‬.‫ד‬
P.O.B. 33111
‫תל אביב‬22111 .‫ד‬.‫ ת‬,
TEL AVIV 61330
Apparatus for performing a medical procedure on a tissue within a body of a subject,
comprising: an ultrasound transmitter (82), which is configured to direct acoustic
energy into the body; a wireless tag (120) configured to be fixed to the tissue and
comprising a transducer (126) for receiving the acoustic energy and a first coil, which
is driven by the transducer to generate first electromagnetic fields outside the body; a
medical device for use in performing the procedure, the device comprising a second
coil (128) configured to generate second electromagnetic fields; and a processing (72)
and display (86) unit, comprising: a plurality of field receiver coils (70), which are
configured to generate first and second signals in response to the first and second
electromagnetic fields, respectively; processing circuitry, which is coupled to receive
the first and second signals, and to process the signals so as to determine position and
orientation coordinates of the tag relative to the medical device; and a display, coupled
to the processing circuitry so as to present a visual indication to an operator of the
medical device of a position and orientation of the medical device relative to the tag.
]54[
177
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
156378
‫מתקן רפואי פולשני עם חישה למיקום ותצוגה‬
]54[
INVASIVE MEDICAL DEVICE
WITH POSITION SENSING AND
DISPLAY
]11[
]92[
]52[
]42[
]44[
10.06.2003
10/173339
]91[ 17.06.2002
]99[ US
Int. Cl.(2010.01) A61B 05//06
BIOSENSE WEBSTER INC., U.S.A.
D. KLIGLER I.P. SERVICES LTD.,
,‫ קליגלר שירותי קניין רוחני בע"מ‬.‫ד‬
P.O.B. 33111
‫תל אביב‬22111 .‫ד‬.‫ ת‬,
TEL AVIV 61330
Apparatus for performing a medical procedure on a tissue within a body of a subject,
comprising: a wireless tag (20) configured to be fixed to the tissue and adapted to emit
radiation, thereby causing first signals to be generated indicative of location and
]54[
178
April 28, 2011-‫כ"ד בניסן התשע"א‬
orientation coordinates of the tag in the body; an invasive medical tool, comprising: a
probe (34), which is adapted to penetrate into the body so as to reach the tissue; a
handle (158), fixed proximally to the probe, and adapted to be manipulated by an
operator of the tool; and a display (38), mounted on the handle, and adapted to present
a visual indication to the operator of an orientation of the probe relative to the tag
based on the location and orientation coordinates; and a processing unit, coupled to
process the first signals so as to determine the location and orientation coordinates of
the tag relative to the probe, and to drive the display responsive to the location and
orientation coordinates.
__________________
]22[]12[
156532
]54[
LIPID MICROPARTICLES, THEIR
PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM
]11[
]92[
17.12.2001
00128556.8
]91[ 27.12.2000
]99[
1221544234
1132131112
Int. Cl.(2010.01) A61K 09//00, 09//16, 38//09
ARES TRADING S.A.,
SWITZERLAND
MARIA DORLY DEL CURTO,
DANIELA CHICCO, PIERANDREA
]52[
]42[
]41[
179
‫ הכנתם ותכשירי‬,‫מיקרוחלקיקים ליפידיים‬
‫רוקחות המכילים אותם‬
EP
EP
April 28, 2011-‫כ"ד בניסן התשע"א‬
]14[
]44[
]54[
ESPOSITO
WO/2002/051386
INTERPHARM LABORATORIES
,‫אינטרפארם מעבדות בע"מ‬
LTD.,
11 ‫רחוב הקישון‬
18 HAKISHON ST.,
‫יבנה‬151 .‫ד‬.‫ ת‬,
P.O.B. 151,
YAVNE 81101
This invention relates to Lipid Microparticles consisting of lipids enriched in
amphiphilic components, which promote the incorporation of peptides and/or proteins,
process for obtaining them as well as use thereof. A cryogenic micronization
manufacturing process for their preparation is also disclosed.
__________________
]22[]12[
156713
]54[
USE OF TRIAZOLO[4,5-D]
PYRIMIDINE DERIVATIVES IN
THE MANUFACTURE OF
MEDICAMENT FOR
ANTAGONISING PURINERGIC
RECEPTORS
]11[
]92[
]52[
]42[
10.01.2002
0100624.6
]91[ 10.01.2001
]99[ GB
Int. Cl.(2010.01) A61K 31//519, A61P 25//28, C07D 48/7/04
VERNALIS RESEARCH LIMITED,
UNITED KINGDOM
WO/2002/055083
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The use of a compound of formula (I): wherein R1 is selected from H, alkyl, aryl,
alkoxy, aryloxy, alkylthio, arylthio, halogen, CN, NR5R6, NR4COR5,
NR4CONR5R6,NR4CO2R7 and NR4SO2R7; R2 is selected from aryl attached via an
unsaturated carbon; R3 is selected from H, alkyl, COR5, CO2 R7, CONR5R6,
CONR4NR5R6 and SO2R7; R4, R5 and R6 are independently selected from H, alkyl
and aryl or where R5 and R6 are in an NR5R6 group, R5 and R6 may be linked to
form a heterocyclic group, or where R4,R5 and R6 are in a (CONR4NR5R6) group,
R4 and R5 may be linked to form a heterocyclic group; and R7 is selected from alkyl
and aryl, or a pharmaceutically acceptable salt thereof or prodrug thereof, in the
treatment or prevention of a disorder in which the blocking of purine receptors,
]14[
]44[
]54[
180
‫] פירימידין‬d–5,4[ ‫שימוש בנגזרות של טריאזולו‬
‫להכנת תרופה למניעת הפעילות של קולטנים‬
‫פורינרגיים‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
particularly adenosine receptors and more particularly A2A receptors, may be
beneficial, particularly wherein said disorder is a movement disorder such as
Parkinson's disease or said disorder is depression, cognitive or memory impairment,
acute or chronic pain, ADHD or narcolepsy, or for neuroprotection in a subject;
compounds of formula (I) for use in therapy; and novel compounds of formula (I) per
se.
__________________
]22[]12[
157231
‫הרכבים קוטלי טפילים לשימוש חיצוני לבעלי‬
‫חיים ושיטות לשימושם‬
]54[
PARASITICIDAL COMPOSITIONS
FOR TOPICAL APPLICATION TO
AN ANIMAL AND METHODS OF
USE
]11[
]92[
]52[
]42[
08.02.2002
60/267373
]91[ 08.02.2001
]99[ US
Int. Cl.(2010.01) A01N 43//08, 53//00, A61K 31//21
SCHERING-PLOUGH LTD.,
SWITZERLAND
WO/2002/062326
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
Solvent system for pyrethroids and pyrethrins comprises a terpene or a terpene
derivative such as a terpene alcohol, aldehyde or ketone. In a preferred embodiment,
the solvent system further comprises an alkylene glycol ether. Compositions
comprising pyrethroids and/or pyrethrins in such a solvent system do not crystallize at
cold temperatures and have increased efficacy compared to formulations containing
conventional solvents3
]14[
]44[
]54[
181
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
158624
)‫–(אריל מותמר‬7–)‫–(אמינו דו–מותמר‬3 ‫תולדות‬
]a–5,4[ ‫של פיראזולו‬
‫ קולטן‬CRF ‫פירידין כאנטגוניסטים של‬
]54[
3-(DISUBSTITUTED AMINO)–7–
(SUBSTITUTED ARYL)
PYRAZOLO[1,5-A]PYRIDINE
DERIVATIVES AS CRF
RECEPTOR ANTAGONISTS
]11[
]92[
]52[
25.04.2002
2001-133207 ]91[ 27.04.2001
]99[ JP
Int. Cl.(2010.01) A61K 31//437, A61P 01//00, 25//00, C07D 47/1/04, C07F 05//02,
07//22
EISAI R&D MANAGEMENT CO.,
LTD., JAPAN
SHIGEKI HIBI, KOICHI KIKUCHI,
YORIHISA HOSHINO, MOTOHIRO
SOEJIMA, TATSUYA YOSHIUCHI,
KOGYOKU SHIN, MUTSUKO ONO,
YOSHINORI TAKAHASHI, HISASHI
SHIBATA, MITSUHIRO INO,
TETSUYA HIRAKAWA
WO/2002/088121
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
JERUSALEM 91450
Compounds represented by the general formula (I), salts thereof, and hydrates of both:
(I) wherein R1 is methoxy, ethyl, methylthio, or the like; R2, R3 and R4 are each
hydrogen, halogeno, or the like; R5 and R6 are each a group represented by the general
formula: -X5-X6-X7 (wherein X5 is a single bond or CO-; X6 is a single bond, NR3a-, or the like; X7 and R3a are each hydrogen, C1-10 alkyl, or the like); and Ar is
phenyl, pyridyl, or the like.
]42[
]41[
]14[
]44[
]54[
182
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
158729
‫מדידת איכות לערוץ עבור מחלק משאבים של‬
‫אות משודר מלווין ארצה‬
]54[
CHANNEL QUALITY
MEASUREMENTS FOR
DOWNLINK RESOURCE
ALLOCATION
]11[
]92[
]52[
14.05.2002
60/290739
]91[ 14.05.2001
]99[ US
Int. Cl.(2010.01) H04B 01//00, 07//005, 07//185, 07//216, 07//26, 17//00, H04J 13//00,
H04L 01//00, 01//20, H04W 52//24, 72//08
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2002/093757
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]42[
]14[
]44[
]54[
In a wireless digital communication system which may employ CDMA technology, a
method (50) and system for obtaining channel quality (CQ) measurements for
downlink resource allocation wherein a User Equipment (UE) (12) continuously
measures RSCP (step) based on a communication on a reference channel provided by
the network. The UE (12) measures timeslot ISCP (step 56) either continuously, by
configuration or by rotation and reports downlink CQ (step 58). The UE (12) may
report the RSCP once and the ISCP per timeslot, or may report some function of the
RSCP/ISCP ratio such as modulation parameters or combined coding of all timeslots.
The applications for division
from this application have
not yet been published
183
201000/221/110
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
159920
‫מטריצות חלבוני פלסמה ושיטות להכנתן‬
]54[
PLASMA PROTEIN MATRICES
AND METHODS FOR THEIR
PREPARATION
]11[
]92[
]52[
18.07.2002
144446
]91[ 19.07.2001
]99[ IL
Int. Cl.(2010.01) A61K 35//12, A61L 27//22, 27//38, 27//56, 27//58, A61P 07//08,
17//02, 19//04, C07K 14//745, C12N 05//02, 05//07, 05//077
PROCHON BIOTECH LTD.
‫ נס ציונה‬,‫פרוכון ביוטק בע"מ‬
AVNER YAYON, RACHEL
‫ רחל גליקליס‬,‫אבנר יאיון‬
GLICKLIS
WO/2003/007873
WEBB & CO.,
,'‫ד"ר וב ושות‬
2 PEKERIS ST., P.O.B. 2189,
5 ‫רח' פקריס‬
REHOVOT 76121
‫רחובות‬5116 .‫ד‬.‫ ת‬,
A freeze dried biocompatible matrix comprising plasma proteins, useful as implants
for tissue engineering as well as in biotechnology, and methods of producing said
matrix are provided. Mechanical and physical parameters can be controlled by use of
auxiliary components or additives which may be removed after the matrix is formed in
order to improve the biological properties of the matrix. The matrices according to the
present invention may be used clinically, per se or as a cell-bearing implant.
]42[
]41[
]14[
]44[
]54[
__________________
]22[]12[
]54[
COMPOSITIONS AND
FABRICATION METHODS FOR
HARDMETALS
]11[
]92[
08.07.2003
60/439838
]91[ 13.01.2003
113443915
1131131119
213459115
1131131119
Int. Cl.(2010.01) C22C 01//05, 29//02
WORLDWIDE STRATEGY
]52[
]42[
184
160248
‫תכשירים ותהליך ליצור של מתכות קשות‬
]99[
US
US
US
April 28, 2011-‫כ"ד בניסן התשע"א‬
]14[
]44[
]54[
HOLDINGS LIMITED, HONG KONG
WO/2004/065645
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Hardmetal compositions each including hard particles having a first material and a
binder matrix having a second, different material comprising rhenium or a Ni-based
superalloy. A two-step sintering process may be used to fabricate such hardmetals at
relatively low sintering temperatures in the solid-state phase to produce substantially
fully-densified hardmetals.
__________________
]22[]12[
160417
]54[
OUTLET ADD-ON MODULE
]11[
]52[
]42[
16.02.2004
Int. Cl.(2010.01) H01R 13//719, 31//06, H04B 03//56
MOSAID TECHNOLOGIES
INCORPORATED, CANADA
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]44[
]54[
185
‫יחידה מוספת לשקע‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A method and a device for upgrading an existing service outlet (e.g. LAN, telephone,
power or CATV outlet) in a building by adding functionality thereto. The functionality
is added by an add-on module (30), connected electrically and secured mechanically to
the existing outlet (42). Several attachment devices are exemplified, including surface
attachment, side clamping, snap locking, strap securing and fastening screws. The addon module may include a service connector (263) for retaining the basic existing outlet
function. The module may be attached permanently or detachably.
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
160454
‫ תוצר ושימוש בו‬,‫שיטה לגידול הפוך‬
]54[
METHOD OF REVERSE
BREEDING, PRODUCT AND USE
THEREOF
]11[
]92[
23.08.2002
01203193.6
]91[ 23.08.2001
]99[ EP
1114551139
2131131111
EP
Int. Cl.(2010.01) A01H 01//04, 05//00, 05//10, C12N 15//63
RIJK ZWAAN ZAADTEELT EN
ZAADHANDEL B.V.
ROBERT HELENE GHISLAIN
DIRKS, CORNELIS MARIA PETRUS
VAN DUN, KORNELIUS REININK,
JACOBUS PETRUS CORNELIS DE
WIT
WO/2003/017753
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
1 ‫רחוב שנקר‬
]52[
]42[
]41[
]14[
]44[
186
April 28, 2011-‫כ"ד בניסן התשע"א‬
]54[
P.O.B. 12688,
‫הרצליה‬15111 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The present invention relates to a method for efficiently producing homozygous
organisms from a heterozygous non-human starting organism, comprising providing of
a heterozygous starting organism; allowing the starting organism to produce haploid
cells; creating homozygous organisms from the haploid cells thus obtained; and
selecting the organisms having the desired set of chromosomes; wherein during
production of the haploid cells no recombination occurs in order to obtain a limited
number of genetically different haploid cells. Recombination can also be prevented or
suppressed.
The applications for division
from this application have
not yet been published
22111//
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
160993
‫צימודים אבחוניים או טיפוליים שהינם אנלוגים‬
‫ שימושים‬,‫של סומאטוסטטין או בומבסין‬
‫עבורם ושיטות לייצור תכשיר רפואי‬
]54[
DIAGNOSTIC OR THERAPEUTIC
SOMATOSTATIN OR BOMBESIN
ANALOG CONJUGATES, THEIR
USES AND METHOD OF
PRODUCING A MEDICAMENT
]11[
]92[
]52[
]42[
20.09.2002
60/323851
]91[ 21.09.2001
]99[ US
Int. Cl.(2010.01) A61K 38//31, A61P 35//00, C07K 14//655
THE ADMINISTRATORS OF THE
TULANE EDUCATIONAL FUND,
U.S.A.
WO/2003/028527
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
21 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61013
Disclosed are peptide agents and uses thereof that are analogs of biologically active
peptides such as somatostatin and bombesin. The compounds of the invention have the
general formula X-Y-Z-Q, where X is a cytotoxic agent, therapeutic agent, detectable
label or chelating group, and Q is a biologically active peptide. In peptide agents of the
invention Y is optionally a hydrophilic polymer or peptide, and Z is a linking peptide
bonded to Q at the amino terminus of Q, having two, three, four, or five, amino acid
residues selected to link X to Q, while retaining the biological activity of Q. Methods
of using these peptide agents in the diagnosis and treatment of diseases are also
]14[
]44[
]54[
187
April 28, 2011-‫כ"ד בניסן התשע"א‬
disclosed.
__________________
]22[]12[
162201
‫תרכובות מצומדות המכילות איזוטופים‬
,‫ תכשירי רוקחות המכילים אותם‬,‫רדיולוגים‬
‫השימוש בהן ושיטה ליצורן‬
]54[
RADIO-ISOTOPE CONJUGATED
COMPOUNDS,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM, USES THEREOF AND
METHOD OF PRODUCTION
THEREOF
]11[
]92[
02.01.2003
02000315.8
]91[ 03.01.2002
]99[ EP
113951411
1531131111
US
Int. Cl.(2010.01) A61K 51//10, A61P 35//00, C07K 19//00
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT,
GERMANY
WO/2003/055917
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]42[
]14[
]44[
]54[
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to methods for diagnosis and treatment of tumours, using
peptides for binding radionuclides. The peptides comprise an antigen-binding site for
the extra domain B (ED-B) of fibronectin.
__________________
]22[]12[
]54[
188
APPARATUS AND METHODS
FOR CONTINUOUS
DESALINATION IN CLOSED
CIRCUIT WITHOUT
CONTAINERS
162713
‫מתקנים ושיטות להתפלה רציפה במעגל סגור‬
‫ללא מיכלים‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]11[
]52[
]42[
]44[
]54[
24.06.2004
Int. Cl.(2010.01) C02F 01//42
DESALITECH LTD.
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
‫דסליטק בע"מ‬
,‫אגמון‬-‫סורוקר‬
14 ‫ רחוב שנקר‬,‫בית נולטון‬
‫הרצליה פיתוח‬
An apparatus for continuous closed-circuit consecutive sequential desalination of
a salt water solution by reverse osmosis (RO) without using containers, the
apparatus comprising;
at least one closed circuit comprising one, or more than one desalination modules
having their respective inlets and outlets connected in parallel by conducting
lines, each of said desalination modules comprising one or more membrane
elements, and a recycling conducting line for recycling concentrate from module
outlets to module inlets;
a feed line for supplying fresh feed of said salt water solution to said at least one
closed circuit; at least one pressurizing device in said feed line for pressurizing
said fresh feed of said salt water solution into said at least one closed circuit and
for creating sufficient counter pressure in said at least one closed circuit to enable
reverse osmosis desalination and replacement of released permeate by fresh feed
of salt water solution;
at least one circulation system for recycling pressurized concentrate from the
outlets to the inlets of said one or more than one desalination modules after
mixing with pressurized fresh feed of salt water solution;
at least one conducting line system for permeate collection from said at least one
closed circuit;
at least one brine effluent conducting line system for removing concentrate from
said at least one closed circuit at a desired recovery level;
at least one valve means to enable periodic discharge of concentrate from said at
least one closed circuit through said at least one brine effluent conducting line
system circuit without stopping desalination;
a monitoring means for monitoring the progress of desalination in said at least
one closed circuit; and
a control system coupled to said monitoring means to enable continuous closed
circuit desalination of a desired recovery to proceed in consecutive sequential
steps under variable or constant pressure conditions by alternating concentrate
flow between a concentrate recycling mode and a concentrate discharge mode
without stopping desalination.
__________________
]22[]12[
189
162856
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫שיטות ומתקן עבור זיהוי ביציות חיות ע"י‬
‫או תנועה‬/‫איתור איתור קצב לב העובר ו‬
]54[
METHODS AND APPARATUS FOR
IDENTIFYING LIVE EGGS BY
DETECTING EMBRYO HEART
RATE AND/OR MOTION
]11[
]92[
]52[
]42[
]14[
]44[
02.05.2003
60/380049
]91[ 06.05.2002
]99[ US
Int. Cl.(2010.01) G01N 21//27
EMBREX, INC., U.S.A.
WO/2003/096028
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
Methods and apparatus for identifying live eggs utilize a cup (430) having a
photodetector (432) therewithin that overlies a portion of an egg. The egg is
illuminated via a light source (420) positioned adjacent the egg. Variations in the
intensity of light passing through the egg is detected via the photodetector (432) which
generates an output signal corresponding to detected light intensity. The output signal
is processed to identify cyclical and non-cyclical variations in light intensity. The egg
is designated as a live egg in response to identifying cyclical and/or non-cyclical
variations in light intensity.
]54[
__________________
]22[]12[
]54[
190
SHORT-ACTING SEDATIVE
HYPNOTIC AGENTS FOR
ANESTHESIA AND SEDATION
AND PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM
162862
‫גורמים היפנוטים משככים לטווח קצר להרדמה‬
‫ושיכוך ותכשירים רוקחיים המכילים אותם‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]11[
]92[
]52[
]42[
]14[
]44[
]54[
24.01.2003
60/351385
]91[ 25.01.2002
]99[ US
113943123
1331531111
US
Int. Cl.(2010.01) A61K 31//216, A61P 23//00, 25//00, C07C 23/5/20, 69//614
THERAVANCE, INC., U.S.A.
WO/2004/037750
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
The invention provides compounds, compositions and methods useful for inducing or
maintaining general anesthesia or sedation in mammals.
2012101
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
163208
‫התקן למדידת ספיקה של נוזלים‬
]54[
LIQUID SUPPLY MEASURING
APPARATUS
]11[
]52[
]42[
]41[
]44[
26.07.2004
Int. Cl.(2010.01) G01R 33//12, G05D 07//06
AP2U.NET LTD.
DANI PELEG
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
A liquid supply measuring apparatus, comprising: a housing having a liquid inlet and a
liquid outlet, supporting a rotor including a shaft and a plurality of vanes attached
thereto, said shaft extending in the housing in a direction allowing rotation of said
vanes by liquid passing through the housing; a current generator associated with said
rotor for producing electrical signals corresponding to the rotation of said rotor; a
controller receiving said signals for processing and producing output signals, and a
rechargeable power storage and supply unit connected to receive electrical signals
April 28, 2011-‫כ"ד בניסן התשע"א‬
191
‫ הרצליה‬,‫ נט בע"מ‬.‫יו‬.‫טו‬.‫אפ‬
‫דני פלג‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
from said current generator to charge said unit and to supply power to said controller
required for its operation.
__________________
]22[]12[
163344
–5–‫–ציקלופנטילאוקסי‬3) –5(–2 ‫תולדות‬
–5–‫–ציאנופיפרידין‬5–)‫דיפלואורומתוקסיפניל‬
‫ תהליך להכנתן ותכשירים‬,‫איל)חומצה אצטית‬
‫המכילים את התרכובות הללו כחומרים פעילים‬
]54[
2-(4-(3-CYCLOPENTYLOXY-4DIFLUOROMETHOXYPHENYL)-4CYANOPIPERIDIN-1-YL)ACETIC
ACID DERIVATIVE COMPOUNDS,
PROCESS FOR THEIR SYNTHESIS
AND COMPOSITIONS
COMPRISING THE COMPOUNDS
AS THE ACTIVE INGREDIENT
]11[
]92[
]52[
07.02.2003
2002-31602
]91[ 08.02.2002
]99[ JP
Int. Cl.(2010.01) A61K 31//451, A61P 01//00, 03//00, 09//10, 11//00, 13//12, 17//06,
19//00, 25//00, 27//00, 29//00, 31//04, 35//02, 37//06, 37//08, 43//00, C07D 21/1/64
ONO PHARMACEUTICAL CO., LTD.,
JAPAN
WO/2003/066590
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]42[
]14[
]44[
]54[
192
Piperidine derivatives represented by the following general formula (I) (wherein each
symbol is as defined in the description) and production intermediates thereof: (I)
Because of having a phosphodiesterase 4 inhibitory activity, the compounds
represented by the general formula (I) are useful in preventing and/or treating
inflammatory diseases, diabetic diseases, allergic diseases, autoimmune diseases, eye
diseases, osteoporosis, bone fracture, arthritis deformans, obesity, overeating,
depression, Parkinson’s disease, dementia, ischemic reperfusion injury, leukemia,
acquired immunodeficiency syndrome (AIDS), shock, systemic inflammatory response
syndrome (SIRS), etc.
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
163488
‫מעמד למטען לסוללה ודיו עבור התקן תקשורת‬
‫נייד בעל מדפסת פנימית‬
]54[
BATTERY AND INK CHARGING
STAND FOR MOBILE
COMMUNICATION DEVICE
HAVING AN INTERNAL PRINTER
]11[
]92[
12.02.2003
PS0492
]91[ 13.02.2002
]99[ AU
PS0493
2931131111
AU
Int. Cl.(2010.01) B41J 03//42, 03//44, 29//393, H04M 01//04, 01//21
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2003/069931
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Battery and ink charging stand (10) includes an ink reservoir, preferably removable,
and has a receptacle (12) for receiving a mobile telecommunications device having an
internal printer. Ink connections (41) disposed in the receptacle engage complimentary
ink inlets of the telecommunications device and provide a conduit for the flow of ink
from the reservoir to the ink storage systems of the device printer 3
]52[
]42[
]14[
]44[
]54[
193
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
163798
‫נגזרת ארילאמידין או מלח שלה וגורם אנטי‬
‫פתרייתי המכיל אותה‬
]54[
ARYLAMIDINE DERIVATIVE OR
SALT THEREOF AND
ANTIFUNGAL AGENT
COMPRISING IT
]11[
]92[
]52[
04.03.2003
2002-60618
]91[ 06.03.2002
]99[ JP
Int. Cl.(2010.01) A61K 31//155, 31//197, 31//4015, 31//421, 31//445, 31//495,
31//551, A61P 31//10, C07C 25/7/18, 25/7/20, 32/3/32, C07D 21/1/56, 22/3/04,
23/3/32, 24/1/08, 26/1/12, 40/3/06
TOYAMA CHEMICAL CO., LTD.,
JAPAN
WO/2003/074476
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
An arylamidine derivative represented by the general formula (1) (wherein X means
optionally substituted lower alkylene or alkenylene; G1 means oxygen, sulfur, or
imino; G2 means carbon or nitrogen; Ra means at least one member selected among
hydrogen, halogeno, and optionally substituted alkyl, cycloalkyl, and alkoxy; R 1 means
optionally protected or substituted amidino; and R2 means substituted amino,
substituted cyclic amino, etc.) or a salt of the derivative. The derivative or salt has
excellent antifungal activity and is highly safe. It is hence useful as a fungicide with
satisfactory behavior in the body.
]42[
]14[
]44[
]54[
194
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
164002
‫ תכשירים רוקחיים המכילים‬,‫תולדות סולפוניל‬
‫אותם לעיכוב היסטון דאצטילאז ותהליכים‬
‫להכנתם‬
]54[
SULFONYL-DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM FOR INHIBITING
HISTONE DEACETYLASE AND
PROCESS FOR THEIR
MANUFACTURE
]11[
]92[
11.03.2003
60/363799
]91[ 13.03.2002
]99[ US
113411313
1432131111
US
Int. Cl.(2010.01) A61K 31//497, C07D 24/3/08, 29/5/22, 40/1/12, 40/1/14, 40/3/04,
40/3/12, 40/3/14, 40/5/12, 40/5/14, 40/9/12, 40/9/14, 41/3/12, 41/3/14, 41/7/12,
47/1/04, 48/7/04, 48/7/08, 49/5/04, 51/3/04
JANSSEN PHARMACEUTICA, N.V.,
BELGIUM
WO/2003/076422
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]52[
]42[
]14[
]44[
]54[
This invention comprises the novel compounds of formula (I) wherein n, m, t, R 1, R2,
R3, R4, L, Q, X, Y, Z and have defined meanings, having histone deacetylase inhibiting
enzymatic activity; their preparation, compositions containing them and their use as a
medicine.
__________________
195
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
164004
,–‫ פיפרידיניל‬,–‫נגזרות פיפראזיניל‬
‫מורפוליניל– כמעכבות חדשות של היסטון‬
‫ תהליך להכנתן והשימוש בהן‬,‫דאצטילאז‬
‫להכנת תרופות‬
]54[
PIPERAZINYL-, PIPERIDINYL- AND
MORPHOLINYL- DERIVATIVES AS
NOVEL INHIBITORS OF HISTONE
DEACETYLASE, PROCESS FOR
THEIR PREPARATION AND USE OF
SAID DERIVATIVES FOR
PREPARATION OF MEDICAMENTS
]11[
]92[
11.03.2003
60/363799
]91[ 13.03.2002
]99[ US
PCT/EP02/14833
1932131111
WO
Int. Cl.(2010.01) A61K 31//4545, 31//506, A61P 35//00, C07D 21/1/14, 21/1/36,
21/1/94, 21/3/78, 24/1/04, 24/1/52, 26/5/30, 40/1/04, 40/3/04, 40/5/04, 40/9/04,
41/3/04, 41/7/04, 47/1/04, 48/7/04, 49/5/04, 51/3/04
JANSSEN PHARMACEUTICA N.V.,
BELGIUM
WO/2003/076438
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]52[
]42[
]14[
]44[
]54[
This invention comprises the novel compounds of formula (I) wherein t, R1, R2, L, Q,
X, Y, Z and (a) have defined meanings, having histone deacetylase inhibiting
enzymatic activity; their preparation, compositions containing them and their use as a
medicine.
__________________
]22[]12[
]54[
]11[
196
INTRANASAL ANALGESIC
COMPOSITION COMPRISING
BUPRENORPHINE
164129
‫ המכיל‬,‫תכשיר משכך כאבים למתן דרך האף‬
‫בופרנורפין‬
19.03.2003
April 28, 2011-‫כ"ד בניסן התשע"א‬
]92[
]52[
]42[
]14[
]44[
]54[
0206448.3
]91[ 19.03.2002
111514135
1132131111
111514239
1132131111
111514132
1132131111
Int. Cl.(2010.01) A61K 09//00
ARCHIMEDES DEVELOPMENT
LIMITED, UNITED KINGDOM
VERNALIS (R & D) LTD., UNITED
KINGDOM
WO/2003/080021
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]99[
GB
GB
GB
GB
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Aqueous formulations suitable for intranasal administration comprise buprenorphine or
a physiologically acceptable salt or ester thereof and (a) a pectin having a degree of
esterification of less than 50%, (b) chitosan and a polyoxyethylene-polyoxypropylene
copolymer (poloxamer) or (c) chitosan and hydroxypropylmethylcellulose. Such
formulations can induce rapid and prolonged analgesia when delivered intranasally to
a patient. The buprenorphine or buprenorphine salt or ester may be delivered to the
bloodstream to produce within 30 minutes a therapeutic plasma concentration of
buprenorphine, Cther, of 0.2 ng/ml or greater which is maintained for a duration T maint
of at least 2 hours.
__________________
]22[]12[
165446
‫שיטות לייצור לבוצ'אטיריזין או מלחים שלו‬
]54[
PROCESSES FOR THE
PREPARATION OF
LEVOCETIRIZINE OR SALTS
THEREOF
]11[
]92[
]52[
]42[
04.12.2003
908/MAS/2002 ]91[ 04.12.2002
]99[ IN
Int. Cl.(2010.01) A61K 31//495, C07D 29/5/088
DR. REDDY'S LABORATORIES
LIMITED., INDIA
197
April 28, 2011-‫כ"ד בניסן התשע"א‬
]14[
]44[
]54[
WO/2004/050647
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The present invention relates to crystalline and amorphous forms of dextrorotatory
dihydrochloride salt of cetirizine, the process for the preparation thereof and
compositions containing the same. The invention also relates to the crystalline and
amorphous forms of levorotatory dihydrochloride salt of cetirizine, the process for the
preparation thereof and compositions containing the same. Both crystalline and
amorphous salt forms of cetirizine dihydrochloride are suitable for pharmaceutical
purposes in the treatment of allergies, including ailments such as chronic and acute
allergic rhinitis, allergic conjunctivitis, pruritus, urticaria and the like.
__________________
]22[]12[
]54[
ADAPTER DEVICE FOR
PROJECTILE FIRED FROM A
LAUNCHING TUBE
]11[
]92[
]52[
]42[
]14[
]44[
26.06.2003
02.08082
]91[ 28.06.2002
Int. Cl.(2010.01) F41F 03//052
MBDA FRANCE, FRANCE
WO/2004/003461
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]54[
198
165576
‫התקן מתאם עבור טיל המשוגר מצינור שיגור‬
]99[
FR
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The invention concerns an adapter device (10) for launching a projectile (12) such as a
missile from a standard launching tube (14), without having to modify the latter. Said
device comprises an adapter tube (24) wherein the projectile (12) is placed, a retaining
ring (22) which is mounted on the end of the launching tube (14) and a fastening
system (26) for securing the adapter tube (24) to the launching tube (14). The adapter
April 28, 2011-‫כ"ד בניסן התשע"א‬
tube (24) has a front part (38) provided with grooves for guiding folded fins of the
projectile (12) and a rear part provided with a base whereon is fixed a pulley (36) for
returning an optical fiber (20) guiding the projectile (12).
__________________
]22[]12[
165608
]54[
STABILISED SOLID
COMPOSITIONS OF FACTOR VII
POLYPEPTIDES, METHODS OF
THEIR PREPARATION AND USES
THEREOF FOR THE
MANUFACTURE OF
MEDICAMENTS
]11[
]92[
20.06.2003
PA200200963 ]91[ 21.06.2002
]99[
113934259
1931431111
Int. Cl.(2010.01) A61K 38//36, C07K 14//745
NOVO NORDISK HEALTH CARE
AG, SWITZERLAND
WO/2004/000347
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]42[
]14[
]44[
]54[
199
VII ‫תכשירים מוצקים מיוצבים של גורם‬
‫ שיטות להכנתם והשימוש בהם‬,‫פוליפפטידיים‬
‫ליצור תרופות‬
DK
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to chemically as well as physically stable compositions
comprising Factor VII or a Factor VII-related polypeptide such that these compositions
can be stored, handled and used at room temperature. The compositions comprises at
least one stability agent selected from: a) a combination of an antioxidant and
mannitol; b) a combination of a methionine and a polyol; c) a combination of a
saccharide and mannitol; d) a combination of sucrose and a polyol ; and e) methionine.
The antioxidant is e.g. homocysteine, cysteine, cystathionine, methionine or
April 28, 2011-‫כ"ד בניסן התשע"א‬
glutathione. The saccharide is e.g. sucrose, dextrose, lactose, maltose, trehalose,
cyclodextrins, maltodextrins or dextrans. The polyol is e.g. mannitol, sorbitol or
xylitol.
__________________
]22[]12[
166305
‫המרת אוטומטי מוידאו מונוסקופי לוידאו‬
‫סטראוסקופי‬
]54[
METHOD FOR CONVERTING A
SEQUENCE OF MONOSCOPIC
IMAGES TO A SEQUENCE OF
STEREOSCOPIC IMAGES
]11[
]52[
]12[
]42[
10.06.2002
Int. Cl.(2010.01) H04N 13//00
150131
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD.
]41[
KARNI VOLOVELSKY, EFRAT
ROTEM
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A method for converting a monoscopic video movie passively acquired using a single
camera to a stereoscopic video movie, said method comprising the following steps: (a)
selection of said original frame from the frames of said monoscopic video movie; (b)
selection of said alternate frame from the frames of said monoscopic video movie such
that a considerable, approximately constant parallax is developed between it and said
original frame; (c) using information representing the relative state of said camera
when capturing said original and said alternate frames to calculate two homography
transformations that rectify said original and said alternate frames; (d) application of
one of said homography transformations to said alternate frame, thereby obtaining a
transformed original frame, which are stereoscopic partners; and (e) repeating said
steps (a) through (d) for the next and each frame in said original monoscopic video
movie.
]44[
]54[
,‫רפאל מערכות לחימה מתקדמות בע"מ‬
‫חיפה‬
‫ אפרת רותם‬,‫קרני וולובלסקי‬
__________________
]22[]12[
200
166467
April 28, 2011-‫כ"ד בניסן התשע"א‬
–‫שיטה לעשיית ושימוש בתאים המבצעים גרוי‬
‫עצמי‬
]54[
METHODS OF MAKING AND
USING AUTO-STIMULATING
CELLS
]11[
]92[
]52[
]42[
23.07.2003
10/205524
]91[ 25.07.2002
]99[ US
Int. Cl.(2010.01) A61K 35//12, 38//00, 39//00
THE TRUSTEES OF THE
UNIVERSITY OF PENNSYLVANIA,
U.S.A.
GUOXING ZHENG, MARK L.
TYKOCINSKI
WO/2004/011673
EDWARD LANGER,
,‫אדוארד לנגר‬
MERKAZ GERON H. 312
‫רעננה‬410 .‫ד‬.‫ ת‬,
P.O.B. 410,
RAANANNA 43103
Methods for transferring one or more proteins to a cell are disclosed. The protein or
proteins to be transferred are in the form of a fusion protein, and contain at least one
domain encoding for a protein or peptide having trans signaling and/or adhesion
function. The fusion protein is transferred to a cell by binding to a lipidated protein,
which has been incorporated into the cell membrane. In an additional aspect of the
invention, methods of making fusion proteins having cis signaling capabilities, as well
as the ability to bind with receptors on the cell’s own surface, are provided. Fusion
proteins incorporating GPI or a homing element, and a constimulator or inhibitor
domain can also be directly transferred to the cell surface. Methods for using cells
which have undergone protein transfer according to the present methods are also
disclosed. This includes use in a cancer vaccine, use for treatment of cancer or
autoimmune disease, and use in determening costimulator threshold levels.
]41[
]14[
]44[
]54[
__________________
]22[]12[
166620
‫תולדות פיראזול ותכשירי רוקחות המכילים‬
‫אותן‬
]54[
PYRAZOLE DERIVATIVES AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
]11[
]92[
]52[
]42[
31.07.2003
60/400967
]91[ 02.08.2002
]99[ US
Int. Cl.(2010.01) A61K 31//4155, 31//4427, C07D 40/3/12, 47/1/04
VERTEX PHARMACEUTICALS
INCORPORATED, U.S.A.
201
April 28, 2011-‫כ"ד בניסן התשע"א‬
]14[
]44[
]54[
WO/2004/001314
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The present invention provides a compound of formula (I) or a pharmaceutically
acceptable derivative thereof. These compounds are inhibitors of protein kinases,
particularly inhibitors of GSK3 mammalian protein kinase. The invention also
provides pharmaceutically acceptable compositions comprising the compounds of the
invention and methods of utilizing those compounds and compositions in the treatment
of various protein kinase mediated disorders.
__________________
]22[]12[
166794
‫קטפת אוספת ומבנה סל‬
]54[
HARVESTER ACCUMULATOR
AND BASKET STRUCTURE
]11[
]92[
]52[
]42[
]44[
10.02.2005
777526
]91[ 12.02.2004
Int. Cl.(2010.01) A01D 46//08
DEERE & COMPANY, U.S.A.
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
A harvester having a receptacle movable between a harvest position for receiving crop
and a dump position for unloading the crop includes an air duct system with a first
duct extending upwardly towards the inlet of an accumulator located adjacent the
receptacle. An air system propels the removed crop upwardly through the air duct
towards the inlet. A second upright duct located adjacent a lower accumulator outlet
directs crop from the accumulator to the receptacle. When the receptacle is raised to
the dump position, all the crop is directed into the accumulator and the outlet is
202
]99[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
blocked so that the harvester can continue to operate while the receptacle is unloaded.
Diverter structure may be provided for facilitating movement of the removed crop
directly into the receptacle when the receptacle is in the harvest position and directing
the removed crop downwardly into the accumulator when the basket is moved towards
the dump position.
__________________
]22[]12[
166842
‫שיטות ומתקן לשחרור מתח באמצעות מספר‬
‫מקורות אנרגיה‬
]54[
METHODS AND APPARATUS FOR
STRESS RELIEF USING
MULTIPLE ENERGY SOURCES
]11[
]92[
]52[
]42[
]14[
]44[
01.08.2003
60/404020
]91[ 16.08.2002
]99[ US
Int. Cl.(2010.01) C21D 01//04, 10//00, C22F 03//00
DONNA M. WALKER, U.S.A.
WO/2004/016815
BOROCHOV, KORAKH & CO.,
,'‫בורוכוב קורח ושות‬
15TH FLOOR, ATIDIM TOWER,
‫מגדל כלל עתידים‬
KIRYAT ATIDIM,
‫אביב‬-‫תל‬51100 .‫ד‬.‫ ת‬,
P.O.B. 58100,
TEL AVIV 61580
Methods are presented for modifying a physical property of a structure, such as
reducing or relieving remaining internal stress, in which two or more energy types are
concurrently applied (140, 142) to the structure to change the physical property of
interest in an accelerated fashion. A first energy type, such as heat, is applied
according to time values and operational settings derived from a first order rate
relationship (151) for the first energy type and from a first order rate relationship (152)
for a second energy type. The second energy type, such as vibration or other timevarying energy form, is applied concurrently for the time value. Methods are also
provided for determining operational settings for concurrent application of multiple
energy types to a structure.
]54[
203
April 28, 2011-‫כ"ד בניסן התשע"א‬
2010010
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
166950
‫תכשירים המכילים אנדוסטטין או מגבירים‬
‫אנדוסטטין ושימושים בהם‬
]54[
COMPOSITIONS COMPRISING
ENDOSTATIN OR INCREASING
ENDOSTATIN AND USES
THEREOF
]11[
]92[
]52[
]42[
]14[
]44[
29.07.2003
60/406470
]91[ 28.08.2002
]99[ US
Int. Cl.(2010.01) A61K 38//39, C07K 14//78
NOVARTIS AG, SWITZERLAND
WO/2004/020469
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
Methods are provided for the treatment of VEGF-induced retinal detachment or retinal
edema by increasing, in an individual afflicted with VEGF-induced retinal detachment
or retinal edema, in vivo concentrations of an endostatin protein in the ocular tissues of
the individual to a retinal detachment or retinal edema inhibiting effective amount.
]54[
__________________
]22[]12[
]54[
204
METHOD OF DIAGNOSIS OF
PREGNANCY-RELATED
167131
‫שיטה לאבחון סיבוכים הקשורים להריון‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
COMPLICATIONS
]11[
]92[
]52[
]42[
]14[
]44[
]54[
28.08.2003
60/406687
]91[ 29.08.2002
Int. Cl.(2010.01) G01N 33//50, 33//68
DIAGNOSTIC TECHNOLOGIES
LTD.
WO/2004/021012
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]99[
AR
‫ חיפה‬,‫דיאגנוסטיקס טכנולוגיות בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A method for diagnosing pregnancy-related complications in a pregnant woman. The
method comprises (a) providing PP13-responding cells having a membrane; (b)
exposing the cells to standard PP13; (c) exposing PP13-responding cells to PP13
obtained from the woman, and (d) determining the existence of a modification in the
permeability of the cell membrane in (b) and in (c) as a result of exposure to PP13. The
modification in permeability in (b) and (c) is then compared, a change in the
permeability of (c) as compared to the permeability in (b) indicating the existence of a
pregnancy complication in the woman.
22111/1
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
167483
‫תהליך להכנת סילוסטזול בעל דרגת ניקיון‬
‫גבוהה‬
]54[
PROCESS FOR OBTAINING
HIGHLY PURE CILOSTAZOL
]11[
]92[
]52[
]42[
16.03.2005
60/553140
]91[ 16.03.2004
]99[ US
Int. Cl.(2010.01) A61K 31//41, 31//4375, 31//47, A61P 19//00, 21//00, C07D 40/1/12
CHEMAGIS LTD.
-‫ בני‬,‫כימאגיס בע"מ מחלקת קניין רוחני‬
]41[
JOSEPH KASPI, VLADIMIR
NADDAKA, ODED ARAD, GUY
205
‫ברק‬
‫ גיא‬,‫ עודד ערד‬,‫ ולדימיר נדקה‬,‫יוסף כספי‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]44[
]54[
‫ שדי סעיד‬,‫דוידי‬
,‫כימאגיס בע"מ‬
56 ‫מחלקת קניין רוחני רחוב לח"י‬
‫בני ברק‬
A process for preparing 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro2(1H)-quinolinone (Cilostazol), the process comprising: reacting 6-hydroxy-3,4dihydroquinolin-2(1H)-one with 5-(4-chlorobutyl)-1-cyclohexyl-1H-terazole in the
presence of a hydrated inorganic base, to thereby obtain a reaction mixture containing
Cilostazol; isolating the Cilostazol from the reaction mixture; slurrying the Cilostazol
in an organic solvent; and crystallizing the Cilostazol in the presence of a base, to
produce Cilostazol, which is substantially free of N-[4-(1-cyclohexyl-1H-tetrazol-5yl)butyl]-6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone,
and has a purity of at least 99.9%.
DAVIDI, SHADY SAEED
CHEMAGIS LTD.,
29 LEHI ST.,BNEI BRAK
__________________
]22[]12[
167530
‫מנגנון נעילה‬
]54[
LOCKING MECHANISM
]11[
]52[
]42[
18.03.2005
Int. Cl.(2010.01) E05B 45//08, 45//10, 45//12
SHEVET HA-LEVI
‫ ישראל‬- ‫ בת ים‬,‫שבט הלוי טכנולוגיות בע"מ‬
TECHNOLOGICAL LTD
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
A lock mechanism for locking a door or the like, the lock mechanism comprising: an
optical device including a light beam emitter and detector spaced apart with a line of
sight path between them, the optical device operative to provide output indicating if a
light beam emitted by the emitter is received by the detector, and a moving member
operative to be displaced between a locked state position wherein the door is locked
and an unlocked state position wherein the door is unlocked; wherein the moving
member is operative to block the line of sight path while in the locked state position
and to clear the line of site path while in the unlocked state position, and wherein the
optical device is operative to activate an electronic device in response to output
indicating that the light beam emitted by the emitter has not been received by the
detector.
]44[
]54[
206
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
167554
‫שיטה והתקנים לשידור נתונים במערכת‬
‫תקשורת מסוג ריבוב חלוקת תדר‬
‫) המשתמשים באורכי סמל‬OFDM(‫אורתוגונלי‬
‫מרובים‬
]54[
METHOD AND APPARATUS FOR
TRANSMITTING DATA IN AN
ORTHOGONAL FREQUENCY
DIVISION MULTIPLEXING
(OFDM) COMMUNICATION
SYSTEM USING MULTIPLE
SYMBOL LENGTHS
]11[
]92[
27.10.2003
60/421309
]91[ 25.10.2002
]99[ US
113491112
1431231119
US
213945211
1531131119
US
Int. Cl.(2010.01) H04B 07//04, 07//06, 07//08, H04L 01//00
QUALCOMM INCORPORATED,
U.S.A.
WO/2004/039027
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]52[
]42[
]14[
]44[
]54[
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
System traffic may be arranged into different categories (e.g., control data, user data,
and pilot data). For each category, one or more OFDM symbols of the proper sizes
may be selected for use based on the expected payload size for the traffic in that
category. For example, control data may be transmitted using OFDM symbols of a first
size, user data may be transmitted using OFDM symbols of the first size and a second
size, and pilot data may be transmitted using OFDM symbols of a third size or the first
size. In one exemplary design, a small OFDM symbol is utilized for pilot and for
transport channels used to send control data, and a large OFDM symbol and the small
OFDM symbol are utilized for transport channels used to send user data.
The applications for division
from this application have
not yet been published
20101112010111
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
207
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
167587
]54[
HUMANIZED ANTIGRANULOCYTE MN-3
ANTIBODY THAT BINDS NCA90
AND KIT COMPRISING SUCH
]11[
]92[
]52[
30.09.2003
60/414341
]91[ 30.09.2002
]99[ US
Int. Cl.(2010.01) A61K 39//395, 51//10, C07K 16//46, 19//00, C12N 15//13, G01N
33//533, 33//534
IMMUNOMEDICS, INC., U.S.A.
WO/2004/029093
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]42[
]14[
]44[
]54[
‫ מאונש הנקשר‬MN – 3 ‫נוגדן אנטי–גרנולוציט‬
‫ וערכה הכוללת את הנ"ל‬MCA – 09–‫ל‬
The present invention provides humanized, chimeric and human MN3 antibodies,
fusion proteins, and fragments thereof. The antibodies, fusion proteins, and fragments
thereof, as well as combinations with other suitable antibodies, are useful for the
treatment and diagnosis of granulocyte related disorders and diseases, such as
leukemia.
__________________
]22[]12[
167849
]54[
ALPHA 2B OR 2B/2C
ADRENOCEPTOR AGONISTS FOR
THE TREATMENT OF
NEURODEGENERATION
]11[
]92[
]52[
]42[
]14[
]44[
07.10.2003
60/417049
]91[ 08.10.2002
]99[ US
Int. Cl.(2010.01) A61K 31//17, 31//4174, A61P 25//16, 25//28, C07D 23/3/00, 23/3/84
ALLERGAN, INC., U.S.A.
WO/2004/032913
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Methods of preventing or retarding the degeneration of neurons. Also disclosed are
]54[
208
‫ או‬B2 ‫אגוניסטים לאדרנוצפטורים מסוג אלפא‬
‫ לטיפול בניוון העצבים‬C2/B2
April 28, 2011-‫כ"ד בניסן התשע"א‬
methods for treating Alzheimer's disease or Parkinson's disease through the
administration of selective alpha 2B or alpha 2B/2C receptor agonists, hereby
incorporated by reference herein.
__________________
]22[]12[
]54[
FEEDER LINK
CONFIGURATIONS TO SUPPORT
LAYERED MODULATION FOR
DIGITAL SIGNALS
]11[
]92[
]52[
]42[
]14[
]44[
20.10.2003
60/421328
]91[ 25.10.2002
Int. Cl.(2010.01) H04B 07//185
THE DIRECTV GROUP, INC., U.S.A.
WO/2004/040820
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]54[
209
168228
‫תצורות קשר של מתקן האכלה לתמוך בוויסות‬
‫בשכבות לסינגלים דיגיטליים‬
]99[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Systems and methods are disclosed for feeder link configurations to layered
modulation. One feeder link system (13A) employs feeder link spot beam to antennas
in distinct coverage areas to enable frequency reuse. In this system 1300, the uplink
signals (116) comprise two distinct feeder link signals (1302A, 1302B). Feeder link
spot beam antennas (1304A, 1304B) can be employed on the satellite (108) to reuse
feeder link spectrum in order to not exceed bandwidth of the layered modulation on the
downlink. The feeder link system (1300) includes a first feeder link antenna (1306A)
and a second feeder link antenna (1306B) transmitting the first link signal at first
frequency and the second link signal at second frequency respectively. Although the
two feeder link frequencies are in substantially the same frequency band, the use of
spot beam antennas (1304, 1304B) with distinct coverage areas (1308A, 1308B)
prevents the first and second feeder link signals (1304A, 1304B) from interfering.
April 28, 2011-‫כ"ד בניסן התשע"א‬
20100//
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
]54[
DISPENSER FOR THE
CONTROLLED RELEASE OF
VOLATILE SUBSTANCES
]11[
]92[
]52[
]42[
23.10.2003
10252950.7
]91[ 14.11.2002
Int. Cl.(2010.01) A61L 09//12
LTS LOHMANN THERAPIESYSTEME AG, GERMANY
MICHAEL FELDHEGE,
MALGORZATA KLOCZKO,
MICHAEL ROREGER
WO/2004/043201
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]41[
]14[
]44[
]54[
168543
‫התקן להספקה מבוקרת של חומרים נדיפים‬
]99[
DE
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
The invention relates to a dispenser for a volatile substance (4), which contains a
reservoir (1) and two control elements. The first control element (6) exerts a control
function that is dependent on the substance characteristics of the volatile substance (4)
and the material characteristics of the constituents of said first control element (6).
However, the second control element (7) exerts a control function that is independent
of the substance characteristics of the volatile substance (4) and the material
characteristics of the constituents of said first control element (6). The first control
element (6) is located between the reservoir (1) and the second control element (7) and
is permeable to at least one volatile substance (4). The second control element (7)
consists of a material that is impermeable to the volatile substance and contains
defined material cavities (8). Perfumes, crop protection agents, pheromones and
repellents, which can be released in a controlled manner, constitute the volatile
substances.
__________________
210
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
168555
‫מטרה המשמשת ליצירת קרום קשיח המכיל‬
‫טיטניום ואלומיניום‬
]54[
TARGET USED TO FORM A
HARD FILM CONTAINING
TITANIUM AND ALUMINUM
]11[
]92[
20.12.2001
2000-402555 ]91[ 28.12.2000
]99[ JP
1112-215415
2331131112
JP
1112-215414
2331131112
JP
1112-114514
1131331112
JP
1112-921511
1532131112
JP
Int. Cl.(2008.04) C23C 14/06, 14/32, 14/34, 30/00
DIVISION FROM 167082
KABUSHIKI KAISHA KOBE SEIKO
SHO (KOBE STEEL, LTD.), JAPAN
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A target for a hard film wherein said target has a relative density of not lower than
95%; and said target has a composition defined by (Ti1-x-y-z-w,Alx, Cry, Siz, Bw), where
0.5 ≤ x ≤ 0.8, 0.06 ≤ y, 0 ≤ z ≤ 0.1, 0 ≤ w ≤ 0.1, x+y+z+w < 1, and x, y, z, and w
denote respectively the atomic ratios of Al, Cr, Si, and B.
]52[
]11[
]42[
]44[
]54[
__________________
]22[]12[
]54[
ATTENUATED PLASMODIUM
SPOROZOITE PARASITE,
PHARMACEUTICAL
COMPOSITIONS AND VACCINES
COMPRISING THE SAME AND
USES THEREOF FOR THE
PREVENTION OF MALARIA
]11[
]92[
]52[
]42[
]14[
]44[
20.11.2003
60/427911
]91[ 20.11.2002
Int. Cl.(2010.01) A61K 39//015
SANARIA INC, U.S.A.
WO/2004/045559
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
211
168651
,‫) מוחלש‬sporozoite( ‫פרזיט פלסמודיום‬
‫תכשירים רוקחיים וחיסונים המכילים אותו‬
‫ושימושים בו למניעת מלריה‬
]99[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫רמת החייל‬
RAMAT HACHAYAL 69710
]54[
The invention comprises a novel method for protecting subjects against malaria. The
method of the invention involves inoculation with attenuated sporozoites, and in
particular, but not limited to subcutaneous, intramuscular, intradermal, mucosal,
submucosal, and cutaneous administration.
__________________
]22[]12[
168694
‫רסק פפאיה ושימוש בו‬
]54[
PAPAYA PUREE AND ITS USE
]11[
]92[
]52[
]42[
]14[
]44[
26.11.2003
A1771/2002
]91[ 26.11.2002
]99[ AT
Int. Cl.(2010.01) A23L 01//212, 01//30, A61K 35//00, 36//185
JI KWANG INC., U.S.A.
WO/2004/047850
HENRY SINAI,
,‫הנרי סיני‬
IP-PARTNERSHIP
4 ‫המייסדים‬
P.O.B 669
‫רעננה‬116 .‫ד‬.‫ ת‬,
RAANANA 43350
The invention relates to a method for producing a puree preparation from Carica
papaya fruit, said method comprising the following steps: the fruit or crushed fruit,
especially in a sieved form, is cooked for at least 30 minutes at normal pressure,
optionally in an aqueous solution which is at least twice the volume of the fruit; the
fruit or crushed fruit which has been cooked is cooled over a period of time of at least
30 minutes in an oxygen-containing atmosphere; and the fruit or crushed fruit which
has been cooled is optionally crushed, mixed and strained until a homogeneous puree
is obtained.
]54[
__________________
]22[]12[
]54[
MOBILE STATION ASSISTED
TIMING SYNCHRONIZATION IN
A CDMA COMMUNICATION
SYSTEM
]11[
15.01.1999
212
168802
‫סינכרון תזמון מסויע לתחנה ניידת במערכת‬
CDMA ‫תקשורת‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]92[
]52[
]11[
]42[
]14[
]44[
]54[
09/008203
]91[ 16.01.1998
]99[ US
Int. Cl.(2010.01) H04B 01//00, 01//707, 07//26, H04J 03//06, 13//00, H04W 56//00
DIVISION FROM 136952
QUALCOMM INCORPORATED,
U.S.A.
WO/1999/037037
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A method for time synchronizing a second base station, wherein a remote station is in
communication with said first base station and said second base station, the method
comprising the steps of:
receiving a signal at said second base station from said remote station; and
adjusting timing of said second base station in accordance with said signal transmitted
from said remote station;
wherein said first base station is receiving a central timing signal, wherein said central
timing is a GPS signal.
__________________
]22[]12[
169332
–‫חומצות ואסטרים (אלקיל–אוקסי‬
‫פ'ניל) קרבוקסילים ותרופות המכילות‬
‫אותם לטיפול בהפרעות מטבוליות‬
]54[
(ALKYLOXYPHENYL)CARBOXYLIC
ACIDS AND ESTERS AND
MEDICAMENTS COMPRISING SAME
FOR TREATING METABOLIC
DISORDERS
]11[
]92[
]52[
09.02.2004
60/447168
]91[
13.02.2003
]99[ US
Int. Cl.(2010.01) A61K 31//195, 31//21, 31//216, A61P 03//04, 03//10, 07//12, 09//10,
C07C 21/7/66, 59//58, 65//21, 69//67, 69//76
WELLSTAT THERAPEUTICS
CORPORATION, U.S.A.
REID W. VON BORSTEL, SHALINI
SHARMA, KIRVIN L. HODGE, ALBERT LEE
WO/2004/073611
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
JERUSALEM 91450
Agents useful for the treatment of various metabolic disorders, such as insulin
resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity,
]42[
]41[
]14[
]44[
]54[
213
April 28, 2011-‫כ"ד בניסן התשע"א‬
artherosclerosis and arteriosclerosis are disclosed. Formula (I) wherein n is 1 or 2; m is
0, 1, 2, 4 or 5; q is 0 or 1; t is 0 or 1; R2 is alkyl from 1 to 3 carbon atoms; R3 is
hydrogen, halo, alkyl having from 1 to 3 carbon atoms, or alkoxy having from 1 to 3
carbon atoms; A is phenyl, unsubstituted or substituted by or 1 or 2 groups selected
from: halo, alkyl having 1 or 2 carbon atoms, perfluoromethyl, alkoxy having 1 or 2
carbon atoms, and perfluoromethoxy; or cycloaldyl having from 3 to 6 ring carbon
atoms wherein the cycloaldyl is unsubstitited or one or two ring carbons are
independently mono-substituted by methyl or ethyl; or a 5 or 6 membered
heteroaromatic ring having 1 or 2 ring heteroatoms selected from N, S and O and the
heteroaromatic ring is covalently bound to the remainder of the compounds of formula
(I) by a ring carbon; and R1 is hydrogen or alkyl having 1 or 2 carbon atoms.
Alternatively, when R1 is hydrogen, the biologically active agent can be a
pharmaceutically acceptable salt of the compound of Formula (I).
__________________
]22[]12[
169375
‫תהליך להכנת שכבות טעונות פוזיטיבית מסוג‬
‫הידרותלציט וברוציט‬
]54[
PROCESS FOR PREPARING
HYDROTALCITE AND BRUCITE
TYPE POSITIVE CHARGED
LAYERS
]11[
]52[
]42[
23.12.2002
Int. Cl.(2010.01) C01B 31//00, 31//24, C01F 07//00
COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH, INDIA
WO/2004/056705
DR. EYAL BRESSLER,
11 TUVAL ST.,
RAMAT GAN 52522
]14[
]44[
]54[
,‫דר' אייל ברסלר עו"פ‬
11 ‫תובל‬
‫ גן‬- ‫רמת‬
An improved process is described for the preparation of surface modified hydrotalcite.
The process comprises reacting a precursor of magnesium and aluminium in the
presence of suitable alkali carbonate at high temperature. The product has a BET
surface area of 20 m2/g and average particle size of 0.5 µm and is useful as halogen
scavenger and fire retardant.
__________________
]22[]12[
214
169412
April 28, 2011-‫כ"ד בניסן התשע"א‬
]54[
ISOLATED AVIRULENT FORM
OF CYPRINUS CARPIO DNA
VIRUS, METHOD FOR ITS
ISOLATION AND AN
IMMUNOGENIC FORMULATION
COMPRISING THE VIRUS
]11[
]92[
]52[
]42[
22.12.2003
153775
]91[ 01.01.2003
]99[ IL
Int. Cl.(2010.01) A61K 39//12, 39//245, C12N 07//00, 07//02, 07//04
YISSUM RESEARCH
‫יישום חברה לפיתוח המחקר של‬
DEVELOPMENT COMPANY OF
,‫האוניברסיטה העברית בירושלים בע"מ‬
THE HEBREW UNIVERSITY OF
‫ירושלים‬
JERUSALEM LTD.
‫לדיג‬
‫אגף‬
,‫הכפר‬
‫ופיתוח‬
‫החקלאות‬
‫משרד‬
MINISTRY OF AGRICULTURE AND
‫דגן‬
‫בית‬
,‫חקלאי‬
‫ממרכז‬
‫המים‬
‫וחקלאות‬
RURAL DEVELOPMENT DEPT.
WO/2004/061093
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
'‫א‬51 ‫רחוב הברזל‬
26A HABARZEL ST.,
‫רמת החייל‬
RAMAT HACHAYAL 69710
]14[
]44[
]54[
Cyprinus –‫ מבודד ובלתי אלים מ‬DNA ‫וירוס‬
‫ שיטה לבידודו ותכשיר רוקחי לחיסון‬,carpio
‫המכיל את הוירוס‬
The present invention provides the isolated causative agent of the disease affecting
Cyprinus carpino and a method for its isolation. The invention further provides
avirulent forms, e.g., live-attenuated form, inactivated form and genetically modified
forms of the virus which may be used for vaccination of susceptible fish.
__________________
]22[]12[
]54[
MEDICATION MANAGEMENT
SYSTEM
]11[
]92[
]52[
]42[
]14[
21.11.2003
10/331034
]91[ 27.12.2002
Int. Cl.(2010.01) G06F 19//00
CAREFUSION 303, INC., U.S.A.
WO/2004/061745
215
169415
‫מערכת לניהול ריפוי‬
]99[
US
April 28, 2011-‫כ"ד בניסן התשע"א‬
]44[
]54[
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A system and method for confirming that a medication administration device has been
programmed with the correct medication administration parameters. A medical
database carrier is used compare medication delivery parameters entered into a
medication administration device to institutionally established guidelines or more
widely accepted protocols to ensure that the medication is delivered in accordance to
those guidelines. The medical database carrier may also be configured to communicate
information regarding medication delivery and other patient information between a
control system in communication with the care-giving facility's other information
systems and a patient specific asset such as an infusion pump. The medical database
carrier may be a smartcard, a PDA such as a PalmTM Pilot, laptop computer, pager,
mobile phone, or other device capable of storing, processing and communicating
information. The system may use either wired or wireless connections to communicate
information between the components of the system.
The applications for division
from this application have
not yet been published
201110020111022011101
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
]54[
216
(R)-3ALKYLOXYTETRADECANOIC
ACID DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME AND USES THEREOF
FOR THE PREPARATION OF
MEDICAMENTS FOR
ENHANCING THE IMMUNE
RESPONSE OF A SUBJECT AND
FOR AMELIORATING OR
PREVENTING DISEASES
169540
‫–אלקילאוקסי‬R)–3( ‫נגזרות של חומצה‬
‫ תכשירים פרמצבטיים‬,‫טטרהדקנואית‬
‫המכילים אותן ושימושן להכנת תרופות להגברת‬
‫התגובה החיסונית ולהקלת או מניעת מחלות‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]11[
]92[
]52[
]42[
]14[
]44[
]54[
06.01.2004
60/438585
]91[ 06.01.2003
]99[ US
Int. Cl.(2010.01) A61K 31//7008, C07H 05//02, 11//04, 13//04, 15//04
CORIXA CORPORATION, U.S.A.
WO/2004/062599
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
Compounds that are adjuvants and immunoeffectors are described and claimed. The
compounds augment antibody production in immunized animals as well as stimulate
cytokine production and activate macrophages. Compositions and methods for using
the compounds as adjuvants and immunoeffectors are also disclosed.
__________________
]22[]12[
169604
‫ווקטור לביטוי שרשרת כבדה או שרשרת קלה‬
Fab ‫ בתאי יונקים וחלק פרגמנט‬IgG ‫של נוגדן‬
‫של שרשרת כבדה או שרשרת רלה בתאים‬
‫בקטריאליים‬
]54[
VECTOR FOR EXPRESSION OF A
HEAVY CHAIN OR LIGHT CHAIN
OF AN IGG ANTIBODY IN
MAMMALIAN CELLS AND A FAB
FRAGMENT PORTION OF A
HEAVY CHAIN OR LIGHT CHAIN
IN BACTERIAL CELLS
]11[
]92[
]52[
08.01.2004
60/439492
]91[ 09.01.2003
]99[ US
Int. Cl.(2010.01) C07K 16//18, 16//28, C12N 01//21, 05//16, 15//70, 15//85, G01N
33//53
MACROGENICS, INC., U.S.A.
WO/2004/063343
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
The present invention provides a dual expression vector, and methods for its use, for
the expression and secretion of a full-length polypeptide of interest in eukaryotic cells,
and a soluble domain or fragment of the polypeptide in bacteria. When expressed in
bacteria, transcription from a bacterial promoter within a first intron and termination at
the stop codon in a second intron results in expression of a fragment of the
polypeptide, e.g., a Fab fragment, whereas in mammalian cells, splicing removes the
bacterial regulatory sequences located in the two introns and generates the mammalian
April 28, 2011-‫כ"ד בניסן התשע"א‬
]42[
]14[
]44[
]54[
217
signal sequence, allowing expression of the full-length polypeptide, e.g., IgG heavy or
light chain polypeptide. The dual expression vector system of the invention can be
used to select and screen for new monoclonal antibodies, as well as to optimize
monoclonal antibodies for binding to antigenic molecules of interest.
__________________
]22[]12[
169663
‫שימוש בווקטורים להסדרת כוויצות שריר הלב‬
‫להכנת תרופות ותרופות המכילות אותם‬
‫הווקטורים‬
]54[
USE OF VECTORS FOR IN VIVO
REGULATION OF CARDIAC
MUSCLE CONTRACTILITY IN
THE PREPARATION OF
MEDICAMENTS AND
MEDICAMENTS CONTAINING
SAID VECTORS
]11[
]92[
]52[
]42[
12.01.2004
10/342120
]91[ 13.01.2003
]99[ US
Int. Cl.(2010.01) C12N 09//14, 15//861, 15//864
THE REGENTS OF THE
UNIVERSITY OF CALIFORNIA,
U.S.A.
WO/2004/062618
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]44[
]54[
218
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A method for regulating in vivo calcium transport in cardiac muscle of animals
suffering from congestive heart failure is disclosed. According to the method, calcium
ATPase activity (which decreases as congestive heart failure develops) and cardiac
muscle contractility augmented by delivering a gene which operatively encodes the
enzyme into the heart. Delivery systems, including but not limited to using adenoassociated viral vectors are provided. Methods for monitoring the expression and effect
of the gene product on cardiac performance are also provided.
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
169667
]54[
ONLINE SOURCE
RECONSTRUCTION FOR
EEG/MEG AND ECG/MCG
]11[
]92[
]52[
]42[
]41[
27.01.2004
60/443234
]91[ 27.01.2003
]99[ US
Int. Cl.(2010.01) A61N 01//00
COMPUMEDICS USA, INC., U.S.A.
MANFRED FUCHS, STEPHAN F.
SANDS
WO/2004/068313
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
1 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
In one embodiment, the present invention includes an EEG system comprising of
sensors which are utilized to gather an electromagnetic signal from a patient; a signal
processing system; and a computer system. The computer system is configured to
support multiple threads of execution. The computer system initiates a first thread of
execution, a measurement module, where the data is filtered and in some cases
averaged. Typically, the data is filtered for a particular latency period. Once the data
has been filtered and averaged, the result is given to a second thread of execution, the
source reconstruction module, which then proceeds to generate a source reconstruction
for the trial. The measurement module then acquires and processes new
electromagnetic data from a new trial while the source reconstruction is being
performed on the most recent trial.
]14[
]44[
]54[
219
ECG/MCG –‫ ו‬EEG/MEG ‫שחזור מקוון עבור‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
]54[
METHODS FOR DIAGNOSIS AND
MONITORING OF
NEUROLOGICAL DISEASE BY
DETECTION OF AN
ENCEPHALOTOXIN
]11[
]92[
]52[
]42[
27.01.2004
60/443219
]91[ 27.01.2003
Int. Cl.(2010.01) G01N 33//483, 33//50
JACOBUS PHARMACEUTICAL
COMPANY, INC., U.S.A.
WO/2004/066943
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]44[
]54[
169889
‫שיטות לאבחנה וניטור של מחלה נוירולוגית‬
‫באמצעות איתור של אנספהלוטוקסין‬
]99[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Encephalotoxin produced by activated mononuclear phagocytes is present in
individuals having neurological disease including neurodegenerative and neuroinflammatory diseases, such as Alzheimer's disease (AD), HIV-1-associated dementia
(HAD), Creutzfeld-Jakob disease, Mild Cognitive Impairment, prion disease, mild
cognitive/ motor dysfunction, acute stroke, acute trauma, or neuro-AIDS. Biochemical
detection of encephalotoxin according to the methods of the invention will allow
diagnosis of neurological disease in early, presymptomatic stages, thereby allowing
early intervention in disease progression as well as identification of subjects or
populations at risk for developing neurodegenerative disease. The methods of the
invention also provide a mechanism for monitoring progression and treatment of
neurological disease.
__________________
220
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
‫הרכב ציפוי המתגבר בטמפרטורת החדר‬
]54[
AMBIENT TEMPERATURE
CURABLE COATING
COMPOSITION
]11[
]92[
26.01.2004
03250594.3
]91[ 30.01.2003
113451114
1131931119
Int. Cl.(2010.01) C09D 18/3/04
AKZO NOBEL COATINGS
INTERANTIONAL B.V., THE
NETHERLANDS
WO/2004/067576
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]42[
]14[
]44[
]54[
169956
]99[
EP
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Ambient temperature curing coating composition comprising - a branched alkoxyfunctional polysiloxane having the formula R2-O-[Si(R1)2-O]n-R2, wherein each R1 is
selected from the group consisting of alkyl, aryl, and alkoxy groups having up to six
carbon atoms, and Osi(OR3)3 groups, wherein each R3 independently has the same
meaning as R1, each R2 is selected from the group consisting of hydrogen and alkyl
and aryl groups having up to six carbon atoms, and wherein n is selected such that the
molecular weight of the polysiloxanes is in the range of from 500 to about 2,000, - a
catalyst, and - an acrylic polymer. The acrylic polymer is substantially free of
functional groups that can react with the polysiloxane or with the catalyst in the
coating composition.
__________________
]22[]12[
]54[
ANTI-PENETRATION FLEXIBLE
COMPOSITE MATERIAL
]11[
]92[
]52[
]42[
]14[
]44[
221
20.10.2003
MI2003A000295 ]91[ 19.02.2003
Int. Cl.(2010.01) F41H 05//04
F. LLI CITTERIO S.P.A., ITALY
WO/2004/074761
LUZZATTO & LUZZATTO,
170018
‫חומר מרוכב גמיש נוגד חדירה‬
]99[
IT
,‫לוצאטו את לוצאטו‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]54[
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to an anti-penetration flexible composite material,
comprising a series of ballistic fibres arranged on one or more overlying layers, in
which at least one portion of said fibres is impregnated with a resin or a polymer in the
form of a viscous or visco-elastic liquid.
__________________
]22[]12[
170252
‫שיטות והתקן לאנליזה של מידע‬
]54[
METHODS AND APPARATUS FOR
DATA ANALYSIS
]11[
]92[
]52[
]42[
]14[
]44[
13.02.2004
10/367355
]91[ 14.02.2003
]99[
Int. Cl.(2010.01) G06F 19//00, H01L 21//66
TEST ADVANTAGE, INC., U.S.A.
WO/2004/075011
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
A method and apparatus for testing semiconductors according to various aspects of the
present invention comprises at test system comprising composite data analysis element
configured to analyze data from more than one dataset. The test system may be
configured to provide the data in an output report. The composite data anaylsis element
suitable performs a spatial analysis to identify patterns and irregularities in the
composite data set. The composite data analysis element may also operate in
conjunction with a various other analysis systems, such as a cluster detection system
and an exclusion system, to refine the composite data analysis. The composite may
also be merged into other data.
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
]54[
222
METHODS FOR PRODUCING
PHENYLALANINE DERIVATIVES
HAVING A QUINAZOLINEDIONE
170349
‫שיטות לייצור נגזרי פנילאלאנין עם שלד‬
‫קווינאזולינדיון‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
SKELETON
]11[
]92[
]52[
]42[
]14[
]44[
]54[
20.02.2004
2003-042560 ]91[ 20.02.2003
]99[ JP
Int. Cl.(2010.01) C07C 22/9/54, 23/3/87, 27/5/42, C07D 23/9/96
AJINOMOTO CO., INC., JAPAN
WO/2004/074264
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
21 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61013
A process for producing a phenylalanine derivative which has a quinazolinedione ring
and is represented by the formula (5), which comprises reacting an acylphenylalanine
derivative represented by the formula (1) with a reagent for carbonyl group
introduction and an anthranilic acid derivative to form an asymmetric urea
intermediate, converting this asymmetric urea intermediate to a quinazolinedione
compound in the presence of a base, and N-alkylating the resultant quinazolinedione
compound at the amide group of the quinazolinedione ring with an N-alkylating agent.
This process is suitable for the industrial production of the phenylalanine derivative
containing a quinazolinedione skeleton, which is a compound highly useful as a
medicine having integrin alpha 4inhibitory activity. In the formulae (1) and (5), R1
represents substituted phenyl, etc.; R2 represents alkyl, etc.; R3 represents
dialkylamino, etc.; and R4 represents alkyl, etc 3
The applications for division
from this application have
not yet been published
201211120121/120121//
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
170547
‫טריז מחתיכה אחת‬
]54[
ONE-PIECE SHIM
]11[
]92[
]52[
]42[
]14[
]44[
02.03.2004
60/450678
]91[ 03.03.2003
]99[ US
Int. Cl.(2010.01) B05C 05//00
MESSIER-BUGATTI, FRANCE
WO/2004/078406
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A one-piece or otherwise unitary annular shim member made from a perforated
]54[
223
April 28, 2011-‫כ"ד בניסן התשע"א‬
metallic material is used to maintain a space between stacked annular preforms during
a manufacturing process, such as densification. The metallic material used preferably
can withstand at least the temperatures encountered during densification. The onepiece structure advantageously simplifies the arrangement of the preforms in a process
chamber and causes less deformation in the preforms. In one example, the shim
member is made from a metallic mesh and may utilize a crimped weave structure.
__________________
]22[]12[
170586
‫מכלול מקש רב–תכליתי עבור התקן אלטרוני‬
]54[
MULTIFUNCTION KEY
ASSMBLY FOR AN
ELECTRONIC DEVICE
]11[
]52[
]42[
30.08.2005
Int. Cl.(2010.01) H01H 09//54
GIL HECHT
ISCAR LTD.
]44[
ISCAR LTD.,
P.O.B. 11,
TEFEN 24959
A multifunction key assembly (26) comprising: two major switches, a first-major
switch (40'), a second-major switch (40"), and four first-minor switches (42'a, 42'b,
42'c, 42'd), all of the switches being electrically connected to each other; a single key
cap (28) mechanically coupled to the two major switches, the single key cap being
capable of selectively activating any one of the four first-minor switches and of
selectively activating the two major switches either separately or simultaneously,
together with any one of the first-minor switches whereby a total of twelve possible
distinct output signals can be outputted from the multifunction key assembly, four
distinct output signals being obtained when the first-major switch is activated together
with any one of the four first-minor switches, four further distinct output signals being
obtained when the second-major switch is activated together with any one of the four
first-minor switches and four yet further distinct output signals being obtained when
the first and second-major switches are simultaneously activated together with any one
of the four first-minor switches.
]54[
224
‫ נהריה‬,‫גיל הכט‬
‫ תפן‬,‫ישקר בע"מ‬
,‫ישקר בע"מ‬
‫תפן‬11 .‫ד‬.‫ ת‬,
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
]54[
PEN-TYPE INJECTOR
]11[
]92[
]52[
]42[
03.03.2004
0304823.8
]91[ 03.03.2003
Int. Cl.(2010.01) A61M 05//315
DCA DESIGN INTERNATIONAL
LIMITED, UNITED KINGDOM
WO/2004/078242
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]14[
]44[
225
170618
‫מזרק דמוי עט‬
]99[
GB
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
April 28, 2011-‫כ"ד בניסן התשע"א‬
]54[
The invention relates to a pen-type injector comprising a housing (2); a cartridge (4)
containing medicinal product, the cartridge (4) being retained within the housing (2);
means for selecting a dose of medicinal product to be expelled; means for expelling the
selected dose of medicinal product .The housing (2) comprises a unitary housing
within which the dose selecting means and the dose expelling means are moveably
retained.
__________________
]22[]12[
170620
‫מנגנוני הנעה המתאימים לשימוש בהתקנים‬
‫לשחרור תרופה‬
]54[
DRIVE MECHANISMS SUITABLE
FOR USE IN DRUG DELIVERY
DEVICES
]11[
]92[
]52[
]42[
03.03.2004
0304824.6
]91[ 03.03.2003
]99[ GB
Int. Cl.(2010.01) A61M 05//315
DCA DESIGN INTERNATIONAL
LIMITED, UNITED KINGDOM
WO/2004/078226
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention relates to a drive mechanism for use in a drug delivery device
comprising: a housing (2); a dose dial sleeve (40) having a helical thread of a first lead;
and a two-part piston rod (14). The said two-part piston rod (14) comprises an outer
part (18) having a helical thread of a second lead and an inner part (16) having a
helical thread of a third lead, whereby the first lead of the thread of the dose dial sleeve
(40) is equal to the sum of the second lead of the thread of the outer part (18) of the
piston rod (14) and the third lead of the thread of the inner part (16) of the piston rod
(14).
]14[
]44[
]54[
__________________
]22[]12[
]54[
226
COMBINATION OF HEPATITIS C
VIRUS (HCV) ANTIGENS FOR
USE IN IMMUNOASSAYS FOR
170719
‫שילובי אנגדי הליבה ואנגדים נוספים של נגיף‬
‫) ושימושם בקביעות‬C (HCV ‫הפאטיטיס‬
HCV – ‫אימונולוגיות של נוגדני אנטי‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
ANTI-HCV ANTIBODIES
]11[
]92[
]52[
]11[
]42[
]44[
]54[
01.04.1991
504352
]91[ 04.04.1990
]99[
Int. Cl.(2010.01) C07K 14//18, G01N 33//576
DIVISION FROM 97741
NOVARTIS VACCINES AND
DIAGNOSTICS, INC., U.S.A.
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A combination of hepatitis C virus (HCV) antigens in one or more polypeptides made
by chemical synthesis or recombinant expression comprising: (a) a first HCV antigen
comprising an epitope from domain of the HCV 1 polyprotein shown in Figure 1 and
(b) a second HCV antigen selected from (i) an HCV antigen comprising an epitope
from the S domain of the HCV 1 polyprotein shown in Figure 1; (ii) an HCV antigen
comprising an epitope from the NS3 domain of the HCV 1 polypeptide shown in
figure 1; (iii) an HV antigen comprising an epitope from the NS4 domain of the HCV
1 polyprotein shown in figure 1 and (iv) an HCV antigen comprising an epitope from
the NS5 domain of the HCV 1 polyprotein shown in figure 1 with the proviso that the
combination is not the peptide p1 with C100-3, the peptide p35 with C100-3, the
peptide p99 with C100-3, or a peptide having amino acids 9 to 177, 100-150 or 1-450
of the HCV 1 polyprotein and with the further proviso that when the combination is
immobilized on the surface of a solid matrix suitable for detection of HCV by
immunoassay the combination does not comprise: (a) a first epitope sequence from the
C domain of the HCV polyprotein; (b) a second epitope sequence from a second
domain of the HCV polyprotein which domain is: (i) the NS3 domain of the HCV
polyprotein; (ii) the NS4 domain of the HCV polyprotein or (iii) the NS5 domain of
the HCV polyprotein and (c) a third epitope sequence from a third domain of the HCV
polyprotein which domain is: (i) the NS3 domain of the HCV polyprotein; (ii) the NS4
domain of the HCV polyprotein or (iii) the NS5 domain of the HCV polyprotein
wherein the third domain is different from the second domain.
__________________
]22[]12[
]54[
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THIAZOLE DERIVATIVES
]11[
]92[
23.03.2004
10/395503
227
]91[
24.03.2003
170873
‫תכשירי רוקחות המכילים תולדות תיאזול‬
]99[
US
April 28, 2011-‫כ"ד בניסן התשע"א‬
]52[
]42[
]14[
]44[
]54[
Int. Cl.(2010.01) A61K 31//427, 31//506, A61P 35//00, 37//00, C07D 41/7/00
BRISTOL-MYERS SQUIBB
COMPANY, U.S.A.
WO/2004/085388
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
Novel cyclic compounds and salts thereof, pharmaceutical compositions containing
such compounds, and methods of using such compounds in the treatment of protein
tyrosine kinase-associated disorders such as immunologic and oncologic disorders.
__________________
]22[]12[
171058
‫גליקולים פוליאוקסיאלקילן או גליקולים‬
‫פוליאוקסיאלקילן שעברו מונואלקילציה‬
‫ואסטריפריקציה פורמולציות המכילות אותם‬
‫והשימוש בהם כחומרים פעילי שתח ובהכנת‬
)‫פורמולציות (כולל פורמולציות רוקחיות‬
]54[
POLYOXYALKYLENE GLYCOLS
OR ESTERIFIED
MONOALKYLATED
POLYOXYALKYLENE GLYCOLS,
FORMULATIONS COMPRISING
THEM AND USE THEREOF AS
SURFACTANTS AND IN THE
PREPARATION OF
FORMULATIONS INCLUDING
PHARMACEUTICAL
FORMULATIONS
]11[
]92[
]52[
]42[
]41[
13.04.2004
0301119-4
]91[ 14.04.2003
]99[ SE
Int. Cl.(2010.01) A61K 09//48, 47//14, C07C 69//66
ASTRAZENECA AB, SWEDEN
CHRISTIAN VON CORSWANT,
KARL HULT, ERIK SODERLIND,
FREDRIK VIKLUND
WO/2004/089869
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
31 AHAD HAAM STREET
21 ‫רחוב אחד העם‬
P.O. BOX 2499
‫תל אביב‬5466 .‫ד‬.‫ ת‬,
TEL AVIV 65202
New non-ionic surfactants in the form of polyoxyalkylene glycol hydroxy fatty acid
derivatives or monoalkylated polyoxyalkylene glycol hydroxy fatty acid derivatives
having a polyoxyalkylene / alkyl polyoxyalkylene chain with a chain-length of 25 455 repeating units and a specified substituent on the hydroxy position of the specified
hydroxy fatty acid, according to the general formula (I) CH3 - (CH2)x - CH - (CH2)y April 28, 2011-‫כ"ד בניסן התשע"א‬
]14[
]44[
]54[
228
CO - [-O - R3 - ]z - O - R1 R2 - O (I); wherein for example R1 is methyl, R2 is
optionally substituted C14 - C22 acyl, alkyl, or alkenyl, R3 is ethylene, x is 2-12, y is 717, (x + y) is 3-19 and z is 25-57; advantageously prepared by involving an enzymatic
process, formulations comprising them, their use as solubilizers and a process
involving a hydrolytic enzyme for preparing them.
__________________
]22[]12[
171150
‫שיטה לקבלת מידע אודות תנועה באמצעות‬
‫שימוש במידע חשבוני המופק ממסוף נייד‬
]54[
METHOD FOR OBTAINING
TRAFFIC INFORMATION USING
BILLING INFORMATION OF
MOBILE TERMINAL
]11[
]92[
27.03.2004
10-2003]91[ 28.03.2003
]99[ KR
0019644
21-11192131131119
KR
1194231
Int. Cl.(2010.01) G08G 01//01, 01//0967, H04B 01//00
SK TELECOM CO., LTD., REPUBLIC
OF KOREA
WO/2004/086806
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]42[
]14[
]44[
]54[
229
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to a method for obtaining traffic information using the
billing information of a mobile terminal. A specified number of a mobile terminal is
obtained from billing information necessary for performing a billing operation when a
telephone call is made using the mobile terminal on a highway (S61, S62 and S63).
The moving time of the mobile terminal between base stations is tracked (S65), such
that information of a traffic state on the highway can be obtained in real time (S66).
The existing mobile communication network is employed to obtain the traffic
information, such that the cost required for operating special vehicles for collecting
traffic information and for obtaining traffic information from information providers
can be reduced. Customer demand can be met as a measurement operations is
continuously carried out and the traffic information abruptly changed is reflected in
real time.
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
]54[
DELAYED RELEASE TABLET
WITH DEFINED CORE
GEOMETRY
]11[
]92[
]52[
]42[
]14[
]44[
23.04.2004
0309342.4
]91[ 24.04.2003
Int. Cl.(2010.01) A61K 09//00, 09//28
JAGOTEC AG, SWITZERLAND
WO/2004/093843
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]54[
171494
‫גלולה עם שחרור מושהה בלעת ליבה בעלת‬
‫מבנה מרחבי מוגדר‬
]99[
GB
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A press-coated tablet comprising a core containing an drug substance, and a coating,
the core being disposed within the coating such that the coating has a first thickness
about an axis A-B and a thickness about an orthogonal axis X-Y, such that the coating
about the axis X-Y is thicker than the coating about the axis A-B, and is adapted to
provide a lag time of between about 2 to 6 hours during which substantially no drug
substance is released.
__________________
]22[]12[
]54[
]11[
230
PANORAMIC FIELD OF VIEW
IMAGING DEVICE
171677
‫מכשיר הדמיה בעל שדה–ראיה פנורמי‬
02.05.2004
April 28, 2011-‫כ"ד בניסן התשע"א‬
]92[
]52[
]42[
]41[
]14[
]44[
]54[
60/466729
]91[ 01.05.2003
]99[ US
Int. Cl.(2010.01) A61B 06//00
GIVEN IMAGING LTD.
‫ יקנעם‬,‫גיוון אימג'ינג בע"מ‬
GAVRIEL J. IDDAN, DAPHNA
‫ עידן‬.‫גבריאל י‬
LEVY, KEVIN RUBEY,
MORDECHAI FRISCH
WO/2004/096008
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
An in vivo imaging device with a curved reflective element and for example a concave
portion of an outer shell of such device. Such curved reflective element may for
example reflect onto an image sensor light rays from an object where such light rays
before reflection are substantially parallel to the plane of the image sensor. An in vivo
imaging device with a reflective surface situated at an angle to an image sensor of such
imaging device. Such an angle may be for example a 45 degree angle so that light rays
that are substantially parallel to a plain of an image sensor of an imaging device may
for example be reflected by the reflective surface onto the image sensor.
__________________
]22[]12[
171916
]54[
INTERFERENCE AND NOISE
ESTIMATION IN AN OFDM
SYSTEM
]11[
]92[
14.05.2004
60/470724
]91[ 14.05.2003
]99[ US
213113591
1431931114
US
Int. Cl.(2010.01) H04J 11//00, H04L 01//20, 27//26
QUALCOMM INCORPORATED,
U.S.A.
WO/2004/104530
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]52[
]42[
]14[
]44[
]54[
231
OFDM ‫הערכת הפרעה ורעש במערכת‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Noise and interference can be independently measured in a multiple user Orthogonal
Frequency Division Multiplexing (OFDM) system (200). Co-channel interference is
measured in a frequency hopping, multiple user, OFDM system by tracking the subcarriers assigned to all users in a particular service area or cell (202). The composite
noise plus interference can be determined by measuring the amount of received power
April 28, 2011-‫כ"ד בניסן התשע"א‬
in a sub-carrier whenever it is not assigned to any user in the cell. A value is stored for
each sub-carrier in the system and the value of noise plus interference can be a
weighted average of the present value with previously stored values. The noise
component can be independently determined in a synchronous system. In the
synchronous system, all users in a system may periodically be prohibited from
broadcasting over a sub-carrier and the received power in the sub-carrier measured
during the period having no broadcasts.
2022///
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
]54[
FLOWER CROP HARVESTER
]11[
]52[
]42[
15.11.2005
Int. Cl.(2010.01) A01D 45//00
STATE OF ISRAEL, MINISTRY OF
AGRICULTURE, AGRICULTURAL
RESEARCH ORGANIZATION THE
VOLCANI CENTER
MENASHEH COHEN, RAFI
REGEV, AHARON WISEBLUM,
MONICK LEV, BOAZ ZION, LIAD
RESHEF, MENASHE LEVI,
YECHIEL STEINMETZ, YAACOV
BEN YAACOV
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]41[
]44[
]54[
232
171969
‫קטפת פרחים‬
‫ מינהל‬,‫ משרד החקלאות‬,‫מדינת ישראל‬
‫ המכון‬,‫ מרכז וולקני‬,‫המחקר החקלאי‬
‫ בית דגן‬,‫להנדסה חקלאית‬
‫ מוניק‬,‫ אהרון וייסבלום‬,‫ רפי רגב‬,‫מנשה כהן‬
‫ יחיאל‬,‫ מנשה לוי‬,‫ ליעד רשף‬,‫ בועז ציון‬,‫לב‬
‫ יעקב בן יעקב‬,‫שטיינמץ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A crop harvester comprising:
a frame having a front end and a rear end;
a conveyer belt assembly, mounted on said frame, having a conveyor belt entrance and
exit and at least an upper pair of conversely rotating conveyor belts extending between
April 28, 2011-‫כ"ד בניסן התשע"א‬
the entrance and exit said pair of belts having a gap therebetween and each comprising
an outer layer belt being soft and undulated and adapted to convey crops in a selected
orientation;
an alignment member, mounted on the frame's front end, for directing the crops into
the conveyor belt entrance;
a stem cutter, mounted on said frame, disposed below the conveyor belt assembly
between the conveyor belt entrance and exit;
a tilting member, integrally formed with or mounted on said frame, disposed below the
conveyor belt exit; and
a collection bed, engaging or integrally formed with the frame, disposed adjacent to
said tilting member, adapted for collection of crops.
__________________
]22[]12[
172109
‫פולימרים פוליתיאואתריים שהם נוזלים‬
‫בטמפרטורות נמוכות‬
]54[
LOW TEMPERATURE LIQUID
POLYTHIOETHER POLYMERS
]11[
]92[
]52[
]42[
04.06.2004
10/456138
]91[ 05.06.2003
]99[ US
Int. Cl.(2010.01) C08G 75//04, C08L 81//02, C09K 03//00
PRC-DESOTO INTERNATIONAL,
INC., U.S.A.
WO/2005/000965
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]14[
]44[
]54[
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Polythioether polymers, curable compositions of polythioether polymers, the process
of making polythioether polymers, and the use of polythioether polymers in sealants,
wherein the polythioether polymers and curable compositions are liquid at a
temperature of 20°C or less, are disclosed.
__________________
]22[]12[
]54[
233
METHOD OF REDUCING THE
VARIANCE OF A SIGNAL-TONOISE RATIO ESTIMATE FOR A
SIGNAL WITH DIFFERENTIAL
172141
–‫שיטה להפחתת השונות של הערכת יחס אות‬
‫רעש עבור אות עם אפנון פאזה דיפרנציאלית‬
‫ומשרעת קוהרנטית‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
PHASE AND COHERENT
AMPLITUDE MODULATION
]11[
]92[
]52[
]42[
]14[
]44[
]54[
19.05.2004
P200301229
]91[ 26.05.2003
Int. Cl.(2010.01) H04L 01//20
MARVELL HISPANIA, S.L., SPAIN
WO/2004/105301
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]99[
ES
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The invention relates to a method of reducing the variance of a signal-to-noise ratio
estimate for a signal with differential phase and coherent amplitude modulation. The
invention is characterised in that, in order to calculate the samples of the noise power
affecting the system, the amplitude and phase increment errors obtained at the receiver
are combined, by shifting said errors (1) and (4) to the corresponding point of the first
ring (6) of the constellation as if said ring had been transmitted and without
undergoing any modification, in order subsequently to calculate the square of the
modulus of the error vector (9). In this way, the invention minimises and equalises the
variance of the samples obtained for the different even and odd values of bits for each
carrier used by the system. In addition, the invention reduces the variance of the
signal-to-noise ratio estimate in a multi-user digital communication system. The
aforementioned estimate is necessary for selecting the number of bits per carrier, such
that same can be adapted to the channel, as well as being necessary as support
information when a diversity receiver is used.
__________________
]22[]12[
]54[
234
METHOD FOR QUANTIFYING
THE COMPOSITION OF A
PRODUCT COMPRISING A
SOLUTION OR DISPERSION
USING NEAR INFRA-RED
172371
‫שיטה לניתוח ההרכב הכמותי של מוצר המכיל‬
‫תמיסה או פיזור על ידי שימוש‬
‫בספקטרוסקופיה אינפרא–אדום קרוב‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
SPECTROSCOPY
]11[
]92[
]52[
]42[
]14[
]44[
]54[
22.05.2004
10326152.4
]91[ 06.06.2003
]99[ DE
Int. Cl.(2010.01) G01N 21//35
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
UHLMANN VISIOTEC GMBH,
GERMANY
WO/2004/107969
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention relates to a method for quantifying the composition of a product,
comprising the following steps: irradiation of the product using a radiation source in
the near infra-red spectrum; capture of the radiation that is reflected or transmitted by
the product and provision of an output signal corresponding to the intensity of the
captured radiation at a number of different wavelengths; determination, based on the
output signal by means of a mathematical method, of whether the product lies within
predetermined integrity criteria. According to the invention, the moving product
contains a solution or homogeneous dispersion and the content of at least one
substance contained in said dispersion or solution is quantitatively determined. The
invention also relates to a device for carrying out said method.
__________________
]22[]12[
]54[
CONFIGURABLE PLC AND
SCADA-BASED CONTROL
SYSTEM
]11[
]92[
20.05.2004
10/460794
235
]91[
12.06.2003
172505
‫ הניתנת לתצורה ומערכת בקרה מבוססת‬PLC
SCADA
]99[
US
April 28, 2011-‫כ"ד בניסן התשע"א‬
]52[
]42[
]14[
]44[
]54[
Int. Cl.(2010.01) G05B 19//418
AIR LIQUIDE ELECTRONICS U.S.
LP, U.S.A.
WO/2005/008349
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention provides an automated configurable control system (CCS) for a
manufacturing process system, which permits a user to address menus on screen
images for initially configuring the process, and for subsequently rapidly adding,
modifying, and deleting components and control signals, without revising software
programs. The control system utilizes a configuration tool (2) for automatically
providing a configuration database file (4) from data inputted by a user into the CCS.
A deployment tool (3) automatically downloads the configuration database file to a
SCADA application (11) responsive thereto for defining the system, monitoring the
status of the processing system, and displaying screen images. The deployment tool
also provides the data via a download application (7) to a PLC application (9) for
defining the objects and logic of the processing system.
__________________
]22[]12[
]54[
SYSTEM AND METHOD FOR
CONFIGURING VOICE READERS
USING SEMANTIC ANALYSIS
]11[
]92[
]52[
]42[
]14[
]44[
11.06.2004
10/464881
]91[ 19.06.2003
Int. Cl.(2010.01) G10L 13//08
IBM CORPORATION, U.S.A.
WO/2004/111997
IBM LABORATORIES,
HAIFA UNIVERSITY,
236
172518
‫שיטה ומערכת להגדרת קוראי קול תוך שימוש‬
‫בניתוחים סמנטיים‬
]99[
US
,‫מעבדות יבמ מחלקת קנין רוחני‬
‫אוניברסיטת חיפה הר הכרמל‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]54[
HAIFA 31905
‫חיפה‬
A system and method for using semantic analysis to configure a voice reader is
presented. A text file includes a plurality of text blocks, such as paragraphs. Processing
performs semantic analysis on each text block in order to match the text block's
semantic content with a semantic identifier. Once processing matches a semantic
identifier with the text block, processing retrieves voice attributes that correspond to
the semantic identifier (i.e. pitch value, loudness value, and pace value) and provides
the voice attributes to a voice reader. The voice reader uses the text block to produce a
synthesized voice signal with properties that correspond to the voice attributes. The
text block may include semantic tags whereby processing performs latent semantic
indexing on the semantic tags in order to match semantic identifiers to the semantic
tags.
__________________
]22[]12[
]54[
USE OF AN ANTIBODY THAT
BLOCKS AN INHIBITORY
RECEPTOR OR STIMULATES AN
ACTIVATING RECEPTOR OF AN
NK CELL FOR THE
PREPARATION OF
MEDICAMENTS, FOR USE IN
COMBINATION WITH A
THERAPEUTIC ANTIBODY, IN
THE TREATMENT OF A DISEASE,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
SAID ANTIBODIES AND
METHODS TO IDENTIFY SAID
ANTIBODIES
]11[
]92[
23.07.2004
60/489489
237
]91[
24.07.2003
172679
‫שימוש בנוגדן שחוסם רצפטור מעכב או המגרה‬
‫ להכנת תרופות‬,NK ‫רצפטור משפעל של תא‬
‫ בטיפול‬,‫לשימוש בשילוב עם נוגדן תרפיואתי‬
‫ תכשירים רפואיים המכילים נוגדנים‬,‫במחלה‬
.‫אלו ושיטות לזיהויים‬
]99[
US
April 28, 2011-‫כ"ד בניסן התשע"א‬
]52[
]42[
]14[
]44[
]54[
Int. Cl.(2010.01) A61K 39//395
INNATE PHARMA, FRANCE
UNIVERSITA DEGLI STUDI DI
PERUGIA, ITALY
WO/2005/009465
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates, generally, to methods and compositions for increasing
the efficiency of therapeutic antibodies. Their efficiency is enhanced through the
increase of the ADCC mechanism. More particularly, the invention relates to the use
of a therapeutic antibody in combination with compounds that block an inhibitory
receptor or stimulate an activating receptor of an NK cell in order to enhance the
efficiency of the treatment with therapeutic antibodies in human subjects
__________________
]22[]12[
]54[
IMAGING SENSOR ARRAY AND
DEVICE AND METHOD FOR USE
THEREOF
]11[
]92[
]52[
]42[
]41[
04.07.2004
60/483893
]91[ 02.07.2003
Int. Cl.(2010.01) A61B 05//05
GIVEN IMAGING LTD.
ARKADY GLUKHOVSKY, ISRAEL
MENDEL, SHMUEL GAN
WO/2005/004033
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
]14[
]44[
238
172878
‫ ומיתקן ושיטה‬,‫מערך חיישנים להדמיה‬
‫לשימוש בו‬
]99[
US
‫ יקנעם‬,‫גיוון אימג'ינג בע"מ‬
,‫פרל כהן צדק לצר‬
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
April 28, 2011-‫כ"ד בניסן התשע"א‬
]54[
A system (12)and method for receiving an in vivo signal, using for example a receiver
(201), a recorder (202)and an antenna array (211 to 217). The receiver (201)may
include for example a switching unit (221) and an amplifier (222), and may be in
proximity to the antenna array (211 to 217).
__________________
]22[]12[
172889
‫מערכת קבורה מאונכת‬
]54[
GRAVEYARD AUGMENTATION
SYSTEM
]11[
]52[
]42[
29.12.2005
Int. Cl.(2010.01) E04H 13//00
URI PONGER
TUVIA SAGIV
]41[
]44[
URI PONGER, TUVIA SAGIV
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
A system for augmented usage of graveyard area comprising a burial unit (10) adapted
for placement above an existing occupied grave (12) and extending vertically partially
into the area designated therefor, said unit having at least one rigid bottom element
(14) adapted to be positioned above an existing grave and to form a support for a
second body (46) and to form together with one or more layers of earth a separation of
about 24-30 cm between the existing grave and the second deceased body, and further
comprising at least one rigid upper element (26) for positioning above said second
body and for sealing a second grave for said second body, said system further
comprising means (42, 52) for retaining a layer of earth above said upper rigid element
wherein said layer of earth is between 24 and 40 cm in height.
]54[
‫ ירושלים‬,‫אורי פונגר‬
‫ תל אביב‬,‫טוביה שגיב‬
‫ טוביה שגיב‬,‫אורי פונגר‬
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
__________________
239
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
173110
‫פורמולציות חצי מוצקות למתן פומי של‬
‫טקסואידים‬
]54[
SEMI-SOLID FORMULATIONS
FOR THE ORAL
ADMINISTRATION OF TAXOIDS
]11[
]92[
]52[
]42[
]14[
]44[
15.07.2004
03291795.7
]91[ 18.07.2003
]99[ EP
Int. Cl.(2010.01) A61K 09//48, 31//337, C07D 30/5/00
AVENTIS PHARMA S.A., FRANCE
WO/2005/013968
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
Semi-solid formulations for the oral administration of taxoids. The present invention
relates to novel formulations of taxoids for oral administration.
]54[
__________________
]22[]12[
173506
‫שיטות לטיהור חלבון שאינו אימונוגלובולין‬
IG–‫המכיל תחום הדומה ל‬
]54[
METHOD FOR THE
PURIFICATION OF A NONIMMUNOGLOBULIN PROTEIN
COMPRISING AN
IMMUNOGLOBULIN-LIKE (IGLIKE) DOMAIN
]11[
]92[
]52[
05.08.2004
157309
]91[ 07.08.2003
]99[ IL
Int. Cl.(2010.01) A61K 38//00, C07K 01//20, 01//22, 14//435, 14//47, 14//54, 14//705,
14//715, 19//00
MERCK SERONO S.A.,
SWITZERLAND
BORIS SCHWARTSBURD, ILANA
BELZER
WO/2005/014621
INTERPHARM LABORATORIES
,‫אינטרפארם מעבדות בע"מ‬
LTD.,
11 ‫רחוב הקישון‬
18 HAKISHON ST.,
‫יבנה‬151 .‫ד‬.‫ ת‬,
P.O.B. 151,
YAVNE 81101
The present invention relates to a method for the purification of non-immunoglobulin
April 28, 2011-‫כ"ד בניסן התשע"א‬
]42[
]41[
]14[
]44[
]54[
240
proteins comprising one or more immunoglobulin-like (Ig-like) domain.
__________________
]22[]12[
]54[
SLURRY FEED APPARATUS FOR
FIBER-REINFORCED
STRUCTURAL CEMENTITIOUS
PANEL PRODUCTION
]11[
]92[
]52[
]42[
02.09.2004
10/664460
]91[ 18.09.2003
Int. Cl.(2010.01) B28B 13//02
UNITED STATES GYPSUM
COMPANY, U.S.A.
WO/2005/032783
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]44[
]54[
173641
‫מכשיר הזנה לדבק חסין–חום לייצור פנלים‬
‫להדבקה עם מבנה מרקמי מחוזק‬
]99[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A feed apparatus for use in depositing a slurry (46) upon a moving web (26) having a
direction of travel includes a main metering roll (50), a companion roll (52) disposed
in closely spaced relation to the metering roll (50) to form a nip (54) therebetween.
The nip (54) is constructed and arranged to retain a supply of the slurry (46), and the
rolls (50, 52) are driven so that slurry (46) retained in the nip (54) progresses over an
upper outer peripheral surface (70) of the metering roll (50) to be deposited upon the
web (26). Also preferably included is a thickness control roll (68) disposed in
operational relationship to the metering roll (50) for controlling thickness of a layer of
slurry (46) drawn from the nip (54) over the outer metering roll surface. Preferably, the
metering roll (50), the companion roll (52) and the thickness control roll (68) are
driven in the same direction.
__________________
241
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
173784
]54[
METHOD AND APPARATUS FOR
IMPROVED LINK LAYER
HANDOFF
]11[
]92[
16.02.2006
60/659132
]91[ 07.03.2005
]99[ US
223113144
1332231115
US
Int. Cl.(2010.01) H04L 12//56, H04W 36//00, 36//08
MOTOROLA, INC., U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]42[
]44[
]54[
242
HANDOFF ‫שיטה ומערכת עבור שכבת קישור‬
‫משופרת‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Various embodiments are described to address the need for an apparatus and method
that improves link layer handoff by addressing the packet-loss problem existing today.
An intermediate buffer management layer (IBML) (201, 211) is introduced below
layer 3 of an OSI-based communications interface. The IBML buffers copies of OSI
layer 3 packets being transmitted via lower layers (205, 215) of the interface and
manages the buffer contents using indications the IBML receives from one or more of
the lower layers. When the IBML receives an indication that a link layer hard handoff
is proceeding, the IBML transfers the presently buffered packets to a corresponding
IBML (202, 212) in the target communications interface. This sub-layer 3 buffer
transfer enables the target communications interface to reduce packet-loss associated
with the hard handoff.
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
173943
‫חיסון למניעת סרטן המבוסס על מולקולת‬
)‫ (וסת– אח של אתרים מוטבעים‬BORIS
]54[
PREVENTIVE CANCER VACCINE
BASED ON BROTHER OF
REGULATOR OF IMPRINTED
SITES MOLECULE (BORIS)
]11[
]92[
]52[
]42[
]14[
]44[
25.08.2004
60/497511
]91[ 25.08.2003
Int. Cl.(2010.01) A61K 39//00
UNIVAX, LLC, U.S.A.
WO/2005/021029
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
Polynucleotides encoding a nonfunctional mutant form of the Brother of Regulator of
243
]99[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
Imprinted Sites (BORIS) molecule, nonfunctional mutated BORIS protein, polypeptide
or peptide and modified protein forms of BORIS are described. These molecules are
used as a therapeutic vaccine against cancer.
__________________
]22[]12[
173973
‫חומצה (נאפתאלניל–מתיל)–אזתידין‬
‫ תרכובות ותכשירי רוקחות‬,‫קרבוקסילית‬
‫המכילים אותו‬
]54[
(NAPHTHALENYL-METHYL)AZETIDINECARBOXYLIC ACID,
DERIVATIVES THEREOF AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING IT
]11[
]92[
27.08.2004
2003-306088 ]91[ 29.08.2003
]99[ JP
1114-221549
1131431114
JP
1114-213351
1131131114
JP
1114-231519
1531431114
JP
Int. Cl.(2010.01) A61K 31//11, 31//135, 31//185, 31//197, 31//198, 31//21, 31//222,
31//27, 31//275, 31//277, 31//397, 31//472, 45//00, A61P 37//06, 37//08, 43//00, C07C
22/9/14, 22/9/22, 22/9/36, 23/3/47, 25/5/41, 27/1/22, C07D 20/5/04, 21/1/04, 21/7/04,
40/5/06
ONO PHARMACEUTICAL CO.,
LTD., JAPAN
WO/2005/020882
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]52[
]42[
]14[
]44[
]54[
244
A compound capable of binding S1P receptors (especially EDG-6, preferably EDG-1
and EDG-6). For example, a compound of the general formula (I), its salt or solvate, or
a prodrug thereof is capable of binding S1P receptors (especially EDG-6, preferably
EDG-1 and EDG-6) and is thus useful in the prevention and/or treatment of
immunological reaction to transplant, graft versus host disease, autoimmune disease,
April 28, 2011-‫כ"ד בניסן התשע"א‬
allergosis, etc. (I) (wherein the ring A is a cyclic group; the ring B is an optionally
substituted cyclic group; X is a spacer with a main chain of 1 to 8 atoms, etc.; Y is a
spacer with a main chain of 1 to 10 atoms, etc.; and n is 0 or 1 provided that when n is
0, m is 1 and R1 is a hydrogen atom or a substituent and that when n is 1, m is 0 or an
integer of 1 to 7 and R1 is a substituent, in which when m is 2 or greater, R1s may be
identical with or different from each other).
The applications for division
from this application have
not yet been published
2011///
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
174166
‫שיטה להתססה חומר צמחי מותססת ותמצית‬
‫חומר צמחי מותסס ושימושיו‬
]54[
METHOD FOR FERMENTATION
OF PLANT MATERIAL AND
FERMENTED PLANT MATERIAL
EXTRACT AND USES THEREOF
]11[
]92[
22.09.2004
2003-336555 ]91[ 26.09.2003
]99[ JP
1114-293412
2131531114
JP
Int. Cl.(2010.01) A23L 01//105, A61K 35//74, C12N 01//20
GEN-ICHIRO SOMA, JAPAN
BIOMEDICAL RESEARCH GROUP
INC., JAPAN
WO/2005/030938
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]52[
]42[
]14[
]44[
]54[
245
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
It is intended to provide a process for safely and less expensively producing a
fermented plant extract containing an immunopotentiator at a high concentration.
Namely, a fermentation and culture method which comprises fermenting a plant
material such as wheat flour by using Pantoea agglomerans which is a gram-negarive
bacterium living in a symbiotic relation with a plant such as wheat or apple. Thus, the
immunopotentiation action of the plant can be extremely enhanced. Moreover, such a
product has a high safety because of being free from contamination with animal-origin
impurities.
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
174201
‫תכשיר מוצק הכולל שכבת פיוגליטזון ושכבה‬
09 ‫הכוללת גלימפריד ופוליסורבט‬
]54[
SOLID PREPARATION
COMPRISING A PIOGLITAZONE
LAYER AND A LAYER
COMPRISINIG GLIMEPIRIDE
AND POLYSORBATE 80
]11[
]92[
]52[
]42[
21.10.2004
2003-371679 ]91[ 31.10.2003
]99[ JP
Int. Cl.(2010.01) A61K 09//20, 31//4439, 31//64, 45//06, 47//26
TAKEDA PHARMACEUTICAL
COMPANY LIMITED, JAPAN
WO/2005/041962
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A solid preparation useful as a diabetes-treating agent or the like and excellent in the
dissolution properties of an insulin sensitizer and an insulin secretagogue, which
comprises an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan
fatty acid ester is provided.
]14[
]44[
]54[
__________________
]22[]12[
]54[
246
SELF-CHECKING OPTICAL ADD
DROP MULTIPLEXER
174229
‫ בעל תכונה של בדיקה עצמית‬OADM
April 28, 2011-‫כ"ד בניסן התשע"א‬
]11[
]52[
]42[
]44[
]54[
09.03.2006
Int. Cl.(2010.01) H04J 14//02
ECI TELECOM LTD.
ECI TELECOM LTD.,
30 HASIVIM ST.,
PETACH TIKVA 49517
‫ פתח תקוה‬,‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
,‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
20 ‫רחוב הסיבים‬
‫פתח תקוה‬
A method for performing add/drop operations in an OADM assembly serving an
optical network and comprising an add unit and a drop unit having a number of ports,
the method comprising performing the following steps within the OADM assembly:
detecting a first signal dropped from the network at the drop unit at a port assigned to
an optical channel having an optical carrier wavelength λ, providing a second signal
having the carrier wavelength λ of said optical channel, said second signal being
suitable for adding to the network via the add unit, performing authentication of said
optical channel by comparing one or more components of said first signal with one or
more components of said second signal serving as a reference, allowing or blocking
the drop operation of said optical channel to a client and/or the add operation of said
optical channel to the network, based on a result of said authentication.
__________________
]22[]12[
174586
‫מכונה לסחיטת פרי–הדר בעלת גודל מוקטן‬
]54[
REDUCED-SIZE CITRUS-FRUITSQUEEZING MACHINE
]11[
]92[
]52[
]42[
28.09.2004
P200302553
]91[ 31.10.2003
]99[ ES
Int. Cl.(2010.01) A23N 01//00, A47J 19//02
ZUMEX, MAQUINAS Y
ELEMENTOS, S.A., SPAIN
WO/2005/041695
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The invention relates to a reduced-size citrus-fruit-squeezing machine of the type that
make use of sets of male/female rotating drums. The inventive machine is
characterised in that it comprises a single female drum and a single male drum, an
auto-orienting blade and a pendulum system which is used to support the turning part
and which dispenses with the need for a second set of drums, by turning the fruit half
that remains after cutting in the direction of the next upper cavity of the female drum.
In addition to providing the same range of services as larger-sized squeezing machines,
the machine also offers improved hygienic conditions owing to the provision of the
]14[
]44[
]54[
247
April 28, 2011-‫כ"ד בניסן התשע"א‬
support pendulum, a ribbed fruit inlet, a peel receptacle and a built-in juice container,
which are isolated from the exterior. In this way, the machine is particularly suitable
for use in hotels that lack space.
__________________
]22[]12[
174826
]54[
ANTIBODIES TO NIK CAPABLE
OF BINDING TO A PORTION OF
NIK COMPRISING A
PHOSPHORYLATED
THREONINE, THEIR
PREPARATION AND USE
]11[
]92[
05.10.2004
158286
]91[ 07.10.2003
]99[ IL
219152
1131431114
IL
Int. Cl.(2010.01) A61K 39//395, A61P 37//00, C07K 16//40, C12N 09//12
YEDA RESEARCH AND
‫ רחובות‬,‫ידע חברה למחקר ופיתוח בע"מ‬
DEVELOPMENT CO. LTD.
DAVID WALLACH,
PARAMESWARAN RAMKRISHNAN
WO/2005/033145
INTERLAB LTD.,
,‫אינטר לאב בע"מ‬
18 HAKISHON ST.
11 ‫הקישון‬
YAVNE 81220
‫יבנה‬
The present invention relates to immunoregulatory molecules. More particularly, the
present invention relates to antibodies or antibody fragments capable of specifically
binding NF-κB-inducing kinase (NIK)/MAP3K14, or a specific portion thereof, and to
use thereof, for example for regulating a biochemical activity of NIK, and/or enabling
detection of NIK or a specific portion thereof.
]52[
]42[
]41[
]14[
]44[
]54[
248
‫ המסוגלים לקשור לחלק של‬NIK ‫נוגדנים ל‬
,‫ המכיל תראונין שעבר פוספורילציה‬NIK
‫הכנתם והשימוש בהם‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
174870
‫תרכובות אנטי–ויראליות ותכשירים המכילים‬
‫אותן‬
]54[
INDOLE ANTIVIRAL
COMPOUNDS AND
COMPOSITIONS COMPRISING
THEM
]11[
]92[
06.10.2004
60/509412
]91[ 07.10.2003
]99[ US
213353115
1132131114
US
Int. Cl.(2010.01) A61K 31//405, 31//655, 31//7052, A61P 31//12, C07D 20/9/04,
C07H 19//04
THE REGENTS OF THE
UNIVERSITY OF MICHIGAN, U.S.A.
WO/2005/034943
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The present invention provides novel chemical compounds and methods for their use.
In particular, the present invention provides indole derivatives (e.g. as shown in
Formula (I)) and related compounds and methods of using indole derivatives and
related compounds as therapeutic agents to treat a number of conditions, including
those associated with viral infection and cardiovascular diseases.
]52[
]42[
]14[
]44[
]54[
__________________
]22[]12[
249
174921
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫מבנה גדר בטחון‬
]54[
SECURITY FENCE
CONSTRUCTION
]11[
]52[
]42[
11.04.2006
Int. Cl.(2010.01) G08B 13//12
EL-FAR ELECTRONICS SYSTEMS
‫ בע"מ‬5000 ‫פר אלקטרוניקה מערכות‬-‫אל‬
2000 LTD.
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A barrier for preventing unauthorized passage therethrough, comprising:
a frame section delimiting at least two sides of said barrier;
a plurality of hollow tubular elements at least indirectly attached to said frame;
a respective light source inside one end of at least some of said tubular elements;
a respective photodetector located inside a second end of at least some of said tubular
elements, and
a control and processing unit electrically connectable to said light sources and
detectors for controllably activating the light sources and processing the signals
formed by said detectors for determining tampering with at least one of said tubular
elements;
each of said photodetectors being configured to receive light that is emitted by the
respective light source and propagated through air in the respective hollow tubular
element.
]44[
]54[
__________________
]22[]12[
]54[
METHOD FOR PRODUCING NSUBSTITUTED 3ßAMINONORTROPANES
]11[
]92[
05.10.2004
10348112.5
]91[ 16.10.2003
21111412911439
2131931114
Int. Cl.(2010.01) C07D 45/1/04
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH,
GERMANY
WO/2005/037831
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]42[
]14[
]44[
]54[
250
174957
‫–אמינו נורטרופאנים‬ß3 ‫שיטה ליצור‬
‫מותמרים על החנקן‬
]99[
DE
DE
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a method for producing, on the basis of the corresponding 3April 28, 2011-‫כ"ד בניסן התשע"א‬
oxonortropane or the corresponding 3 alpha-aminonortropane, N-substituted betaaminonortropanes of formula (I), wherein R 2is defined as in the claims. According to
the inventive method, the starting compounds are converted to the corresponding
imines by means of an arylmethylamine or an arylaldehyde, said imines are
tautomerized or isomerized and then hydrolyzed. The invention also relates to the
novel compounds of formula (V), wherein R 2and Ar are defined as in the claims3
__________________
]22[]12[
175172
‫שימוש חוזר מגביל למערכת תקשורת אלחוטית‬
]54[
RESTRICTIVE REUSE FOR A
WIRELESS COMMUNICATION
SYSTEM
]11[
]92[
28.10.2004
60/516558
]91[ 30.10.2003
]99[
213142114
2131131114
Int. Cl.(2010.01) H04W 16//02, 16//10, 16//12
QUALCOMM INCORPORATED,
U.S.A.
WO/2005/043948
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]52[
]42[
]14[
]44[
]54[
251
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
For restrictive reuse, each cell (or each sector) is assigned (1) a set of usable subbands
that may be allocated to users in the cell and (2) a set of forbidden subbands that is not
used. The usable and forbidden sets for each cell are orthogonal to one other. The
usable set for each cell also overlaps the forbidden set for each neighboring cell. A
user u in a cell x may be allocated subbands in the usable set for that cell. If user u
observes/causes high level of interference from/to a neighboring cell y, then user u
may be allocated subbands from a 'restricted' set containing subbands included in both
the usable set for cell x and the forbidden set for cell y. User u would then
observe/cause no interference from/to cell y. The subband restriction may be extended
to avoid interference from multiple neighboring cells.
April 28, 2011-‫כ"ד בניסן התשע"א‬
The applications for division
from this application have
not yet been published
2022112
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
175187
‫רישום נתוני אולטראסאונד עם תמונה שהושגה‬
‫קודם לכן‬
]54[
REGISTRATION OF
ULTRASOUND DATA WITH PREACQUIRED IMAGE
]11[
]92[
]52[
]42[
]44[
25.04.2006
11/114847
]91[ 26.04.2005
]99[ US
Int. Cl.(2010.01) A61B 05//06, 08//00
BIOSENSE WEBSTER, INC., U.S.A.
D. KLIGLER I.P. SERVICES LTD.,
,‫ קליגלר שירותי קניין רוחני בע"מ‬.‫ד‬
P.O.B. 33111
‫תל אביב‬22111 .‫ד‬.‫ ת‬,
TEL AVIV 61330
A system and method for imaging a target in a patient's body uses a pre-acquired
image of the target and a catheter having a position sensor and an ultrasonic imaging
sensor. The catheter is placed in the patient's body and positional information of a
portion of the catheter in the patient's body is determined using the position sensor.
The catheter is used to generate an ultrasonic image of the target using the ultrasonic
imaging sensor. An image processor is used for determining positional information for
any pixel of the ultrasonic image of the target and registering the pre-acquired image
with the ultrasonic image; and a display is used for displaying the registered preacquired image and ultrasonic image.
]54[
252
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
175190
‫רישום מפה אלקטרו–אנטומית עם תמונה‬
‫שהושגה קודם לכן באמצעות אולטרא–סאונד‬
]54[
REGISTRATION OF ELECTROANATOMICAL MAP WITH PREACQUIRED IMAGE USING
ULTRASOUND
]11[
]92[
]52[
]42[
]44[
25.04.2006
11/114801
]91[ 26.04.2005
]99[ US
Int. Cl.(2010.01) A61B 08//00, G01S 15//89
BIOSENSE WEBSTER, INC., U.S.A.
D. KLIGLER I.P. SERVICES LTD.,
,‫ קליגלר שירותי קניין רוחני בע"מ‬.‫ד‬
P.O.B. 33111
‫תל אביב‬22111 .‫ד‬.‫ ת‬,
TEL AVIV 61330
A medical imaging system for imaging a patient's body includes a catheter having a
position sensor and an ultrasonic imaging sensor wherein the position sensor transmits
electrical signals indicative of positional information of a portion of the catheter in a
patient's body and the ultrasonic imaging sensor transmits ultrasonic energy at a target
in the patient's body, receives ultrasonic echoes reflected from the target in the
patient's body and transmits signals relating to the ultrasonic echoes reflected from the
target in the patient's body. A positioning processor is operatively connected to the
]54[
253
April 28, 2011-‫כ"ד בניסן התשע"א‬
catheter for determining positional information of the portion of the catheter based on
the electrical signals transmitted by the position sensor. The system also includes a
display and an image processor operatively connected to the catheter, the positioning
processor and the display. The image processor displays on the display a catheter icon
in a same orientation as an orientation of the portion of the catheter in the patient's
body based on positional information derived from the position sensor. The image
processor also generates an ultrasonic image of the target based on the signals
transmitted by the ultrasonic sensor and depicts in real-time the generated ultrasound
image on a display in a same orientation as the orientation of the portion of the catheter
in the patient's body based on positional information derived from the position sensor.
__________________
]22[]12[
175285
–‫ לא‬,‫ לעיסות‬,‫צורות מתן במנות יחידניות‬
‫טבליות ותהליכים להכנתן‬
]54[
NON-TABLETTED, CHEWABLE,
INDIVIDUALLY DOSED
ADMINISTRATION FORMS AND
PROCESS FOR THEIR
PRODUCTION
]11[
]92[
]52[
]42[
]14[
]44[
09.11.2004
P200302612
]91[ 10.11.2003
]99[ ES
Int. Cl.(2010.01) A61K 09//00, 09//20
ALMIRALL, S.A., SPAIN
WO/2005/048974
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Non-tabletted, individually dosed administration forms comprising a composition of at
least one pharmaceutically active substance dissolved or dispersed within a matrix
material comprising a mixture of at least 0,2% by weight of a gelatine, at least one
stabilising agent and at least one water-soluble alcohol and/or water as a solvent,
which composition is plastic at elevated temperature, characterised in that : the
stabilising agent is selected from the group consisting of (i) esters of glycerine and
fatty acids; (ii) products resulting from the alcoholysis / esterification reaction of such
esters of glycerine and fatty acids with polyethylenglycols; and, in that the stabilising
agent has a melting point in the range of 42° C to 63° C, in that water is present in an
amount not greater than 46% by weight of the composition.
]54[
__________________
254
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
175439
‫רצועה לפקק משאף‬
]54[
INHALER CAP STRAP
]11[
]92[
]52[
]42[
]41[
]14[
]44[
10.11.2004
0303029-3
]91[ 17.11.2003
]99[ SE
Int. Cl.(2010.01) A61M 15//00
ASTRAZENECA AB, SWEDEN
MARTIN BUNCE
WO/2005/046774
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
An inhaler (1) for dispensing doses of medicament from a container under user
activation said inhaling which comprises a body (7) which includes a mouthpiece (5)
through which the medicament is dispensed and a cap (2) which can be place in a
position to substantially occlude the mouthpiece (5). The cap (2) is attached to said
body (7) by a strap (3) which pivots from said body (7), said cap (2) being arranged to
slide on the strap (3) such that the cap (2) must translate away from the mouthpiece (5)
prior to the pivoting of the strap (3).
]54[
__________________
]22[]12[
]54[
]11[
255
ADJUSTING THE TRANSMIT
POWER LEVEL OF A CELLULAR
COMMUNICATION TERMINAL
CAPABLE OF PEER-TO-PEER
COMMUNICATIONS
175691
‫כוונון העברת רמת האנרגיה של מסוף תקשורת‬
‫סלולרי המסוגל להתחבר אל חיבור של אמצעי‬
‫תקשורת‬
19.11.2004
April 28, 2011-‫כ"ד בניסן התשע"א‬
]92[
]52[
]42[
]14[
]44[
]54[
60/523989
]91[ 21.11.2003
213354141
1331331114
Int. Cl.(2010.01) H04L 12//56
QUALCOMM INCORPORATED,
U.S.A.
WO/2005/053253
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]99[
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
In a multiple-access network, network access terminals (106) can communicate with
network infrastructure access nodes (104), or conduct peer-to-peer communications
(110). The access terminals are adapted to adjust the transmit power level in response
to power control commands received from the access nodes and from other access
terminals.
The applications for division
from this application have
not yet been published
202200/
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
175708
‫ תוכנת בקרה ותווך לאחסון‬,‫מערכת ניהול סחורה‬
‫מידע‬
]54[
MERCHANDISE MANAGEMENT
SYSTEM, CONTROL PROGRAM
AND INFORMATION STORAGE
MEDIUM
]11[
]92[
]52[
17.05.2006
2005-168785 ]91[ 08.06.2005
]99[ JP
Int. Cl.(2010.01) B65G 61//00, G06F 03//147, G06G 01//12, G06K 17//00, G06Q
30//00
DAI NIPPON PRINTING CO. LTD.,
JAPAN
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
April 28, 2011-‫כ"ד בניסן התשע"א‬
]42[
]44[
256
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A merchandise management system, comprising a display device provided in an
exhibit position of a product, and a portable information processing device for
changing a display content on the display device,
the display device, comprising:
a displaying device which comprises a display medium that retains a displayed status
without electrical power, and which displays product information corresponding to the
product placed in the exhibit position in which the display device is provided, using
the display medium;
a non-volatile storing device which stores at least display device identification
information for identifying the display device from other display devices;
a controlling device which controls a change of the displayed status, based on an
electrical power signal, and change information for changing the displayed status; and
a receiving device which receives the change information and the electrical power
signal from the information processing device via radio communication, and outputs
the received change information and electrical power signal to the controlling device,
the information processing device, comprising:
a change information generating device which generates the change information based
on the displayed status to be changed;
an electrical power signal generating device which generates the electrical power
signal for driving the controlling device; and
a transmitting device which transmits the electrical power signal and the change
information generated respectively to the display device, based on the display device
identification information corresponding to the display device on which the displayed
status is to be changed,
Wherein the system further comprises a server device comprising:
And indication information generating device which generates status indication
information that indicates the displayed status to be changed; and
An indication information transmitting device which transmits the generated status
indication information to the information processing device, wherein the information
processing device further comprises an indication information receiving device which
receives the transmitted status indication information, wherein the change information
generating device generates the change information based on the received status
indication information, wherein the status indication information includes location
information which indicates a location in a store of the display device for which the
displayed status be changed; and
The information processing device further comprises a location image displaying
device which displays an image of a location that indicates the location based on the
location information included in the transmitted status indication information.
__________________
257
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
175794
‫מערכת לחיבור פרופילים‬
]54[
PROFILE CONNECTING SYSTEM
]11[
]92[
]52[
]42[
]44[
21.05.2006
05011815
]91[
01.06.2005
]99[
EP
Int. Cl.(2010.01) F16B 07//00, 07//18
KANYA AG, SWITZERLAND
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
21 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61013
Profile connecting systems having profile bars and connecting elements and assembly thereof. The profile
bars may have at least one axial elongated hole and on the profile outer sides slots for nut block connections.
Profile connections may be assembled by inserting and fixing an abutment, for example, a self-cutting
threaded insert, into the bore of an axial elongated hole in a first profile bar. Adjacent to the installation
length of the threaded insert and of the head of a screw, an axially running wrench opening may be provided
in the tubular body of the axial elongated hole. The length and width of the wrench opening may permit
guidance there through of a assembly tool, for example, socket wrench with joints or with a substantially
spherical socket wrench head with flats, at an insertion angle to the longitudinal axis of the profile bar and the
coupling of the socket wrench to the head of the screw.
]54[
258
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
175801
‫שיטה עבור ייצור תרכובת ציקלואלקילידאן‬
‫ביסוקסאזולין אופטית פעילה ואמצעי ביניים‬
‫מזה‬
]54[
METHOD FOR PRODUCING
OPTICALLY ACTIVE
CYCLOALKYLIDENE
BISOXAZOLINE COMPOUND
AND INTERMEDIATE THEREOF
]11[
]92[
]52[
]42[
21.12.2004
2003-424580 ]91[ 22.12.2003
]99[ JP
Int. Cl.(2010.01) C07C 23/3/60, C07D 26/3/12, 26/3/14, 26/3/52
SUMITOMO CHEMICAL
COMPANY, LIMITED., JAPAN
WO/2005/061438
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
Disclosed is an optically active cycloalkylidene bisamidoalcohol compound
represented by the following formula (3): (3) (wherein R1 represents a C1-6 alkyl group,
an optionally substituted phenyl group, an optionally substituted aralkyl group or a
hydrogen atom, or two R1s bonded to a same carbon atom form a ring together with
the carbon atom; R2 represents a C1-6 alkyl group, an optionally substituted aralkyl
group or an optionally substituted phenyl group; and * represents an asymmetric
center). Also disclosed is a method for producing such an optically active
cycloalkylidene bisamidoalcohol compound. Further disclosed is a method for
producing an optically active cycloalkylidene bisoxazoline compound represented by
the following formula (4): (4) (wherein R1, R2 and * are as defined above).
]14[
]44[
]54[
__________________
259
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
175991
‫שיטה ומנגנון לגילוי קרינה באורך גל תוך‬
‫שימוש בגלאי לאורך גל שונה‬
]54[
METHOD AND APPARATUS FOR
DETECTING RADIATION AT ONE
WAVELENGTH USING A
DETECTOR FOR A DIFFERENT
WAVELENGTH
]11[
]92[
]52[
]42[
]14[
]44[
23.11.2004
10/729143
]91[ 04.12.2003
]99[ US
Int. Cl.(2010.01) G01J 05//00, 05//10
RAYTHEON COMPANY, U.S.A.
WO/2005/062009
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
An apparatus includes a resonator portion responsive to electromagnetic radiation
within a frequency range, a converter portion responsive to radiation received by the
resonator portion for emitting electromagnetic radiation within a different frequency
range, and a detector portion which detects the radiation emitted by the converter
portion. According to one feature, the resonator portion, the converter portion and the
detector portion are respective parts of an integrated circuit. According to a different
feature, the radiation emitted by the converter portion is infrared energy.
]54[
__________________
]22[]12[
]54[
PROCESS FOR PURIFYING (-)-∆9TRANSTETRAHYDROCANNABINOL
]11[
]92[
]52[
]42[
17.12.2004
0329635.7
]91[ 23.12.2003
Int. Cl.(2010.01) C07D 31/1/80
JOHNSON MATTHEY PUBLIC
LIMITED COMPANY, UNITED
260
176197
–‫–∆ טרנס‬0– )–( ‫תהליך לטיהור‬
‫טטראהידרוקנאבינול‬
]99[
GB
April 28, 2011-‫כ"ד בניסן התשע"א‬
]14[
]44[
]54[
KINGDOM
WO/2005/061480
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A preparative separation process wherein (-)-delta-3trans-tetrahydrocannabinol is
separated from a mixture of cannabinoids is disclosed. The process comprises at least
one chromatographic step wherein a mobile phase passes through a stationary phase.
The stationary phase comprises a derivatised polysaccharide and the mobile phase
comprises carbon dioxide3
__________________
]22[]12[
]54[
STERNUM REINFORCING DEVICE
TO BE USED AFTER A
STERNOTOMY OR A STERNAL
FRACTURE
]11[
]92[
]52[
]42[
]41[
]14[
]44[
15.02.2005
RM2004A000082 ]91[ 16.02.2004
Int. Cl.(2010.01) A61B 17//80
SIC BREVETTI S.R.L., ITALY
JACOB ZEITANI
WO/2005/077289
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
]54[
261
176559
‫מתקן חיזוק לעצם החזה לשימוש לאחר‬
‫ניתוח או שבר בעצם החזה‬
]99[
IT
,‫ד"ר מרק פרידמן בע"מ‬
‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
1
‫ גן‬-‫רמת‬
A sternum reinforcing device to be used after a sternotomy or a sternal fracture, made
of a biocompatible material, comprises an elongated modular member (10) with a pair
of legs (20, 30), that are joined each other by a body portion (4), and a pair of arms (6,
April 28, 2011-‫כ"ד בניסן התשע"א‬
7). The legs (20, 30) can be fitted in an intercostal space of the thorax of a patient,
laterally to the sternum, and can be bent in a mutually opposite direction, on the
internal side of the thorax, after being fitted therein. The arms (6, 7), extending from
one side to the other of the body portion (4) and orthogonally to the pair of legs (20,
30), constitute a male part and a female part, respectively, of a prismatic type coupling
for consecutive modular members.
__________________
]22[]12[
176629
,‫ תהליך להכנתן‬,‫תולדות של סולפונאמיד‬
‫תכשירים רפואיים המכילים אותן ושימושן‬
‫בייצור תרופה לטיפול במחלות מתווכות על ידי‬
‫ – אנדרנוצפטור‬β2
]54[
SULFONAMIDE DERIVATIVES,
PROCESS FOR THEIR
PREPARATION,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USE THEREOF FOR
THE MANUFACTURE OF A DRUG
FOR THE TREATMENT OF Β2ADRENOCEPTOR-MEDIATED
DISEASES
]11[
]92[
12.01.2005
04290168.6
]91[ 22.01.2004
]99[ EP
141191133
1131931114
GB
113111153
1331131114
US
Int. Cl.(2010.01) A61K 31//18, A61P 11//06, 11//08, C07C 31/1/08, 32/3/41, C07D
21/3/40, 33/5/02
PFIZER INC., U.S.A.
WO/2005/080324
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention relates to compounds of formula (1) and to processes for the preparation
]52[
]42[
]14[
]44[
]54[
262
April 28, 2011-‫כ"ד בניסן התשע"א‬
of, intermediates used in the preparation of, compositions containing and the uses of,
such derivatives. The compounds according to the present invention are useful in
numerous diseases, disorders and conditions, in particular inflammatory, allergic and
respiratory diseases, disorders and conditions.
__________________
]22[]12[
176707
‫ תכשירים‬,‫נגזרות של חומצה אנתרנילית‬
‫רוקחיים המכילים אותן ושימוש בהן להכנת‬
‫תרופות לטיפול במצבים המגיבים לעיכוב של‬
‫דיהידרואורוטאט–דהידרוגנאז‬
]54[
ANTHRANILIC ACID
DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USES THEREOF FOR
THE PREPARATION OF
MEDICAMENTS FOR THE
TREATMENT OF A CONDITION
RESPONSIVE TO INHIBITION OF
DIHYDROOROTATEDEHYDROGENASE
]11[
]92[
]52[
04.02.2005
0400234-1
]91[ 06.02.2004
]99[ SE
Int. Cl.(2010.01) A61K 31//196, 31//24, 31//40, 31//4965, 31//5375, A61P 19//00,
C07C 23/3/54, 32/1/28, 32/1/30, C07D 20/7/06, 21/1/14, 24/1/02, 26/5/06
CHELSEA THERAPEUTICS, INC.,
U.S.A.
WO/2005/075410
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]42[
]14[
]44[
]54[
Compounds of formula (I), for clinical treatment of autoimmune diseases,
inflammatory diseases, organ transplant rejection and malignant neoplasia. A
pharmaceutical composition comprising a compound of formula (I) in an amount
giving a daily dosage of from 0.005 mg/kg to 10 mg/kg body weight, in particular
from 0.025 mg/kg to 2 mg/kg body weight.
__________________
263
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
176727
‫סוליה מעוקמת באלכסון‬
]54[
DIAGONALLY TWISTED SOLE
]11[
]92[
]52[
]42[
10.01.2005
00044/04
]91[ 13.01.2004
]99[ CH
Int. Cl.(2010.01) A43B 07//22, 13//14, 13//24
MASAI MARKETING & TRADING
AG, SWITZERLAND
WO/2005/067754
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
The invention relates to a diagonally twisted sole (3) consisting of a lower sole (12)
and a median sole bottom (11) connected to the lower sole (12). Various hard inserts
(15) can be introduced into the lower sole (12). Together, said lower sole (12) and a
twisted, flexible, rigid or elastic plate (16) can form an intermediate sole (12, 16)
which can consist of a plurality of parts. The twisted plate (16) is a flat plate or a plate
of various thicknesses.
]14[
]44[
]54[
__________________
]22[]12[
]54[
SATELLITE/HANDS-FREE
INTERLOCK SYSTEMS AND/OR
COMPANION DEVICES FOR
RADIOTERMINALS AND
RELATED METHODS
]11[
]92[
06.04.2005
60/560221
]91[ 07.04.2004
223134392
9231931115
Int. Cl.(2010.01) H04B 07//185
]52[
264
176728
‫ללא שימוש בידיים‬/‫מערכות שילוב לווייניות‬
‫או התקנים נלווים עבור רדיו טרמינלים‬/‫ו‬
‫ושיטות הקשורות‬
]99[
US
US
April 28, 2011-‫כ"ד בניסן התשע"א‬
]42[
]14[
]44[
]54[
ATC TECHNOLOGIES, LLC, U.S.A.
WO/2005/101692
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
A radioterminal may include a transceiver, a hand-held interface coupled to the
transceiver, and an interlock coupled to the transceiver. The transceiver may be
configured to transmit and receive wireless communications, and the transceiver may
be further configured to transmit high power communications at a high maximum
power and/or EIRP and to transmit low power communications at a low maximum
power and/or EIRP. The interlock may be configured to prevent the transceiver from
transmitting high power communications at a power and/or EIRP that exceeds a
threshold when the hand-held interface is activated. Related methods are also
discussed.
__________________
]22[]12[
176730
‫שיטה לייצור גרגירים עם מעט אבק מתוספים‬
‫לפולימרים‬
]54[
METHOD OF PRODUCING LOWDUST GRANULES FROM
POLYMER ADDITIVES
]11[
]92[
]52[
]42[
14.01.2005
04100246.0
]91[ 23.01.2004
]99[ EP
Int. Cl.(2010.01) B01J 02//22, C08K 05//13, 07//16, 13//02
CIBA SPECIALTY CHEMICALS
HOLDING INC., SWITZERLAND
WO/2005/071008
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]44[
]54[
265
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a technically advantageous method of producing low-dust
April 28, 2011-‫כ"ד בניסן התשע"א‬
granules of polymer additives or polymer additive mixtures. The granule-forming
polymer additives are mixed together, the mixture is converted into a workable mass
and pressed through an orifice. The pre-shaped strand-like extruded mass is cooled
and, while still in a workable state, formed into granules by rolling, impressing,
cooling and comminuting.
__________________
]22[]12[
176767
‫תהליך לייצור ריבארוקסבאן ושימוש‬
‫בריבארוקסבאן המיוצר באמצאותו להכנת‬
‫מניעה של הפרעות‬/‫תרופה לטיפול‬
‫תרמבואואמבוליות‬
]54[
METHOD FOR PRODUCING
RIVAROXABAN AND USE OF THE
RIVAROXABAN PRODUCED
THEREBY IN THE PREPARATION
OF A MEDICAMENT FOR THE
PROPHYLAXIS/TREATMENT OF
THROMBOEMBOLIC DISORDERS
]11[
]92[
]52[
]42[
31.12.2004
102004002044.2 ]91[ 15.01.2004
]99[ DE
Int. Cl.(2010.01) A61K 31//5377, C07D 40/9/14, 41/3/14
BAYER SCHERING PHARMA AG,
GERMANY
WO/2005/068456
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]44[
]54[
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a method for producing 5-chloro-N-{(5S)-2-oxo-3-[4-(3-oxo4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide from
2-[(2S)-2-oxiranylmethyl]-1H-isoindol-1,3(2H)-dione, 4-(4-aminophenyl)-3morpholinone, and 5-chlorothiophene-2-carbonyl chloride.
__________________
]22[]12[
]54[
WALL MOUNTING BRACKET FOR
RADIATORS
]11[
12.07.2006
266
176813
‫משען קיר להצבת מקרנים‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]92[
]52[
]42[
]41[
]44[
]54[
267
PD2005A000214 ]91[ 12.07.2005
Int. Cl.(2010.01) F24D 19//02
MB S.R.L., ITALY
ARDUINO BORDIGNON
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
]99[
IT
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11
‫רמת גן‬
A wall mounting bracket for radiators, particularly of the type provided with radiating
modules connected in a n upper region and in a lower region by manifolds, which
comprises a plate to be fixed to a wall, from an upper part of which a cantilevered
portion protrudes for stably supporting the upper manifold of a radiator;
characterized in that it further comprises means for locking the lower manifold of the
radiator, which form an upper abutment and at least one lateral abutment, respectively
for the upper portion and for at least the portion that lies furthest, with respect to the
wall, of the lower manifold of the radiator, which are adapted to prevent movements of
the radiator in an upward direction and at least in the opposite direction with respect to
the wall;
And further characterized in that said means for locking the lower manifold of the
radiator comprise a hook-shaped body, which is pivoted to a lower part of said plate
and can be turned, during the mounting of the radiator, from a disengagement position
to a position for stable engagement with the lower manifold of the radiator and for
automatic locking thereto, said hook-shaped body, when arranged in said engagement
position, surrounding at least the upper portion and the portion that lies furthest with
respect to the wall of the lower manifold of the radiator, thus forming said upper
abutment and said at least one lateral abutment, means for preventing rotation from the
engagement position to the disengagement position being associated with said hookshaped body.
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
176898
‫ תכשירים‬,‫תרכובות קושרות גורם גדילה‬
‫ ושימוש בהם להכנת תכשירים‬,‫המכילים אותן‬
‫רוקחיים‬
]54[
GROWTH FACTOR-BINDING
COMPOUNDS, COMPOSITIONS
COMPRISING THEM AND USES
THEREOF IN THE
MANUFACTURE OF
PHARMACEUTICAL
COMPOSITIONS
]11[
]92[
]52[
]42[
27.01.2005
60/539613
]91[ 27.01.2004
]99[ US
Int. Cl.(2010.01) A61K 31//195, 47//48, C07C 22/9/00
UNIVERSITY OF SOUTH FLORIDA
YALE UNIVERSITY, U.S.A.
]14[
]44[
268
WO/2005/072779
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
Growth factor binding compounds having a plurality of acyclic isophthalic acid groups
attached to a non-peptide organic scaffold and pharmaceutical compositions of the
same are disclosed. Methods of administering and using the growth factor binding
compounds or the growth factor binding compositions are also taught. These novel
growth factor binding compounds are useful for treating angiogenesis, excessive
cellular proliferation, tumor growth, and a combination thereof as well as inhibiting
growth factor binding to cells and phosphorylation.
__________________
]22[]12[
177124
‫תכנית קידוד עם יכולת חיזוי‬
]54[
PREDICTIVE CODING SCHEME
]11[
]92[
]52[
]42[
20.12.2004
1020040071853 ]91[ 13.02.2004
]99[ DE
Int. Cl.(2010.01) G10L 19//00, 19//04
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V., GERMANY
WO/2005/083683
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
21 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61013
The invention is based on an adaptive prediction algorithm which can be controlled by
a speed coefficient in order to work at a first adaptation speed and with a first degree of
precision of adaptation and degree of precision of prediction in the event that the speed
coefficient has a first value and with a second degree of precision of adaptation, which
is lower than the first, and with a degree of precision of prediction, which is higher
than the first in the event that the speed parameter has a second value, wherein the
periods of adaptation occurring after the reset times during which the prediction errors
are initially increased as a result of the not yet adapted prediction coefficients, are
reduced by initially adjusting the speed parameter to the first value (42) and after a
while adjusting it to the second value (50). When the speed parameter is readjusted to
the second value after a specific time period after the reset times, the prediction errors
and the residuals that are to be transferred are optimized or smaller than with the first
speed parameter value.
]14[
]44[
]54[
269
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
177385
‫תחמושת מעוטפת בעלת ליבה עשויה כחטיבה‬
‫אחת‬
]54[
JACKETED ONE PIECE CORE
AMMUNITION
]11[
]92[
]52[
]42[
23.02.2005
10/783032
]91[ 23.02.2004
]99[ US
Int. Cl.(2010.01) F42B 12//06
GENERAL DYNAMICS ORDNANCE
AND TACTICAL SYSTEMS CANADA INC., CANADA
JOHN MACDOUGALL
WO/2005/080910
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
A jacketed projectile having one-piece steel core provides good performance regarding
chamber pressure, barrel wear and accuracy by separating the jacket from a central
tapered portion of the core by providing an encircling air gap that facilitates engraving
of the jacket during firing.
]41[
]14[
]44[
]54[
__________________
]22[]12[
]54[
270
DERIVATIVES OF
ALKYLPIPERAZINE- AND
ALKYLHOMOPIPERAZINE-
177422
–‫תולדות של אלקילפיפראזין‬
‫ שיטה‬,‫ואלקילהומופיפראזין–קרבוקסילטים‬
FAAH ‫להכנתן והשימוש בהן כמעכבי אנזים‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
CARBOXYLATES, PREPARATION
METHOD THEREOF AND USE OF
SAME AS FAAH ENZYME
INHIBITORS
]11[
]92[
]52[
]42[
]14[
]44[
]54[
25.02.2005
0401953
]91[ 26.02.2004
]99[ FR
Int. Cl.(2010.01) A61K 31//425, 31//47, 31//495, 31//496, 31//506, 31//551, A61P
25//00, 29//00, 31//00, 33//00, 35//00, 37//00, C07D 29/5/185, 40/1/10, 40/3/06,
41/3/06, 41/7/06
SANOFI-AVENTIS, FRANCE
WO/2005/090322
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The invention relates to a compound having general formula (I), wherein: n = 1 or 2; p
represents an integer varying between 1 and 7; A is selected from one or more X, Y
and/or Z groups; X = optionally-substituted methylene; Y = C2-alkenylene, optionally
substituted, or C2-alkynylene; Z = C3-7-cycloalkyl; G = single bond, O, S, SO, SO2,
C=O or CH(OH); R1 represents an aryl- or heteroaryl-type group; and R2 represents a
hydrogen atom or a C1-6-alkyl group; R3 represents a hydrogen atom or a C1-6-alkyl, C37--cycloalkyl, C3-7-cycloalkyl-C1-3-alkyl group, said compound taking the form of a
base, an acid addition salt, a hydrate or a solvate. The invention also relates to the use
thereof as FAAH enzyme inhibitors for the treatment of pain, inflammation,
neurodegenerative diseases, etc.
__________________
]22[]12[
177518
0 ‫–אוקסאדנין מותמרת בעמדה‬0 ‫תרכובת‬
]54[
9-SUBSTITUTED 8-OXOADENINE
COMPOUND
]11[
]92[
]52[
]42[
24.03.2005
2004-093672 ]91[ 26.03.2004
]99[ JP
Int. Cl.(2010.01) A61K 31//522, 31//5377, C07D 47/3/18
DAINIPPON SUMITOMO PHARMA
CO., LTD., JAPAN
271
April 28, 2011-‫כ"ד בניסן התשע"א‬
]14[
]44[
]54[
ASTRAZENECA AB, SWEDEN
WO/2005/092893
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
An 8-oxoadenine compound represented by the formula (1): [wherein ring A
represents a 6- to10-membered aromatic carbocycle, etc.; R represents halogeno, alkyl,
etc.; n is an integer of 0 to 2; Z1 represents alkylene; X2 represents oxygen, sulfur, SO2,
NR5, CO, CONR5, NR5CO, etc.; Y1, Y2, and Y3 each independently represents a single
bond or alkylene; X1 represents oxygen, sulfur, NR4 (wherein R4 represents hydrogen
or alkyl), or a single bond; R2 represents (un)substituted alkyl, etc.; and R1 represents
hydrogen, hydroxy, alkoxy, alkoxycarbonyl, haloalkyl, etc.] or a pharmaceutically
acceptable salt thereof. They have immunoregulatory activity such as interferoninducing activity and are useful as an antiviral agent, antiallergic, etc.
__________________
]22[]12[
177586
‫רקמה‬/‫מערכת ושיטה לגידול תרביות תאים‬
‫צמחיים‬
]54[
PLANT CELL/TISSUE
CULTURING SYSTEM AND
METHOD
]11[
]92[
]52[
]42[
]41[
]14[
]44[
24.02.2005
10/784295
]91[ 24.02.2004
]99[ US
Int. Cl.(2010.01) C12M 01//04, C12N 01//04
PROTALIX LTD.
‫ כרמיאל‬,‫פרוטליקס בע"מ‬
YOSEPH SHAALTIEL
‫יוסף שאלתיאל‬
WO/2005/080544
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
A device, system and method for axenically culturing and harvesting cells and/or
tissues, including bioreactors and fermentors. The device is preferably disposable but
nevertheless may be used continuously for a plurality of consecutive
culturing/harvesting cycles prior to disposal of same. This invention also relates to
April 28, 2011-‫כ"ד בניסן התשע"א‬
]54[
272
batteries of such devices which may be used for large-scale production of cells and
tissues. According to preferred embodiments of the present invention, the present
invention is adapted for use with plant cell culture.
__________________
]22[]12[
177612
]54[
BREAST CANCER RESISTANCE
PROTEIN (BCRP) AND METHODS
FOR IDENTIFYING INHIBITORS
THEREOF
]11[
]92[
]52[
]11[
]42[
05.02.1999
60/073763
]91[ 05.02.1998
]99[ US
Int. Cl.(2010.01) A61K 31//4985, A61P 35//00, C07K 14//47, C12Q 01//02
DIVISION FROM 137466
UNIVERSITY OF MARYLAND,
BALTIMORE, U.S.A.
WO/1999/040110
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A Breast Cancer Resistance Protein (BCRP) comprising an amino acid sequence of
SEQ. ID No. 1 wherein said BCRP induces resistance to cancer chemotherapeutic drug
in breast cancer cells 3
]14[
]44[
]54[
BCRP( ‫חלבון המקנה עמידות בפני סרטן השד‬
‫) ושיטות לזהות את המעכבים שלו‬
22121/0
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
]54[
METHOD FOR REDUCING
CYANIDE LEVEL IN
MESOTRIONE SAMPLES
]11[
]92[
03.03.2005
0406894.6
273
]91[
26.03.2004
177723
‫שיטה להקטנת רמת ציאניד בדוגמאות‬
‫מסוטריאון‬
]99[
GB
April 28, 2011-‫כ"ד בניסן התשע"א‬
]52[
]42[
]14[
]44[
]54[
Int. Cl.(2010.01) C07C 31/5/06, 31/7/24
SYNGENTA PARTICIPATIONS AG,
SWITZERLAND
WO/2005/092846
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A method for reducing the cyanide levels in a mesotrione sample, said method
comprising: (i) taking an aqueous solution of the mesotrione sample in an aqueous
solvent, (ii) adjusting the pH of said aqueous solution to a value of 9.5 or higher, and
(iii) crystallising the mesotrione out of solution is disclosed.
__________________
]22[]12[
177945
‫פרודראגים של תרכובות אנטיויראליות של‬
‫פיפרזין ופיפרידין מותמר‬
]54[
PRODRUGS OF PIPERAZINE AND
SUBSTITUTED PIPERIDINE
ANTIVIRAL AGENTS
]11[
]92[
03.03.2005
60/533320
]91[ 15.03.2004
]99[ US
113195192
2132131114
US
Int. Cl.(2010.01) A61K 31//675, A61P 31//12, 31//18, C07F 09//09, 09//572, 09//6561
BRISTOL-MYERS SQUIBB
COMPANY, U.S.A.
WO/2005/090367
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
This invention provides for prodrug Compounds (I), pharmaceutical compositions
thereof, and their use in treating HIV infection. Also, this invention provides for
intermediate Compounds (II) useful in making prodrug Compounds (I).
]52[
]42[
]14[
]44[
]54[
274
April 28, 2011-‫כ"ד בניסן התשע"א‬
The applications for division
from this application have
not yet been published
2022112
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
]54[
]11[
]92[
]52[
]42[
]14[
]44[
]54[
275
5-(5-MEMBERED SUBSTITUTED
HETEROARYL) SUBSTITUTED
IMIDAZO[4,5-B]PYRIDINES AND
PHARMACEUTICAL
FORMULATIONS COMPRISING
THEM AS P-38 KINASE
INHIBITORS
178103
‫ – (הטרואריל‬4 ‫פירידינים מותמרים על ידי‬
–B5,4[‫מחומש מותמר) ותכשירי רוקחות‬
‫]אימידאזו‬
‫ המכילים אותם כמעכבי‬P–38‫קינז‬
25.01.2005
60/540830
]91[ 30.01.2004
]99[ US
Int. Cl.(2010.01) A61K 31//4188, A61P 29//00, C07D 47/1/04
ELI LILLY AND COMPANY, U.S.A.
WO/2005/075478
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention provides kinase inhibitors of Formula I.
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
178255
‫שיטה ומערכת ליישום של שירותי תקשורת‬
‫בחיוב‬
]54[
METHOD AND SYSTEM FOR
IMPLEMENTING CHARGING
COMMUNICATION SERVICES
]11[
]92[
]52[
]42[
22.03.2005
200410032101.3 ]91[ 24.03.2004
]99[
Int. Cl.(2010.01) H04L 12//14, H04M 15//00
HUAWEI TECHNOLOGIES CO, LTD.,
CHINA
WO/2005/091558
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]14[
]44[
]54[
276
CN
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
In a method for implementing the communication service charging, the charging
system comprises a charging module and a expression analyzer. Firstly, the charging
module determines a elementary expression factor, and the user configures the
expression according to the gives expression factor; the charging module analyzes each
expression factor after reading the communication record, and transmits each value of
expression factor to the expression analyzer; the expression analyzer operates the
expression according to the expression configured by the user, and the value of
expression factor transmitted from the charging moduule, finally returns the result to
the charging module, and the charging module searches the corresponding charging
rate according to the result to operate the charging. The present invention makes it
more agile and convenient to set the charging rule, and improves the expajndability of
the program. It supports the new service requirement rapidly, unifies the description of
the charging strategy and reduces the maintenance work.
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
178398
‫כלי סינון למחסניות בנות החלפה‬
]54[
REPLACEABLE CARTRIDGE
FILTER JUG
]11[
]92[
]52[
]42[
]14[
]44[
03.11.2004
PD2004A000095 ]91[ 08.04.2004
]99[ IT
Int. Cl.(2010.01) B01D 35//143, C02F 01//00
LAICA S.P.A., ITALY
WO/2005/097293
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Replaceable cartridge (8) filtering jug (1) comprising a vessel (6) containing water
requiring filtration and a vessel (10) for the collection of filtered water in which the
vessels are connected through the cartridge (8) together with means (18) for counting
the filtering cycles performed by the cartridge in order to determine the state of
exhaustion of the same which comprise at least one float level detector (19) associated
with one of the vessels (6, 10) and capable of generating at least one counting signal
fed to counting means as a result of the corresponding water level being reached within
the corresponding vessel.
]54[
277
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
178474
‫נוגדים מונושבטיים לגורם גידול הפאטוציטית‬
‫ותכשירי רוקחות המכילים אותם‬
]54[
MONOCLONAL ANTIBODIES TO
HEPATOCYTE GROWTH
FACTOR AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
]11[
]92[
]52[
13.08.2004
10/825060
]91[ 15.04.2004
]99[ US
Int. Cl.(2010.01) A61K 39//395, C07K 16//22, 16//30, C12N 05//20, G01N 33//53,
33//563, 33//574, 33//577
GALAXY BIOTECH, LLC, U.S.A.
WO/2005/107800
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The present invention is directed toward a neutralizing monoclonal antibody to
hepatocyte growth factor, a pharmaceutical composition comprising same, and
methods of treatment comprising administering such a pharmaceutical composition to
a patient, such as for inhibiting glioblastoma.
]42[
]14[
]44[
]54[
__________________
278
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
178568
‫נוהל צמיג מאוד המכיל חומר פעיל כאשר‬
‫האנטיגניות או הפעילות של החומר הפעיל‬
‫ חיסון‬,‫ שיטה להכנתו ותכשיר אימונוגני‬,‫נשמרת‬
‫או קיט המכילים אותו‬
]54[
HIGHLY VISCOUS LIQUID
COMPRISING AN ACTIVE AGENT
WHERE THE ANTIGENICITY OR
ACTIVITY OF THE ACTIVE
AGENT IS PRESERVED,
METHOD FOR ITS
PREPARATION AND AN
IMMUNOGENIC COMPOSITION
VACCINE OR KIT COMPRISING
THE SAME
]11[
]92[
]52[
]42[
28.04.2005
0409795.2
]91[ 30.04.2004
]99[
Int. Cl.(2010.01) A01N 01//00, A61K 09//00
GLAXOSMITHKLINE
BIOLOGICALS S.A., BELGIUM
WO/2005/105978
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]44[
]54[
GB
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to a method of drying biological and other labile samples
so that they can be preserved as a highly viscous liquid. The method involves the steps
of preparing a preservation sample by dissolving/suspending an active agent in a
solution of a stabilising agent, subjecting the preservation sample to such temperature
and pressure conditions that the preservation sample loses solvent by evaporation
without freezing or bubbling to form a foam and removing solvent until the
preservation sample dries to form a highly viscous liquid. The stabilising solution
comprises a glass forming polyol and a second component which decreases the flow
rate of the highly viscous liquid formed by the method.
__________________
]22[]12[
]54[
ELECTRONIC THERMOMETER WITH FLEX CIRCUIT
LOCATION
]11[
]92[
]52[
]42[
26.10.2006
11/265984
]91[
03.11.2005
Int. Cl.(2010.01) A61B 05//01, G01K 01//14
SHERWOOD SERVICES AG, SWITZERLAND
279
178902
‫מדחם אלקטרוני עם אתר מעגל גמיש‬
]99[
US
April 28, 2011-‫כ"ד בניסן התשע"א‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
]44[
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
An electronic thermometer comprising:
a probe tip adapted to be heated to a temperature by an object for use in measuring the temperature of the object:
a deformable circuit element including a deformable electrical conductor and at least one temperature
sensor electrically connected to the electrical conductor for detecting the temperature of the probe tip;
a probe shaft supporting the probe tip and deformable circuit element and including an end portion; and
a locating member further comprising a locating structure, wherein said locating structure comprises
a nub projecting outward from the locating member and engaging an opening in the deformable circuit
element for at least temporarily locating the deformable circuit element.
__________________
]22[]12[
]54[
280
PIPE COUPLINGS AND METHODS
178978
‫מחברים לצינור ושיטות לאבטוח חלקי צנרת‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
FOR SECURING PIPE ELEMENTS
]11[
]92[
]52[
]42[
]14[
]44[
10.05.2005
60/571596
]91[ 14.05.2004
]99[
Int. Cl.(2010.01) B21D 39//04, F16L 17//00
VICTAULIC COMPANY, U.S.A.
WO/2005/114023
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
A deformable mechanical pipe coupling is disclosed. The coupling has a plurality of
interconnectable segments that straddle the ends of pipe elements to be joined. The
segments have arcuate surfaces that engage outer surfaces of the pipe elements. The
outer surfaces subtend an angle of less than 180° and have radii of curvature greater
than the radii of curvature of the pipe element outer surfaces. The segments have
adjustably tightenable connection members for connecting the segments to one
another. When the connection members are tightened, the arcuate surfaces deform and
conform to the radius of curvature of the outer surface of the pipe elements.
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
v
201//10
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
]54[
]11[
]52[
]42[
]44[
281
179026
METHOD FOR FINDING
PROTECTED PATH IN MESH
NETWORKS
02.11.2006
Int. Cl.(2010.01) H04J 14//02, H04L 12//56
ECI TELECOM LTD.
ECI TELECOM LTD.,
‫שיטה לאיתור מסלול מוגן ברשתות תקשורת‬
MESH ‫מסוג‬
‫ פתח תקוה‬,‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
,‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
20 ‫רחוב הסיבים‬
‫פתח תקוה‬
A method of finding a primary communication path in a mesh network, which would
be at once a protected path having a fully guaranteed segmented node or node-link
protection. The method comprises defining a required protection type and further
selecting each specific path segment of the desired communication path based on
initial user's requirements and topology information of the network. Each specific
node path segment N for the communication path is selected upon ensuring that it can
be protected in the network by a node backup path satisfying the initial user's
requirements. Each specific link path segment L for the communication path is chosen
if it can be protected in the network by a link backup path satisfying the initial user's
requirements and if the node path segment N to which segment L leads cannot be
protected by a suitable node backup path.
30 HASIVIM ST.,
PETACH TIKVA 49517
]54[
__________________
]22[]12[
179082
‫נוהלי מערך חיבוריות אינטרנט מופחת‬
]54[
MINIMIZED IP CONNECTIVITY
ESTABLISHMENT PROCEDURES
]11[
]92[
09.05.2005
60/569238
]91[ 10.05.2004
]99[ US
113541191
2431531114
US
113542594
2431531114
US
113544211
1431131114
US
21-11141131131114
KR
1142534
21-11151131531115
KR
1191241
Int. Cl.(2010.01) H04L 12//28, 29//12
LG ELECTRONICS INC., REPUBLIC
OF KOREA
WO/2005/109768
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
For a broadband wireless access system, a method of configuring an IP address for a
fixed/mobile station that changes from idle mode to receiving mode or when
performing handover such that IP address configuration procedures are simplified. The
base station determines whether the mobile station that changes from idle mode to
receiving mode or performs handover needs to re-configure its IP address, and informs
this to the mobile station, which can then selectively configure its IP address according
to the needs of configuring its IP address.
April 28, 2011-‫כ"ד בניסן התשע"א‬
]52[
]42[
]14[
]44[
]54[
282
__________________
]22[]12[
179160
]54[
SUBSTITUTED N-ARYL
BENZAMIDES AND RELATED
COMPOUNDS FOR TREATMENT
OF AMYLOID DISEASES AND
SYNUCLEINOPATHIES
]11[
]92[
12.05.2005
60/570669
]91[ 12.05.2004
]99[ US
113113515
2132231114
US
Int. Cl.(2010.01) A61K 31//18, A61P 03//10, 25//00, 25//28, C07C 31/1/21
PROTEOTECH, INC., U.S.A.
WO/2005/113489
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
Substituted diaryl compounds of the Formulae (I, II, III), where the variables are as
defined in the claims, and their pharmaceutically acceptable derivatives, their
synthesis, pharmaceutical compositions containing them, and their use in the treatment
of amyloid diseases, including Aß amyloidosis, such as observed in Alzheimer's
disease, IAPP amyloidosis, such as observed in type 2 diabetes, and synucleinopathies,
such as observed in Parkinson's disease, and the manufacture of medicaments for such
treatment are provided.
]52[
]42[
]14[
]44[
]54[
283
‫–אריל ותרכובות‬N–‫בנזואמידים מותמרים ב‬
‫קשורות לשימוש בטיפול במחלות אמילואידיות‬
‫ובפתולוגיות הקשורות לגן סינוקליין‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
]54[
METHODS FOR TOTAL
NITROGEN REMOVAL FROM
WASTE STREAMS
]11[
]92[
]52[
]42[
13.05.2005
60/571344
]91[ 14.05.2004
Int. Cl.(2010.01) C02F 03//30
NORTHWESTERN UNIVERSITY,
U.S.A.
WO/2005/113456
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]44[
]54[
179212
‫שיטה לסילוק כולל של חנקן מזרמי שופכין‬
]99[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A method and related apparatus for oxidation and reduction of a reduced aqueous
nitrogen contaminant.
__________________
284
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
179215
‫פורמולציות אבקתיות לשאיפה המכילות‬
‫אננטיומרים טהורים של ביתא–אגוניסטים‬
]54[
INHALATION POWDER
FORMULATIONS CONTAINING
ENANTIOMERICALLY PURE
BETA-AGONISTS
]11[
]92[
]52[
]42[
11.05.2005
102004024451.0 ]91[ 14.05.2004
]99[ DE
Int. Cl.(2010.01) A61K 31//538, A61P 11//00, C07D 26/5/36
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH,
GERMANY
WO/2005/110359
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]44[
]54[
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to inhalation powder formulations containing enantiomerically
pure beta-agonists of formula (1), wherein the radicals R1, R2, R3 and R4 are defined as
in claims and descriptions and are optionally embodied in the form the
pharmaceutically acceptable acid addition salts thereof and are optionally combined
with a pharmaceutically acceptable accessory agent. A method for producing said
formulations and the use thereof in the form of a drug, in particular as a drug for
treating respiratory tract diseases are also disclosed.
__________________
]22[]12[
]54[
MICRORNAS AND USES
THEREOF
]11[
]92[
14.05.2005
10/709572
213413544
113511451
113511443
285
]91[
14.05.2004
2431531114
1932131114
1932131114
179285
‫ ושימושיהם‬RNA ‫מיקרו‬
]99[
US
US
US
US
April 28, 2011-‫כ"ד בניסן התשע"א‬
]52[
]42[
]14[
]54[
113511454
1432131114
US
113511111
2532231114
US
113539112
1132131114
US
113539913
1131231115
US
113111441
2431931115
US
113115134
1531931115
US
113111941
9131931115
US
Int. Cl.(2010.01) C12N 15//11, C12Q 01//68
ROSETTA GENOMICS LTD.
‫ רחובות‬,‫רוזטה ג'נומיקס בע"מ‬
WO/2005/111211
Described herein are novel polynucleotides associated with prostate and lung cancer.
The polynucleotides are miRNAs and miRNA precursors. Related methods and
compositions that can be used for diagnosis, prognosis, and treatment of those medical
conditions are disclosed. Also described herein are methods that can be used to
identify modulators of prostate and lung cancer.
__________________
]22[]12[
179413
‫שיטה לאספקת אוכלוסיית תאים בתרבית‬
‫מועשרת בתאי אב המטופויאטיים מדם מוצא‬
]54[
METHOD OF PROVIDING A
CULTURED CELL POPULATION
ENRICHED IN HEMATOPOIETIC
PROGENITOR CELLS FROM
EXTRACTED BLOOD
]11[
]92[
01.06.2005
60/576266
]91[ 01.06.2004
]99[
113511511
2531431114
Int. Cl.(2010.01) C12N 05//074, 05//078
KWALATA TRADING LIMITED,
CYPRUS
WO/2005/120090
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]52[
]42[
]14[
]44[
]54[
286
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A method is provided for use with extracted blood, including (a) applying blood to a
first gradient suitable for selecting first-pass cells having a density less than 1.077
g/ml; (b) applying the first-pass cells to a second gradient suitable for selecting
second-pass cells having a density between 1.055 and 1.074 g/ml; (c) increasing the
number of cells having a density between 1.055 and 1.074 g/ml, by culturing the
second-pass cells for a period lasting between 3 and 30 days; and (d) identifying
endothelial progenitor cells in the cultured cells. Other embodiments are also
April 28, 2011-‫כ"ד בניסן התשע"א‬
described.
This specification was examined in accordance
with regulation 35 of the Patent Regulations,
5728 - 1968
‫ לתקנות‬01 ‫פירוט זה נבחן בהתאם לתקנה‬
211/ – ‫ תשכ"ח‬2‫הפטנטים‬
__________________
]22[]12[
179458
‫ תכשיר‬,‫תולדות הטרואריליות מותמרות‬
‫ שיטה להכנת תכשיר‬,‫פרמצבטי הכולל אותן‬
‫פרמצבטי ושימיש שלהן‬
]54[
SUBSTITUTED HETEROARYL
DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
SAME, METHOD OF PRODUCING
PHARMACEUTICAL
COMPOSITIONS AND USE
THEREOF
]11[
]92[
]52[
02.06.2005
60/577354
]91[ 04.06.2004
]99[ US
Int. Cl.(2010.01) A61K 31//506, A61P 03//10, C07D 40/1/04, 40/1/12, 40/1/14,
40/3/04, 40/3/14, 40/5/14, 40/9/14, 41/3/14, 41/7/14
ARENA PHARMACEUTICALS, INC.,
U.S.A.
WO/2005/121121
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The present invention relates to certain substituted aryl and heteroaryl derivative of
Formula (I) that are modulators of metabolism, especially of the activity of a GPCR,
referred to herein as RUP3. Accordingly, compounds of the present invention are
useful in the treatment of metabolic-related disorders and complications thereof, such
as, diabetes and obesity.
]42[
]14[
]44[
]54[
__________________
287
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
179803
]54[
MULTICARRIER MODULATION
SYSTEM WITH CYCLIC DELAY
DIVERSITY
]11[
]92[
]52[
]42[
03.06.2005
60/577083
]91[ 04.06.2004
]99[ US
Int. Cl.(2010.01) H04J 01//00, 13//00, H04L 01//20, 05//02, 27//26
QUALCOMM INCORPORATED,
U.S.A.
WO/2005/122516
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Techniques to transmit data with cyclic delay diversity and pilot staggering are
described. For cyclic delay diversity, OFDM symbols having different cyclic delay
durations are generated. The cyclic delay durations for the OFDM symbols may be
selected to be time varying with respect to the cyclic delay durations for OFDM
symbols transmitted by a neighboring base station. An FDM pilot is generated and
multiplexed on multiple sets of subbands in different symbol periods. Waveforms for a
second radio technology (e.g., W-CDMA) may be generated for data to be transmitted
with this radio technology. The OFDM symbols are multiplexed onto time slots used
for OFDM, and the waveforms for the second radio technology are multiplexed onto
time slots used for this radio technology. One or multiple modulated signals may be
generated based on the multiplexed OFDM symbols and waveforms. Each modulated
signal is transmitted from a respective antenna.
]14[
]44[
]54[
‫ בעלת גיוון‬MULTICARRIER ‫מערכת אפנון‬
‫השהיה מעגלי‬
__________________
]22[]12[
]54[
288
LIQUID PRE-FORMULATIONS
COMPRISING A LOW VISCOSITY
NON-LIQUID CRYSTALLINE
179815
‫נוזלים המכילים גבישים לא–נוזליים בעלי‬
‫ הרכבים ושימוש בהם‬,‫צמיגות נמוכה‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
MIXTURE, FORMULATIONS AND
USE THEREOF
]11[
]92[
]52[
]42[
]14[
]44[
]54[
06.06.2005
0412530.8
]91[ 04.06.2004
]99[ GB
151111439
2431231115
GB
151412231
2131431115
GB
Int. Cl.(2010.01) A61K 08//04, 08//37, 08//55, 09//10, 09//12
CAMURUS AB, SWEDEN
WO/2005/117830
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to pre-formulations comprising low viscosity, non-liquid
crystalline, mixtures of: a) at least one neutral diacyl lipid and/or at least one
tocopherol; b) at least one phospholipid; c) at least one biocompatible, oxygen
containing, low viscosity organic solvent; wherein at least one bioactive agent is
dissolved or dispersed in the low viscosity mixture and wherein the pre-formulation
forms, or is capable of forming, at least one liquid crystalline phase structure upon
contact with an aqueous fluid. The preformulations are suitable for generating
parenteral, non-parenteral and topical depot compositions for sustained release of
active agents. The invention additionally relates to a method of delivery of an active
agent comprising administration of a preformulation of the invention, a method of
treatment comprising administration of a preformulation of the invention and the use
of a preformulation of the invention in a method for the manufacture of a medicament.
__________________
]22[]12[
179879
‫תמיכת מצב סרק של תחנה ניידת במערכת גישה‬
‫אלחוטית‬
]54[
SUPPORTING IDLE MODE OF
MOBILE STATION IN WIRELESS
ACCESS SYSTEM
]11[
]92[
07.06.2005
10-2004]91[ 07.06.2004
]99[ KR
0041539
21-11152331131115
KR
1129321
21-11151131931115
KR
1123151
Int. Cl.(2010.01) H04W 52//02, 60//04, 68//00, 68//12
LG ELECTRONICS INC., REPUBLIC
]52[
]42[
289
April 28, 2011-‫כ"ד בניסן התשע"א‬
]14[
]44[
]54[
OF KOREA
WO/2005/120178
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A method of supporting a mobile station that is in an idle mode in a wireless
communication system using a paging controller comprises entering an idle mode by a
mobile station, receiving a paging command (S32) from a base station in the same
paging group, the paging command comprising a paging command action code
associated with performing ranging while the mobile station is in the idle mode to
verify availability (S33) of the mobile station with respect to at least one of the base
stations in the paging group, wherein the paging command is generated from the base
station in response to a paging announcement (S31 ) from the paging controller, and
exiting the idle mode and establishing communication with one of the plurality of base
stations, wherein the plurality of base stations in the same paging group receive an idle
mode exist status from the paging controller.
__________________
]22[]12[
179941
‫הרכב ליטוש עבור מתכות אצילות‬
]54[
POLISHING COMPOSITION FOR
NOBLE METALS
]11[
]92[
]52[
]42[
01.07.2005
10/901420
]91[ 28.07.2004
]99[ US
Int. Cl.(2010.01) C09C 03//06, C09G 01//02
CABOT MICROELECTRONICS
CORPORATION, U.S.A.
WO/2006/023105
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
21 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61013
The invention provides a polishing composition and a method of chemically-
]14[
]44[
]54[
290
April 28, 2011-‫כ"ד בניסן התשע"א‬
mechanically polishing a substrate comprising a noble metal, the polishing
composition comprising (a) an oxidizing agent that oxidizes a noble metal, (b) an
anion selected from the group consisting of sulfate, borate, nitrate, and phosphate, and
(c) a liquid carrier. The invention further provides a polishing composition and a
method of chemically-mechanically polishing a substrate comprising ruthenium, the
polishing composition comprising (a) an oxidizing agent that oxidizes ruthenium
above the +4 oxidation state, (b) a polishing additive selected from the group
consisting of metal sequestering polymers, metal chelators, organic thiols, compounds
that reduce ruthenium tetraoxide, lactones, and &agr;-hydroxycarbonyl compounds.
__________________
]22[]12[
179976
‫מערכת איכון עיקבית רבת תחנות‬
]54[
MULTI-SHIP COHERENT
GEOLOCATION SYSTEM
]11[
]92[
]52[
]42[
02.06.2005
10/867056
]91[ 14.06.2004
]99[ US
Int. Cl.(2010.01) G01S 01//24, 05//14
BAE SYSTEMS INFORMATION
AND ELECTRONIC SYSTEMS
INTEGRATION INC., U.S.A.
WO/2005/124385
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
A system is provided for rapidly ascertaining the position of a pulse train emitter such
as a radar using multiple collectors without requiring more than one platform to
measure the same pulse. Thus time-of-arrival measurements at a number of collecting
platforms are performed, with the positions of the platforms being accurately
ascertainable using GPS data, and with time synchronization between the spaced-apart
collectors performed by utilizing atomic clocks. In the multi-ship case, geolocation can
be performed on ten milliseconds of data as opposed to 30 seconds of data for
measurements involving a single platform. The subject system is preferable to
conventional time-difference-of-arrival geolocation system because those systems
require that each of the collecting platforms measure the same pulse from the emitter,
which severely constrains the flight paths of the collectors, limits the amount of usable
data, and increases the system’s sensitivity requirements.
]14[
]44[
]54[
291
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
180052
‫מערכת לחולל כוח מגלי ים‬
]54[
SYSTEM FOR GENERATING
ENERGY FROM SEA WAVES
]11[
]52[
]42[
]44[
14.12.2006
Int. Cl.(2010.01) E02B 09//00, F03B 13//00
ELAZAR TAGANSKY
‫ ראש העין‬,‫אלעזר טגנסקי‬
ELAZAR TAGANSKY,
,‫אלעזר טגנסקי‬
P.O.B 230
‫ראש העין‬520 .‫ד‬.‫ ת‬,
ROSH HAAYN 48101
A system for generating energy from sea waves flowing towards a shore, comprising:
(a) a long channel delineated by a shore-facing side wall, an opposed sea-facing
side wall, a distal end wall and a proximate end wall interconnecting said side
walls, said channel being arranged to be supported in the sea along the shore
with the bottom of said channel being below sea level and the top of said
channel being positioned above sea level;
(b) a plurality of one-way apertures piercing said sea-facing side wall, each
aperture being closed by a hinged shutter unit, said shutter unit opening
inwards under pressure of said sea waves and re-closing after entry of a wave
to retain the water level in said channel above sea level in the absence of
external wave pressure, capturing water from waves which enter said channel
through said one-way apertures;
(c) at least one outlet port of said channel, wherein water in said channel forms
an artificial river at a level above sea level which flows out of said channel
through said outlet port due to both potential and kinetic energy, the
discharged water returning to the sea, and
(d) at least one energy conversion device positioned in the path of said water
flowing out of said channel to be driven by the flow of said water to produce
rotational energy.
]54[
This specification was examined in
292
‫ לתקנות‬01 ‫פירוט זה נבחן בהתאם לתקנה‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
211/ – ‫ תשכ"ח‬2‫הפטנטים‬
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
__________________
]22[]12[
180123
‫ריבוב שדרים עבור מערכת תקשורת סלולרית‬
‫מרובת אותות‬
]54[
MULTIPLEXING FOR A MULTICARRIER CELLULAR
COMMUNICATION SYSTEM
]11[
]92[
14.06.2005
60/580810
]91[ 18.06.2004
]99[ US
213114421
1131431114
US
Int. Cl.(2010.01) H04B 01//69, 01//713, H04J 13//02, 13//06, H04L 05//02
QUALCOMM INCORPORATED,
U.S.A.
WO/2006/009715
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
For quasi-orthogonal multiplexing in an OFDMA system, multiple (M) sets of traffic
channels are defined for each base station. The traffic channels in each set are
orthogonal to one another and may be pseudo-random with respect to the traffic
channels in each of the other sets. The minimum number of sets of traffic channels (L)
is used to support a given number of (U) terminals selected for data transmission,
where each terminal transmits data and pilot symbols on its traffic channel. A base
station receives data transmissions from all terminals and may perform receiver spatial
processing on received symbols with spatial filter matrices to obtain detected data
symbols. The spatial filter matrix for each subband may be derived based on channel
response estimates for all terminals transmitting on that subband.
]52[
]42[
]14[
]44[
]54[
__________________
293
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
180169
‫תהליך לאיפיון תרבית תאים פוליקלונלית‬
]54[
PROCEDURE FOR
CHARACTERIZATION OF A
POLYCLONAL CELL LINE
]11[
]92[
20.07.2005
PA200401133 ]91[ 20.07.2004
]99[ DK
PA200401991
1132131114
DK
Int. Cl.(2010.01) C12N 15//09, C12Q 01//68, G01N 33//68
SYMPHOGEN A/S, DENMARK
WO/2006/007853
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]42[
]14[
]44[
]54[
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention provides a structural characterization platform that can be used
to assess the stability of a polyclonal cell line during production, as well as batch-tobatch consistency of the final polyclonal products. The structural characterization
platform is based on genetic analyses as well as protein characterization techniques
that alone or in combination provide the necessary information to characterize the
polyclonal cell line and final products. The collection of different homologous proteins
to be analyzed with the platform techniques if for example a recombinant polyclonal
antibody or a mixture of monoclonal antibodies.
201012/
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
]54[
ICE-CONTAINING PRODUCTS
]11[
]92[
20.06.2005
04254314.0
]91[ 19.07.2004
1415492534
2331431114
Int. Cl.(2010.01) A23G 09//32, 09//44
UNILEVER PLC, UNITED
KINGDOM
WO/2006/007922
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]42[
]14[
]44[
294
180386
‫מוצרים המכילים קרח‬
]99[
EP
EP
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]54[
‫רמת החייל‬
An unaerated ice-containing product is provided which comprises at -18°C, a first
population of frozen particles having a particle size of greater than 0.5 mm and a
second population of frozen particles having a mean particle size such that the ratio of
the mean particle size for the first population to the mean particle size for the second
population is greater than 10 and less than 100, wherein the ratio of the weight of the
first population of particles to the weight of the second population is from 2:3 to 9:1
and the first population and second population together provide at least 90% of the
frozen particles present in the product. A process for making such products is also
provided.
__________________
]22[]12[
]54[
STRETCH FILM
]11[
]52[
]42[
]14[
]44[
16.07.2004
Int. Cl.(2010.01) B29D 28//00
MEGAPLAST S.A., GREECE
WO/2006/018028
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]54[
295
180445
‫פילים אלסטי‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A stretch film comprising a base film (1) made of a stretchable plastic film material, a
multiplicity of holes (2) in the base film (1) arranged in several columns (3) along a
main direction (X), at least one reinforcement strip (5) made of a stretchable plastic
film material, said reinforcement strip (5) being arranged and fixed on the base film
(1) in an area between two adjacent columns (3) of holes (2) is characterized in that
the thickness of the base film (1) is greater than or equal to the thickness of the
reinforcement strip. Further, the width (w) of the reinforcement strip (5) is as great as
possible, but is such that the reinforcement strip does not contact or overlap the holes
(2) in the adjacent columns (3) of holes (2). The reinforcement strip (5) may be 15
fixed to the base film so as to be inseparable and indistinguishable from the base film
(1).
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
]54[
SOLID-STATE SUSPENSION
LASER WITH SEPARATE
EXCITATION AND EXTRACTION
]11[
]92[
]52[
]42[
]14[
]44[
03.08.2005
10/915229
]91[ 10.08.2004
Int. Cl.(2010.01) H01S 03//14
RAYTHEON COMPANY, U.S.A.
WO/2006/026037
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]54[
296
180485
‫לייזר תרחיף מצב–מוצק עם עירור ומיצוי‬
‫נפרדים‬
]99[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A solid-state suspension laser (10). The novel laser (10) includes a gain medium (12)
comprised of a plurality of solid-state gain particles (26) suspended in a fluid (28). The
laser (10) also includes a pump source (20) for pumping the gain particles (26) and a
resonator (14) for amplifying and outputting laser light generated by the gain medium
(12). In an illustrative embodiment, the gain medium (12) is adapted to flow, and the
pumping of the gain medium (12) occurs outside of the resonator (14). The flow
velocities and the densities of the gain particles (26) in the gain medium (12) can be
optimized for optimal absorption efficiency during the pumping and/or for optimal
extraction efficiency in the resonator (14) as well as for overall laser performance
optimization, including power, efficiency and beam quality scalability.
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
180507
‫כבל גמיש ועמיד בפני מים ומכרסמים המתאים‬
‫במיוחד לשימוש ככבל תקשורת אופטי‬
]54[
HIGHLY FLEXIBLE WATERPROOF, RODENT-PROOF
CABLES PARTICULARLY
USEFUL AS OPTICAL
COMMUNICATION CABLES
]11[
]52[
]42[
02.01.2007
Int. Cl.(2010.01) H01B 07//00
TELDOR WIRES AND CABLES
‫ קיבוץ עין דור‬,‫טלדור מוליכים וכבלים בע"מ‬
LTD.
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1665( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל איילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
A highly flexible water-proof, rodent-proof cable, comprising an optically or
electrically conductive center region, a layer of a yarn of high tensile strength and
water blocking properties overlying the center region, a layer of soft annealed steel
wires in the form of a braid overlying the yarn layer, and an outer jacket of a
polymeric material overlying the steel-wire layer.
]44[
]54[
__________________
]22[]12[
]54[
]11[
297
SEQUENCE FOR IMPROVING
EXPRESSION OF NUCLEIC ACID
180531
‫רצף לשיפור ביטוי חומצת גרעין‬
07.07.2005
April 28, 2011-‫כ"ד בניסן התשע"א‬
]92[
]52[
]42[
]41[
]14[
]44[
]54[
60/587007
]91[ 08.07.2004
PCT/EP2004/51405
1131431114
Int. Cl.(2010.01) C12Q 01//68
CHROMAGENICS B.V., THE
NETHERLANDS
ARIE PIETER OTTE, THEODORUS
HENDRIKUS JACOBUS KWAKS,
RICHARD GEORGE ANTONIUS
BERNARDUS, HENRICUS JOHANNES
MARIA VAN BLOKLAND
WO/2006/005718
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]99[
US
WO
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
The invention provides a novel anti-repressor element, which is useful for improving
expression of nucleic acid in host cells. Methods using the novel anti-repressor element
for producing a protein of interest are also provided. The invention also provides new
configurations of expression cassettes comprising anti-repressor elements.
__________________
]22[]12[
180662
‫ריפוד לקסדה‬
]54[
HELMET LINER
]11[
]92[
]52[
]42[
]44[
11.01.2007
11/337040
]91[
19.01.2006
Int. Cl.(2010.01) A42B 03//00, A63B 71//10
GENTEX CORPORATION, U.S.A.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]54[
A helmet liner (10) comprising:
an upper helmet engaging side and a lower head engaging side;
a pair of oval shaped cutouts defining a forehead cushioning strip (18);
a pair of J-shaped cutouts defining a rear cushioning strip (30); and
a centrally positioned crown cushioning strip (12) formed between said oval shaped cutouts and said Jshaped cutouts.
298
]99[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
180674
‫קלטת כירורגית‬
]54[
SURGICAL CASSETTE
]11[
]92[
]52[
]42[
]44[
11.01.2007
11/338491
]91[ 24.01.2006
]99[ US
Int. Cl.(2010.01) A61B 17//00, A61M 01//00, F04B 43//12
ALCON, INC., SWITZERLAND
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A surgical cassette, comprising: (a) a body having an exterior; (b) a flexible sheet
attached to the body, the sheet containing at least one first molded fluid channel, the at
least one first molded fluid channel projecting outwardly from the exterior of the body
and wherein the flexible sheet is tapered so as to form a tapered section of the at least
]54[
299
April 28, 2011-‫כ"ד בניסן התשע"א‬
one first molded fluid channel; and (c) at least one second molded fluid channel
formed in the body and located so as to correspond with the tapered section of the at
least one first molded fluid channel to form a transition fluid channel region, the
transition fluid channel region being of relatively uniform cross-sectional area; and
wherein the at least one first molded fluid channel and the transition fluid channel
region are of approximately the same uniform cross-sectional area.
__________________
]22[]12[
180678
‫שימוש של שילוב של מעכב רנין ושל מעכב‬
‫חלבון אפלוקס בהכנת תרופות לשיפור הזמינות‬
‫הביולוגית של מעכב רנין‬
]54[
USE OF A COMBINATION OF A
RENIN INHIBITOR AND AN
EFFLUX PROTEIN INHIBITOR IN
THE PREPARATION OF
MEDICAMENTS FOR
IMPROVING BIOAVAILABILITY
OF A RENIN INHIBITOR
]11[
]92[
]52[
]42[
]14[
]44[
02.08.2005
60/598700
]91[ 03.08.2004
]99[ US
Int. Cl.(2010.01) A61K 31//165, 38//13, A61P 09//00, 09//12
NOVARTIS AG, SWITZERLAND
WO/2006/013094
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention provides a method for improving the bioavailability of a renin
inhibitor, preferably, of a delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid
derivative, which method comprises co-administering to a mammal, especially a
human, in need of such treatment, a combination of a renin inhibitor, or a
pharmaceutically acceptable salt thereof, and an efflux protein inhibitor.
]54[
__________________
300
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
180687
‫תכשירי המתקה‬
]54[
SWEETENER COMPOSITIONS
]11[
]52[
]42[
]41[
]44[
14.01.2007
Int. Cl.(2010.01) A23G 03//00
INNOVA S.A., LUXEMBOURG
AVRAM BANIEL
‫אברהם בניאל‬
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A method for forming a sweetener composition having enhanced sweetness compared
to a comparable amount of at least one solid sweetener carbohydrate in a free
unassociated form from which the composition is formed, the method comprising: (a)
mixing the at least one solid sweetener carbohydrate in particulate form and a plurality
of solid nano-particles into a dry mixture; (b)compressing the mixture to form a dense
solid mass comprising a plurality of units, said units comprising a core formed from
said particles wherein said core, nano-particles display on their surfaces, oxygens
contained in their chemical composition, which molecules are associated with the
solid sweetener carbohydrate which coats the same; (c) melting the dense solid mass
to form a liquid; and (d) cooling the liquid to form the dry sweetener composition
having enhanced sweetness compared to a comparable amount of the at least one solid
sweetener carbohydrate in a free unassociated form, from which the composition is
formed.
]54[
__________________
]22[]12[
]54[
PROGRAMMABLE WALLBOX
DIMMER
]11[
]92[
]52[
]42[
14.07.2005
10/892510
]91[ 15.07.2004
Int. Cl.(2010.01) G05B 19//10
LUTRON ELECTRONICS CO., INC.,
U.S.A.
WO/2006/019918
]14[
301
180704
‫עמעם למתג תאורה הניתן לתכנות‬
]99[
US
April 28, 2011-‫כ"ד בניסן התשע"א‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
]44[
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
A programmable wallbox dimmer is disclosed. Upon entering a programming mode,
the dimmer presents a main menu from which the user may select one or more features
to program. The user may scroll through a list of programmable features by actuating
the dimmer's raise/ lower intensity actuator. The user may select a highlighted feature
by actuating the dimmer's control switch. The dimmer may enter a value selection
mode that is associated with the selected feature. In the value selection mode, the user
may scroll through a list of features that define the selected feature by actuating the
dimmer's raise/lower intensity actuator. The user may select a value for the selected
feature. The selected value may be stored in the dimmer's memory. Entering the
programming mode is achieved by actuating the control switch while powering up or if
the control switch has been actuated for at least a predetermined period of time.
__________________
]22[]12[
]54[
METHOD FOR THE FULLY
AUTOMATED PRODUCTION OF
A PIEZOELECTRIC SWITCH
AND A PROCESS THEREFOR
]11[
]52[
]42[
15.01.2007
Int. Cl.(2010.01) H01L 41//00
BARAN ADVANCED
TECHNOLOGIES (1986) LTD.
ARMAND DEZIDERIU
ROSENBERG
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]41[
]44[
302
180715
‫שיטה ותהליך לייצור אוטומטי של מפסקים‬
‫פיאזו– אלקטרים‬
‫) בע"מ‬1611( ‫ברן טכנולוגיות מתקדמות‬
‫ארמנד דז'דריו רוזנברג‬
,‫לוצאטו את לוצאטו‬
‫ עומר‬,‫גן תעשייה‬
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
April 28, 2011-‫כ"ד בניסן התשע"א‬
]54[
(a)
(b)
(c)
(d)
(e)
A method for fully automated production of a piezoelectric switch
comprising the steps of:
providing a pliable metal sheet, suitable to flex under pressure;
providing and attaching to said metal sheet a piezoelectric ceramic element,
which is capable of developing an electric potential under pressure;
providing a conductive elastomeric element juxtaposed to and in contact on
one side with said piezoelectric ceramic element;
providing a switching circuit, printed in a PCB, having two electrically
disconnected ports, said PCB being juxtaposed to and in contact with the
other side of said contractive elastomeric element; and
bending both sides of said metal sheet to clamp over said PCB, to create a
sandwich-like structure enclosing said piezoelectric ceramic element and said
elastomeric element.
__________________
]22[]12[
180852
‫נוגדן או מקטע של נוגדן ותכשירים המכילים‬
CD545 –‫אותם לטיפול במחלות הקשורות ב‬
]54[
ANTIBODY OR FRAGMENT
THEREOF AND COMPOSITIONS
COMPRISING THEM FOR
TREATING DISEASE
ASSOCIATED WITH CD154
]11[
]92[
]52[
]42[
]14[
]44[
26.07.2005
60/591337
]91[ 26.07.2004
]99[
Int. Cl.(2010.01) A61K 39//395, C07K 16//28
BIOGEN IDEC MA INC., U.S.A.
WO/2006/033702
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
The present invention provides peptides, and fragments thereof, and antibodies, or
fragments thereof comprising the same, wherein the peptide comprises at least one
amino acid substitution compared to wild type 5c8 antibody. The present invention
also provides compositions and methods of treating CD154-related diseases or
disorders in a subject.
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
303
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
180971
‫מערכת מגה זרימה‬
]54[
MEGA FLOW SYSTEM
]11[
]92[
]52[
]42[
]14[
]44[
04.08.2004
10/912143
]91[ 06.08.2004
]99[ US
Int. Cl.(2010.01) A01K 63//00, 63//04, C02F 01//74
ISRAEL HADDAS
WO/2006/013576
FLASHPOINT IP,
2 RABAN GAMLIEL ST.,
ELAD 40800
]54[
‫ כפר סבא‬,‫ישראל הדס‬
,‫פלאש פוינט אייפי‬
5 ‫רחוב רבן גמליאל‬
‫אלעד‬
An aerated recirculated aquaculture system (10) including a culture tank (12) and an
aeration and circulation system (18). The culture tank (12) houses live aquaculture.
The culture tank (12) defines a first flow path. The aeration and circulation system (18)
includes an aeration device configured to aerate water. The aeration device defines a
second flow path. The first flow path and second flow path at least partially defining a
substantially closed flow path (16, 24 and 26) sequentially passing through the culture
tank (12) and the aeration device (20). The aeration and circulation system (18) is
configured to circulate the water around the substantially closed flow path (16, 24 and
26).
__________________
]22[]12[
181118
]54[
AUTOMATIC INJECTOR
]11[
]92[
04.08.2005
60/599054
]91[ 06.08.2004
]99[
223135114
1231431115
Int. Cl.(2010.01) A61M 05//00, 05//20, 05//32
]52[
304
‫מזרק אוטומטי‬
US
US
April 28, 2011-‫כ"ד בניסן התשע"א‬
]42[
]14[
]44[
]54[
MERIDIAN MEDICAL
TECHNOLOGIES, INC., U.S.A.
WO/2006/017732
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
An auto-injector for dispensing a predetermined dose of medicament is disclosed. The
auto-injector includes a needle cover that is configured to move from a retracted
position to an extended locked position. The auto-injector includes a first locking
assembly to hold the needle cover in a locked retracted position and a second locking
assembly to hold the needle cover in a locked extended position.
The applications for division
from this application have
not yet been published
2010101
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
]54[
USE OF TRANSTHYRETIN AS A
BIOMARKER FOR
COLORECTAL ADENOMA,
METHOD FOR DETECTION AND
TEST SYSTEM
]11[
]52[
]42[
]14[
]44[
13.08.2004
Int. Cl.(2010.01) G01N 33//574, 33//78
INDIVUMED GMBH, GERMANY
WO/2006/015616
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
305
545586
‫שימוש בטרנסתירטין כביומרקר לאדנומה של‬
‫ שיטת גילוי ומערכת בדיקה‬,‫הישר‬/‫המעי הגס‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]54[
The invention is directed to a method for detecting colorectal adenoma and/or
colorectal carcinoma comprising the steps: a) providing an isolated sample material
which has been taken from an individual, b) determining the level of transthyretin in
said isolated sample material, and c)comparing the determined level of transthyretin
with a reference value. The invention is further directed to a method for discriminating
between colorectal adenoma and colorectal carcinoma as well as to a method for
monitoring the course of colorectal adenoma and/or colorectal carcinoma and/or the
treatment of colorectal adenoma and/or colorectal carcinoma. Moreover, the invention
is directed to a test system and an array for use in these methods. Furthermore, the
invention is directed to the use of transthyretin as a biomarker for a detection of
colorectal adenoma and/or colorectal carcinoma in an individual.
__________________
]22[]12[
181298
‫איבנדרונט סודיום מוצק וקריסטליני ותהליכים‬
‫להכנתו‬
]54[
SOLID AND CRYSTALLINE
IBANDRONATE SODIUM AND
PROCESSES FOR PREPARATION
THEREOF
]11[
]92[
23.08.2005
60/604026
]91[ 23.08.2004
]99[ US
113131114
2131131115
US
Int. Cl.(2010.01) A61K 31//663, A61P 19//10, C07F 09//38
TEVA PHARMACEUTICAL
‫ פתח‬,‫טבע תעשיות פרמצבטיות בע"מ‬
INDUSTRIES LTD.
‫תקוה‬
]52[
]42[
]41[
]14[
]44[
]54[
306
JUDITH ARONHIME, REVITAL
‫ מיכאל‬,‫ רוויטל ליפשיץ‬,‫יהודית ארונהיים‬
LIFSCHITZ, MICHAEL
‫ תומס בייר‬,‫פינחסוב‬
PINCHASOV, THOMAS BAYER
WO/2006/024024
TEVA PHARMACEUTICAL
,‫טבע תעשיות פרמצבטיות בע"מ‬
INDUSTRIES LTD.,
5 ‫בזל‬
5 BASEL ST.,
‫פתח תקוה‬2160 .‫ד‬.‫ ת‬,
P.O.B. 3190,
PETAH TIQVA 49131
The present invention relates to solid amorphous and crystalline forms of ibandronate
April 28, 2011-‫כ"ד בניסן התשע"א‬
sodium.
__________________
]22[]12[
]54[
METHOD OF PREPARING
POLY(ADP-RIBOSE)
POLYMERASE INHIBITORS
]11[
]92[
]52[
]42[
12.09.2005
60/612457
]91[ 22.09.2004
Int. Cl.(2010.01) C07D 48/7/06
CANCER RESEARCH
TECHNOLOGY LIMITED, UNITED
KINGDOM
PFIZER INC, U.S.A.
WO/2006/033003
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]14[
]44[
]54[
181322
‫– ריבוז) פולימראזות‬ADP( ‫שיטה להכנת מעכבי‬
]99[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The invention relates to a new and convergent route to small molecule inhibitors of
poly(ADP-ribose) polymerase, such as 8-fluoro-2-{4-[(methylamino)methyl]phenyl}1,3,4,5-tetrahydro-6H-azepino [5,4,3-cd]indol-6-one, via a key Sonogashira coupling
reaction and a Cul-promoted indole formation.
__________________
]22[]12[
]54[
PACKET TRANSMISSION IN A
WIRELESS COMMUNICATION
SYSTEM USING MULTIPLE
ANTENNAS
]11[
]92[
17.08.2005
10-20040064551
21-11141141145
21-1115-
307
]91[
17.08.2004
181351
‫שידור יחידת נתונים במערכת תיקשורת‬
‫אלחוטית המשתמשת במכפל משושים‬
]99[
KR
9131331114
KR
1331931115
KR
April 28, 2011-‫כ"ד בניסן התשע"א‬
]52[
]42[
]14[
]44[
]54[
1123411
Int. Cl.(2010.01) H04B 07//02
LG ELECTRONICS INC., REPUBLIC
OF KOREA
WO/2006/019258
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A method of retransmitting packet data in a wireless communication system comprises
receiving a link map information element from a transmitting station having three
antennas to achieve space time transmit diversity, wherein first, second and third
packet data are transmitted from first, second and third antenna of the transmitting
station, respectively. The method also comprises transmitting a non-acknowledgement
signal to the transmitting station if at least one packet data from the transmitting station
is not properly decoded. The method also comprises receiving the packet data from the
transmitting station, wherein at least two of retransmitted packet data are transmitted
from different antennas of the transmitting station, and one of retransmitted packet
data is transmitted from the same antenna of the transmitting station. The retransmitted
packet data are received with an information element comprising a retransmission
count associated with a number of retransmission made by the transmitting station.
__________________
]22[]12[
]54[
MULTICHANNEL
DECORRELATION IN SPATIAL
AUDIO CODING
]11[
]92[
24.08.2005
60/604725
]91[ 25.08.2004
113411294
2131431115
113415414
1531131115
Int. Cl.(2010.01) G10L 19//00
DOLBY LABORATORIES
]52[
]42[
308
181406
‫הפרדת ערוצים בקידוד קול מרחבי‬
]99[
US
US
US
April 28, 2011-‫כ"ד בניסן התשע"א‬
]14[
]44[
]54[
LICENSING CORPORATION, U.S.A.
WO/2006/026452
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Each of N audio signals are filtered with a unique decorrelating filter (38)
characteristic, the characteristic being a causal linear time-invariant characteristic in
the time domain or the equivalent thereof in the frequency domain, and, for each
decorrelating filter characteristic, combining (40, 44, 46), in a time and frequency
varying manner, its input (Zi) and output (Z-i) signals to provide a set of N processed
signals (X i). The set of decorrelation filter characteristics are designed so that all of
the input and output signals are approximately mutually decorrelated. The set of N
audio signals may be synthesized from M audio signals by upmixing (36), where M is
one or more and N is greater than M.
__________________
]22[]12[
]54[
FEEDER-CELL FREE METHOD
AND MEDIUM FOR CULTURING
HUMAN EMBRYONIC STEM
CELLS
]11[
]92[
08.09.2005
60/608040
]91[ 08.09.2004
113135211
1331131115
Int. Cl.(2010.01) C12N 05//16
WISCONSIN ALUMNI RESEARCH
FOUNDATION, U.S.A.
WO/2006/029198
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]52[
]42[
]14[
]44[
]54[
309
181438
‫שיטה ומצע נטולי תאי הזנה לתרבת תאי גזע‬
‫אנושיים‬
]99[
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Previous methods for culturing human embryonic stem cells have required either
April 28, 2011-‫כ"ד בניסן התשע"א‬
fibroblast feeder cells or a medium, which has been exposed to fibroblast feeder cells
in order to maintain the stem cells in an undifferentiated state. It has now been found
that if high levels of fibroblast growth factor are used in a medium with gamma amino
butyric acid, pipecholic acid, lithium and lipids, the stem cells will remain
undifferentiated indefinitely through multiple passages, even without feeder cells or
conditioned medium. A humanized matrix of human proteins can be used as a
basement matrix to culture the cells. New lines of human embryonic stem cells made
using these culture conditions, the medium and the matrix, will never have been
exposed to animal cells, animal products, feeder cells or conditioned medium.
__________________
]22[]12[
181682
‫תהליך להכנת גבינות מסורתיות‬
]54[
PROCESS FOR PRODUCING
TRADITIONAL TYPE CHEESES
]11[
]92[
]52[
]42[
]14[
]44[
13.09.2005
0409736
]91[ 14.09.2004
Int. Cl.(2010.01) A23C 19//02
INGREDIA, FRANCE
WO/2006/030128
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
The invention relates to a method of producing a ripened or traditional-type cheese
from lactose-depleted powder protein concentrates. The invention also relates to a base
composition that is used in said method, containing water, fat and powders comprising
lactose-depleted dairy protein concentrates, the protein/water weight ratio being
between 0.3 and 0.9 %. The invention further relates to powders used in said
composition, comprising less than 10 % lactose by weight.
310
]99[
FR
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
181696
]54[
ANTILOCK AND ANTISKID
MECHANICAL TORQUE BRAKE
SYSTEM FOR BICYCLES AND
OTHER WHEEL DRIVEN
VEHICLES
]11[
]52[
]42[
04.03.2007
Int. Cl.(2010.01) B60T 08//52, B62L 01//02
P.&P. SAFETY BRAKING (2004)
LTD
ZALMAN PELES
DR. EYAL BRESSLER,
11 TUVAL ST.,
RAMAT GAN 52522
]41[
]44[
]54[
311
‫מנגנון בלימה למניעת נעילה ומניעת החלקה‬
‫לאופנים וכלי רכב גלגליים אחרים‬
‫ ) בע"מ‬5004( ‫ בלמי בטיחות‬.‫ את פ‬.‫פ‬
‫זלמן פלס‬
,‫דר' אייל ברסלר עו"פ‬
11 ‫תובל‬
‫ גן‬- ‫רמת‬
An anti-lock brake system for decelerating or ending the rotation of a wheel,
comprising means for mechanically lowering and maintaining an applied braking
force to a level that is lower than the forward torque force of the wheel such that
unsafe wheel locking is prevented; wherein said means comprises at least one movable
push rod and at least one force applying member coupled thereto for facilitating
applying of a frictional braking force toward a wheel, wherein said force applying
member is adapted for forward movement with said wheel such that when forward
movement of said force applying member occurs, said push rod automatically acts on
said force applying member so as to cause said force applying member to move in an
April 28, 2011-‫כ"ד בניסן התשע"א‬
anti-braking manner so as to release the lock on said wheel.
__________________
]22[]12[
]54[
INDIRECT FIRE WEAPON
AIMING DEVICE
]11[
]92[
]52[
]42[
]14[
]44[
08.09.2005
2004/7231
]91[ 09.09.2004
Int. Cl.(2010.01) F41G 03//16
CSIR, SOUTH AFRICA
WO/2006/027753
DANIEL FREIMANN & CO.,
5 DROYANOV ST., 10TH FLOOR ,
TEL AVIV 63143
312
181813
‫התקן להכוונה בלתי ישירה של כלי ירי‬
]99[
ZA
,'‫דניאל פריימן ושות‬
10 ‫ בית כלל קומה‬5 ‫דרויאנוב‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]54[
‫תל אביב‬
An indirect fire weapon aiming device (10) is provided for providing aiming
information to an indirect fire weapon comprising a launcher mounted to a base. The
device (10) includes an angular displacement sensor (12) mountable to the base to
provide an angular displacement output, and an azimuth communicator (14) mountable
to the launcher to communicate the launcher azimuth to the angular displacement
sensor (12) so that the angular displacement sensor (12) can measure the angular
displacement of the launcher relative to a reference bearing and provide the angular
displacement output.
__________________
]22[]12[
181831
]54[
METHOD FOR
ENANTIOSELECTIVE
PREPARATION OF SULPHOXIDE
DERIVATIVES
]11[
]92[
]52[
]42[
05.10.2005
0410483
]91[ 05.10.2004
]99[
Int. Cl.(2010.01) C07C 31/5/02, C07D 47/1/04
SIDEM PHARMA S.A.,
LUXEMBOURG
WO/2006/037894
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]44[
]54[
313
‫שיטה להכנה אננטיו בררנית של תולדות‬
‫סולפוקסיד‬
FR
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention concerns enantioselective preparation of sulphoxide derivatives
or their salts. The method consists in performing an enantioselective oxidation of a
sulphur of general formula (I) A - CH2 - S B, wherein: A is a diversely substituted
pyridinyl ring and B is a heterocyclic radical comprising an imidazo-pyridinyl ring,
using an oxidizing agent in the presence of a titanium(IV)-based catalyst and a chiral
ligand consisting of a cyclic beta or gamma-amino-alcohol, in an organic solvent,
April 28, 2011-‫כ"ד בניסן התשע"א‬
followed, if required, by salt formation with a base. The invention is useful for
preparing sulphoxides useful in therapeutics.
__________________
]22[]12[
181834
‫ראש חיתוך ומתאם‬
]54[
CUTTING HEAD AND ADAPTOR
]11[
]92[
]52[
]42[
]41[
11.03.2007
174721
]91[ 02.04.2006
]99[ IL
Int. Cl.(2010.01) B23Q 11//00
ISCAR LTD.
‫ תפן‬,‫ישקר בע"מ‬
CAROL SMILOVICI, DAVID
‫ אסף בלס‬,‫ דוד פלדמן‬,'‫קרול שמילוביץ‬
FELDMAN, ASSAF BALLAS
ISCAR LTD.,
,‫ישקר בע"מ‬
P.O.B. 11,
‫תפן‬11 .‫ד‬.‫ ת‬,
TEFEN 24959
An adaptor for a cutting tool comprising:
a rod defining a fluid path;
a cap attached to an end of the rod;
the rod and the cap defining a fluid path;
at least part of the cap being configured to support a nozzle to deliver fluid from the
fluid path to a cutting area;
wherein the cap has a radial dimension of sufficient dimension to engage a cutting
head and the rod has a length of sufficient dimension to engage a tool holder, a
combination thereof linking the cutting-head to the tool holder in an axial direction,
characterized in that:
the adaptor has an adaptor channel having a generally cylindrical adaptor wall that
extends axially through the adaptor, a forward portion of the adaptor wall forms an
adaptor thread in which the nozzle is treadingly engaged.
]44[
]54[
__________________
]22[]12[
]54[
SUBSTITUTED BICYCLIC
IMIDAZO-3-YL-AMINE
COMPOUNDS
]11[
]92[
08.09.2005
102004044884.1
314
]91[
14.09.2004
181848
–3–‫תרכובות מותמרות של אימידזו ביציקלי‬
‫איל–אמין‬
]99[
DE
April 28, 2011-‫כ"ד בניסן התשע"א‬
]52[
]42[
]14[
]44[
]54[
Int. Cl.(2010.01) A61K 31//4188, A61P 25//00, C07D 47/1/04
GRUNENTHAL GMBH, GERMANY
WO/2006/029980
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
The invention relates to substituted bicyclic imidazo-3-ylamine compounds of general
formula (I), methods for production, medicaments containing the same and use thereof
for the production of medicaments.
__________________
]22[]12[
]54[
NOSE FILTER
]11[
]92[
13.03.2007
60/681843
]91[ 17.05.2005
PCT/IL
1131431111
2006/000509
Int. Cl.(2010.01) A61M 15//08
BORIS KASHMAKOV
LEVI TOLMASOV
ARKADY TOLMASOV
]52[
]42[
]44[
]54[
315
181884
‫מסנן אף‬
]99[
US
WO
‫ יפו‬- ‫ תל אביב‬,‫בוריס קשמקוב‬
‫ גן‬- ‫ רמת‬,‫לוי טולמסוב‬
‫ חולון‬,‫ארקדי טולמסוב‬
,‫אדיסון עורכי פטנטים בע"מ‬
‫בני עטרות‬
115 .‫ד‬.‫ ת‬,
EDISON PATENT ATTORNEYS
LTD.,
P.O.B. 182,
BNEY ATAROT 60991
In one aspect, the present invention is directed to a nose filter adapted to be inserted
into a nostril, the nose filter comprising: a housing having an external shape
corresponding to the nostril, for forcing breathed air to pass through the housing;
filtering membrane(s), for filtering inhaled air; and valve(s), for forcing inhaled air to
pass through the filtering membrane(s), and bypass the filtering membrane(s) upon
exhalation. According to a preferred embodiment of the invention the housing
comprises a first air passageway(s), through the filtering membranes; and a second air
passageway(s), bypassing the filtering membranes; wherein the valves are operative to
block the second air passageway(s) upon inhalation, and operative to open the second
passageway(s) upon exhalation.
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
181893
‫מסך לצפייה חד–כיוונית‬
]54[
ONE-WAY VIEWABLE SCREEN
]11[
]92[
]52[
]42[
]14[
]44[
15.09.2005
10/941795
]91[ 15.09.2004
Int. Cl.(2010.01) B32B 03//24
MILLIKEN & COMPANY, U.S.A.
WO/2006/031987
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
A screen (10) or fencing structure which provides one-way viewing characteristics
under conditions of substantially equal lighting on each side of the structure is
described. The structure has a fabric which has a light transmission of about 2.8% to
about 25%. The first side (12) of the structure has an overall light reflectance to light
transmission ratio of greater or equal to about 2.5,. and the opposite side (14) of the
structure has an overall light reflectance to light transmission ratio of less than or equal
to about 2. Fabrics that can be used to make screen are also described.
]99[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
316
181898
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫כימרות אנטגוניסטיות המכילות מוטאינים של‬
,)IL–9( 0–‫) ואינטרלוקין‬IL–4( 5 – ‫אינטרלוקין‬
‫ פולינוקליאוטיד‬,‫תכשירים המכילים אותן‬
‫ שיטות להכנתן והשימוש בהן‬,‫המקודד להן‬
]54[
INTERLEUKIN-4 (IL-4) AND
INTERLEUKIN-9 (IL-9)
CHIMERIC MUTEIN RECEPTOR
ANTAGONISTS, COMPOSITIONS
COMPRISING THEM,
POLYNUCLEOTIDE ENCODING
THEM, METHODS OF THEIR
PRODUCTION AND USES
THEREOF
]11[
]92[
21.09.2005
60/612275
]91[ 22.09.2004
]99[ US
223111931
1132131114
US
Int. Cl.(2010.01) C07H 21//04, C07K 14//435, 14//54, C12P 21//04
AEROVANCE, INC., U.S.A.
WO/2006/036878
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
]52[
]42[
]14[
]44[
]54[
Chimeric polypeptide antagonists that include an interleukin-4 (IL-4) mutein linked to
an interleukin-9 (IL-9) mutein are provided, as are polynucleotides encoding the IL-4
and IL9 chimeric mutein antagonists. Also provided are methods of using the chimeric
mutein antagonists and encoding polypeptides to reduce or inhibit the responsiveness
of a cell to a cytokine such as IL-4, IL-9 and/or interleukin-13. Methods using the
compositions to treat disorders such as pulmonary disorders (e.g., asthma) also are
provided.
__________________
]22[]12[
181913
‫חומרים המכילים טלור ותכשירים המכילים‬
‫חומרים אלה‬
]54[
TELLURIUM COMPOUNDS AND
THEIR USE AS
IMMUNOMODULATORS
]11[
]92[
]52[
]42[
]41[
15.09.2005
60/610660
]91[ 17.09.2004
]99[ US
Int. Cl.(2010.01) A61K 31//555, 45//06, A61P 37//02, C07C 39/5/00
BIOMAS LTD.
‫ סבא‬- ‫ כפר‬,‫ביומאס בע"מ‬
BENJAMIN SREDNI, MICHAEL
‫ מיכאל אלבק‬,‫בנימין שרדני‬
ALBECK
WO/2006/030437
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]14[
]44[
317
]54[
MOSHE AVIV TOWER, 54TH
1 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
Novel tellurium-containing compounds and uses thereof as immunomodulators are
disclosed
__________________
]22[]12[
181926
‫תהליך לאיזומריזציה של זרמי הזנה שאינם‬
‫בשווי משקל המכילים קסילן‬
]54[
PROCESS FOR ISOMERIZING
NON-EQUILIBRIUM XYLENECONTAINING FEED STREAMS
]11[
]92[
]52[
]42[
]14[
]44[
06.09.2006
11/226493
]91[ 14.09.2005
Int. Cl.(2010.01) C07C 05//22
UOP LLC, U.S.A.
WO/2007/032979
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
Reduced co-production of toluene and C9 and higher aromatics such as
trimethylbenzene, methylethylbenzene, and diethylbenzene is achieved in processes
for the isomerization of xylenes to close to equilibrium using a layered catalyst having
a thin outer layer of molecular sieve and hydrogenation metal component on a core,
wherein at least 75 mass-% of the hydrogenation metal component is in the outer layer.
]99[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
]54[
METHOD FOR PROVIDING
TERRAIN ALERT AND DISPLAY
UTILIZING TEMPERATURE
COMPENSATED AND GPS
ALTITUDE DATA
]11[
15.09.2005
318
182003
‫שיטה להספקת אזעקת שטח ותצוגה העושה‬
GPS ‫שימוש בטמפרטורת פיצוי ונתוני גובה של‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]92[
]52[
]42[
]14[
]44[
]54[
60/610606
]91[ 17.09.2004
]99[ US
223112421
1331331115
US
Int. Cl.(2010.01) G01C 23//00
UNIVERSAL AVIONICS SYSTEMS
CORPORATION, U.S.A.
WO/2006/137859
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A method of accounting for errors in the altitude reporting of a terrain alert and
warning system (TAWS) is disclosed wherein errors due to non-standard atmospheric
conditions, incorrect altimeter setting and air data computer (ADC) sensor error are
detected and corrected for by compensating ADC altitudes for cold temperatures as
well as using global positioning system (GPS) altitude data to confirm the accuracy of
the ADC altitude information at all times.
__________________
]22[]12[
]54[
RELEASABLE SECURING
APPARATUS AND METHOD OF
USING SAME
]11[
]92[
]52[
]42[
29.09.2005
10/956669
]91[ 01.10.2004
Int. Cl.(2010.01) B62K 15//00
STUDIO MODERNA SA,
SWITZERLAND
WO/2006/037752
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]14[
]44[
]54[
319
182057
‫התקן אבטוח הניתן לשחרור ושיטה לשימוש בו‬
]99[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A securing apparatus that releasably secures two or more mechanical elements is
April 28, 2011-‫כ"ד בניסן התשע"א‬
provided. The securing apparatus (20) may be attached to one mechanical element and
include abutment surfaces (160) that abut at least one additional mechanical element.
Forces exerted by the at least one additional mechanical element and the securing
apparatus (20) on each other serve to maintain the securing apparatus in a locked
position. The securing apparatus may include a locking member (170) that includes a
protruded portion that extends at least partially beneath the securing apparatus (20) and
at least one mechanical element. A pull-ring (180) may be provided to rotate the
locking member (170) and release the mechanical elements being secured.
__________________
]22[]12[
182374
‫מערכת לתשלום מוקדם עבור מוני כוח‬
‫אלקטרוניים באמצעות שימוש בכרטיס חכם‬
‫עם התקן ניתוק אוטומטי‬
]54[
PREPAYMENT SYSTEM FOR
ELECTRIC POWER METERS USING
A CONTACTLESS SMART CARD
WITH AN AUTOMATIC SUPPLY
CUT-OFF DEVICE
]11[
]92[
]52[
]42[
]14[
]44[
30.09.2005
PA/A/04/010077 ]91[ 12.10.2004
Int. Cl.(2010.01) G06Q 30//00
IUSA S.A. DE C.V., MEXICO
WO/2006/041276
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
The invention relates to the use of a meter comprising only one piece which is
completely covered and which does not come into contact with the exterior, including
a prepayment system and a more efficient method of controlling the supply of electric
power and obtaining relevant information from the meter using contactless smart cards.
320
]99[
MX
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
182435
‫מתקן לחיבור‬
]54[
COUPLING APPARATUS
]11[
]92[
]52[
]42[
]14[
]44[
06.10.2005
10/963209
]91[ 11.10.2004
]99[ US
Int. Cl.(2010.01) F16D 03//50, 03//72, 13//72
KAMATICS CORPORATION, U.S.A.
WO/2006/042216
BOROCHOV, KORAKH & CO.,
,'‫בורוכוב קורח ושות‬
15TH FLOOR, ATIDIM TOWER,
‫מגדל כלל עתידים‬
KIRYAT ATIDIM,
‫אביב‬-‫תל‬51100 .‫ד‬.‫ ת‬,
P.O.B. 58100,
TEL AVIV 61580
Disclosed herein is a single piece unitary metal coupling (10) having a first end and a
second end and a convolution (14, 18, 22) between the first and second ends (26, 30).
Further disclosed herein is a method for making a single piece unitary construction
flexible coupling including machining from a starting material, one or more single
piece unitary construction flexible couplings having a first coupling end (26) and a
second coupling end (30) and one or more convolutions at the first and second ends.
]54[
__________________
321
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
182439
‫תוצרי ביניים השימושיים בהכנת אריפיפרזול‬
‫ושיטות להכנת תוצרי הביניים ואריפיפרזול‬
]54[
INTERMEDIATES USEFUL FOR
THE PREPARATION OF
ARIPIPRAZOLE AND METHODS
FOR THE PREPARATION OF
THE INTERMEDIATES AND
ARIPIPRAZOLE
]11[
]52[
]42[
08.10.2004
Int. Cl.(2010.01) C07C 49//755, C07D 24/1/04, 40/1/12
SUVEN LIFE SCIENCES LIMITED,
INDIA
WO/2006/038220
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]14[
]44[
]54[
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The invention disclosed in this application relates to an improved process for the
preparation of aripiprazole (1) which comprises (i) Reacting 6-hydroxy-l-indanone
(11) with 1,4-dihalobutane (12) in the presence of a base and a solvent at a
temperature in the range of 90 to 110 deg C to form the novel intermediate 6-(4-halo
butoxy)-indan-l-one (3), (ii) reacting the novel intermediate with 1(2,3dichlorophenyl)-piperazine (9) to get another novel intermediate 6-[4-[4-(2,3dichlorophenyl)-l-piperazinyl] butoxy]-indan-l-one (2) and (iii) Reacting the resulting
novel compound with sodium azide. The invention also relates to the novel
intermediates of the formulae (2) & (3) and processes for their preparation.
__________________
]22[]12[
]54[
322
ELECTRIC MOTOR-DRIVEN
WATER CRAFT WHICH IS
COOLED BY THE SURROUNDING
182482
‫כלי שיט מונע חשמלית המקורר על ידי המים‬
‫הסובבים‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
WATER
]11[
]92[
]52[
]42[
]14[
]44[
]54[
07.10.2005
102004049615.3 ]91[ 12.10.2004
Int. Cl.(2010.01) B63H 11//08, 21//17
ROTINOR GMBH, GERMANY
WO/2006/040078
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]99[
DE
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
The invention relates to an electric motor-driven water craft comprising a fuselage
(10), on which the user can at least partially lie or stand. Said fuselage (10) comprises a
flow channel with a screw (2) that is driven by an electric motor (3) and contains the
electric motor (3) and batteries (5, 6), in addition to a control device (4) for the electric
motor and the screw (2), said items being housed at least partially in the flow channel
(8). The aim of the invention is to maintain a higher power for motor-driven water craft
of this type. To achieve this, the batteries (5, 6) are located in a water-tight housing (9)
and at least some sections of said batteries are in thermally conductive contact with the
housing (9), the housing (9) consists at least partially of a thermally conductive
material and/or the electric motor (3) is an internal-rotor motor, the stator (21) is in
thermally conductive contact with a housing (35) of the electric motor (3) by means of
a heat conducting unit (22), at least part of the region of the housing (35) that is
assigned to the heat conducting unit (22) consists of a thermally conductive material
and the housing (35) is located at least partially in the flow channel (8).
__________________
]22[]12[
182544
‫שיטה לייצור תרכובות פירימידין‬
]54[
METHOD OF PRODUCTION OF
PYRIMIDINE COMPOUNDS
]11[
]92[
]52[
]42[
04.11.2005
2004-328689 ]91[ 12.11.2004
]99[ JP
Int. Cl.(2010.01) C07D 23/9/34, 23/9/47, 40/1/04, 40/3/04
SUMITOMO CHEMICAL
COMPANY, LIMITED., JAPAN
323
April 28, 2011-‫כ"ד בניסן התשע"א‬
]14[
]44[
]54[
WO/2006/051891
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
4-amino-6-alkynyloxypyrimidine compounds shown by the formula (V) which has a
controlling activity against pests can be produced by the method which comprises the
first step which produces a 4-fluoro-6-alkynyloxypyrimidine compound shown by the
formula (I) by making a 4,6-difluoropyrimidine compound shown by the formula (II)
react with an alcohol compound shown by the formula (III) in the presence of a tertiary
amine; and the second step which produces the 4-amino-6-alkynyloxypyrimidine
compound shown by the formula (V) by making the 4-fluoro-6-alkynyloxypyrimidine
compound shown by the formula (I) react with an amine compound shown by the
formula (IV)
__________________
]22[]12[
182566
‫אריג רב שכבתי נספג מחוזק ושיטה ליצורו‬
]54[
REINFORCED ABSORBABLE
MULTILAYERED FABRIC AND
METHOD OF MANUFACTURE
]11[
]92[
]52[
]42[
]14[
]44[
17.10.2005
60/620624
]91[ 20.10.2004
]99[ US
Int. Cl.(2010.01) A61L 15//24, 15//28, 26//00, B32B 05//26
ETHICON, INC., U.S.A.
WO/2006/044881
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
The present invention is directed to a multilayered fabric comprising a first absorbable
nonwoven fabric and a second absorbable woven or knitted fabric, and its method of
manufacture.
324
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
]54[
OPHTHALMIC DISPLAY
COMPRISING AN OPHTHALMIC
LENS AND OPTICAL IMAGE
]11[
]92[
]52[
]42[
07.10.2005
0452541
]91[ 05.11.2004
Int. Cl.(2010.01) G02B 27//01
ESSILOR INTERNATIONAL
(COMPAGNIE GENERALE
D'OPTIQUE), FRANCE
WO/2006/048564
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]44[
]54[
182567
‫תצוגה עינית המכילה עדשות עיניות ודמות‬
‫אופטית‬
]99[
FR
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to an ophthalmic display provided with an ophthalmic lens which
comprises an optical image insert (400) provided with a polarisation direction and used
for forming optical beams and for guiding said beams towards a user's eye, thereby
enabling to visualise an informational content (I). The display also comprises at least
one polarisation element placeable on the lens face, wherein said polarisation element
is constituted by an adjustable polarisation element (2A, 2B).
__________________
]22[]12[
325
182612
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫התקן דנטלי להגיינה של הלחי ויחידה לשימוש‬
‫חד–פעמי‬
]54[
BUCCODENTAL HYGIENE
APPARATUS AND DISPOSABLE
UNIT
]11[
]92[
]52[
]42[
]14[
]44[
28.10.2005
0411556
]91[ 28.10.2004
Int. Cl.(2010.01) A61C 17//02, 17//06
JOSEPH OHAYON, FRANCE
WO/2006/045966
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
The invention relates to buccodental hygiene and an apparatus comprising a jet
cleaning device with a liquid reservoir, an adjustable cannula, a hydraulic propulsion
device, an evacuation device operating by suction, comprising a suction device, a
liquid receptacle and an adjustable suction cannula (46) and an operational control
device. In the location of the evacuation liquid receptacle the device forms a housing
into which a suction orifice (22) opens out and the evacuation liquid receptacle
comprises a fixed reservoir (24, 34) with a suction opening. The unit formed by the
reservoir (24, 34), the tube (40) and the adjustable cannula (46) is disposable. The
above is of application to buccodental hygiene.
]99[
FR
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
182647
]54[
ORAL PREPARATION HAVING
IMPROVED BIOAVAILABILITY
]11[
]92[
22.11.2005
10-2004]91[ 23.11.2004
]99[ KR
0096390
Int. Cl.(2010.01) A61K 09//20, 47//30, A61P 19//10
DONG WHA PHARM. CO., LTD,
]52[
]42[
326
‫תכשיר אורלי בעל זמינות ביולוגית‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]14[
]44[
]54[
REPUBLIC OF KOREA
WO/2006/057507
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to an oral preparation of N-hydroxy-4- {5- [4- (5isopropyl-2 -methyl- 1, 3-thiazol-4-yl)phenoxy] pentoxy}-benzamidine having
improved bioavailability . More particularly, the present invention relates to an oral
preparation comprising: N-hydroxy-4- {5- [4- (5-isopropyl-2-methyl-l, 3-thiazol-4- yl)
phenoxy] pentoxy}-benzamidine or pharmaceutically acceptable salt thereof; and one
or more carbonates selected from the group consisting of alkalimetal carbonate,
alkalimetal bicarbonate and alkaline earth metal carbonate, and/or one or more
disintegrants selected from the group consisting of sodium starch glycolate, carmellose
calcium and croscarmellose sodium. The oral preparation according to the present
invention inhibits gelation of N-hydroxy-4- {5- [4- (5-isopropyl-2-methyl-l, 3-thiazol4-yl) p henoxy] pentoxy}-benzamidine or pharmaceutically acceptable salt thereof in
the early stage of release, which increases dissolution rate and remarkably raises
bioavailability.
__________________
]22[]12[
]54[
RAISED PLATEN FOR FIBER
OPTIC COMPONENT CLEANING
DEVICE
]11[
]92[
]52[
]42[
30.09.2005
10/994929
]91[ 22.11.2004
Int. Cl.(2010.01) G02B 06//38
ILLINOIS TOOL WORKS INC.,
U.S.A.
WO/2006/054184
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
]14[
]44[
327
182839
‫לוחית מורמת עבור מתקן נקוי למרכיב של סיב‬
‫אופטי‬
]99[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫רמת החייל‬
RAMAT HACHAYAL 69710
]54[
A cleaning device (10) is configured for cleaning a male portion of an aligning-type
fiber optic connector (50). The device includes a container (12) having an opening (14)
in a face (18) formed in a side of the container. A plurality of discrete soft, large work
surfaces (16a-16c) are disposed on a face formed in a side of the container. The
surfaces are disposed in side-by-side relation to one another having open regions (30a30d) between the surfaces. The open regions are at an elevation lower than an
elevation of the plurality of work surfaces. A plurality of cleaning wipes (20) are
located inside the container. The wipes are fed from the inside of the container through
the opening and placed on the work surface for cleaning the connector.
__________________
]22[]12[
182970
–‫–דאוקסי‬53 ‫תכשירים ותהליכים להכנת‬
‫אנטראציקלין‬
]54[
COMPOSITIONS AND
PROCESSES FOR PREPARING 13DEOXY-ANTHRACYCLINES
]11[
]92[
]52[
]42[
08.11.2005
10/982873
]91[ 08.11.2004
]99[ US
Int. Cl.(2010.01) C07H 01//00, 15//252
GEM PHARMACEUTICALS, LLC,
U.S.A.
WO/2006/052915
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
13-benzenesulfonylhydrazone anthracyclines useful in producing improved yields in
the synthesis 13-deoxyanthrcyclines, and an improved method of reducing 13benzene-sulfonylhydrazone anthracyclines to 13-deoxyanthrcyclines wherein the
reduction reaction is maintained at temperatures of about 55 °C to 64 °C without
stirring or agitation. The reaction is completed with the addition of aqueous
bicarbonate which forms the 13-deoxyanthracycline and precipitates. The precipitates
are filtered and the precipitate and filtrate are extracted separately with organic
April 28, 2011-‫כ"ד בניסן התשע"א‬
]14[
]44[
]54[
328
solvents. The crude 13-deoxy anthracycline can be converted to 5-imino-13-deoxy
anthracycline by reaction with methanolic ammonia. The reaction can also be
performed with an acidic pyridinium salt instead of a strong acid so that neutralization
of the reaction or extraction of the product is not necessary, thereby facilitating
purification.
__________________
]22[]12[
183052
‫זיווד עבור קולט שמש‬
]54[
ENCLOSURE FOR A SOLAR
COLLECTOR
]11[
]52[
]42[
08.05.2007
Int. Cl.(2010.01) F24J 02//46
MAGEN ECO ENERGY A.C.S. LTD.
]41[
]44[
MICHAEL PLASCHKES
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
A solar collector (2), comprising: an enclosure (6) having a bottom and side wall
surfaces substantially made of plastic material and a transparent top surface; at least
one panel unit (4) composed of elongated conduits (8) interconnected at each end by a
manifold (14, 16); said panel unit being movably affixed inside said enclosure and
sized to freely expand and contract within said enclosure due to thermal changes, and
said enclosure having at least one controllable air vent mechanism (18) responsive to
expansion and contraction of said panel unit.
]54[
329
‫ אגודה שיתופית חקלאית‬- ‫מגן אקו אנרג'י‬
‫ קבוץ מגן‬,‫בע"מ‬
‫מיכאל פלשקס‬
,‫ ברגמן וגולר‬,‫וולף‬
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
183156
‫מתקנים להחדרה דרך תעלה ישרה כדי ליצור‬
‫ ושיטות‬,‫תצורה מתעקלת מוגדרת מראש‬
‫לשימוש במתקנים אלה‬
]54[
DEVICES FOR INTRODUCTION
INTO A BODY VIA A
SUBSTANTIALLY STRAIGHT
CONDUIT TO FORM A
PREDEFINED CURVED
CONFIGURATION AND
METHODS EMPLOYING SUCH
DEVICES
]11[
]92[
28.12.2005
11/028655
]91[ 05.01.2005
]99[ US
113113541
2931131115
US
Int. Cl.(2010.01) A61B 17//00, 17//32, 17//56, A61F 02//30
TZONY SIEGAL
]52[
]42[
330
‫ ירושלים‬,‫צוני סיגל‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]14[
]44[
]54[
WO/2006/072941
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
1 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
A device for introduction into a body in a straight configuration and assuming within
the body a predefined curved configuration, includes an elongated element formed
from a number of segments interconnected so as to form effective hinges
therebetween. When the elongated element is confined to a straight state, the effective
hinges transfer compressive forces from each segment to the next so that the elongated
element can be pushed to advance it through a conduit. When the elongated element is
not confined to a straight state, the effective hinges allow deflection of each segment
relative to adjacent segments until abutment surfaces of the segments come into
abutment, thereby defining a fully flexed state of the elongated element with a
predefined curved configuration. The device can be produced with a wide range of
two-dimensional and three-dimensional curved forms, and has both medical and nonmedical applications
__________________
]22[]12[
]54[
PROCESS FOR
MANUFACTURING REINFORCED
CAPILLARY MEMBRANES AND
THE MEMBRANES THUS
OBTAINED
]11[
]92[
]52[
]42[
18.11.2005
04447254.6
]91[ 19.11.2004
Int. Cl.(2010.01) B01D 69//08
VLAAMSE INSTELLING VOOR
TECHNOLOGISCH ONDERZOEK
(VITO), BELGIUM
331
183230
‫תהליך לייצור ממברנות קפלריות מחוזקות‬
‫והממברנות המתקבלות‬
]99[
EP
April 28, 2011-‫כ"ד בניסן התשע"א‬
]14[
]44[
]54[
WO/2006/053406
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
A process for manufacturing asymmetric braid reinforced capillary ultra- or microfiltration membranes (1), comprising the subsequent steps of pulling a tubular braid (5)
through a spinneret (7) and coating the braid with a dope, characterised in that prior to
said coating step, the braid is impregnated with a non-coagulation liquid, being a liquid
which does not cause coagulation of said dope, when brought in contact with said
dope. The result is a membrane with an outer skin, i.e. smaller pores near the outside
diameter than near the inside diameter, and a coating which is closely arranged around
the outside diameter of the braid, without any substantial penetration of the coating
into the braid.
__________________
]22[]12[
]54[
SECURITY ELEMENT HAVING A
VIEWING-ANGLE DEPENDENT
ASPECT
]11[
]92[
]52[
]42[
10.11.2005
04029170.0
]91[ 09.12.2004
Int. Cl.(2010.01) B42D 15//00
SICPA HOLDING S.A.,
SWITZERLAND
WO/2006/061301
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]44[
]54[
332
183350
‫אלמנט אבטחה בעל היבט תלוי בזוית ראייה‬
]99[
EP
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention discloses a security element having a coating layer which appears
transparent at certain angles of view, giving visual access to underlying information,
whilst staying opaque at other angles of view. Documents of value, right, identity,
security labels or branded goods comprising said security element, as well as a method
April 28, 2011-‫כ"ד בניסן התשע"א‬
for producing said security element, are also disclosed. Using appropriate substrate
surfaces, optically variable and otherwise angle-dependent visual effects can be
realized.
__________________
]22[]12[
183358
‫בקבוקון להכנת תמיסה תאית‬
]54[
FLASK FOR PREPARING A
CYTOLOGICAL SUSPENSION
]11[
]92[
]52[
]42[
]14[
]44[
28.11.2005
0412710
]91[ 30.11.2004
]99[
Int. Cl.(2010.01) B01L 03//14, C12M 01//24
MACLIP, FRANCE
WO/2006/058989
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
The invention concerns a flask for preparing a fixer-based cytological suspension,
equipped with filtering means (4) at least partly immersed in the suspension,
characterized in that the filtering means (4) are in the form of a basket-forming
filtering material web, whereof the periphery (5) is fixed on the flask and whereof the
center (6) is connected to a tube (7), extending towards the opening (2) of the flask,
associated with position-maintaining means (8) in the flask and adapted to allow
through a pipette for drawing the suspension.
333
FR
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
183388
]54[
INSTRUMENT FOR TREATING
AMBLYOPIA USING AUTOMATIC
FREQUENCY CONVERSION LASER
]11[
]92[
18.08.2005
200520114140.8 ]91[ 19.07.2005
]99[ CN
11151121943234
2131131115
CN
Int. Cl.(2010.01) A61B 18//20, A61N 05//067
DANLAI FUNG, CHINA
DANLAI FUNG, ZHISHENG LI
WO/2007/009300
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH FLOOR,
‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
7 JABOTINSKY ST.,
1
RAMAT GAN 52520
‫ גן‬-‫רמת‬
An automatic frequency variable laser therepentic instrument for amblyopia consists of
a laser generator, a circular shading of light system which is provided in the output
light path, and a control circuit. The instrument is provided with a lens which can
adjust the height and the angle of the output light path.
]52[
]42[
]41[
]14[
]44[
]54[
‫ המשתמש‬AMBLYOPIA ‫כלי לטיפול ב‬
‫בלייזר משנה תדר אוטומטי‬
__________________
]22[]12[
]54[
334
METHOD AND APPARATUS FOR
PREPARATION OF CARBON
DIOXIDE MINERAL WATER
FOR BALNEOTHERAPY
183486
‫שיטה ומתקן להכנת מים מינרליים לבלנאותרפיה‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]11[
]52[
]42[
]44[
]54[
28.05.2007
Int. Cl.(2010.01) A61H 33//02, B01F 03//04, 03//12, E03C 01//01
GENNADY KATSNELSON
‫ באר שבע‬,‫גנדי כצנלסון‬
GENNADY KATSNELSON,
,‫גנדי כצנלסון‬
13/18 HA-HIL ST.
12/11 ‫החייל‬
BEER -SHEVA 84463
‫באר שבע‬
A system for producing mineral water, comprising a pressure tank having a water inlet
for receiving a stream of heated water, and a water outlet for discharging mineral
water produced therein; a perforated vessel provided in said pressure tank, said
perforated vessel comprising mineral salts disposed thereinside; sprinkling means for
sprinkling the stream of heated water received via said water inlet on the outer walls of
said perforated vessel; and a gas inlet connected to a source of pressurized gas for
maintaining positive pressure in the tank.
__________________
]22[]12[
183491
‫מכשיר עזר להקלדה‬
]54[
TYPING AID APPARATUS
]11[
]52[
]42[
29.05.2007
Int. Cl.(2010.01) B41J 02//14, G06F 03//02
DOV ZAIDER
ZAIDER KISUFIT HILA
]44[
]54[
‫ נתניה‬,‫דב זיידר‬
‫ נתניה‬,‫כיסופית הילה זיידר‬
DOV ZAIDER,
,‫דב זיידר‬
15 GIVATI ST., APT#8
15/1 ‫גבעתי‬
NETANYA 42463
‫נתניה‬
A typing aid apparatus, comprising:
means for obtaining the position of a cursor on a display of a computer;
means for obtaining the content displayed in a window around said cursor;
communication means with the computer;
a display, for displaying said window; and
a power supply, for operating the electronic components of said apparatus.
__________________
]22[]12[
]54[
335
METHOD FOR PREPARATION OF
ORGANOFLUORO COMPOUNDS
IN ALCOHOL SOLVENTS
183548
‫שיטה להכנת תרכובות אורגנופלואור בממיסים‬
‫אלכהולים‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]11[
]92[
]52[
]42[
]14[
]44[
]54[
09.12.2005
10-2004]91[ 15.12.2004
]99[
0106553
21-11152131331115
1114422
Int. Cl.(2010.01) C07C 17//007, C07F 13//00
FUTURECHEM CO, LTD.,
REPUBLIC OF KOREA
THE ASAN FOUNDATION OF
WO/2006/065038
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
KR
KR
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to a method for preparation of organofluoro compounds
containing radioactive isotope fluorine- 18. More particularly, the present invention
relates to a method for preparation of organofluoro compound by reacting fluorine salt
containing radioactive isotope fluorine- 18 with alkyl halide or alkyl sulfonate in the
presence of alcohol of Chemistry (Figure 1) as a solvent to obtain high yield of
organofluoro compound. Synthesis reaction according to the present invention may be
carried out under mild condition to give high yield of the organofluoro compounds and
the reaction time is decreased, and thereby is suitable for the mass production of the
organofluoro compounds.
__________________
]22[]12[
]54[
PROCESS FOR THE PURIFICATION
OF GABAPENTIN
]11[
]92[
]52[
]42[
]14[
15.12.2005
MI2004A002418 ]91[ 17.12.2004
Int. Cl.(2010.01) C07C 22/7/40, 22/9/28
ZACH SYSTEM S.P.A., ITALY
WO/2006/064041
336
183745
‫שיטה לנקוי גבפנטין‬
]99[
IT
April 28, 2011-‫כ"ד בניסן התשע"א‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
]44[
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
The present invention relates to a process for the purification of gabapentin. The
process relates to the addition of hydrochloric acid to an aqueous solution or
suspension of gabapentin, before, during or after the concentration step of that solution,
and the subsequent slurry of the gabapentin by the addition of an alcoholic solvent. The
so obtained gabapentin has an high purity degree and, in particular, is characterized by
a low content of lactam.
__________________
]22[]12[
183831
‫קטעים של חלבון סראט אשר קושרים חלבון‬
‫נוטש‬
]54[
FRAGMENTS OF A SERRATE
PROTEIN WHICH BIND A
NOTCH PROTEIN
]11[
]52[
]11[
]42[
29.04.1992
Int. Cl.(2010.01) C07K 14//435, 19//00, C12N 15//12, 15//62
DIVISION FROM 101728
YALE UNIVERSITY, U.S.A.
INDIANA UNIVERSITY
RESEARCH AND TECHNOLOGY
CORPORATION, U.S.A.
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
154 ‫אבן גבירול‬
P.O.B. 11490,
‫תל אביב‬11460 .‫ד‬.‫ ת‬,
TEL AVIV 62038
A substantially purified fragment of a Serrate protein which is the portion of the
Serrate protein with the greatest homology to the amino acud sequence as depicted in
figure 15 (SEQ ID No 9) from about amino acid numbers 79-282, which fragment is
characterized by the ability in vitro, when expressed on the surface of a first cell, to
bind to a Notch protein expressed on the surface of a second cell.
]44[
]54[
The applications for
division from this
application have not yet
been published
201111/
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
337
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
]54[
DATA PROCESSING APPARATUS
HAVING MEMORY PROTECTION
UNIT
]11[
]92[
]52[
]42[
]14[
]44[
29.09.2005
11/028501
]91[ 04.01.2005
Int. Cl.(2010.01) G06F 12//14
ARM LIMITED, UNITED KINGDOM
WO/2006/072756
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]54[
183909
‫התקן עיבוד נתונים בעל מערכת הגנת זיכרון‬
]99[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A data processor (100) has a memory operable to store data values; a memory
protection unit (130) operable to associate memory attributes with portions of said
memory and to identify a plurality of memory regions corresponding to respective
address ranges of said memory. The memory protection unit is operable to associate
with at least one of the plurality of memory regions (150) a respective memory region
specifier comprising an attributes field (230) for defining a set of memory attributes
associated with said memory region and a sub-region field (240) for holding a subregion membership value. The sub-region membership value specifies, for each of a
plurality of sub-regions of the memory region, whether respective sub-regions (160-1
to 160-8) are member sub-regions or non-member sub-regions such that said memory
attributes are applied to said member sub-regions but are not applied to said nonmember sub-regions.
__________________
]22[]12[
]54[
OPERATING SYSTEM
MIGRATION WITH MINIMAL
STORAGE AREA NETWORK
RECONFIGURATION
]11[
07.12.2005
338
183950
‫נדידה של מערכת הפעלה בתוך רשת‬/‫מעבר‬
‫) עם מינימום שינוי תצורה של‬SAN( ‫האחסון‬
‫רשת האחסון‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]92[
]52[
]42[
]14[
]44[
]54[
11/011244
]91[ 14.12.2004
]99[ US
Int. Cl.(2010.01) G06F 09//445, H04L 12//24
IBM CORPORATION, U.S.A.
WO/2006/063959
SUZANNE EREZ, IBM R&D
,R&D ‫ מעבדות יבמ‬,‫סוזן ארז‬
LABORATORIES,
‫ הר הכרמל‬,‫אוניברסיטת חיפה‬
HAIFA UNIVERSITY,
‫חיפה‬
HAIFA 31905
Methods, systems, and computer program products are provided for migrating an
operating system from a source computer to a destination computer. Some
embodiments include identifying a destination adapter of the destination computer that
is coupled for data communications to a SAN that is also coupled for data
communications to a source adapter of the source computer, logging off a virtual port
name of the source adapter from the login manager, deregistering the virtual port name
from the source adapter, registering the virtual port name with the destination adapter,
and logging on the destination adapter to the login manager with the virtual port name.
Typical embodiments also include transferring the operating system from the source
computer to the destination computer
__________________
]22[]12[
]54[
PLASMA-ELECTRIC POWER
GENERATION SYSTEM
]11[
]92[
18.03.2002
60/277374
]91[ 19.03.2001
113134111
1131131112
213141439
2431131111
Int. Cl.(2008.04) H05H 1/12
DIVISION FROM 157157
THE REGENTS OF THE
UNIVERSITY OF CALIFORNIA,
U.S.A.
]52[
]11[
]42[
339
183993
‫מערכת פלזמה –חשמלית לייצור כוח‬
]99[
US
US
US
April 28, 2011-‫כ"ד בניסן התשע"א‬
]41[
]14[
]44[
]54[
UNIVERSITY OF FLORIDA
RESEARCH FOUNDATION, INC.,
U.S.A.
NORMAN ROSTOKER, HENDRIK J.
MONKHORST
WO/2002/082873
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
1 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
A system and apparatus for controlled fusion in a field reversed configuration (FRC)
magnetic topology and conversion of fusion product energies directly to electric
power. Preferably, plasma ions are magnetically confined in the FRC while plasma
electrons are electrostatically confined in a deep energy well, created by tuning an
externally applied magnetic field. In this configuration, ions and electrons may have
adequate density and temperature so that upon collisions they are fused together by the
nuclear force, thus forming fusion products that emerge in the form of an annular
beam. Energy is removed from the fusion product ions as they spiral past electrodes of
an inverse cyclotron converter. Advantageously, the fusion fuel plasmas that can be
used with the present confinement and energy conversion system include advanced
(aneutronic) fuels.
__________________
]22[]12[
]54[
METHOD FOR CONTINUOUSLY
PRODUCING A FLEXIBLE
COMPLEX AND SAID FLEXIBLE
COMPLEX
]11[
]92[
]52[
]42[
]14[
]44[
19.12.2005
0413448
]91[ 17.12.2004
Int. Cl.(2010.01) B29C 65//02
PENNEL & FLIPO, FRANCE
WO/2006/067321
SANFORD T.COLB & CO.,
340
184000
‫שיטה לייצור ברציפות של מתחם גמיש ומתחם‬
‫גמיש‬
‫של הנ"ל‬
]99[
FR
,'‫ קולב ושות‬.‫סנפורד ט‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The invention relates to a method for continuously producing a flexible complex,
which comprises or consists of at least one sealed pouch, consisting in applying an
antisticking agent to at least one web of coated fabric (10) in areas used for forming
one or several pouches, in continuously assembling said web of coated fabric (10)
provided with the antisticking agent (14) applied thereto with the web of coated fabric
(20) by heating and/or pressure and a flexible complex comprising at least one sealed
pouch, wherein the internal surface of said sealed pouch is partially coated with an
antisticking agent, in particular on one face thereof.
P.O.B. 2273,
REHOVOT 76122
]54[
__________________
]22[]12[
]54[
WINDOW PANE WITH SECURITY
ELEMENT
]11[
]92[
]52[
]42[
22.12.2005
102004062060.1 ]91[ 23.12.2004
Int. Cl.(2010.01) E06B 03//66, 05//12
SAINT-GOBAIN GLASS FRANCE,
FRANCE
WO/2006/070159
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]44[
]54[
341
184005
‫שמשת חלון עם אביזר בטיחות‬
]99[
DE
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to a window pane (1) to reduce the effect of a pressure wave or
shock after an explosion, said window pane being provided with a security element and
comprising at least two panes arranged at a separation from each other enclosing a
space between said panes which are assembled to each other in the boundary regions
thereof by means of a spacer frame with the formation of edge grooves. Said window
pane (1) is characterised in that the security element is flexible, made from a highly
tear-resistant material, arranged in at least one of the edge grooves and at least one end
of the security element is run outside the edge groove.
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
184258
‫שיטה ומערכת לסימולציה גרפית בזמן אמת של‬
‫דפורמציה רוטציונית גדולה ומניפולציה‬
‫באמצעות שימוש בעקומה מודלית‬
]54[
METHOD AND SYSTEM OF
REAL-TIME GRAPHICAL
SIMULATION OF LARGE
ROTATIONAL DEFORMATION
AND MANIPULATION USING
MODAL WARPING
]11[
]92[
]52[
]42[
26.12.2005
60/639386
]91[ 27.12.2004
]99[ US
Int. Cl.(2010.01) G06F 09//455, 17//50, G06T 13//00, 17//20
SEOUL NATIONAL UNIVERSITY
INDUSTRY FOUNDATION,
REPUBLIC OF KOREA
WO/2006/071038
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]44[
]54[
342
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A real-time simulation method and system for large deformations is provided. Green's
nonlinear strain tensor accurately models large deformations. Modal analysis based on
a linear strain tensor has been shown to be suitable for real-time simulation, but is
accurate only for moderately small deformations. In the present invention, the
rotational component of an infinitesimal deformation is identified, and traditional
linear modal analysis is extended to track that component. And the invention develops
a procedure to integrate the small rotations occurring at the nodal points. An
interesting feature of the formulation is that it can implement both position and
orientation constraints in a straightforward manner. These constraints can be used to
interactively manipulate the shape of a deformable solid by dragging/twisting a set of
nodes. Experiments show that the technique runs in real-time even for a complex
model, and that it can simulate large bending and/or twisting deformations with
April 28, 2011-‫כ"ד בניסן התשע"א‬
acceptable realism.
__________________
]22[]12[
184279
‫תהליך ומנגנון לטיפול באשפה‬
]54[
WASTE TREATMENT PROCESS
AND APPARATUS
]11[
]92[
29.06.2006
0513299.8
]91[ 29.06.2005
]99[ GB
111413231
1131931111
GB
Int. Cl.(2010.01) F23G 05//027
ADVANCED PLASMA POWER
LIMITED, UNITED KINGDOM
WO/2007/000607
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A process for the treatment of waste, the process comprising: (i) either (a) a
gasification step comprising treating the waste in a gasification unit in the presence of
oxygen and steam to produce an offgas and a char, or (b) a pyrolysis step comprising
treating the waste in a pyrolysis unit to produce an offgas and a char; and (ii) a plasma
treatment step comprising subjecting the offgas and the char to a plasma treatment in a
plasma treatment unit in the presence of oxygen and, optionally, steam.
]52[
]42[
]14[
]44[
]54[
__________________
343
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
184358
‫שיטה ומעגל לשיפור גודל ותצורה של זרם המוצא‬
‫של ממירי הספק מתגיים‬
]54[
METHOD AND CIRCUITRY FOR
IMPROVING THE MAGNITUDE
AND SHAPE OF THE OUTPUT
CURRENT OF SWITCHING
POWER CONVERTERS
]11[
]52[
]42[
02.07.2007
Int. Cl.(2010.01) G05F 01//67, H02M 03//00
BEN GURION UNIVERSITY OF
‫ הרשות למחקר‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
THE NEGEV RESEARCH AND
‫שבע‬-‫ באר‬,‫ופיתוח‬
DEVELOPMENT AUTHORITY
SHMUEL BEN-YAAKOV
‫שמואל בן יעקב‬
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Apparatus of a grid-connected switching inverter for injecting its current into a power
line comprises: (a) an electrical energy source for providing the substantially DC
voltage to the apparatus; (b) a switching inverter connected to the electrical energy
source for converting the substantially DC voltage of the electrical energy source to a
high frequency alternating voltage; (c) a waveform generator for controlling the
magnitude and shape of the alternating high frequency voltage outputted from the
switching inverter by means of a control signal fed into the switching inverter; (d) an
inductor connected to an output of the switching inverter for generating an alternating
current from the alternating high frequency voltage, wherein the magnitude of the
alternating current depends on a frequency of the alternating high frequency voltage:
(e) a rectifier connected in series with the inductor for rectifying the alternating current
and for outputting a rectified unipolar alternating current, wherein the rectified average
value of the alternating current is proportional to the absolute magnitude of the power
line voltage; and (f) a polarity commutator connected to an output of the rectifier for
converting the rectified unipolar alternating current into a bipolar alternating current,
and for injecting the bipolar alternating current into a power line, wherein the bipolar
alternating current is substantially in phase with and of shape of the power line voltage
of the power line.
]41[
]44[
]54[
__________________
]22[]12[
]54[
344
MEASURING MEMBER AND
DEVICE FOR DETERMINING THE
BLOOD FLOW OF THE
GASTROINTESTINAL TRACT, AS
184568
‫גוף מדידה והתקן לקביעת זרימת הדם בדרכי‬
‫הקיבה והמעיים וכן לקביעת ניעות המעיים‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
WELL AS FOR REGISTRATING
THE INTESTINAL PERISTALSIS
]11[
]92[
]52[
]42[
]14[
]44[
08.02.2006
1028320
]91[ 17.02.2005
Int. Cl.(2010.01) A61B 05//0285
Q-PIDT BV, THE NETHERLANDS
WO/2006/088355
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
The invention relates to a measuring member and a device to be used for determining
the blood flow of the gastrointestinal tract, said measuring member comprising an
intestinal probe, having its distal end provided with a flexible inflatable body and at
least one pressure sensor mounted on this supporting body. After bringing the
inflatable flexible body at the predetermined pressure, the pressure sensor will abut the
intestinal wall and the measured pressure development, which represents a measure for
the blood flow of the gastrointestinal tract, is transformed into a graphical image with
the help of the device and/or is transformed into actual values for the blood flow of the
gastrointestinal tract. Further, the measuring member measures the development of the
pressure within the inflatable flexible body, which represents a measure for the
intestinal peristalsis.
]99[
NL
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
184654
]54[
ICE CONFECTION
]11[
]92[
]52[
]42[
17.07.2007
06118523
]91[ 07.08.2006
]99[ EP
Int. Cl.(2010.01) A23G 09//20, 09//32, 09//38, 09//46
UNILEVER PLC, UNITED
KINGDOM
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
]44[
345
‫קונפקציה מוקפאת‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫רמת החייל‬
RAMAT HACHAYAL 69710
]54[
An ice confection comprising: 1 to 8 wt% fat; a total solids content of from 10 to
25wt%; an ice structuring protein (ISP); at least 0.1wt% aerating agent, the confection
being obtainable by a process comprising aerating a mix with an aerating gas which
contains at least 50% by volume of carbon dioxide, nitrous oxide or mixtures thereof.
__________________
]22[]12[
184803
]54[
PURIFIED ANTIBODIES AGAINST
EPHA2, METHODS FOR THEIR
PRODUCTION,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USE THEREOF IN
THE PREPARATION OF
MEDICAMENTS FOR TREATING
CANCER
]11[
]92[
]52[
06.02.2006
60/650047
]91[ 04.02.2005
]99[ US
Int. Cl.(2010.01) A61K 39//395, 47//48, C07H 21//04, C07K 16//00, 16//18, 16//28,
16//30, C12P 21//06
RAVEN BIOTECHNOLOGIES, U.S.A.
WO/2006/084226
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
Provided herein is disclosure about the development and characterization of an
antibody that binds to antigen EphA2 which is present on a variety of human cancers
from breast, lung, prostate, and colons. Methods of diagnosing and treating various
cancers by using such antibodies directed against this antigen are also disclosed.
]42[
]14[
]44[
]54[
,‫ שיטות להכנתם‬,EPHA 2 ‫נוגדנים טהורים‬
‫תכשירים רפואיים המכילים אותם ושימושם‬
‫בהכנת תרופות לטיפול בסרטן‬
__________________
]22[]12[
346
184865
April 28, 2011-‫כ"ד בניסן התשע"א‬
]54[
USE OF AN IL-2 MUTEIN IN THE
MANUFACTURE OF A
MEDICAMENT FOR TREATING
RENAL CELL CARCINOMA
]11[
]92[
]52[
]42[
27.01.2006
60/647496
]91[ 27.01.2005
Int. Cl.(2010.01) A61K 38//20, 47//48
NOVARTIS VACCINES AND
DIAGNOSTICS, INC., U.S.A.
WO/2008/081510
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]44[
]54[
‫ להכנת תרופה לטיפול‬IL–2 ‫שימוש במוטאין‬
‫בגידולים ממאירים בכליות‬
]99[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Methods for treating renal cell carcinoma using low doses of IL-2 are disclosed. In
particular, the invention relates to methods of treating metastatic renal cell carcinoma
in patients who are renally impaired and/or intolerant of high dose IL-2 therapy. The
therapeutic regimen described herein significantly inhibits tumor growth with reduced
toxicity and adverse side effects compared to high dose IL-2 therapy.
__________________
]22[]12[
184913
‫בקרת צבע לתאורה סורקת‬
]54[
COLOR CONTROL FOR
SCANNING BACKLIGHT
]11[
]92[
]52[
]42[
29.07.2007
60/820808
]91[ 31.07.2006
]99[ US
Int. Cl.(2010.01) G09G 03//36, H05B 33//02
MICROSEMI CORP - ANALOG
‫ אנאלוג מיקסד סינגל‬- ‫מיקרוסמי קורפ‬
MIXED SIGNAL GROUP LTD.
‫ הוד השרון‬,‫גרופ בע"מ‬
]41[
DROR KORCHARZ, ARKADIY
PEKER, ALON FERENTZ
347
‫ אלון פרנץ‬,‫ ארקדי פיקר‬,‫דרור קורצרז‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]44[
]54[
MICROSEMI CORP - ANALOG
‫ אנאלוג מיקסד סינגל‬- ‫מיקרוסמי קורפ‬
MIXED SIGNAL GROUP LTD.,
,‫גרופ בע"מ‬
1 HANAGAR ST.,
1550 .‫ד‬.‫ ת‬1 ‫הנגר‬
P.O.B. 7220,
‫הוד השרון‬
HOD HASHARON 45421
A backlighting system for use with a display exhibiting a plurality of lighting regions,
the system comprising:
a color manager;
a plurality of luminaires, each exhibiting an optical output, each of said luminaires
comprising a plurality of colored LED strings (80) and arranged to illuminate a unique
one of the plurality of lighting regions of the display with the optical output of the
respective luminaire, the optical output of each of the respective luminaires restricted
to the respective unique lighting region;
a color sensor (60) arranged to receive light from one of the plurality of luminaires;
and
a plurality of thermal sensors secured at a particular location relative to said plurality
of luminaires and spatially separated from all other of said plurality of thermal sensors,
said plurality of thermal sensors being fewer in number than said plurality of
luminaires;
said color manager, responsive to said plurality of thermal sensors and said color
sensor, operative to calculate an estimated thermal temperature for at least one of said
plurality of luminaires and control a drive signal of each of said plurality of luminaires
so as to maintain a uniform color, said controlled drive signal being responsive to said
calculated estimated thermal temperature.
__________________
]22[]12[
]54[
ISOLATED ANTI-CD30
ANTIBODIES LACKING FUCOSE
RESIDUES, HOST CELLS
CAPABLE OF PRODUCING
THEM, METHODS EMPLOYING
THEM AND USE THEREOF IN
PREPARATION OF
MEDICAMENTS
]11[
]92[
]52[
]42[
17.02.2006
60/654197
]91[ 18.02.2005
Int. Cl.(2010.01) C07K 16//18, 16//30
BRISTOL-MYERS SQUIBB
COMPANY, U.S.A.
WO/2006/089232
REINHOLD COHN AND PARTNERS,
]14[
]44[
348
184950
fucose ‫ חסרי שאריות‬CD30 ‫נוגדני אנטי‬
,‫ תאי מאכסן המסוגלים לייצר אותם‬,‫מבודדים‬
‫שיטות ושימושם בהכנת תרופות‬
]99[
US
,‫ריינהולד כהן ושותפיו‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
The invention pertains to anti-CD30 antibodies that lack fucosyl residues. The
antibodies of the invention exhibit increased antibody-dependent cellular cytotoxicity
(ADCC) activity, including the ability to lyse CD30-expressing cell lines that are not
lysed by the fucosylated form of the antibodies. The invention also provides host cells
that express the anti-CD30 antibodies that lack fucosyl residues, wherein the host cells
are deficient for a fucosyl transferase. Methods of using the antibodies to inhibit the
growth of CD30+ cells, such as tumor cells, are also provided.
__________________
]22[]12[
185232
‫מערכת ושיטה לשמירת תצורה של מזרון מתנפח‬
]54[
SYSTEM AND METHOD FOR
MAINTAINING AIR INFLATABLE
MATTRESS CONFIGURATION
]11[
]92[
16.02.2006
60/653303
]91[ 16.02.2005
]99[ US
223955143
2531131111
US
Int. Cl.(2010.01) A47C 27//10, A61G 07//05, B60C 23//00
KCI LICENSING, INC., U.S.A.
WO/2006/089050
EITAN MEHULAL LAW GROUP,
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
10 ABBA EBEN BLVD.,
,‫פטנטים‬
P.O. B. 2081,
10 ‫שדרות אבא אבן‬
HERZLIYA 46120
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
A system and method for maintaining an air inflation mattress configuration sufficient
for patient support and comfort. Infrared illumination levels are measured within
individual or groups of inflated mattress chambers. A staggered approach to
illumination monitoring of chambers or sections to eliminate crosstalk between the
infrared sensors is carried out. Distributed microprocessor controllers established in a
network configuration utilizing controller network protocols reduces the wiring and
connections necessary for the assembled system. Various mattress cushion
construction techniques, such as sewing and or RF welding methods, are used for the
creation of individual chambers utilizing specific types of IR translucent, transparent
or reflective materials. The construction of the cushions and bladders in the system
includes the use of various types of fabrics with low to high air loss qualities as
required. The overall mattress assembly, including the control systems and the
methodologies associated with such control systems, provide a unique approach to the
maintenance of a consistently comfortable patient support surface. The use of a
]52[
]42[
]14[
]44[
]54[
349
April 28, 2011-‫כ"ד בניסן התשע"א‬
handheld unit for both programming the system and downloading information about
the operation of the system is also anticipated. The specific cushion construction
designs associated with the head, body, and foot cushion components of the mattress
are tailored to operate specifically with the control capabilities (sensors and air flow
regulators) of the invention.
__________________
]22[]12[
]54[
SYSTEM AND METHOD FOR
COMPUTERIZED ORDERING
]11[
]92[
08.02.2006
60/655410
]91[ 24.02.2005
113423319
1131331115
Int. Cl.(2010.01) G06Q 30//00
DOLPHIN SOFTWARE LTD.
WO/2006/090360
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]42[
]14[
]44[
]54[
350
185337
‫מערכת ושיטה לסידור ממוחשב‬
]99[
US
US
‫ לוד‬,‫דולפין תוכנה בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention discloses a method and system for computerized ordering at
least one product being a part of a final shopping list. The system comprises a first
computerized trolley configured to facilitate a user to select at least one product among
products being offered by one or more shops associated with the first trolley, thus
giving rise to at least one first computerized order line corresponding to the selected
product and being a part of a first shopping list; at least one second computerized
trolley, each one of said second trolleys configured to automatically generate at least
one second computerized order line matching to said first order line and comprising a
product being offered by one or more shops associated with the second trolley, said
second order line being a part of a second shopping list; wherein the final shopping list
is configured to be based on said first shopping list or on said second shopping list.
The method comprises providing said first computerized trolley, providing at least one
April 28, 2011-‫כ"ד בניסן התשע"א‬
said second computerized trolley, and facilitating compiling the final shopping list on
the basis of said first shopping list or said second shopping list.
2022121
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
]54[
SEMI-POWERED LOWER
EXTREMITY EXOSKELETON
]11[
]92[
]52[
]42[
13.04.2006
60/671348
]91[ 13.04.2005
Int. Cl.(2010.01) A61F 02//74
THE REGENTS OF THE
UNIVERSITY OF CALIFORNIA,
U.S.A.
WO/2006/113520
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]14[
]44[
]54[
351
186181
‫שלד חיצוני לגפיים התחתונה בעל הספקת כוח‬
‫חלקית‬
]99[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The lower extremity exoskeleton comprises two leg supports connectable to person's
lower limbs and configured to rest on the ground during their stance phase. Each leg
support comprises a thigh link and a shank link; a knee joint configured to allow
flexion and extension between the shank link and the thigh link. The lower extremity
exoskeleton further comprises an exoskeleton trunk connectable to the person's upper
body. The exoskeleton trunk is connectable to the thigh links of the leg supports
allowing for the flexion and extension between the leg supports and the exoskeleton
trunk. Two torque generators are coupled to each of the knee joints. A power unit,
capable of providing power, is coupled to the torque generators. In operation when a
leg support is in a stance phase and climbing a slope or stairs, the power unit injects
power into the respective torque generator thereby extending the respective knee angle.
When a leg support is in stance phase and not climbing a slope or stairs, the power unit
does not inject any power to the respective torque generator, but without dissipating
any stored power in said power unit, it forces the torque generator to resist flexion of
April 28, 2011-‫כ"ד בניסן התשע"א‬
the respective knee joint. When a leg support is in a swing phase, the power unit does
not inject any power to the respective torque generator, but without dissipating any
stored power in said power unit, it forces the torque generator to minimize its
resistance to knee flexion and extension.
__________________
]22[]12[
186259
‫התקן החתמה להשמת ניחוח ושיטה לבחינת‬
‫הניחוח‬
]54[
STAMP DEVICE FOR APPLYING
A FRAGRANCE AND METHOD
FOR TESTING FRAGRANCES
]11[
]92[
]52[
]42[
]14[
]44[
30.03.2006
167810
]91[ 31.03.2005
Int. Cl.(2010.01) A45D 34//00
ITMAKESENSE LTD.
WO/2006/103670
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
A fragrance tester for applying a fragrance comprising a mechanism for providing a
visible indication and a fragrance applicator for applying the fragrance, the tester
adapted to apply the fragrance in proximity of said visible indication.
352
]99[
IL
‫ אביב‬-‫ תל‬,‫איטמייקסנס בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
186404
‫שיטות והתקנים לקידוד דיבור ברצועות תדרים‬
‫רחבה‬
]54[
METHODS AND APPARATUS FOR
WIDEBAND SPEECH CODING
]11[
]92[
03.04.2006
60/667901
]91[ 01.04.2005
]99[
113149315
1131431115
Int. Cl.(2010.01) G10L 19//14, 21//02, 21//04
QUALCOMM INCORPORATED,
U.S.A.
WO/2006/107840
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]52[
]42[
]14[
]44[
]54[
353
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A wideband speech encoder according to one embodiment includes a narrowband
encoder and a highband encoder. The narrowband encoder is configured to encode a
narrowband portion of a wideband speech signal into a set of filter parameters and a
corresponding encoded excitation signal. The highband encoder is configured to
encode, according to a highband excitation signal, a highband portion of the wideband
speech signal into a set of filter parameters. The highband encoder is configured to
generate the highband excitation signal by applying a nonlinear function to a signal
based on the encoded narrowband excitation signal to generate a spectrally extended
signal.
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
186896
‫התקן עבור ערבוב מתמשך‬
]54[
APPARATUS FOR CONTINUOUS
BLENDING
]11[
]92[
]52[
]42[
]14[
]44[
19.04.2006
11/113492
]91[ 25.04.2005
]99[
Int. Cl.(2010.01) B01F 09//00, 09//02, 15//02
HARSCO CORPORATION, U.S.A.
WO/2006/115910
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]54[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The present invention provides a continuous blender having a drive unit assembly with
a shell assembly mounting assembly and a shell assembly structured to be removably
coupled to the shell assembly mounting assembly by one or more clamps. The drive
unit assembly may be coupled to shell assemblies having different lengths and
diameters. Thus, by changing the shell assembly coupled to the drive unit assembly,
the output of the continuous blender may be dramatically changed.
__________________
]22[]12[
186905
‫התקן ושיטה להכלת דליפת גז‬
]54[
APPARATUS AND METHOD FOR
LEAK CONTAINMENT
]11[
]92[
]52[
]42[
25.10.2007
11/590029
]91[ 31.10.2006
]99[ US
Int. Cl.(2010.01) F16J 13//02, F16K 35//10, F17C 13//06
AIR PRODUCTS AND CHEMICALS,
354
April 28, 2011-‫כ"ד בניסן התשע"א‬
]44[
]54[
355
INC., U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A fluid storage and leak containment apparatus comprising:
(a) a fluid storage vessel assembly comprising at least one vessel having an interior, an
exterior and an outlet opening between the interior and the exterior;
(b) a fluid flow fitting (203) sealably connected to the outlet opening and adjacent the
exterior of the at least one vessel, wherein the fluid flow fitting is adapted for
withdrawing reactive gas from the interior of the vessel;
(c) a containment enclosure (201) having an interior, an exterior, an open end and an
extraction port adapted for the withdrawal of gas from the interior of the containment
enclosure, wherein the open end is adapted to fit over and around the fluid flow fitting
such that the containment enclosure surrounds the fluid flow fitting and is adapted to
collect any reactive gas leaking from the fluid flow fitting; and
(d) an attachment member connected to the containment enclosure, wherein the
attachment member is adapted to irremovably attach the containment enclosure to the
fluid storage vessel assembly and to press the open end of the enclosure against the
fluid storage vessel assembly around the fluid flow fitting;
wherein the removable attachment member comprises at least one elastic body having
a first end and a second end, the first end being connected to the exterior of the
containment enclosure and the second end has a magnet fixed to it to provide a
removable magnetic attachment to the fluid storage vessel assembly such that the
elastic body is in tension.
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
187205
‫קו–תפר בגד ושיטה ייצור קו–תפר ללא קמטים‬
‫בן חלקי בגד‬
]54[
GARMENT SEAM AND METHOD
FOR PRODUCING A WRINKLE
FREE SEAM BETWEEN
GARMENT COMPONENTS
]11[
]92[
22.07.2002
01129786.7
]91[ 18.10.2001
]99[
213149445
2231131111
Int. Cl.(2010.01) A41D 27//24, D05B 01//18
DIVISION FROM 161460
GUANGDONG ESQUEL TEXTILES
CO., LTD., CHINA
WO/2003/032763
SANFORD T.COLB & CO.,
P.O.B. 2273,
]52[
]11[
]42[
]14[
]44[
356
CN
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]54[
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A method of manufacturing wrinkle-free garment seams and garments made therefrom
comprises (a) placing a bonding element comprising a thermal adhesive between
garment components; (b) stitching along a seam line; and (c) applying heat and/or
pressure to cause the adhesive to melt and flow along the seam to bond at least one
garment component. The thermal adhesive has a melting point of higher than about
150°C, preferably in the range about 160°C to about 190°C. Alternatively, a bonding
element comprising any adhesive material and having a substantially U shape is used
to make various seams, such as a yoke seam, a shoulder seam, a side seam, a pocket
seam, a hem button stay seam, a sleeve seam, a collar seam, etc. Wrinkle free
garments, such as shirts, pants, blouses, skirts, etc. incorporating the seams are
produced.
__________________
]22[]12[
187568
‫מכונת חיתוך לחיתוך גלילים או גלילי חומר‬
‫ארג‬
]54[
CUTTING MACHINE TO CUT
ROLLS OR LOGS OF WEB
MATERIAL
]11[
]92[
]52[
]42[
]14[
]44[
19.05.2006
FI2005A000113 ]91[ 27.05.2005
]99[ IT
Int. Cl.(2010.01) B26D 03//16
FABIO PERINI S.P.A., ITALY
WO/2006/126229
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The cutting machine comprises pairs of coaxial blades to simultaneously cut two rolls
(R) for each cutting cycle.
]54[
357
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
187719
‫פיצול תמונה במערכות בדיקה אופטיות‬
]54[
IMAGE SPLITTING IN OPTICAL
INSPECTION SYSTEMS
]11[
]92[
28.11.2007
60/861303
]91[ 28.11.2006
]99[ US
223344144
1132231114
US
Int. Cl.(2010.01) G01N 21//95, 21//956, H01L 21//66
NEGEVTECH, LTD.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]42[
]44[
]54[
‫ בע"מ‬,‫נגבטק‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
In an optical inspection tool, an image of an object under inspection, such as a
semiconductor wafer, may be obtained using imaging optics defining a focal plane.
Light comprising the image can be detected using multiple detectors which each
register a portion of the image. The image of the object at the focal plane can be split
into two, three, or more parts by mirrors or other suitable reflecting elements
positioned tangent to the focal plane and/or with at least some portion at the focal
plane with additional portions past the focal plane so that the focal plane lies between
the imaging optics and the splitting apparatus. In some embodiments, reflective planes
may be arranged to direct different portions to different detectors. Some reflective
planes may be separated by a gap so that some portions of the light are directed while
some portions pass through the gap.; Other splitting elements may comprise a group of
transmissive and reflective areas interspersed in an element positioned at or in the
focal plane, with some portions of the light are reflected to detectors while other
portions pass through the element(s) to other detectors. Splitting apparatuses and
elements may be cascaded.
__________________
358
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
187923
‫שיטה לטיפול בפירות או בירקות עם יוני‬
‫ תכשירים תואמים וערכה המשתמשת‬,‫פוספיט‬
‫בתכשירים‬
]54[
METHOD FOR TREATING FRUIT
OR VEGETABLES WITH
PHOSPHITE IONS,
COMPOSITIONS THEREFOR AND
A KIT FOR USE THEREOF
]11[
]92[
]52[
]42[
]44[
06.12.2007
0610688
]91[ 07.12.2006
Int. Cl.(2010.01) A23B 07//10, 07//154
XEDA INTERNATIONAL, FRANCE
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
Method for treating fruit or vegetables comprising use of a treatment composition
comprising a compound which allows the release of phosphite ions H2PO3- at a
temperature between 30 and 60 degrees Celsius.
]99[
FR
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
188023
]54[
LINEAR THUMB-PIECE
ACTUATION LATCH
MECHANISM
]11[
]92[
]52[
]42[
10.12.2007
11/657879
]91[ 24.01.2007
]99[
Int. Cl.(2010.01) E05B 03//00, E05C 01//02
SARGENT MANUFACTURING
COMPANY, U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]44[
]54[
359
‫מנגנון נעילה עם הפעלה לינארית‬
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A thumb-piece latch mechanism (300) which has ergonomic features comprising:
an inner plate (2) and an outer plate (16), which plates are secured together with a latch
mechanism therebetween;
a thumb-piece (1) extending into the inner plate and secured to a thumb-piece glide
plate (6) in the latch mechanism and which said thumb-piece moves linearly up and
April 28, 2011-‫כ"ד בניסן התשע"א‬
down;
said thumb-piece glide plate moveable linearly up and down in the latch mechanism
with the thumb-piece when the thumb-piece is moved up and down, respectively;
a spindle rotably mounted to the inner plate;
a spindle turn plate secured to the spindle and which rotates when the spindle is
rotated;
a permissive spring having one end connected to the spindle turn plate and the other
end connected to the thumb-piece glide plate;
a spindle tail secured to the spindle in the same plane and which rotates when the
spindle is rotated; and
a latch connected to the spindle tail which moves a latch bolt transversely to the
spindle tail when the spindle tail is rotated;
wherein when the thumb-piece is depressed the thumb-piece glide plate is moved
downward and the spindle turnplate is rotated, rotating the spindle, and the spindle tail
thereby moving the latch bolt transversely from a door frame.
__________________
360
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
‫שיטה לייצור קרבוקסאמידים‬
]54[
METHOD FOR PRODUCING
CARBOXAMIDES
]11[
]92[
]52[
]42[
07.06.2006
102005028293.8 ]91[ 18.06.2005
Int. Cl.(2010.01) C07D 23/1/16
BAYER CROPSCIENCE AG,
GERMANY
WO/2006/136287
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]44[
]54[
188174
]99[
DE
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to a novel method for producing known, fungicidally
effective 1,3-dimethyl-5-fluoro-1H-pyrazole-4-carboxamides from the corresponding
acid fluoride and aniline derivatives in the absence of an acid acceptor.
__________________
]22[]12[
188191
‫שסתום סולונואיד‬
]54[
SOLENOID VALVE
]11[
]92[
]52[
]42[
]14[
]44[
15.06.2006
MI2005A001148 ]91[ 17.06.2005
]99[ IT
Int. Cl.(2010.01) F16K 25//00, 31//06
R.P.E. S.R.L., ITALY
WO/2006/134479
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A flow cut-off solenoid valve (1) in a fluid feeding circuit containing water vapour
presents a guiding cylinder (16); a slider (5) , which comprises a shutter (25) and a
piston (23) which is slidingly coupled to the guiding cylinder (16) along a determined
axis (A) ; a solenoid (4) actuating said slider (4) ; and a valve body (2) in which a
passage section (15) of the fluid is made, which is defined by an annular wall (14) and
is adapted to be selectively closed by the shutter (25) which is insertable with
interference in the passage section (15) in contact with the annular wall (14) .
]54[
361
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
]54[
SYSTEMS FOR OPERATING TOP
DOWN/BOTTOM UP COVERING
FOR ARCHITECTURAL
OPENINGS
]11[
]92[
19.12.2007
60/871015
]91[ 20.12.2006
223354251
2432131114
Int. Cl.(2010.01) E06B 09//08
HUNTER DOUGLAS INC., U.S.A.
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]42[
]44[
]54[
362
188261
‫מערכת להפעלת כיסוי למעלה למטה ולמטה‬
‫למעלה לפתחים אדריכליים‬
]99[
US
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
A top down/bottom up covering for an architectural opening comprising in
combination:
a generally cylindrical roller, a pair of end caps for supporting said roller for reversible
rotation about a longitudinal axis, a reversibly rotatable drive member associated with
said roller and a drive element for reversibly rotating said drive member to effect
relative reversible rotation of said roller about said longitudinal axis, a flexible shade
material having a top edge and a bottom edge, a top rail secured to said top edge of
said shade material, a bottom rail secured to a bottom edge of said shade material, a
first plurality of lift cords anchored at a top end to said roller and at a bottom end to
said bottom rail,
at least two reversibly rotatable spools mounted within said roller and operably
connected to said drive member for selected rotation by said drive member, a second
plurality of lift cords individually anchored at a top end to an associated one of said
spools and at a bottom end to said top rail, said drive member including a non-circular
shaft on which said spools are mounted for unitary rotation with said shaft, a threaded
shaft mounted on said non-circular shaft for unitary rotation therewith, a first follower
April 28, 2011-‫כ"ד בניסן התשע"א‬
threadedly mounted on said threaded shaft and keyed to said roller for unitary rotation
with said roller, and
at least one abutment stop releasably positionable on said threaded shaft on at least one
side of said first follower to limit threaded movement of said first follower along said
threaded shaft in at least one direction and to prevent rotation of said non-circular shaft
when in engagement with said at least one abutment stop, whereby rotation of said
roller in a first direction will cause said top rail to engage said roller and cause said
flexible material to be wrapped around said roller and rotation of said roller in an
opposite direction will unroll said flexible material from said roller allowing said
bottom rail to drop and will thereafter allow said top rail to drop 3
__________________
]22[]12[
]54[
363
MONOCLONAL ANTIBODY THAT
BINDS AND NEUTRALIZES
HUMAN NOGO, A
PHARMACEUTICAL
COMPOSITION COMPRISING IT
188282
‫ אנושי‬NOGO ‫נוגדן מונוקלונלי אשר נקשר ל‬
‫ תכשיר רוקחי המכיל אותו‬,‫ומנטרל אותו‬
‫והשימוש בו‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
AND USES THEREOF
]11[
]92[
]52[
]42[
]14[
]44[
]54[
03.07.2006
0513766.6
]91[ 05.07.2005
]99[ GB
151544134
2432131115
GB
Int. Cl.(2010.01) A61K 39//395, A61P 19//10, 25//28, C07K 16//18, 16//22, C12N
15//63
GLAXO GROUP LIMITED, UNITED
KINGDOM
WO/2007/003421
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
26A HABARZEL ST.,
'‫א‬51 ‫רחוב הברזל‬
RAMAT HACHAYAL 69710
‫רמת החייל‬
The present invention relates to antibodies to NOGO, pharmaceutical formulations
containing them and to the use of such antibodies in the treatment and/or prophylaxis
of neurological diseases/disorders.
__________________
]22[]12[
188319
– 5 ,5 ,5 ‫הפחתה אסימטרית של‬
‫טריפלואורואצטון‬
]54[
ASYMMETRIC REDUCTION OF
1,1,1-TRIFLUOROACETONE
]11[
]92[
]52[
]42[
28.06.2006
05106261.0
]91[ 08.07.2005
]99[ EP
Int. Cl.(2010.01) C12P 07//04
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2007/006650
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The invention relates to a scalable biocatalytic process for the preparation of S- 1,1,1trifluoro-2-propanol with a enantiomeric excess of > 99 % by asymmetric microbial
reduction of 1,1,1-trifluoroacetone with Baker's yeast.
]14[
]44[
]54[
__________________
364
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
]54[
SURVEILLANCE SYSTEM AND
METHOD FOR DETECTING
FORBIDDEN MOVEMENT
ALONG A PREDETERMINED
PATH
]11[
]92[
30.06.2006
169487
]91[ 30.06.2005
241214
1431131115
Int. Cl.(2010.01) G08B 13//196
PLANUM VISION LTD.
WO/2007/004217
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]52[
]42[
]14[
]44[
]54[
188349
‫מערכת מעקב ושיטה לזיהוי תנועה אסורה‬
‫לאורך נתיב הנקבע מראש‬
]99[
IL
IL
‫ לציון‬- ‫ ראשון‬,‫פלנום ויז'ן בע"מ‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The present invention relates to a surveillance system for detecting forbidden
movement in any direction at one or more locations along a road. The system
comprises cameras that are in data communication with a control station for detecting
the forbidden movement; mobile platforms that are movable along a desired path along
the road; mechanical connectors for connecting the cameras to the mobile platforms,
that create an adjustable projection of the spatial distance between the camera and the
mobile platform; and a control station for receiving and processing data from and
transferring data the cameras.
__________________
]22[]12[
188429
‫מטוס בעל רמת בטיחות גבוהה‬
]54[
HIGH SECURITY AIRCRAFT
]11[
]52[
]42[
]41[
]14[
]44[
07.07.2005
Int. Cl.(2010.01) B64B 01//02, B64C 31//032
NIMBUS S.R.L., ITALY
ALFREDO CAPUANI
WO/2007/007353
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
1 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
365
April 28, 2011-‫כ"ד בניסן התשע"א‬
]54[
The aircraft (10) comprises an elongated framework (26) provided with propelling
means and direction-control planes. The framework is coupled to a pneumatic
chamber (16) suited to be filled with lighter-than-air gas and comprising two tubular
branches (12, 14) joined to form a V-shaped profile, with an aerodynamic-lift surface
(22, 24) extending therebetween.
__________________
]22[]12[
188437
‫מתקן תאורה אוטומטי נייד‬
]54[
AUTOMATIC MOBILE
LUMINOUS DEVICE
]11[
]92[
]52[
]42[
08.06.2006
U200501534
]91[ 28.06.2005
]99[ ES
Int. Cl.(2010.01) B60Q 07//00, F21V 21//096, H01H 36//00
TORRE & TORRE INNOVACION,
S.L., SPAIN
WO/2007/000481
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
516 ‫רחוב הירקון‬
P.O.B. 6451,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61063
The invention relates to an automatic luminous device which uses neither an external
manual switch, said switch being replaced by an internal automatic switch which
actuates the device only when the device is resting on a sufficiently-dense metal
surface, nor a connection cable to an external power source, the latter being replaced
by a preferably-rechargeable battery. The invention is intended to be used as en
emergency light for police vehicles or as an auxiliary back-up light and is equipped
with a base or casing (1) and a translucent screen (2) which are coupled to one another
in order to form a single body. The base of the casing (1) is provided externally with
two or more permanent magnets (3) which serve to block the movement of the casing
(1) when the latter is disposed on a sufficiently-dense metal platform (4). In addition,
the casing (1) is provided internally with an automatic activation switch (5) which is
solidly connected to a connector (6) by means of a flange (16) which is, in turn, solidly
]14[
]44[
]54[
366
April 28, 2011-‫כ"ד בניסן התשע"א‬
connected to a pin (7). Moreover, standard wiring means are used to connect one such
connector (6) to a rechargeable battery (8), an external auxiliary connector (9) and the
charge (10) which is perfectly insulated from the rest of the elements forming the
device by means of any type of separator element.
__________________
]22[]12[
]54[
ALERTNESS SENSING
SPECTACLES
]11[
]92[
]52[
]42[
10.08.2006
2005904308
]91[ 11.08.2005
Int. Cl.(2010.01) G08B 21//06
SLEEP DIAGNOSTICS PTY LTD.,
AUSTRALIA
WO/2007/016739
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]44[
]54[
367
188439
‫משקפיים רגישות לעירנות‬
]99[
AU
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Spectacles for use in an eye monitoring system include a pair of ocular frames and a
sensor unit adapted to be positioned adjacent an eye of the wearer. A nose bridge
connects the ocular frames and incorporates an adjustment mechanism for adjusting
the vertical position of the sensor unit relative to the eye. A frame arm extends from
the outer edge of each ocular frame and is adapted to fit over the ear of a wearer. The
sensor unit incorporates two infra red emitters at different angles and an infra red
detector recessed into the surface of the unit to reduce the proportion of signal received
by said detector which is not from the signal emitter reflected by the eye or eyelids.
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
188518
‫תצוגת פאז'ים תוך שימוש בשינוי מיקום תוך‬
‫כדי תרגום של פוליפפטידים מאוחים‬
]54[
PHAGE DISPLAY USING
COTRANSLATIONAL
TRANSLOCATION OF FUSION
POLYPEPTIDES
]11[
]92[
]52[
]42[
30.06.2006
05106236.2
]91[ 08.07.2005
]99[ EP
Int. Cl.(2010.01) C12N 15//10, C40B 40//02
UNIVERSITY OF ZURICH,
SWITZERLAND
WO/2007/006665
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
The present invention relates to a filamentous phage display method wherein the
polypeptides of interest displayed on the phage particle are cotranslationally
translocated across the cytoplasmic membrane of Gram-negative bacteria based on the
signal recognition particle pathway. This method is particularly suitable for
polypeptides, which are known to be difficult to display on phages, and for proteins of
cDNA libraries and other combinatorial libraries, in particular when derived from very
fast folding, stable protein scaffolds. The invention further relates to phage or
phagemid vectors useful in the method comprising a gene construct coding for a fusion
polypeptide comprising the polypeptide to be displayed on the phage particle and an
N-terminal signal sequence promoting cotranslational translocation.
]14[
]44[
]54[
368
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
188767
‫ מכשיר בדיקה ומכשיר ליטוגרפי‬,‫שיטת מדידה‬
]54[
METHOD OF MEASUREMENT,
INSPECTION APPARATUS AND
LITHOGRAPHIC APPARATUS
]11[
]92[
]52[
]42[
14.01.2008
11/656004
]91[ 22.01.2007
]99[ US
Int. Cl.(2010.01) B81B 01//00
ASML NETHERLANDS B.V., THE
NETHERLANDS
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A method of measuring an overlay error in a substrate the method comprising:
projecting a beam of radiation onto a plurality of targets at a position on the substrate
measuring radiation reflected from each of the plurality of targets on the substrate
using a scatterometer and detecting and calculating an extent of the overlay error from
the reflected radiation wherein the calculation assumes that a proportion of the overlay
error in each target deriving from asymmetry of the targets is constant for the plurality
of positions.
]44[
]54[
__________________
]22[]12[
]54[
369
VARIABLE-LAND, MULTIPLE
HEIGHT FLUTE CONTOUR
DESIGN FOR ENDODONTIC
188947
‫עיצוב קונטור חריצים עם גובה משתנה ועם‬
‫חלקים מורמים משתנים עבור פצירות‬
‫אנדודונטיות‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
FILES
]11[
]92[
]52[
]42[
]14[
]44[
]54[
26.07.2006
60/703766
]91[ 28.07.2005
]99[ US
223439411
1531431111
US
Int. Cl.(2010.01) A61C 05//02
STEPHEN L. BUCHANAN, U.S.A.
WO/2007/016278
SELIGSOHN GABRIELI & CO.,
,'‫זליגסון גבריאלי ושות‬
31 YAVNE ST.,
21 ‫רח' יבנה‬
P.O.B. 1426,
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61013
A tapered endodontic rotary file for shaping or cleaning a root canal in a tooth has one
or more flutes spiraling along the length of the file. The diameters of the one or more
flutes tapers in a non-uniform manner from a first diameter in a shank portion of the
file to a smaller diameter in a tip portion of the file such that at least one flute region
intermediate the shank portion and the tip portion has a diameter less than a straight
line taper from the shank portion to the tip portion. The flutes can also be landed and
the width of the lands can be varied along the length of the file. In particular, the width
of the lands in the intermediate region are wider than the width in the tip or shank
portion.
__________________
]22[]12[
]54[
]11[
]92[
]52[
]42[
]14[
]44[
370
FEMALE QUICK COUPLING
FITTING ELEMENT FOR PIPES
189016
‫) מקשר‬QUICK FEMALE( ‫אלמנט מחבר‬
‫מותאם עבור צינורות‬
31.07.2006
MI2005A001521 ]91[ 03.08.2005
]99[
Int. Cl.(2010.01) F16L 29//00, 37//113, 37//34
STUCCHI S.P.A., ITALY
WO/2007/014944
SANFORD T.COLB & CO.,
IT
,'‫ קולב ושות‬.‫סנפורד ט‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
A female element (1) is described comprising a hollow internal body (2) having an end
(3) provided with fastening means (5) to one of the pipes to be joined, a hollow
external body (7) coaxial with said internal body (2) and having an end (8) which
axially protrudes with respect to another end (4) of the internal body (2) opposite to
that provided with fastening means (5), one rigid central stem (9) coaxially supported
by said internal body (2) by means of a transversal perforated base (18) and having a
widened end (10) near said protruding end (8) of the external body (7), an axially
sliding sealing bush (12) coaxially arranged about said stem (9) and elastically stressed
to be engaged with said widened end (10) of the stem (9) to prevent the passage of
fluid within the female element (1), a cleaning bush (14) coaxially arranged about the
sealing bush (12) and axially stressed in position so as to prevent the entrance of dirt
about the sealing bush (12) and a lock sleeve (16) arranged about the protruding end
(8) of the external body (7) and engageable with a complementary end of a male
element to ensure the stable union of the two male and female elements of the fitting.
The stem (9) is fixed to said base (18) by means of at least one half bush (25) radially
fitted and axially locked in corresponding seats (26, 27) of said stem (9) and said base
(18)
P.O.B. 2273,
REHOVOT 76122
]54[
__________________
]22[]12[
]54[
MULTIPOLAR, MULTI-LUMEN,
VIRTUAL-ELECTRODE
CATHETER WITH AT LEAST
ONE SURFACE ELECTRODE
]11[
]92[
]52[
]42[
21.08.2006
11/209024
]91[ 22.08.2005
Int. Cl.(2010.01) A61B 18//18
ST. JUDE MEDICAL, ATRIAL
FIBRILLATION DIVISION, INC.,
U.S.A.
371
189066
–‫קטטר אלקטרודה וירטואלית רב–קוטבי רב‬
‫חללי עם לפחות אלקטרודת פני–שטח אחת‬
]99[
US
April 28, 2011-‫כ"ד בניסן התשע"א‬
]14[
]44[
WO/2007/024785
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
Multipolar, multi lumen, virtual-electrode catheters (10I) and methods for treatment
(e.g., treatment of cardiac arrhythmias) with such catheters (10I) are disclosed. The
catheters (10I) have at least two internal lumens (14, 16), and at least one internal,
flexible electrode (18) rides in each internal lumen. The flexible electrodes (18) carry
treatment energy (e.g., radiofrequency energy). The energy exits the catheters (10I) via
at least one exit feature (e.g., slots, portholes (26), or micro pores). The methods for
treatment include operating the catheters (10I) in different modes depending upon
location and type of treatment to be performed. The treatment energy delivered by one
of the internal, flexible electrodes (18) may be directed to the other internal, flexible
electrode (20); or the energy delivered by one or both of the internal, flexible
electrodes (18, 20) may be directed to one or more surface electrodes (22).
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
189551
‫מערכת ושיטת יישור‬
]54[
ALIGNMENT SYSTEM AND
METHOD
]11[
]92[
17.10.2006
60/729626
]91[ 24.10.2005
]99[ US
223543411
2132131111
US
Int. Cl.(2010.01) G02B 06//42
ONDINE INTERNATIONAL LTD.,
BARBADOS
WO/2007/050432
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The present invention provides an alignment system (100) comprising a base (10)
]52[
]42[
]14[
]44[
]54[
372
April 28, 2011-‫כ"ד בניסן התשע"א‬
having a feature (12) that accepts a first optical element (14), a first eccentric element
(18) having a through hole (20) that accepts an eccentric assembly (22) comprising a
second eccentric element (26) having a feature (28) that accepts a second optical
element (30) and is attached to the second optical element (30) via second attachment
means (32), wherein the first eccentric element (18) is engaged with the base (10) via
first attachment means (24) and axial alignment between optical axis of the first optical
element (14) and optical axis of the second optical element (30) is achieved by
rotationally adjusting at least one of the eccentric elements (18, 26) relative to the base
(10). The present invention also provides methods to make and use this alignment
system (100).
__________________
]22[]12[
189604
‫שיטה להרכבת מכלול לצימוד צינורות‬
]54[
METHOD OF ASSEMBLING A
PIPE COUPLING
]11[
]92[
]52[
]42[
]14[
]44[
21.06.2006
11/210376
]91[ 24.08.2005
Int. Cl.(2010.01) F16L 25//00
VICTAULIC COMPANY, U.S.A.
WO/2007/024326
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
A stop assembly for limiting motion of a shank of a fastener through an opening in a
body is disclosed. The stop assembly has a retention element that is positionable on the
shank. The retention element has a first surface that engages the shank for holding it at
a predetermined position on the shank. A second surface on the retention element
engages the body, and limits the motion of the shank relative to the body. Application
of sufficient force to the body or removal of the retention element from the shank will
allow the body and the fastener to move relatively to one another.
373
]99[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
189719
‫מכשיר לגילוי אש בציוד חשמלי‬
]54[
APPARATUS FOR FIRE
DETECTION IN AN ELECTRICAL
EQUIPMENT RACK
]11[
]92[
]52[
]42[
]14[
]44[
11.10.2006
102005052777.9 ]91[ 04.11.2005
]99[ DE
Int. Cl.(2010.01) G08B 17//00
AMRONA AG, SWITZERLAND
WO/2007/051517
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
The invention relates to a device for detecting a fire in switchgear cabinets (100),
comprising a suction pipe system (2) which communicates with the switchgear cabinet
(100) to be monitored via at least one suction hole (2') and via which a representative
air sample is withdrawn from the switchgear cabinet (100) to be monitored, and an
early fire detection module (10) that is equipped with at least one detection unit (11)
for detecting at least one fire parameter in the air sample sucked in via the suction pipe
system (2) and a controller for outputting an early fire detection signal in response to a
detection result output by means of the at least one detection unit (1). In order to offer
optimum protection of the switchgear cabinet (100) to be monitored, regardless of the
size of the switchgear cabinet (100) and the space available between the housing cover
of the switchgear cabinet (100) and the ceiling of the room, the early fire detection
module (10) is embodied as an insertable rack (100') which is to be inserted into the
switchgear cabinet (100) to be monitored.
]54[
__________________
374
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
189724
‫מפזר תערובת מלט לייצור לוח עם תכונות של‬
‫מלט‬
]54[
SLURRY SPREADER FOR
CEMENTITIOUS BOARD
PRODUCTION
]11[
]92[
]52[
]42[
02.09.2005
11/217720
]91[ 01.09.2005
]99[ US
Int. Cl.(2010.01) B28B 03//00, B32B 01//00, 37//00
UNITED STATES GYPSUM
COMPANY, U.S.A.
WO/2007/030102
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]44[
]54[
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention provides a board forming system comprising a forming table comprising
a belt with a surface for conveying a backing layer; a mixer fitted with a mechanism
capable of depositing cementitious slurry material over a top surface of the backing
layer; and a slurry spreader positioned downstream of the mixer, wherein a portion of
the slurry spreader comprises a plurality of apertures which are connected to a source
of pressurized fluid. The slurry spreader is configured such that the pressurized fluid
flows out of the slurry spreader through the apertures so as to provide a continuous
film of fluid across an outer surface of the slurry spreader. The slurry spreader is
positioned such that it can contact at least a portion of the cementitious slurry after the
slurry exits the discharge and before the slurry is spread across the width of the
backing layer such that the thickness of the slurry is approximately equal to the desired
slurry thickness for board formation. The invention further provides methods for
forming cementitious board comprising the use of the slurry spreader.
__________________
]22[]12[
]54[
TOOL HEAD COMPRISING AN
ADJUSTMENT MOTOR
]11[
]92[
]52[
]42[
]14[
22.07.2006
102005043851.2 ]91[ 13.09.2005
Int. Cl.(2010.01) B23B 31//32
KOMET GROUP GMBH, GERMANY
WO/2007/031147
375
189964
‫ראש כלי עבודה עם מנוע מכוון‬
]99[
DE
April 28, 2011-‫כ"ד בניסן התשע"א‬
]44[
]54[
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
The invention relates to a tool head for use in machine tools. The tool head comprises
at least one working slide (16) which can be adjusted relative to a basic body (10), and
an adjusting motor (24) which is arranged in the basic body (10) and acts on the
working slide (16) via gear means (22). The adjusting motor, configured as an electric
motor, comprises a stator (45) arranged in the basic body and a rotor (56) which runs
round in the stator, bears an output shaft (50) and is mounted in two pivot bearings (52,
54) arranged at a distance from one another, wherein one of the pivot bearings (54) is
arranged with an outer ring (58) in a basic body-mounted stator housing (60) and with
an inner ring (62) directly or indirectly on the output shaft. According to the invention,
the stator housing (60) comprises a sleeve part (66) which partially engages axially
over the stator on its outer side and is fixedly connected to the stator (45) in terms of
rotation and displacement, and a bearing cover (68) which closes off the sleeve part on
the gear side and bears the outer ring (58) of the first pivot bearing (54). The second
pivot bearing (52) is arranged in a separate centring ring (70) fastened inside the stator
(45) on that side facing away from the bearing cover of the stator housing.
__________________
]22[]12[
190355
]54[
CONTROL SYSTEM FOR AN ARC
FURNACE
]11[
]92[
]52[
]42[
12.09.2006
0519163.0
]91[ 20.09.2005
]99[ GB
Int. Cl.(2010.01) F27B 03//28, F27D 11//00, 19//00
ADVANCED MINERAL RECOVERY
TECHNOLOGIES LTD, UNITED
KINGDOM
WO/2007/034138
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
]14[
]44[
376
‫מערכת בקרה עבור כבשן‬
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫רמת החייל‬
RAMAT HACHAYAL 69710
]54[
A control system for and method of controlling a vertical position of at least one
electrode of an arc furnace, where the arc furnace comprises a furnace transformer
having a primary, input side and a secondary, output side which is electrically
connected to the at least one electrode, the control system comprising : at least one
current-measuring device for measuring a current as drawn by the arc furnace; a
voltage-measuring device for measuring a voltage as applied across the arc furnace;
and a control unit for dynamically determining a setpoint for the vertical position of
the at least one electrode based on the measured values of current and voltage, and
providing an actuating output for driving a lifting arrangement to adjust the vertical
position of the at least one electrode so as to follow the dynamically-determined
setpoint.
__________________
]22[]12[
190537
]54[
EGFR DEPENDENT
MODULATION OF CHEMOKINE
EXPRESSION AND INFLUENCE
ON THERAPY AND DIAGNOSIS
OF TUMORS AND SIDE EFFECTS
THEREOF
]11[
]92[
]52[
]42[
11.10.2006
05022127.4
]91[ 11.10.2005
]99[
Int. Cl.(2010.01) G01N 33//50, 33//574, 33//68
MERCK PATENT GMBH,
GERMANY
WO/2007/042286
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]14[
]44[
377
‫ של ביטוי כמוקין והשפעה‬EGFR–‫אפנון תלוי ב‬
‫על טיפול ואבחון גידולים ותופעות לוואי שלהם‬
EP
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
April 28, 2011-‫כ"ד בניסן התשע"א‬
]54[
The invention relates to diagnosis and therapy of tumors utilizinging the epidermal
growth factor (EGFR) by means of chemical inhibitors or monoclonal antibodies. The
invention relates also to skin irritations, preferably skin rash, in conjunction and
associated with the treatment of tumor cells that utilize EGF receptor with anti-cancer
agents. The invention is also directed to methods of predicting the efficiency of a
tumor therapy / tumor response in a patient based on the treatment with EGFR
inhibitors, especially anti-EGFR antibodies. The invention further relates to a method
of determining the optimum dose of an anti- cancer agent in EGFR related tumor
therapy.
__________________
]22[]12[
191007
‫מחבר בעל חלל עם כיווניות זויתית‬
]54[
COUPLING HAVING
ANGULARLY ORIENTED CAVITY
]11[
]92[
]52[
]42[
]14[
]44[
26.10.2006
60/730305
]91[ 26.10.2005
Int. Cl.(2010.01) F16L 17//00, 23//00
VICTAULIC COMPANY, U.S.A.
WO/2008/008088
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
A coupling for joining pipe elements in end to end relation is disclosed. The coupling
includes interconnectable coupling segments having connection members at opposite
ends. The connection members are tightenable for drawing the segments toward one
another and into engagement with the pipe elements. Each segment has a concavity
positioned between inwardly projecting arcuate surfaces that engage grooves in the
pipe elements. The concavities house a sealing member that extends circumferentially
around the pipe elements. Angularly oriented surfaces are positioned adjacent to the
connection members. The surfaces on facing segments engage one another and cause
the segments to rotate in opposite directions about an axis perpendicular to the pipe
elements. The concavities are angularly oriented with respect to the axis so that when
the segments rotate, the cavities receive the sealing member without distorting it. A
method of joining pipe elements end to end is also disclosed.
378
]99[
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
201//10
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
8‫שטרם פורסמו‬
__________________
]22[]12[
]54[
DISPENSING DEVICE FOR
SINGLE USE
]11[
]92[
]52[
]42[
07.12.2006
2090/05
]91[ 29.12.2005
Int. Cl.(2010.01) B05C 17//005
SULZER MIXPAC AG,
SWITZERLAND
WO/2007/073607
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]44[
]54[
379
192483
‫כלי חלוקה לשימוש יחיד‬
]99[
CH
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The dispensing device for single use includes a multicomponent cartridge (1), a mixer
(8) having a mixer housing (9), as well as closure means for closing the outlets (4, 5)
of the multicomponent cartridge. These closure means are connected to the mixer
housing and comprise a respective closure stopper (13, 14) for each outlet that is
insertable in an outlet (4, 5) of the multicomponent cartridge and is deformable such
that upon rotation of the mixer housing relative to the cartridge, the closure stoppers
(13, 14) are removed from the outlets (4, 5) of the multicomponent cartridge. Such an
easily removable closure by means of deformable closure stoppers allows a very
economical manufacture of dispensing devices that are intended to be used only once
at it is required in medicine and in other fields.
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
193714
‫מדפסת הזרקת דיו‬
]54[
INKJET PRINTER
]11[
]92[
27.02.2007
JP2006]91[ 28.02.2006
]99[ JP
052142
JP20062131131111
JP
162377
Int. Cl.(2010.01) B41J 02//01, 29//377
MASTERMIND CO. LTD., JAPAN
CHIZUO OZAWA
WO/2007/099704
FISHER WEILER JONES,
,‫פישר וילר ג'ונס‬
26 HABARZEL STREET
51 ‫הברזל רמת החיל‬
RAMAT HACHAYAL,
‫תל אביב‬
TEL-AVIV 69710
A heating lamp unit (40) is mounted on a head carriage (10) of an inkjet printer (1).
Since the heating lamp unit (40) is positioned very close to an ink drop, which is
discharged from the inkjet head (11) and dropped on a recording medium (30), and
that the heating lamp unit can directly harden the ink drop with heat, the ink drop can
be efficiently fixed. When the heating lamp unit (40) is arranged very close to the
inkjet head (11), there are possibilities of generating clogging of the nozzle of the
inkjet head (11) and thermal failure of the inkjet head itself due to heat released from
the heating lamp (40). Since the heating lamp unit (40) can be efficiently cooled by a
cooling mechanism (50) using heat pipes (51, 52), the inkjet head can be prevented
from being heated.
]52[
]42[
]41[
]14[
]44[
]54[
380
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
]54[
VEHICLE ARRESTING DEVICE
]11[
]92[
]52[
]11[
]42[
08.01.2004
0303119.2
]91[ 12.02.2003
Int. Cl.(2010.01) E01F 13//12
DIVISION FROM 170247
QINETIQ LIMITED, UNITED
KINGDOM
WO/2004/072382
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. B. 2081,
HERZLIYA 46120
]14[
]44[
]54[
381
194527
‫התקן לעיצרת כלי רכב‬
]99[
GB
‫ עורכי דין ועורכי‬,‫קבוצת איתן מהולל‬
,‫פטנטים‬
10 ‫שדרות אבא אבן‬
‫הרצליה‬5011 .‫ד‬.‫ ת‬,
A vehicle arresting device comprising a flexible substrate (1) adapted to be laid flat on
the ground in the path of a vehicle to be arrested with one or more transverse rows of
upwardly-directed spikes (8) attached to the substrate at a leading portion thereof,
wherein the spikes are attached to the substrate by penetrating respective spikes
through respective portions (1a) of the substrate.
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
195308
‫מגיבים כימי–נהורניים‬
]54[
CHEMILUMINESCENT
REAGENTS
]11[
]92[
]52[
]11[
]42[
]44[
02.03.2003
10/096075
]91[ 12.03.2002
]99[ US
Int. Cl.(2010.01) C07D 30/5/00
DIVISION FROM 154700
ENZO LIFE SCIENCES, INC., U.S.A.
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A chemiluminescent reagent of formula I as depicted in the specification wherein Q
comprises a cycloalkyl or polycycloalkyl group attached covalently to the 4-membered
ring portion of said dioxetane above directly or indirectly through a linkage group;
April 28, 2011-‫כ"ד בניסן התשע"א‬
]54[
382
wherein Z comprises hydrogen, alkyl, aryl, aralkyl, alkaryl, heteroalkyl, heteroaryl,
cycloalkyl or cycloheteroalkyl; and wherein R1 and R2 comprise chemical moieties
attached to different sites of a cyclic ring attached to said dioxetane, and wherein R 1 is
enzymatically converted into R1* which comprises a chemical reactive group G1, and
wherein R2 is attached to said cyclic ring through an oxygen atom and comprises a
chemical reactive group G2 which reacts with said G1 to convert said dioxetane to an
unstable light-emitting dioxetane form.
__________________
]22[]12[
195374
‫ קולי עם גנום מופחת החסר רצפים מוחדרים‬.‫אי‬
‫וצלקות‬
]54[
E. COLI WITH REDUCED
GENOME LACKING INSERTION
SEQUENCES AND SCARS
]11[
]92[
]52[
]11[
]42[
22.01.2003
10/057582
]91[ 23.01.2002
]99[ US
Int. Cl.(2010.01) C12N 01//08, 01//21, C12P 21//02, C12R 01//19
DIVISION FROM 162911
WISCONSIN ALUMNI RESEARCH
FOUNDATION, U.S.A.
WO/2003/070880
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
The present invention provides a bacterium having a genome that is genetically
engineered to be at least 2 to about 20% smaller than the genome of its native parent
strain. A bacterium with a smaller genome can produce a commercial product more
efficiently. The present invention also provides methods for deleting genes and other
DNA sequences from a bacterial genome. The methods provide precise deletions and
seldom introduces mutations to the genomic DNA sequences around the deletion sites.
Thus, the methods can be used to generate a series of deletions in a bacterium without
increasing the possibility of undesired homologous recombination within the genome.
In addition, some of the methods provided by the present invention can also be used
for replacing a region of a bacterial genome with a desired DNA sequence.
]14[
]44[
]54[
__________________
383
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
195439
‫תהליכים לזיהוי פעילות אנזימטית‬
]54[
PROCESSES FOR THE
DETECTION OF ENZYMATIC
ACTIVITY
]11[
]92[
]52[
]11[
]42[
]44[
02.03.2003
10/096075
]91[ 12.03.2002
]99[ US
Int. Cl.(2010.01) C12Q 01//00, G01N 33//50
DIVISION FROM 154700
ENZO LIFE SCIENCES, INC., U.S.A.
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A process for detecting the presence or quantity of enzymatic activity of interest in a
sample, said process comprising the steps of:
]54[
)a) providing:
(i)
said sample suspected of containing enzymatic activity;
(ii)
a chemiluminescent reagent of formula I as depicted in the
specification,
wherein Q comprises a cycloalkyl or polycycloalkyl group attached covalently to the
4-membered ring portion of said dioxetane above directly or indirectly through a
linkage group; wherein Z comprises hydrogen, alkyl, aryl, aralkyl, alkaryl, heteroalkyl,
heteroaryl, cycloalkyl or cycloheteroalkyl; and wherein R1 and R2 comprise chemical
moieties attached to different sites of a cyclic ring attached to said dioxetane, and
wherein R1 is enzymatically converted into R1* which comprises a chemical reactive
group G1, and wherein R2 is attached to said cyclic ring through an oxygen atom and
comprises a chemical reactive group G2 which reacts with said G1 to convert said
dioxetane to an unstable light-emitting dioxetane form,
(iii)
reagents or buffers for carrying out chemiluminescent reactions;
(b) forming a mixture of:
(1) (i),(ii) and (iii); or
(2) (ii) and (iii) and contacting said mixture of (ii) and (iii) with (i);
(c) enzymatically converting the chemiluminescent reagent of (a)(ii) into an
384
April 28, 2011-‫כ"ד בניסן התשע"א‬
unstable light-emitting dioxetane form; and
(d) measuring the quantity of light generated by said enzymatic conversion in
step (c).
__________________
]22[]12[
195704
‫שיטה לריכוז איזוטופ חמצן‬
]54[
METHOD FOR CONCENTRATING
OXYGEN ISOTOPE
]11[
]92[
02.03.2004
2003-057439 ]91[ 04.03.2003
]99[ JP
1119-111352
1431431119
JP
1119-923413
2231331119
JP
Int. Cl.(2010.01) B01D 59//34
DIVISION FROM 170576
TAIYO NIPPON SANSO
CORPORATION, JAPAN
WO/2004/078325
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ירושלים‬1255 .‫ד‬.‫ ת‬,
JERUSALEM 91013
A method for concentrating oxygen isotope which comprises irradiating ozone with a
specific light to thereby selectively decompose an isotopomer of ozone containing an
isotope of oxygen, and separating the oxygen formed by the decomposition of the
ozone from undecomposed ozone, to concentrate the oxygen isotope in the oxygen
separated. A system for concentrating oxygen isotopes comprises a means (11) for
forming ozone from a raw material of oxygen, an ozone separating means (12) for
separating the ozone formed in said ozone forming means from the raw material
oxygen, an ozone photodegradation means (13) for irradiating the ozone separated by
the ozone separating means (12) with a light having a specific wave length, to
selectively decompose the ozone containing an oxygen isotope in its molecule, and an
oxygen separation means for separating the oxygen formed in the ozone
photodegradation means (13) by the decomposition of ozone from undecomposed
ozone, to thereby concentrate an oxygen isotope in the oxygen. The method allows the
practice of the concentration of 17O or 18O, which is a stable isotope of oxygen, with a
simple and convenient system of devices.
]52[
]11[
]42[
]14[
]44[
]54[
385
April 28, 2011-‫כ"ד בניסן התשע"א‬
__________________
]22[]12[
196082
‫חומצה נוקליאוטידי המכילה רצף נוקליאוטידי‬
‫שמקודד שרשרת של נוגדן סלקטיבי לקישור‬
TNF ‫ליגנד–רצפטור המשפיע מוות תאי ע"י‬
‫ ושימושים הקשורים‬DR5 )‫(גורם נמק גידולים‬
‫לכך‬
]54[
NUCLEIC ACID COMPRISING A
NUCLEOTIDE SEQUENCE THAT
ENCODES A CHAIN OF AN
ANTIBODY SELECTIVE FOR
TUMOR NECROSIS FACTORRELATED APOPTOSIS-INDUCING
LIGAND RECEPTOR DR4 AND
USES THEREOF
]11[
]92[
]52[
]11[
]42[
01.11.2002
60/346402
]91[ 01.11.2001
]99[ US
Int. Cl.(2010.01) C07K 16//28, C12N 05//10, 05//12, 15//13
DIVISION FROM 161685
UAB RESEARCH FOUNDATION,
U.S.A.
TONG ZHOU, ROBERT P.
KIMBERLY, ALBERT F.
LOBUGLIO, DONALD J.
BUCHSBAUM, WILLIAM J.
KOOPMAN
WO/2003/037913
JMB, FACTOR & CO. LTD.,
,‫ פקטור אנד קו בע"מ‬,‫ג'יי אמ בי‬
HAR HOTZVIM HI-TECH PARK,
‫ הר חוצבים‬,‫רחוב המרפא‬
P.O.B. 45087,
‫ירושלים‬45011 .‫ד‬.‫ ת‬,
JERUSALEM 91450
An antibody of the invention interacts with human DR5 or with human DR4 to
produce agonistic or antagonistic effects downstream of the receptor including
inhibition of cell proliferation and apoptosis. Nucleic acid sequences and amino acid
sequences of DR5 and DR4 antibodies have been elucidated and vectors and cells
containing and expressing these sequences have been generated. Methods and uses for
]41[
]14[
]44[
]54[
386
April 28, 2011-‫כ"ד בניסן התשע"א‬
the antibodies are detailed including treatment of apoptosis-related disease and
treatment of dysregulated cell growth.
__________________
]22[]12[
196213
‫בידוד תרמי של חבילות‬
]54[
THERMAL INSULATION OF
PACKAGES
]11[
]52[
]42[
]41[
25.12.2008
Int. Cl.(2010.01) B32B 27//06, B65D 05//60, 81//38
PUTERMAN DISTRIBUTORS
‫ אביב‬- ‫ תל‬,‫פוטרמן יזום ניהול ושיווק‬
ARIEL PUTTERMAN, MOSHE
‫ משה זך‬,‫אריאל פוטרמן‬
ZACH
WEBB & CO.,
,'‫ד"ר וב ושות‬
2 PEKERIS ST., P.O.B. 2189,
5 ‫רח' פקריס‬
REHOVOT 76121
‫רחובות‬5116 .‫ד‬.‫ ת‬,
An apparatus for covering and thermally insulating one or more packages,
]44[
]54[
the apparatus comprising: at least one insulating sheet comprising one or more
layers of bubbles being coated, at least on an outer side of said insulating sheet,
with a reflective layer, wherein said at least one insulating sheet is foldable about a
top and four sides of the one or more packages and comprises laterally-separated
sides being disposable on the sides of the one or more packages, while leaving
elongated ventilation openings between neighboring edges of said side of the at
least one insulating sheet, about corners of the one or more packages.
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
‫ לתקנות‬01 ‫פירוט זה נבחן בהתאם לתקנה‬
211/ – ‫ תשכ"ח‬2‫הפטנטים‬
__________________
]22[]12[
]54[
387
ANTIBODIES DIRECTED
AGAINST POLYPEPTIDES
CAPABLE OF BINDING TO
196509
–‫נוגדנים כנגד פוליפפטידים הנקשרים ל‬
‫ ותכשירים רוקחיים המכילים אותם‬LDCAM
April 28, 2011-‫כ"ד בניסן התשע"א‬
LDCAM AND PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME
]11[
]92[
]52[
]11[
]42[
]14[
]44[
05.08.1999
60/095663
]91[ 07.08.1998
]99[
Int. Cl.(2010.01) A61K 39//395, C07K 16//18
DIVISION FROM 140938
IMMUNEX CORPORATION, U.S.A.
WO/2000/008057
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]54[
an antibody directed against a polypeptide that is at least 80% identical to an amino
acid sequence selected from the group consisting of: (a) amino acids x1 to 364 of SEQ
id no 2 wherein x1 is amino acid 1 or 21
(b) amino acids x1' to 330 of SEQ id no 4 wherein x1' is amino acid 1 or 21 (c) amino
acids y1 to 330 of SEQ id no 6 wherein y1 is amino acid 1 or 21 and wherein said
polypeptide is capable of binding to an LDCAM polypeptide of SEQ ID No 20 or SEQ
ID No. 22
US
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
__________________
]22[]12[
]54[
ABSORBENT ARTICLES
INCLUDING AN IMPROVED
ODOUR CONTROL SYSTEM
]11[
]92[
]52[
]42[
09.08.2007
06016652.7
]91[ 09.08.2006
Int. Cl.(2010.01) A61L 15//46
THE PROCTER & GAMBLE
COMPANY, U.S.A.
WO/2008/018044
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
]14[
]44[
]54[
388
196628
‫פריטים סופגים הכוללים מערכת משופרת‬
‫לבקרת ריח‬
]99[
EP
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
Absorbent articles which are provided with an odour control system. The odour control
system includes at least two classes of odour control materials, wherein a first class
April 28, 2011-‫כ"ד בניסן התשע"א‬
comprises at least a material having low volatility, and a second class comprises at
least a material having high volatility. The odour control system is provided in the
absorbent article in a selected position and amount to provide a prolonged odour
control action.
__________________
]22[]12[
200258
‫שיטה להשמת טקסטורה לגיליון רציף של בד‬
‫בעזרת מכלול לקופסת יניקה גלילית עם רמות‬
‫יניקה מרובות ושונות‬
]54[
METHOD FOR APPLYING A
TEXTURE TO A CONTINUOUS
SHEET OF FABRIC THROUGH A
CYLINDRICAL SUCTION BOX
WITH MULTIPLE, SEPARATE
SUCTION LEVELS
]11[
]52[
30.08.2006
Int. Cl.(2010.01) B21F 11//00, B44B 05//00, D04H 01//46, D21F 01//48, 01//50,
01//52
DIVISION FROM 177788
N.R. SPUNTECH INDUSTRIES
‫ טבריה עלית‬,‫ ספונטק תעשיות בע"מ‬.‫ר‬.‫נ‬
LTD.
YUVAL BERENSTAIN
‫יובל ברנשטיין‬
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
‫באר שבע‬5255 .‫ד‬.‫ ת‬,
BEER-SHEVA 84152
A method for applying a texture to a surface of a substantially continuous sheet of
fabric and performing a de-watering process on the patterned fabric using a single
cylindrical suction box, the method comprising: (a) providing a substantially
cylindrical suction box with at least one lower suction pressure suction chamber and at
least one higher suction pressure suction chamber, said suction box configured with at
least one longitudinal texturing slot opening into said at least one lower suction
pressure suction chamber and at least one longitudinal de-watering slot opening into
said at least one higher suction pressure suction chamber; and (b)
passing the
fabric over said suction box such that at least a portion of the fabric passes over said
texturing slot during a texturing process and then passes over said de-watering slot
during the de-watering process.
]11[
]42[
]41[
]44[
]54[
__________________
389
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
200933
‫שיטה לזיהוי חלבון ולקביעת כמותו בתערובות‬
‫מורכבות באמצעות בחירת אפיניות ששל מקטעי‬
‫פפטיד נבחרים‬
]54[
METHOD FOR PROTEIN
IDENTIFICATION AND
QUANTIFICATION IN COMPLEX
MIXTURES UTILIZING AFFINITY
SELECTION OF CONSTITUENT
PEPTIDE FRAGMENTS
]11[
]92[
04.05.2001
60/203227
]91[ 05.05.2000
]99[ US
113111214
9231531111
US
113111941
9231531111
US
Int. Cl.(2010.01) G01N 33//68
DIVISION FROM 152620
PURDUE RESEARCH
FOUNDATION, U.S.A.
FRED E. REGNIER
WO/2001/086306
PEARL COHEN ZEDEK LATZER,
,‫פרל כהן צדק לצר‬
5 SHENKAR ST.,
5 ‫ רח' שנקר‬,1 ‫ים‬-‫מרכז גב‬
P.O.B. 12704,
‫הרצליה‬15104 .‫ד‬.‫ ת‬,
HERZLIYA 46733
A method for detecting a difference in the concentration of a protein present in a first
sample and in a second sample, each sample comprising a plurality of proteins the
method comprising: fragmenting proteins in the first and second samples to yield at
least one peptide in each sample, covalently attaching a first isotopic variant of a
chemical moiety to a peptide in the first sample to yield at least one first isotopically
labeled peptide, covalently attaching a first isotopic varient of the chemical moiety to a
peptide in the second sample to yield at least one second isotopically labled peptide
wherein the first and second isotopically labeled peptides are chemically equivalent yet
isotopically distinct, mixing at least portions of the first and second samples to yield a
combined sample and subjecting the combined sample to mass spectrometric analysis
to determine a normalized isotope ratio characterizing peptides derived from proteins
whose concentration is the same in the first and second samples and an isotope ratio of
the first and second isotopically labeled peptides wherein a difference in the isotope
ratio of the first and second isotopically labeled peptides and the normalized isotope
ratio is indicative of a difference in concentration in the first and second samples of a
protein derived from the peptide.
]52[
]11[
]42[
]41[
]14[
]44[
]54[
__________________
390
April 28, 2011-‫כ"ד בניסן התשע"א‬
]22[]12[
202313
‫שיטות התפלה ומערכות שכוללות שיקוע‬
‫תרכובת קרבונט‬
]54[
DESALINATION METHODS AND
SYSTEMS THAT INCLUDE
CARBONATE COMPOUND
PRECIPITATION
]11[
]92[
27.06.2008
60/937786
]91[ 28.06.2007
]99[
123124931
1132131114
123149911
2431131111
Int. Cl.(2010.01) B01D 61//02, C02F 01//66
CALERA CORPORATION, U.S.A.
WO/2009/006295
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]52[
]42[
]14[
]44[
]54[
US
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
Desalination methods that include carbonate compound precipitation are provided. In
certain embodiments, feed water is subjected to carbonate compound precipitation
conditions prior to desalination. In certain embodiments, desalination waste brine is
subjected to carbonate compound precipitation conditions. In yet other embodiments,
both feed water and waste brine are subjected to carbonate compound precipitation
conditions. Aspects of embodiments of the invention include carbone dioxide
sequestration. Embodiments of the invention further employ a precipitate product of
the carbonate compound precipitation conditions as a building material, e.g., a cement.
Also provided are systems configured for use in methods of the invention.
__________________
]22[]12[
]54[
OIL CONTAINING STARCH
GRANULES FOR DELIVERING
BENEFIT-ADDITIVES TO A
SUBSTRATE
]11[
]92[
]52[
]11[
]42[
17.03.2005
10/803586
]91[ 18.03.2004
Int. Cl.(2010.01) C11D 03//50
DIVISION FROM 177761
COLGATE-PALMOLIVE
COMPANY, U.S.A.
WO/2005/090538
]14[
391
203243
– ‫גרגרי עמילן המכילים שמן לאספקת תוספי‬
‫תועלת למצע‬
]99[
US
April 28, 2011-‫כ"ד בניסן התשע"א‬
]44[
]54[
,'‫זליגסון גבריאלי ושות‬
21 ‫רח' יבנה‬
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
An oil containing starch granule comprising:
(a) a starch, said starch being present in an amount to form an effective
matrix for said granule;
(b) a perfume oil comprising ingredients having a calculated Clog P of at
least 3, said Clog P being the calculated octanol to water partition
coefficient, said perfume oil being capable of providing a benefitadditive to a substrate upon contact therewith; and
(c) an effective amount of an organic compound comprising a quaternary
ammonium compound for inhibiting the migration of said oil to the
surface of said starch granule, said compound being as shown and
described in the specification.
2///12
The parent application from which
this application has been divided has
not yet been published
‫בקשת הורה לבקשה זו שטרם פורסמה‬
__________________
]22[]12[
]54[
OIL CONTAINING STARCH
GRANULES FOR DELIVERING
BENEFIT ADDITIVES TO A
SUBSTRATE
]11[
]92[
]52[
]11[
]42[
17.03.2005
10/803749
]91[ 18.03.2004
Int. Cl.(2010.01) C11D 03//22
DIVISION FROM 178027
COLGATE-PALMOLIVE
COMPANY, U.S.A.
WO/2005/090537
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
]14[
]44[
392
203244
– ‫גרגרי עמילן המכילים שמן לאספקת תוספי‬
‫תועלת למצע‬
]99[
US
,'‫זליגסון גבריאלי ושות‬
21 ‫רח' יבנה‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]54[
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
TEL AVIV 61013
An oil containing starch granule comprising:
(a) a starch, said starch being present in an amount to form an effective
matrix for said granule;
(b) an oil, said oil being capable of providing a benefit-additive to a substrate
upon contact therewith; and
(c) an effective amount of an organic compound comprising a quaternary
ammonium compound for inhibiting the migration of said oil to the
surface of said starch granule, said compound being as shown and
described in the specification.
__________________
]22[]12[
203245
– ‫גרגרי עמילן המכילים שמן לאספקת תוספי‬
‫תועלת למצע‬
]54[
OIL CONTAINING STARCH
GRANULES FOR DELIVERING
BENEFIT-ADDITIVES TO A
SUBSTRATE
]11[
]92[
]52[
]11[
]42[
17.03.2005
10/803586
]91[ 18.03.2004
]99[
Int. Cl.(2010.01) C11D 03//50
DIVISION FROM 177761
COLGATE-PALMOLIVE
COMPANY, U.S.A.
WO/2005/090538
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
An oil containing starch granule comprising:
]14[
]44[
]54[
US
,'‫זליגסון גבריאלי ושות‬
21 ‫רח' יבנה‬
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
(a) a starch, said starch being present in an amount to form an effective
matrix for said granule;
(b) a perfume oil comprising ingredients having a calculated Clog P of at
393
April 28, 2011-‫כ"ד בניסן התשע"א‬
least 3, said Clog P being the calculated octanol to water partition
coefficient, said perfume oil being capable of providing a benefitadditive to a substrate upon contact therewith; and
(c) an effective amount of an organic compound for inhibiting the migration
of said oil to the surface of said starch granule, said compound being
represented by the following structure:
wherein R1 and R2 are each independently, H or:
(a) C1-C22 alkylenecarboxy moiety having the formula -(CH2)eR3
wherein R3 is -NHCOR4; or -COR4; or -NR5COR4; and
R4 and R5 are each independently C1-C22 alkyl or alkenyl; and
e is an integer from 1 to 22; or
(b) C1-C22 linear or branched alkyl; or
(c) C1-C22 linear or branched alkenyl; or
(d) C2-C22 substituted or unsubstituted alkylenoxy; or
(e) C3-C22 substituted or unsubstituted alkylenoxy alkyl; or
(f) C6-C22 substituted or unsubstituted aryloxy; or
(g) C7-C22 substituted or unsubstituted alkylenaryl; or
(h) C7-C22 substituted or unsubstituted alkylenoxyaryl; or
394
April 28, 2011-‫כ"ד בניסן התשע"א‬
(i) C7-C22 oxyalkylenaryl; or
(j) an anionic unit having the formula: -(CH2)yR6
wherein R6 is -SO3M, -OSO3M, -PO3M, -OPO3M, Cl or mixtures thereof,
wherein M is hydrogen, or one or more salt forming cations sufficient to
satisfy charge balance, or mixtures thereof;
y is an integer from 1 to about 22; or
(k) a mixture comprising at least two of (a) through (j); and
q is an integer from 0 to about 22;
m is an integer from 0 to about 22;
Q is (CH2)m or (CH2CHR7O);
R7 is independently hydrogen, methyl, ethyl, propyl or benzyl;
B is H or OH; and
Y is CR1 or N, and
wherein the organic compound is selected not to be an amido amine.
2///12
The parent application from which
this application has been divided has
not yet been published
‫בקשת הורה לבקשה זו שטרם פורסמה‬
__________________
]22[]12[
]54[
395
OIL CONTAINING STARCH
GRANULES FOR DELIVERING
BENEFIT-ADDITIVES TO A
SUBSTRATE
203246
– ‫גרגרי עמילן המכילים שמן לאספקת תוספי‬
‫תועלת למצע‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
]11[
]92[
]52[
]11[
]42[
]14[
]44[
]54[
17.03.2005
10/803749
]91[ 18.03.2004
]99[
Int. Cl.(2010.01) C11D 03//22
DIVISION FROM 178027
COLGATE-PALMOLIVE
COMPANY, U.S.A.
WO/2005/090537
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
An oil containing starch granule comprising:
US
,'‫זליגסון גבריאלי ושות‬
21 ‫רח' יבנה‬
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
(a) a starch, said starch being present in an amount to form an effective
matrix for said granule;
(b) an oil, said oil being capable of providing a benefit-additive to a substrate
upon contact therewith; and
(c) an effective amount of an organic compound for inhibiting the migration
of said oil to the surface of said starch granule, said compound being as
described in the specification.
__________________
]22[]12[
204302
‫פולינוקלאוטיד המכיל רצף חומצה נוקלאית‬
‫המקודד רדף חלבון כימרי המכיל מעטפת ווירוס‬
‫ ווקטור ביטוי ושיטה לגילוי‬,‫ורצפטור וויראלי‬
‫גורם‬
]54[
POLYNUCLEOTIDE SEQUENCE
COMPRISING A NUCLEIC ACID
ENCODING A CHIMERIC
POLYPEPTIDE COMPRISING A
VIRUS COAT AND VIRAL
RECEPTOR, EXPRESSION
VECTOR AND METHOD FOR
IDENTIFYING AN AGENT
]11[
]92[
]52[
]11[
21.08.2002
09/934060
]91[ 21.08.2001
]99[ US
Int. Cl.(2010.01) A61K 38//17, 39//12, C07K 19//00
DIVISION FROM 160512
396
April 28, 2011-‫כ"ד בניסן התשע"א‬
]42[
]14[
]44[
]54[
UNIVERSITY OF MARYLAND,
BALTIMORE, U.S.A.
WO/2003/016333
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
,‫ריינהולד כהן ושותפיו‬
'‫א‬51 ‫רחוב הברזל‬
‫רמת החייל‬
The invention relates to chimeric molecules comprising a virus coat sequence and a
receptor sequence that can interact with each other to form a complex that is capable of
binding a co-receptor. Such chimeric molecules therefore exhibit functional properties
characteristic of a receptor-coat protein complex and are useful as agents that inhibit
virus infection of cells due to occupancy of a co-receptor present on the cell. In
particular aspects, the chimeric polypeptide includes an immunodeficiency virus
envelope polypeptide, such as that of HN , SN, FIV, FeL V, FPV and herpes virus.
Receptor sequences suitable for use in a chimeric polypeptide include, for example,
CD4 DID2 and CD4M9 sequences.
__________________
]22[]12[
204550
‫שיטה ומערכת לביצוע מסירה במערכת תקשורת‬
‫ כגון מסירה קשיחה‬,‫אלחוטית‬
]54[
METHOD AND SYSTEM FOR
PERFORMING A HANDOFF IN A
WIRELESS COMMUNICATION
SYSTEM, SUCH AS A HARD
HANDOFF
]11[
]92[
]52[
]11[
]42[
11.08.2000
09/372261
]91[ 11.08.1999
]99[ US
Int. Cl.(2010.01) H04B 01//707, H04W 52//28, 52//40, 72//06
DIVISION FROM 181977
QUALCOMM INCORPORATED,
U.S.A.
WO/2001/011914
]14[
397
April 28, 2011-‫כ"ד בניסן התשע"א‬
]44[
]54[
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ מרמורק‬,4 ‫שער הגיא‬
‫רחובות‬5512 .‫ד‬.‫ ת‬,
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
A mobile station (102) transmits a plurality of channels including a pilot channel and
at least one information channel. In the exemplary embodiment, the base station (106)
determines the adequacy of the transmission energy of the reverse link signal in
accordance with the received energy of the reverse link pilot signal. In the present
invention, the pilot channel transmission power is retained at the level it was prior to
the frequency search excursion, while increasing the transmission energy of at least
one other channel transmitted by the mobile station. In addition, when the mobile
station (102) is not capable of increasing the transmission energy of all of the
information channels, the mobile station (102) generates a ranking of the importance
of the different information channels and selectively increases the transmission power
of those channels.
__________________
]22[]12[
205515
‫מולטיקסט מסונכרן‬/‫תקשורת שידור‬
]54[
SYNCHRONIZED
BROADCAST/MULTICAST
COMMUNICATION
]11[
]92[
]52[
]11[
]42[
20.01.2005
60/537955
]91[ 20.01.2004
]99[ US
Int. Cl.(2010.01) H04B 07//26, H04J 11//00, H04L 05//02, 27//26, H04W 04//06
DIVISION FROM 171796
QUALCOMM INCORPORATED,
U.S.A.
WO/2005/071867
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
‫רחובות‬5512 .‫ד‬.‫ ת‬,
]14[
]44[
398
April 28, 2011-‫כ"ד בניסן התשע"א‬
]54[
An apparatus for synchronized broadcast comprising a receiver, comprising:
means for receiving a first transmission slot;
means for identifying a portion of the first transmission slot comprising the broadcast
information modulated using a first modulation format and a unicast portion carrying
the first information modulated using a second modulation format, wherein the first
and second modulation formats are different;
means for demodulating the unicast portion; and
means for demodulating the broadcast portion.
__________________
]22[]12[
]54[
SATELLITE/HANDS-FREE
INTERLOCK SYSTEMS AND/OR
COMPANION DEVICES FOR
RADIOTERMINALS AND
RELATED METHODS
]11[
]92[
06.04.2005
60/560221
223134392
399
]91[
07.04.2004
9231931115
208120
‫או‬/‫ללא שימוש בידים ו‬/‫מערכות שילוב לוויניות‬
‫התקנים נלווים כבור רדיו טרמינלים ושיטות‬
‫הקשורות‬
]99[
US
US
April 28, 2011-‫כ"ד בניסן התשע"א‬
]52[
]11[
]42[
]14[
]44[
]54[
Int. Cl.(2010.01) H04B 07//185
DIVISION FROM 176728
ATC TECHNOLOGIES, LLC, U.S.A.
WO/2005/101692
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
,‫ד"ר יצחק הס ושותפיו‬
516 ‫רחוב הירקון‬
‫תל אביב‬1451 .‫ד‬.‫ ת‬,
A radioterminal comprising: a transceiver that is configured for space-based
communications and for terrestrial wireless communications; an antenna that is
selectively configurable in at least a low profile or a high profile orientation; and a
satellite interlock that is configured to prevent the transceiver from transmitting spacebased communications at a high power and/or EIRP that is greater than or equal to a
threshold responsive to the antenna being configured in the low profile orientation, to
allow the transceiver to transmit space-based communications at the high power and/or
EIRP that is greater than or equal to a threshold responsive to the antenna being
configured in the high profile orientation, and to allow the transceiver to transmit
terrestrial wireless communications at a low power and/or EIRP that is less than or
equal to a threshold independent of the antenna's orientation.
__________________
400
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫פטנטים‬
‫‪PATENTS‬‬
‫פטנטים שניתנו‬
‫‪PATENTS GRANTED‬‬
‫‪251194‬‬
‫‪251914‬‬
‫‪259911‬‬
‫‪254194‬‬
‫‪254142‬‬
‫‪255914‬‬
‫‪242111‬‬
‫‪242344‬‬
‫‪241151‬‬
‫‪241553‬‬
‫‪241114‬‬
‫‪241449‬‬
‫‪249149‬‬
‫‪249151‬‬
‫‪249452‬‬
‫‪249194‬‬
‫‪249343‬‬
‫‪244141‬‬
‫‪244415‬‬
‫‪244511‬‬
‫‪244114‬‬
‫‪245111‬‬
‫‪245112‬‬
‫‪245441‬‬
‫‪245151‬‬
‫‪245399‬‬
‫‪241244‬‬
‫‪241939‬‬
‫‪241111‬‬
‫‪241149‬‬
‫‪244119‬‬
‫‪244231‬‬
‫‪244439‬‬
‫‪244514‬‬
‫‪244441‬‬
‫‪244349‬‬
‫‪241114‬‬
‫‪241111‬‬
‫‪293539‬‬
‫‪251413‬‬
‫‪251155‬‬
‫‪259111‬‬
‫‪254242‬‬
‫‪254112‬‬
‫‪255911‬‬
‫‪242159‬‬
‫‪242314‬‬
‫‪241112‬‬
‫‪241554‬‬
‫‪241123‬‬
‫‪241443‬‬
‫‪241334‬‬
‫‪249121‬‬
‫‪249445‬‬
‫‪249441‬‬
‫‪249344‬‬
‫‪244243‬‬
‫‪244935‬‬
‫‪244525‬‬
‫‪244111‬‬
‫‪245111‬‬
‫‪245235‬‬
‫‪245933‬‬
‫‪245194‬‬
‫‪245194‬‬
‫‪241241‬‬
‫‪241995‬‬
‫‪241152‬‬
‫‪241114‬‬
‫‪241313‬‬
‫‪244213‬‬
‫‪244412‬‬
‫‪244511‬‬
‫‪244441‬‬
‫‪244323‬‬
‫‪241141‬‬
‫‪241149‬‬
‫‪293423‬‬
‫‪295145‬‬
‫‪252314‬‬
‫‪251394‬‬
‫‪254211‬‬
‫‪254411‬‬
‫‪255131‬‬
‫‪242149‬‬
‫‪242353‬‬
‫‪241211‬‬
‫‪241412‬‬
‫‪241124‬‬
‫‪241493‬‬
‫‪241391‬‬
‫‪249232‬‬
‫‪249913‬‬
‫‪249412‬‬
‫‪249352‬‬
‫‪244254‬‬
‫‪244941‬‬
‫‪244524‬‬
‫‪244111‬‬
‫‪244393‬‬
‫‪245242‬‬
‫‪245944‬‬
‫‪245511‬‬
‫‪245113‬‬
‫‪241291‬‬
‫‪241912‬‬
‫‪241541‬‬
‫‪241121‬‬
‫‪241311‬‬
‫‪244243‬‬
‫‪244421‬‬
‫‪244595‬‬
‫‪244499‬‬
‫‪244155‬‬
‫‪241153‬‬
‫‪241111‬‬
‫‪291115‬‬
‫כ"ד בניסן התשע"א‪April 28, 2011-‬‬
‫‪295144‬‬
‫‪252111‬‬
‫‪251153‬‬
‫‪259311‬‬
‫‪254445‬‬
‫‪255111‬‬
‫‪242115‬‬
‫‪242394‬‬
‫‪241291‬‬
‫‪241413‬‬
‫‪241129‬‬
‫‪241491‬‬
‫‪241314‬‬
‫‪249245‬‬
‫‪249921‬‬
‫‪249414‬‬
‫‪249341‬‬
‫‪244213‬‬
‫‪244914‬‬
‫‪244519‬‬
‫‪244119‬‬
‫‪244394‬‬
‫‪245211‬‬
‫‪245911‬‬
‫‪245515‬‬
‫‪245114‬‬
‫‪241111‬‬
‫‪241923‬‬
‫‪241591‬‬
‫‪241415‬‬
‫‪241341‬‬
‫‪244214‬‬
‫‪244999‬‬
‫‪244599‬‬
‫‪244411‬‬
‫‪244152‬‬
‫‪241152‬‬
‫‪241111‬‬
‫‪219213‬‬
‫‪295452‬‬
‫‪252514‬‬
‫‪251113‬‬
‫‪259141‬‬
‫‪254121‬‬
‫‪255151‬‬
‫‪255439‬‬
‫‪242391‬‬
‫‪241211‬‬
‫‪241939‬‬
‫‪241114‬‬
‫‪241491‬‬
‫‪241144‬‬
‫‪249292‬‬
‫‪249922‬‬
‫‪249111‬‬
‫‪249311‬‬
‫‪244141‬‬
‫‪244111‬‬
‫‪244512‬‬
‫‪244534‬‬
‫‪244133‬‬
‫‪245221‬‬
‫‪245951‬‬
‫‪245514‬‬
‫‪245111‬‬
‫‪241125‬‬
‫‪241111‬‬
‫‪241419‬‬
‫‪241411‬‬
‫‪241341‬‬
‫‪244139‬‬
‫‪244922‬‬
‫‪244523‬‬
‫‪244131‬‬
‫‪244111‬‬
‫‪241113‬‬
‫‪241231‬‬
‫‪241921‬‬
‫‪295421‬‬
‫‪252942‬‬
‫‪251535‬‬
‫‪259452‬‬
‫‪254915‬‬
‫‪255111‬‬
‫‪255419‬‬
‫‪242313‬‬
‫‪241223‬‬
‫‪241951‬‬
‫‪241532‬‬
‫‪241412‬‬
‫‪241111‬‬
‫‪249211‬‬
‫‪249134‬‬
‫‪249153‬‬
‫‪249311‬‬
‫‪244195‬‬
‫‪244144‬‬
‫‪244411‬‬
‫‪244559‬‬
‫‪244143‬‬
‫‪245211‬‬
‫‪245994‬‬
‫‪245543‬‬
‫‪245419‬‬
‫‪245314‬‬
‫‪241192‬‬
‫‪241495‬‬
‫‪241444‬‬
‫‪241315‬‬
‫‪244132‬‬
‫‪244112‬‬
‫‪244522‬‬
‫‪244141‬‬
‫‪244111‬‬
‫‪241114‬‬
‫‪241241‬‬
‫‪241912‬‬
‫‪299321‬‬
‫‪252111‬‬
‫‪251514‬‬
‫‪259443‬‬
‫‪254141‬‬
‫‪254311‬‬
‫‪255411‬‬
‫‪242311‬‬
‫‪242314‬‬
‫‪241912‬‬
‫‪241544‬‬
‫‪241423‬‬
‫‪241129‬‬
‫‪249119‬‬
‫‪249115‬‬
‫‪249193‬‬
‫‪249144‬‬
‫‪244194‬‬
‫‪244142‬‬
‫‪244454‬‬
‫‪244543‬‬
‫‪244112‬‬
‫‪245214‬‬
‫‪245194‬‬
‫‪245549‬‬
‫‪245429‬‬
‫‪245314‬‬
‫‪241115‬‬
‫‪241424‬‬
‫‪241494‬‬
‫‪241322‬‬
‫‪244111‬‬
‫‪244154‬‬
‫‪244514‬‬
‫‪244145‬‬
‫‪244431‬‬
‫‪244341‬‬
‫‪241221‬‬
‫‪241114‬‬
‫‪299195‬‬
‫‪252133‬‬
‫‪251941‬‬
‫‪259421‬‬
‫‪254153‬‬
‫‪254111‬‬
‫‪255494‬‬
‫‪242111‬‬
‫‪242343‬‬
‫‪241153‬‬
‫‪241542‬‬
‫‪241141‬‬
‫‪241122‬‬
‫‪249111‬‬
‫‪249114‬‬
‫‪249432‬‬
‫‪249151‬‬
‫‪249331‬‬
‫‪244114‬‬
‫‪244491‬‬
‫‪244541‬‬
‫‪244495‬‬
‫‪245111‬‬
‫‪245111‬‬
‫‪245445‬‬
‫‪245414‬‬
‫‪245393‬‬
‫‪241114‬‬
‫‪241934‬‬
‫‪241131‬‬
‫‪241111‬‬
‫‪244144‬‬
‫‪244231‬‬
‫‪244515‬‬
‫‪244514‬‬
‫‪244411‬‬
‫‪244314‬‬
‫‪241113‬‬
‫‪241111‬‬
‫‪401‬‬
‫‪211121‬‬
‫‪211141‬‬
‫‪213131‬‬
‫‪213923‬‬
‫‪213111‬‬
‫‪213319‬‬
‫‪241215‬‬
‫‪241991‬‬
‫‪241523‬‬
‫‪241495‬‬
‫‪241341‬‬
‫‪242294‬‬
‫‪242424‬‬
‫‪242412‬‬
‫‪235491‬‬
‫‪231149‬‬
‫‪111111‬‬
‫‪111413‬‬
‫‪241234‬‬
‫‪244911‬‬
‫‪245334‬‬
‫‪212241‬‬
‫‪212592‬‬
‫‪212414‬‬
‫‪211215‬‬
‫‪211441‬‬
‫‪211411‬‬
‫‪219293‬‬
‫‪219421‬‬
‫‪214114‬‬
‫‪214441‬‬
‫‪214124‬‬
‫‪215111‬‬
‫‪215441‬‬
‫‪215159‬‬
‫‪215192‬‬
‫‪211231‬‬
‫‪211434‬‬
‫‪214399‬‬
‫‪213914‬‬
‫‪231511‬‬
‫‪231291‬‬
‫‪239231‬‬
‫‪211514‬‬
‫‪211191‬‬
‫‪213135‬‬
‫‪213114‬‬
‫‪213192‬‬
‫‪213354‬‬
‫‪241244‬‬
‫‪241995‬‬
‫‪241512‬‬
‫‪241491‬‬
‫‪241341‬‬
‫‪242139‬‬
‫‪242911‬‬
‫‪242414‬‬
‫‪234331‬‬
‫‪231214‬‬
‫‪111155‬‬
‫‪111411‬‬
‫‪214349‬‬
‫‪244141‬‬
‫‪245191‬‬
‫‪212221‬‬
‫‪212591‬‬
‫‪212492‬‬
‫‪211145‬‬
‫‪211411‬‬
‫‪211451‬‬
‫‪219211‬‬
‫‪219411‬‬
‫‪219353‬‬
‫‪214414‬‬
‫‪214135‬‬
‫‪215114‬‬
‫‪215192‬‬
‫‪215151‬‬
‫‪215191‬‬
‫‪211211‬‬
‫‪211441‬‬
‫‪214111‬‬
‫‪213199‬‬
‫‪231442‬‬
‫‪231114‬‬
‫‪239243‬‬
‫‪234194‬‬
‫‪211512‬‬
‫‪211414‬‬
‫‪213131‬‬
‫‪213194‬‬
‫‪213519‬‬
‫‪213344‬‬
‫‪241223‬‬
‫‪241914‬‬
‫‪241412‬‬
‫‪241411‬‬
‫‪241391‬‬
‫‪242143‬‬
‫‪242914‬‬
‫‪242534‬‬
‫‪234413‬‬
‫‪231291‬‬
‫‪111151‬‬
‫‪111211‬‬
‫‪211424‬‬
‫‪249111‬‬
‫‪245452‬‬
‫‪212145‬‬
‫‪212494‬‬
‫‪212423‬‬
‫‪211191‬‬
‫‪211912‬‬
‫‪211134‬‬
‫‪219221‬‬
‫‪219195‬‬
‫‪219313‬‬
‫‪214911‬‬
‫‪214151‬‬
‫‪214333‬‬
‫‪215121‬‬
‫‪215149‬‬
‫‪215449‬‬
‫‪211144‬‬
‫‪211411‬‬
‫‪214119‬‬
‫‪213211‬‬
‫‪231411‬‬
‫‪231111‬‬
‫‪231421‬‬
‫‪239111‬‬
‫כ"ד בניסן התשע"א‪April 28, 2011-‬‬
‫‪211549‬‬
‫‪211442‬‬
‫‪213145‬‬
‫‪213194‬‬
‫‪213414‬‬
‫‪213311‬‬
‫‪241225‬‬
‫‪241111‬‬
‫‪241411‬‬
‫‪241143‬‬
‫‪241315‬‬
‫‪242151‬‬
‫‪242955‬‬
‫‪242549‬‬
‫‪234544‬‬
‫‪234114‬‬
‫‪233413‬‬
‫‪112313‬‬
‫‪119395‬‬
‫‪249959‬‬
‫‪245144‬‬
‫‪212111‬‬
‫‪212995‬‬
‫‪212111‬‬
‫‪211111‬‬
‫‪211954‬‬
‫‪211141‬‬
‫‪219131‬‬
‫‪219129‬‬
‫‪219143‬‬
‫‪214954‬‬
‫‪214534‬‬
‫‪214345‬‬
‫‪215239‬‬
‫‪215192‬‬
‫‪215411‬‬
‫‪211111‬‬
‫‪211155‬‬
‫‪214111‬‬
‫‪211344‬‬
‫‪231999‬‬
‫‪232311‬‬
‫‪231114‬‬
‫‪239119‬‬
‫‪211414‬‬
‫‪211414‬‬
‫‪213119‬‬
‫‪213211‬‬
‫‪213452‬‬
‫‪213144‬‬
‫‪241112‬‬
‫‪241111‬‬
‫‪241411‬‬
‫‪241141‬‬
‫‪241194‬‬
‫‪242159‬‬
‫‪242911‬‬
‫‪242519‬‬
‫‪234594‬‬
‫‪234111‬‬
‫‪233214‬‬
‫‪112394‬‬
‫‪119441‬‬
‫‪241313‬‬
‫‪245121‬‬
‫‪211431‬‬
‫‪212154‬‬
‫‪212113‬‬
‫‪212141‬‬
‫‪211951‬‬
‫‪211121‬‬
‫‪211332‬‬
‫‪219542‬‬
‫‪219192‬‬
‫‪214914‬‬
‫‪214514‬‬
‫‪214395‬‬
‫‪215244‬‬
‫‪215415‬‬
‫‪215395‬‬
‫‪211114‬‬
‫‪211435‬‬
‫‪214154‬‬
‫‪211114‬‬
‫‪231244‬‬
‫‪232119‬‬
‫‪231412‬‬
‫‪239531‬‬
‫‪211419‬‬
‫‪211112‬‬
‫‪213121‬‬
‫‪213213‬‬
‫‪213441‬‬
‫‪213112‬‬
‫‪241144‬‬
‫‪241124‬‬
‫‪241451‬‬
‫‪241195‬‬
‫‪241439‬‬
‫‪242112‬‬
‫‪242132‬‬
‫‪242592‬‬
‫‪234513‬‬
‫‪235354‬‬
‫‪233211‬‬
‫‪112494‬‬
‫‪119243‬‬
‫‪241132‬‬
‫‪245241‬‬
‫‪211152‬‬
‫‪212141‬‬
‫‪212519‬‬
‫‪212114‬‬
‫‪211111‬‬
‫‪211511‬‬
‫‪211321‬‬
‫‪219411‬‬
‫‪219115‬‬
‫‪214911‬‬
‫‪214549‬‬
‫‪214325‬‬
‫‪215211‬‬
‫‪215511‬‬
‫‪215392‬‬
‫‪211124‬‬
‫‪211411‬‬
‫‪214111‬‬
‫‪211441‬‬
‫‪213451‬‬
‫‪232292‬‬
‫‪231955‬‬
‫‪239944‬‬
‫‪211444‬‬
‫‪211115‬‬
‫‪211114‬‬
‫‪213221‬‬
‫‪213494‬‬
‫‪213431‬‬
‫‪241145‬‬
‫‪241211‬‬
‫‪241419‬‬
‫‪241512‬‬
‫‪241413‬‬
‫‪241313‬‬
‫‪242114‬‬
‫‪242523‬‬
‫‪234912‬‬
‫‪235341‬‬
‫‪233141‬‬
‫‪112939‬‬
‫‪119195‬‬
‫‪241512‬‬
‫‪244443‬‬
‫‪211115‬‬
‫‪212121‬‬
‫‪212551‬‬
‫‪212115‬‬
‫‪211231‬‬
‫‪211511‬‬
‫‪211115‬‬
‫‪219949‬‬
‫‪219444‬‬
‫‪214141‬‬
‫‪214543‬‬
‫‪214111‬‬
‫‪215211‬‬
‫‪215551‬‬
‫‪215111‬‬
‫‪215323‬‬
‫‪211914‬‬
‫‪211312‬‬
‫‪211131‬‬
‫‪213154‬‬
‫‪232113‬‬
‫‪231155‬‬
‫‪239949‬‬
‫‪211421‬‬
‫‪211141‬‬
‫‪211111‬‬
‫‪213211‬‬
‫‪213411‬‬
‫‪213424‬‬
‫‪241194‬‬
‫‪241245‬‬
‫‪241911‬‬
‫‪241544‬‬
‫‪241491‬‬
‫‪241319‬‬
‫‪242245‬‬
‫‪242431‬‬
‫‪242413‬‬
‫‪235419‬‬
‫‪231399‬‬
‫‪111111‬‬
‫‪111144‬‬
‫‪241113‬‬
‫‪244491‬‬
‫‪211552‬‬
‫‪212231‬‬
‫‪212551‬‬
‫‪212441‬‬
‫‪211292‬‬
‫‪211524‬‬
‫‪211119‬‬
‫‪219994‬‬
‫‪219491‬‬
‫‪214121‬‬
‫‪214441‬‬
‫‪214154‬‬
‫‪215145‬‬
‫‪215433‬‬
‫‪215151‬‬
‫‪215155‬‬
‫‪211149‬‬
‫‪211311‬‬
‫‪214391‬‬
‫‪213111‬‬
‫‪231111‬‬
‫‪231234‬‬
‫‪239123‬‬
‫‪402‬‬
‫פטנטים שחודשו‬
‫‪PATENTS RENEWED‬‬
‫‪215151‬‬
‫‪215911‬‬
‫‪215919‬‬
‫‪215414‬‬
‫‪215424‬‬
‫‪211419‬‬
‫‪211119‬‬
‫‪211114‬‬
‫‪211419‬‬
‫‪211491‬‬
‫‪211144‬‬
‫‪211914‬‬
‫‪211934‬‬
‫‪211443‬‬
‫‪211541‬‬
‫‪211144‬‬
‫‪211191‬‬
‫‪211112‬‬
‫‪292341‬‬
‫‪291941‬‬
‫‪293312‬‬
‫‪241241‬‬
‫‪241933‬‬
‫‪241419‬‬
‫‪249521‬‬
‫‪245591‬‬
‫‪241453‬‬
‫‪244242‬‬
‫‪241413‬‬
‫‪243353‬‬
‫‪251311‬‬
‫‪252451‬‬
‫‪252449‬‬
‫‪252351‬‬
‫‪252333‬‬
‫‪251194‬‬
‫‪251219‬‬
‫‪251243‬‬
‫‪251193‬‬
‫‪251114‬‬
‫‪251991‬‬
‫‪251932‬‬
‫‪251451‬‬
‫‪215152‬‬
‫‪215915‬‬
‫‪215944‬‬
‫‪215445‬‬
‫‪215511‬‬
‫‪211412‬‬
‫‪211514‬‬
‫‪211141‬‬
‫‪211411‬‬
‫‪211224‬‬
‫‪215143‬‬
‫‪211192‬‬
‫‪211939‬‬
‫‪211444‬‬
‫‪211545‬‬
‫‪211141‬‬
‫‪211192‬‬
‫‪211191‬‬
‫‪292345‬‬
‫‪291151‬‬
‫‪293311‬‬
‫‪241215‬‬
‫‪241913‬‬
‫‪241144‬‬
‫‪249432‬‬
‫‪245511‬‬
‫‪241451‬‬
‫‪244255‬‬
‫‪241121‬‬
‫‪243144‬‬
‫‪251312‬‬
‫‪252911‬‬
‫‪252499‬‬
‫‪252345‬‬
‫‪252334‬‬
‫‪251111‬‬
‫‪251133‬‬
‫‪251245‬‬
‫‪251191‬‬
‫‪251111‬‬
‫‪251911‬‬
‫‪251911‬‬
‫‪251455‬‬
‫‪215141‬‬
‫‪215919‬‬
‫‪215941‬‬
‫‪215491‬‬
‫‪215542‬‬
‫‪211421‬‬
‫‪211511‬‬
‫‪211113‬‬
‫‪211445‬‬
‫‪211212‬‬
‫‪215113‬‬
‫‪211231‬‬
‫‪211931‬‬
‫‪211419‬‬
‫‪211544‬‬
‫‪211111‬‬
‫‪211113‬‬
‫‪214454‬‬
‫‪292393‬‬
‫‪295133‬‬
‫‪293343‬‬
‫‪241214‬‬
‫‪241911‬‬
‫‪241151‬‬
‫‪249129‬‬
‫‪245111‬‬
‫‪241115‬‬
‫‪244211‬‬
‫‪244113‬‬
‫‪243453‬‬
‫‪251144‬‬
‫‪252929‬‬
‫‪252411‬‬
‫‪252341‬‬
‫‪252332‬‬
‫‪251112‬‬
‫‪251139‬‬
‫‪251244‬‬
‫‪251192‬‬
‫‪251112‬‬
‫‪251919‬‬
‫‪251951‬‬
‫‪251441‬‬
‫כ"ד בניסן התשע"א‪April 28, 2011-‬‬
‫‪215144‬‬
‫‪215911‬‬
‫‪215911‬‬
‫‪215491‬‬
‫‪215591‬‬
‫‪211941‬‬
‫‪211514‬‬
‫‪211154‬‬
‫‪211444‬‬
‫‪212314‬‬
‫‪219151‬‬
‫‪211214‬‬
‫‪211912‬‬
‫‪211453‬‬
‫‪211549‬‬
‫‪211155‬‬
‫‪211443‬‬
‫‪214521‬‬
‫‪292394‬‬
‫‪299941‬‬
‫‪293341‬‬
‫‪242442‬‬
‫‪241945‬‬
‫‪241123‬‬
‫‪249254‬‬
‫‪245294‬‬
‫‪241519‬‬
‫‪241315‬‬
‫‪244122‬‬
‫‪243141‬‬
‫‪251553‬‬
‫‪252913‬‬
‫‪252121‬‬
‫‪252391‬‬
‫‪252331‬‬
‫‪251111‬‬
‫‪251131‬‬
‫‪251249‬‬
‫‪251115‬‬
‫‪251114‬‬
‫‪251915‬‬
‫‪251955‬‬
‫‪251441‬‬
‫‪215115‬‬
‫‪215143‬‬
‫‪215941‬‬
‫‪215429‬‬
‫‪215599‬‬
‫‪223144‬‬
‫‪211544‬‬
‫‪211152‬‬
‫‪211411‬‬
‫‪211153‬‬
‫‪219155‬‬
‫‪211244‬‬
‫‪211911‬‬
‫‪211451‬‬
‫‪211595‬‬
‫‪211535‬‬
‫‪211411‬‬
‫‪214513‬‬
‫‪292111‬‬
‫‪291113‬‬
‫‪293344‬‬
‫‪242132‬‬
‫‪241991‬‬
‫‪241111‬‬
‫‪241154‬‬
‫‪244335‬‬
‫‪241515‬‬
‫‪241394‬‬
‫‪244441‬‬
‫‪243114‬‬
‫‪251552‬‬
‫‪252214‬‬
‫‪252121‬‬
‫‪252111‬‬
‫‪252311‬‬
‫‪251124‬‬
‫‪251114‬‬
‫‪251242‬‬
‫‪251111‬‬
‫‪251151‬‬
‫‪251912‬‬
‫‪251954‬‬
‫‪251491‬‬
‫‪215214‬‬
‫‪215141‬‬
‫‪215993‬‬
‫‪215421‬‬
‫‪215591‬‬
‫‪223911‬‬
‫‪211511‬‬
‫‪211141‬‬
‫‪211412‬‬
‫‪211151‬‬
‫‪211511‬‬
‫‪211211‬‬
‫‪211952‬‬
‫‪211494‬‬
‫‪211594‬‬
‫‪211534‬‬
‫‪211421‬‬
‫‪214244‬‬
‫‪292145‬‬
‫‪291111‬‬
‫‪293511‬‬
‫‪242491‬‬
‫‪241139‬‬
‫‪241511‬‬
‫‪241191‬‬
‫‪244191‬‬
‫‪241411‬‬
‫‪241311‬‬
‫‪244112‬‬
‫‪243145‬‬
‫‪251519‬‬
‫‪252291‬‬
‫‪252111‬‬
‫‪252111‬‬
‫‪252314‬‬
‫‪251121‬‬
‫‪251111‬‬
‫‪251244‬‬
‫‪251122‬‬
‫‪251141‬‬
‫‪251111‬‬
‫‪251959‬‬
‫‪251492‬‬
‫‪215251‬‬
‫‪215111‬‬
‫‪215991‬‬
‫‪215411‬‬
‫‪215511‬‬
‫‪215111‬‬
‫‪211524‬‬
‫‪211194‬‬
‫‪211135‬‬
‫‪211124‬‬
‫‪211512‬‬
‫‪211219‬‬
‫‪211949‬‬
‫‪211492‬‬
‫‪211434‬‬
‫‪211512‬‬
‫‪211131‬‬
‫‪214229‬‬
‫‪291941‬‬
‫‪292331‬‬
‫‪291539‬‬
‫‪293319‬‬
‫‪241119‬‬
‫‪241511‬‬
‫‪241125‬‬
‫‪244213‬‬
‫‪245445‬‬
‫‪241314‬‬
‫‪244239‬‬
‫‪243149‬‬
‫‪251521‬‬
‫‪252114‬‬
‫‪252543‬‬
‫‪252121‬‬
‫‪252345‬‬
‫‪251121‬‬
‫‪251151‬‬
‫‪251221‬‬
‫‪251119‬‬
‫‪251144‬‬
‫‪251114‬‬
‫‪251941‬‬
‫‪251411‬‬
‫‪215223‬‬
‫‪215114‬‬
‫‪215994‬‬
‫‪215931‬‬
‫‪215514‬‬
‫‪215411‬‬
‫‪211431‬‬
‫‪211114‬‬
‫‪211114‬‬
‫‪211414‬‬
‫‪211444‬‬
‫‪211119‬‬
‫‪211992‬‬
‫‪211411‬‬
‫‪211414‬‬
‫‪211552‬‬
‫‪211143‬‬
‫‪211149‬‬
‫‪213124‬‬
‫‪292343‬‬
‫‪291515‬‬
‫‪293311‬‬
‫‪241244‬‬
‫‪241559‬‬
‫‪241114‬‬
‫‪249141‬‬
‫‪245145‬‬
‫‪241441‬‬
‫‪244231‬‬
‫‪241141‬‬
‫‪251499‬‬
‫‪251351‬‬
‫‪252512‬‬
‫‪252431‬‬
‫‪252319‬‬
‫‪251111‬‬
‫‪251154‬‬
‫‪251214‬‬
‫‪251231‬‬
‫‪251141‬‬
‫‪251111‬‬
‫‪251944‬‬
‫‪251939‬‬
‫‪403‬‬
251454
251152
244123
244911
244411
245214
245434
245142
241949
241515
241111
244219
244131
241194
241111
241541
241131
243151
211143
212945
211514
211141
219995
215243
211524
213144
234415
231119
233411
112393
251451
251119
244141
244421
244441
245111
245515
245344
241931
241591
241191
244214
244491
241144
241111
241111
243211
211119
211134
212411
211543
211119
219111
215192
211521
232431
234414
234111
233444
251414
251414
244131
244419
244444
245114
245552
241241
241414
241124
241111
244195
244413
241139
241115
241114
243291
211111
211311
212114
211411
211311
219149
211135
213141
231541
235495
234112
233445
251433
251424
244215
244545
244439
245154
245111
241114
241411
241144
241319
244921
244411
241224
241911
241111
243144
211231
211311
212113
211435
211322
219324
211422
213142
239414
235491
234434
233441
251594
251451
244245
244513
244119
245141
245141
241191
241424
241154
244111
244991
244113
241214
241411
241411
243934
211115
211314
212311
211112
219111
219314
211341
213254
239415
235494
234414
111143
251111
251414
244234
244144
244152
245959
245111
241111
241492
241421
244119
244954
244195
241292
241431
241459
243114
211141
211314
212349
211114
219214
219315
214949
213111
239192
235441
231511
111415
251121
251191
244111
244421
245111
245452
245454
241911
241442
241411
244113
244524
244351
241241
241594
241411
243419
211911
212141
211214
211199
219245
214521
211214
213411
239141
235591
231111
111311
251121
251141
244114
244445
245211
245431
245111
241954
241441
241441
244291
244114
244333
241112
241514
241115
243114
211111
212211
211913
211191
219244
214315
211454
213511
234953
235429
233259
112139
‫פטנטים שתוקפם פקעו בגלל אי תשלום אגרת חידוש‬
PATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL
FEES
211191
211491
211151
219141
219223
294441
294531
294491
221132
223111
223291
404
211193
211451
211321
219154
219251
294444
294539
294124
221313
223115
223295
211141
211121
211391
219111
219259
294521
294531
294119
221394
223191
223251
211145
211125
211351
219145
219251
294514
294534
254391
221395
223111
223211
211144
211123
211359
219141
219242
294541
294134
211559
221341
223141
223241
211131
211111
211334
219211
219244
294559
294133
221113
221341
223214
223129
211411
211119
211331
219222
219114
294511
294429
221111
221354
223225
223142
211424
211191
219115
219225
294414
294532
294421
221113
221331
223215
223151
April 28, 2011-‫כ"ד בניסן התשע"א‬
223151
244254
244414
244191
244399
241159
241239
241915
241415
241539
241455
214152
214119
211541
211119
219111
219215
219441
219194
291222
291495
241211
223119
244951
244443
244144
244393
241154
241111
241991
241414
241194
241192
214295
214952
211551
211494
219119
219231
219443
219191
291244
291442
223144
244911
244411
244152
244311
241144
241121
241949
241419
241191
241334
214313
214951
211131
211491
219193
219144
219451
219153
291115
291515
223141
244442
244412
244114
244341
241222
241124
241951
241415
241149
241331
249331
214919
212241
211419
219154
219921
219414
219414
291113
291542
223114
244194
244431
244143
241111
241243
241125
241911
241413
241113
243121
244114
214441
212324
211411
219111
219951
219511
214191
291191
241134
213515
244149
244111
244131
241124
241242
241113
241911
241511
241111
243534
211344
211935
211112
211121
219214
219912
219511
214151
291924
241514
292941
244419
244114
244314
241114
241211
241149
241911
241519
241111
251125
219112
211459
211542
211343
219241
219911
219535
294349
291941
242239
244191
244451
244113
244311
241144
241214
241929
241914
241514
241133
224545
219141
211411
211121
211312
219254
219934
219111
291133
291951
242441
‫פטנטים שחודשו לעשרים שנה‬
PATENTS RENEWED FOR 20 YEARS
243142
251513
212353
‫צווי הארכה שחודשו‬
EXTENSION ORDERS RENEWED
14494
405
35541
33412
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫פטנטים שפג תוקפם‬
‫‪PATENTS EXPIRED‬‬
‫‪39491‬‬
‫‪39442‬‬
‫‪39112‬‬
‫‪39394‬‬
‫‪34191‬‬
‫‪34211‬‬
‫‪34211‬‬
‫‪34919‬‬
‫‪34912‬‬
‫‪34444‬‬
‫‪34514‬‬
‫‪39411‬‬
‫‪39441‬‬
‫‪39141‬‬
‫‪39311‬‬
‫‪34111‬‬
‫‪34223‬‬
‫‪34219‬‬
‫‪34131‬‬
‫‪34943‬‬
‫‪34411‬‬
‫‪34413‬‬
‫‪39421‬‬
‫‪39414‬‬
‫‪39114‬‬
‫‪39313‬‬
‫‪34111‬‬
‫‪34229‬‬
‫‪34214‬‬
‫‪34111‬‬
‫‪34949‬‬
‫‪34414‬‬
‫‪34411‬‬
‫כ"ד בניסן התשע"א‪April 28, 2011-‬‬
‫‪39135‬‬
‫‪39455‬‬
‫‪39152‬‬
‫‪39311‬‬
‫‪34111‬‬
‫‪34221‬‬
‫‪34255‬‬
‫‪34113‬‬
‫‪34911‬‬
‫‪34411‬‬
‫‪34414‬‬
‫‪39134‬‬
‫‪39454‬‬
‫‪39144‬‬
‫‪39131‬‬
‫‪39332‬‬
‫‪34139‬‬
‫‪34254‬‬
‫‪34149‬‬
‫‪34941‬‬
‫‪34415‬‬
‫‪34411‬‬
‫‪39139‬‬
‫‪39493‬‬
‫‪39141‬‬
‫‪39114‬‬
‫‪39319‬‬
‫‪34144‬‬
‫‪34251‬‬
‫‪34142‬‬
‫‪34941‬‬
‫‪34411‬‬
‫‪34451‬‬
‫‪39111‬‬
‫‪39491‬‬
‫‪39191‬‬
‫‪39119‬‬
‫‪39314‬‬
‫‪34143‬‬
‫‪34244‬‬
‫‪34111‬‬
‫‪34911‬‬
‫‪34421‬‬
‫‪34443‬‬
‫‪39143‬‬
‫‪39499‬‬
‫‪39114‬‬
‫‪39111‬‬
‫‪39319‬‬
‫‪34141‬‬
‫‪34293‬‬
‫‪34124‬‬
‫‪34924‬‬
‫‪34911‬‬
‫‪34441‬‬
‫‪406‬‬
‫ה לחוק‬14 ‫הודעה לפי סעיף‬
1611-‫הפטנטים התשכ"ז‬
‫בכוונת רשם הפטנטים ליתן צו‬
‫להארכת תקופת הגנה ע"פ פרק‬
,‫ לחוק הפטנטים‬1‫ סימן ב‬,'‫ד‬
‫ לגבי הפטנט‬1611-‫התשכ"ז‬
:‫המפורט מטה‬
NOTICE under section 64E of the
Patents Law, 5727-1967
It is the intention of the
Commissioner of Patents to grant an
order for the extension of the period
of protection of the following patent
in accordance with Chapter Four,
Article Two bis, of the Patents Law,
5727-1967
No. of basic patent:
The order will be in effect until
Acceptance published in Journal
No.:
Title of invention:
211559
1131331124
2132335
:‫מס' פטנט בסיסי‬
:‫הצו יעמוד בתוקפו עד ליום‬
:'‫קיבול פורסם ביומן מס‬
:‫שם האמצאה‬
[ ‫פירידציניל( פניל‬-2-‫אוקסו‬-1- ‫מתיל‬-4-‫טטרהידרו‬-1,4,5,1)-4]]-(-)
‫דיניטריל‬
-22/2121(-/[[-)-(TETRAHYDRO-4-METHY-6-OXO-3-PYRIDAZINYL)-PHENYL]
PHENYL] HYDRAZONO] PROPANEDINITRILEPHARMACEUTICALLY
ACCEPTABLE ALTS THEREOF AN
Proprietors:
:‫בעלי הפטנט‬
‫הידרזונו[ פרופן‬
ORION OYJ
Any person desiring to oppose the
said grant of an order may, within
three months from the date of this
journal, serve to the Commissioner
of Patents a notice of opposition
under Section 64F of the Law, as
prescribed by Rule 3 of the Patent
Regulations (extension of period of
protection – procedure of
application for order, opposition to
order, application to annul) 57581998.
407
‫כל המעוניין להתנגד למתן צו‬
‫הארכה רשאי תוך שלושה‬
‫ להגיש‬,‫חודשים מתאריך יומן זה‬
‫לרשם הפטנטים הודעה התנגדות‬
‫ בדרך‬,‫ו לחוק‬14 ‫לפי סעיף‬
‫ לתקנות‬2 ‫הקבועה בתקנה‬
‫הפטנטים (הארכת תקופה הגנה‬
,‫– סדרי דין בבקשה לצו‬
,)‫ ובבקשה לביטול‬,‫בהתנגדות לצו‬
1661-‫התשנ"ח‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫הודעה‬
NOTICE
Under section 66 of the Patents
Law, 5727-1967
This is to notify that permission
has been granted to the owner of
Patent Application No.
Acceptance published in journal
To amend the specification of the
said Patent Application.
Any person may oppose such
grant of permission within three
months from the date of this
Patents Journal, as prescribed by
section 67 of the Law and by
regulation 99 of the Patent
Regulations, 5728-1968.
408
21//12
1/011/
,‫ לחוק הפטנטים‬11 ‫לפי סעיף‬
1611-‫תשכ"ז‬
‫מודע בזאת כי ניתנה רשות‬
'‫לבעלת בקשת הפטנט מס‬
‫דבר הקיבול פורסם ביומן‬
‫לתקן את הפירוט של בקשת‬
‫הפטנט האמורה‬
‫כל אדם רשאי להתנגד למתן‬
‫הרשות תוך שלושה חודשים‬
‫ כפי‬,‫מתאריך יומן פטנטים זה‬
‫ לחוק ובתקנה‬11 ‫שנקבע בסעיף‬
-‫ התשכ"ח‬,‫ לתקנות הפטנטים‬66
.1611
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫שינויים בפרטים רשומים בפנקס‬
CHANGES IN PARTICULARS ENTERED IN REGISTER
409
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫תיקונים ביומן‬
Gournal Corrections
Patent application No
No. of Patent:
CORRECT DATE OF
APPLICATION
06.12.2001
410
2110//
00122
'‫בקשת פטנט מס‬
:‫מספר יומן בו נפלה טעות‬
‫תקן את תאריך הבקשה‬
1182080112
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫מדגמים‬
DESIGNS
‫מדגמים שנרשמו‬
DESIGNS REGISTERED
Class
41225
14)12(
1431131113
‫סוג פרסום‬
POCARED DIAGNOSTICS LTD.
Couvette
Convention date (U.S.A.)
1531131113
Class
43314
15)12(
1231131121
‫כוס אופטית‬
)‫תאריך האמנה (ארצות הברית‬
‫סוג פרסום‬
‫שוקת אלומיניום בע"מ‬
‫פרופיל‬
SHOKET ALUMINIUM LTD.
Profile
Class
43455
11)11(
2931531121
‫סוג פרסום‬
‫זים זום בע"מ‬
‫מלכודת זבובים‬
ZEEMZOOM LTD.
Fly trap
Class
43134 ,43131
3)14(
1331431121
‫סוג פרסום‬
CURVER LUXEMBOURG SARL
Hamper
Convention date (OHIM)
411
1231131121
‫סל‬
)‫תאריך האמנה (איחוד אירופי‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫סוג פרסום‬
‫‪51131 ,51134‬‬
‫(‪15)12‬‬
‫‪1131331121‬‬
‫שרון בלגזל‬
‫פרופיל‬
‫‪Class‬‬
‫‪SHARON BELGAZAL‬‬
‫‪Profile‬‬
‫סוג פרסום‬
‫‪44454 ,44451 ,44455‬‬
‫‪44412 ,44411 ,44453‬‬
‫‪44441 ,44442 ,44441‬‬
‫‪44445 ,44444 ,44449‬‬
‫‪44443 ,44444 ,44441‬‬
‫‪44411 ,44412 ,44411‬‬
‫‪44414‬‬
‫(‪1)11‬‬
‫‪9231531113‬‬
‫‪Class‬‬
‫‪DIESEL S.P.A‬‬
‫מכנסיים‬
‫‪Pants‬‬
‫סוג פרסום‬
‫‪44951‬‬
‫(‪1)14‬‬
‫‪1931931113‬‬
‫אנטילופ שיווק (‪ )1664‬בע"מ‬
‫סוליה‬
‫סוג פרסום‬
‫‪Class‬‬
‫‪ANTELOPE SHIVUK (1994) LTD.‬‬
‫‪Sole‬‬
‫‪44141‬‬
‫(‪1)15‬‬
‫‪2531131113‬‬
‫איטיק‪ ,‬חברה למסחר בינלאומי ולהשקעות‬
‫בע"מ‬
‫מערכת ריהוט‬
‫‪Class‬‬
‫‪I.T.I.C LTD.‬‬
‫‪Forniture set‬‬
‫‪41151‬‬
‫כ"ד בניסן התשע"א‪April 28, 2011-‬‬
‫‪412‬‬
‫סוג פרסום‬
‫דורון מינדלין‬
‫סכין לפיצה‬
‫כ"ד בניסן התשע"א‪April 28, 2011-‬‬
‫(‪4)19‬‬
‫‪1131331113‬‬
‫‪Class‬‬
‫‪DORON MINDLIN‬‬
‫‪Pizza knife‬‬
‫‪413‬‬
Class
41941
14)11(
2431331113
‫סוג פרסום‬
‫סמואל ג'ו‬
‫מתקן לקופסת סיגריות‬
SAMUEL JOE
Cigarette box device
Class
41915
11)12(
1232131113
‫סוג פרסום‬
SANOFI-AVENTIS
Tablet
Convention date (France)
Class
1131431113
41529
1)12(
2232231113
KETER PLASTIC LTD.
Chair
Convention date (U.S.A.)
Class
2131431113
41511
11)11(
2132231113
‫טבליה‬
)‫תאריך האמנה (צרפת‬
‫סוג פרסום‬
‫כתר פלסטיק בע"מ‬
‫כסא‬
)‫תאריך האמנה (ארצות הברית‬
‫סוג פרסום‬
‫זים זום בע"מ‬
‫מלכודת זבובים‬
ZEEMZOOM LTD.
Fly trap
Class
DANA BANKI
Toy
414
43321
12)12(
1131131121
‫סוג פרסום‬
‫דנה בנקי‬
‫צעצוע‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
51122 ,51121
1)14(
1131131121
Class
‫סוג פרסום‬
‫קליל תעשיות בע"מ‬
‫אביזר נעילה לחלונות‬
KLIL INDUSTRIES LTD.
Windows locking device
51153
1)14(
1132231121
Class
‫שלמה נורמטוב‬
‫או הפסקת נחירות‬/‫חגורה להחלשת ו‬
SHLOMO NORMATOV
Belt for the weakening and/or cessation of
snoring
41593
3)19(
2532231113
Class
‫סוג פרסום‬
‫סוג פרסום‬
MARS, INCORPORATED
Packaging
Convention date (OHIM)
Class
2531531113
41919
22)11(
1932131111
‫אריזה‬
)‫תאריך האמנה (איחוד אירופי‬
‫סוג פרסום‬
‫צלי ונעם לייזר ארט בע"מ‬
ZALI AND NOAM LASER ART
LTD.
‫מגנט‬
Magnet
Class
IVGENIA TYOMKIN
415
43395
12)11(
1131131121
‫סוג פרסום‬
‫איבגניה טיומקין‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫סקייטבורד‬
‫כ"ד בניסן התשע"א‪April 28, 2011-‬‬
‫‪Skate board‬‬
‫‪416‬‬
Class
41135
3)19(
1331331113
‫סוג פרסום‬
‫עומר נודלמן‬
‫מגש‬
OMER NUDELMAM
Tray
Class
41921
19)11(
2931331113
‫סוג פרסום‬
‫כתר פלסטיק בע"מ‬
‫מתקן אמבטיה‬
KETER PLASTIC LTD.
Bath device
Class
41514
19)11(
1432131111
‫סוג פרסום‬
ARMAND SERFATY
Cartridge for dispenser for wet and dry paper
Convention date (U.S.A.)
1131131111
Class
41142
3)12(
2132131113
‫מחסנית למושיט לנייר יבש ורטוב‬
)‫תאריך האמנה (ארצות הברית‬
‫סוג פרסום‬
RECKITT & COLMAN (OVERSEAS) LIMITID
Aerosol container
Convention date (OHIM)
Class
41129
24)11(
1432131113
3RESEARCH
Keyboard
417
‫מיכל אירוסול‬
)‫תאריך האמנה (אוהיים‬
2231131113
‫סוג פרסום‬
IN MOTION LTD
‫מקלדת‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫תאריך האמנה (ארצות הברית)‬
‫כ"ד בניסן התשע"א‪April 28, 2011-‬‬
‫‪9231431113‬‬
‫)‪Convention date (U.S.A.‬‬
‫‪418‬‬
Class
41154 ,41151
3)19(
2131231121
‫סוג פרסום‬
‫מרדכי קליינר‬
‫אריזה‬
MORDECHI KLEINER
Package
Class
43145
3)19(
1431131121
‫סוג פרסום‬
‫מרדכי קליינר‬
‫אריזה‬
MORDECHI KLEINER
Package
Class
43513
14)11(
2432131113
‫סוג פרסום‬
‫מוריס טופז‬
‫התקן סגירת פצע‬
MORIS TOPAZ
Wound closure device
Class
43142
3)12(
1931131121
‫סוג פרסום‬
BULGARI S.P.A3
Bottle
Convention date (OHIM)
1531931121
Class
43413
4)14(
1431431121
‫בקבוק‬
)‫תאריך האמנה (איחוד אירופי‬
‫סוג פרסום‬
CURVER LUXEMBOURG SARL
Box with lid
Convention date (OHIM)
419
1131231121
‫קופסה עם מכסה‬
)‫תאריך האמנה (איחוד אירופי‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
Class
43434 ,43431 ,43435
15)12(
2931431121
‫סוג פרסום‬
‫א כוכב מוצרי אלומיניום בע"מ‬.‫פ‬
P.A COCHAV ALUMINUM
PRODUCTS LTD.
‫פרופיל‬
Profile
Class
43135
3)14(
1331431121
‫סוג פרסום‬
CURVER LUXEMBOURG SARL
Hamper with cover
Convention date (OHIM)
Class
1231131121
43311
21)22(
1531131121
Bicycle seat with locking device
51115 ,51114
22)12(
2331131121
TAL AZULAY JEWELLERY LTD.
Jewel
Class
51259 ,51251
9)12(
2932131121
THE STANLEY WORKS ISRAEL
LTD.
420
‫סוג פרסום‬
‫אינו וויז'ן בע"מ‬
‫מושב אופניים בעל התקן נעילה‬
INO VISION LTD.
Class
‫סל עם מכסה‬
)‫תאריך האמנה (איחוד אירופי‬
‫סוג פרסום‬
‫טל אזולאי תכשיטים בע"מ‬
‫תכשיט‬
‫סוג פרסום‬
‫דה סטנלי וורקס ישראל בע"מ‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫תיק לכלי עבודה‬
‫תאריך האמנה (ארצות הברית)‬
‫כ"ד בניסן התשע"א‪April 28, 2011-‬‬
‫‪2131131121‬‬
‫‪Tool bag‬‬
‫)‪Convention date (U.S.A.‬‬
‫‪421‬‬
Class
51114
11)19(
1132131121
‫סוג פרסום‬
KONINKLIJKE PHILIPS ELECTRONICS N.V3
Shaver
Convention date (OHIM)
Class
‫מכונת גילוח‬
)‫תאריך האמנה (איחוד אירופי‬
1131531121
41149
4)11(
1931431113
‫סוג פרסום‬
COLGATE-PALMOLIVE COMPANY
Toothbrush
Convention date (U.S.A.)
‫מברשת שיניים‬
)‫תאריך האמנה (ארצות הברית‬
1931231113
41411 ,41443 ,41444
41414 ,41419 ,41411
41431 ,41413 ,41411
41435 ,41431 ,41432
Class
1)11(
1132131113
‫סוג פרסום‬
DIESEL S.P.A
‫מכנסיים‬
Pants
Class
51142
11)19(
9231131121
‫סוג פרסום‬
LSI INDUSTRIES, INC3
‫תאורה‬
Lighting
41151
422
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫סוג פרסום‬
‫סנו מפעלי ברונוס בע"מ‬
‫בקבוק‬
‫כ"ד בניסן התשע"א‪April 28, 2011-‬‬
‫(‪3)12‬‬
‫‪1132131113‬‬
‫‪Class‬‬
‫‪SANO BRUNOS ENTERPRISES‬‬
‫‪LTD.‬‬
‫‪Bottle‬‬
‫‪423‬‬
43295
3)12(
2231931121
Class
‫סוג פרסום‬
PARFUMS GIVENCHY
Bottle
Convention date (France)
Class
2431331113
51111
19)11(
2131331121
‫סוג פרסום‬
‫לינאה מקלחונים בע"מ‬
‫מקלחון‬
LINEA MIKLAHONIM LTD.
Shower enclosure
Class
‫בקבוק‬
)‫תאריך האמנה (צרפת‬
43912
21)21(
1231431121
‫סוג פרסום‬
‫הדר רוזן בע"מ‬
‫כיסוי למושב הרכב‬
HADAR ROSEN LTD.
Seat cover
Class
43533
21)21(
2531131121
‫ אביזרי רכב בע"מ‬.‫ק‬.‫ט‬
‫כיסוי גלגל לרכב‬
T.C. AVISAREI RECHEV B.M.
Vehicle wheel cover
Class
T.C. AVISAREI RECHEV B.M.
Vehicle dash board cover
424
‫סוג פרסום‬
43112 ,43111
21)21(
2531131121
‫סוג פרסום‬
‫ אביזרי רכב בע"מ‬.‫ק‬.‫ט‬
‫כיסוי ללוח השעונים לרכב‬
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫מדגמים שבוטלו‬
‫‪DESIGNS VOID‬‬
‫‪94145‬‬
‫כ"ד בניסן התשע"א‪April 28, 2011-‬‬
‫‪94144‬‬
‫‪94149‬‬
‫‪11229‬‬
‫‪11213‬‬
‫‪11214‬‬
‫‪94143‬‬
‫‪94144‬‬
‫‪425‬‬
‫מדגמים שחודשו‬
‫‪DESIGNS RENEWED‬‬
‫‪34972 41541 42263 42264 42265 42266 42267 42268 42328‬‬
‫‪42543‬‬
‫כ"ד בניסן התשע"א‪April 28, 2011-‬‬
‫‪42541 42542‬‬
‫‪34971‬‬
‫‪34954‬‬
‫‪42461‬‬
‫‪42442‬‬
‫‪426‬‬
‫שינוי שם‬
‫מס' מדגמים‪:‬‬
‫‪93214 ,41951‬‬
‫שינוי שם בעלת המדגמים‬
‫תנה תעשיות (‪ )1661‬בע"מ‬
‫ל‪-‬‬
‫חברת תנה תעשיות בע"מ‬
‫שינוי שם מ‪-‬‬
‫חברת תנה תעישות בע"מ‬
‫ל‪ -‬תנה תעשיות חברה בע"מ‬
‫מיזוג של תנה תעשיות חברה בע"מ‬
‫ל‪ -‬שטראוס מים בע"מ‬
‫רח' הסיבים ‪46‬‬
‫פתח תקווה ‪46511‬‬
‫ישראל‬
‫‪41161 ,41556‬‬
‫שינוי שם בעלת המדגמים‬
‫חברת תנה תעשיות בע"מ‬
‫ל‪ -‬תנה תעשיות חברה בע"מ‬
‫מיזוג של תנה תעשיות חברה בע"מ‬
‫ל‪-‬שטראוס מים בע"מ‬
‫רח' הסיבים ‪46‬‬
‫פתח תקווה ‪46511‬‬
‫ישראל‬
‫כ"ד בניסן התשע"א‪April 28, 2011-‬‬
‫‪427‬‬
‫כ"ד בניסן התשע"א‪April 28, 2011-‬‬
‫‪428‬‬
‫מפתחות לבקשות שקובלו‬
‫‪INDICES OF APPLICATIONS ACCEPTED‬‬
‫מפתח שמי‬
‫אבי אפרתי ‪115112 -‬‬
‫אהרון משה ‪111520 -‬‬
‫אוניברסיטת בן‪-‬גוריון בנגב‪ ,‬הרשות למחקר‬
‫ופיתוח ‪114251 -‬‬
‫אורי פונגר ‪115116 -‬‬
‫אי‪ .‬סי‪ .‬איי‪ .‬טלקום בע"מ ‪116051 , 114556 -‬‬
‫איטמייקסנס בע"מ ‪111556 -‬‬
‫אלעזר טגנסקי ‪110055 -‬‬
‫אל‪-‬פר אלקטרוניקה מערכות ‪ 5000‬בע"מ ‪-‬‬
‫‪114651‬‬
‫אפ‪.‬טו‪.‬יו‪ .‬נט בע"מ ‪112501 -‬‬
‫ארקדי טולמסוב ‪111114 -‬‬
‫בוריס קשמקוב ‪111114 -‬‬
‫ביומאס בע"מ ‪111612 -‬‬
‫ברן טכנולוגיות מתקדמות (‪ )1611‬בע"מ ‪-‬‬
‫‪110115‬‬
‫גיוון אימג'ינג בע"מ ‪115111 , 111111 -‬‬
‫גיל הכט ‪110511 -‬‬
‫גנדי כצנלסון ‪112411 -‬‬
‫‪NAME INDEX‬‬
‫ידע חברה למחקר ופיתוח בע"מ ‪114151 -‬‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים בע"מ ‪-‬‬
‫‪116415‬‬
‫ישקר בע"מ ‪110511 -‬‬
‫ישקר בע"מ ‪111124 , 110511 -‬‬
‫ישראל הדס ‪110611 -‬‬
‫כימאגיס בע"מ מחלקת קניין רוחני ‪-‬‬
‫‪111412‬‬
‫כיסופית הילה זיידר ‪112461 -‬‬
‫לוי טולמסוב ‪111114 -‬‬
‫מגן אקו אנרג'י ‪ -‬אגודה שיתופית חקלאית‬
‫בע"מ ‪112055 -‬‬
‫מדינת ישראל‪ ,‬משרד החקלאות‪ ,‬מינהל‬
‫המחקר החקלאי‪ ,‬מרכז וולקני‪ ,‬המכון‬
‫להנדסה חקלאית ‪111616 -‬‬
‫מיקרוסמי קורפ ‪ -‬אנאלוג מיקסד סינגל‬
‫גרופ בע"מ ‪114612 -‬‬
‫משרד החקלאות ופיתוח הכפר‪ ,‬אגף לדיג‬
‫וחקלאות המים ממרכז חקלאי ‪116415 -‬‬
‫דב זיידר ‪112461 -‬‬
‫דולפין תוכנה בע"מ ‪115221 -‬‬
‫דיאגנוסטיקס טכנולוגיות בע"מ ‪111121 -‬‬
‫דסליטק בע"מ ‪115112 -‬‬
‫נ‪.‬ר‪ .‬ספונטק תעשיות בע"מ ‪500551 -‬‬
‫נגבטק‪ ,‬בע"מ ‪111116 -‬‬
‫נען‪-‬דן מערכות השקייה בע"מ ‪151105 -‬‬
‫וריסיטי בע"מ ‪155165 -‬‬
‫סרקונט בע"מ ‪110411 -‬‬
‫טבע תעשיות פרמצבטיות בע"מ ‪111561 -‬‬
‫טוביה שגיב ‪115116 -‬‬
‫טלדור מוליכים וכבלים בע"מ ‪110501 -‬‬
‫עמוס נוי ‪155165 -‬‬
‫ידע חברה למחקר ופיתוח בע"מ ‪154506 -‬‬
‫כ"ד בניסן התשע"א‪April 28, 2011-‬‬
‫פ‪ .‬את פ‪ .‬בלמי בטיחות (‪ ) 5004‬בע"מ ‪-‬‬
‫‪111161‬‬
‫פוטרמן יזום ניהול ושיווק ‪161512 -‬‬
‫‪429‬‬
- ‫רפאל מערכות לחימה מתקדמות בע"מ‬
111205
111520 - ‫שבט הלוי טכנולוגיות בע"מ‬
111246 - ‫פלנום ויז'ן בע"מ‬
111511 - ‫פרוטליקס בע"מ‬
156650 - ‫פרוכון ביוטק בע"מ‬
154506 - ‫פרוכון בע"מ‬
112151 - ‫צוני סיגל‬
116515 - ‫רוזטה ג'נומיקס בע"מ‬
141140 - ‫פט בע"מ‬-‫רז‬
ACTIVE BIOTECH AB - 2/1/1/
ADVANCED MINERAL RECOVERY
TECHNOLOGIES LTD - 190355
ADVANCED PLASMA POWER
LIMITED - 184279
AEROVANCE, INC. - 181898
AGENSYS, INC. - 147902 , 150018
AHARON MOSHE - 167530
AIR LIQUIDE ELECTRONICS U.S. LP 172505
AIR PRODUCTS AND CHEMICALS,
INC. - 186905
AJINOMOTO CO., INC. - 170349
AKZO NOBEL COATINGS
INTERANTIONAL B.V. - 169956
ALCON, INC. - 180674
ALLERGAN, INC. - 167849
ALMIRALL, S.A. - 175285
ALTUS PHARMACEUTICALS, INC. 142393
AMOS NOY - 155692
AMRONA AG - 189719
AP2U.NET LTD. - 163208
APPLIED RESEARCH SYSTEMS ARS
HOLDING N.V. - 173506
ARCHIMEDES DEVELOPMENT
LIMITED - 164129
ARENA PHARMACEUTICALS, INC. 179458
ARES TRADING S.A. - 156532
ARKADY TOLMASOV - 181884
ARM LIMITED - 183909
ASML NETHERLANDS B.V. - 188767
ASTRAZENECA AB - 171058 , 175439 ,
177518
430
ATC TECHNOLOGIES, LLC - 176728 ,
208120
AVENTIS PHARMA S.A. - 173110
AVI EFRATY - 162713
BAE SYSTEMS INFORMATION AND
ELECTRONIC SYSTEMS
INTEGRATION INC. - 179976
BARAN ADVANCED TECHNOLOGIES
(1986) LTD. - 180715
BAYER CROPSCIENCE AG - 188174
BAYER SCHERING PHARMA AG 176767
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT - 162201
BAYLOR COLLEGE OF MEDICINE 169889
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY - 184358
BIOGEN IDEC MA INC. - 180852
BIOMAS LTD. - 181913
BIOMEDICAL RESEARCH GROUP INC.
- 174166
BIOSENSE WEBSTER INC. - 156376 ,
156378
BIOSENSE WEBSTER, INC. - 175187 ,
175190
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH - 174957 ,
179215
BORIS KASHMAKOV - 181884
BRISTOL-MYERS SQUIBB COMPANY 170873
BRISTOL-MYERS SQUIBB COMPANY April 28, 2011-‫כ"ד בניסן התשע"א‬
177945
BRISTOL-MYERS SQUIBB COMPANY 184950
CABOT MICROELECTRONICS
CORPORATION - 179941
CALERA CORPORATION - 202313
CAMURUS AB - 179815
CANCER RESEARCH TECHNOLOGY
LIMITED - 181322
CAREFUSION 303, INC. - 169415
CHELSEA THERAPEUTICS, INC. 176707
CHEMAGIS LTD. - 167483
CHROMAGENICS B.V. - 180531
CIBA SPECIALTY CHEMICALS
HOLDING INC. - 176730
COLGATE-PALMOLIVE COMPANY 203243 , 203244 , 203245 , 203246
COMPUMEDICS USA, INC. - 169667
CORIXA CORPORATION - 169540
COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH - 169375
CSIR - 181813
DAI NIPPON PRINTING CO. LTD. 175708
DAINIPPON SUMITOMO PHARMA CO.,
LTD. - 177518
DANLAI FUNG - 183388
DCA DESIGN INTERNATIONAL
LIMITED - 170618 , 170620
DEERE & COMPANY - 166794
DEPOMED, INC. - 153464
DESALITECH LTD. - 162713
DIAGNOSTIC TECHNOLOGIES LTD. 167131
DISENO DE SISTEMAS EN SILICIO,
S.A. - 172141
DOLBY LABORATORIES LICENSING
CORPORATION - 181406
DOLPHIN SOFTWARE LTD. - 185337
DONG WHA PHARM. CO., LTD - 182647
DONNA M. WALKER - 166842
DOV ZAIDER - 183491
DR. REDDY'S LABORATORIES
LIMITED. - 165446
431
ECI TELECOM LTD. - 174229 , 179026
EDWARDS VACUUM, INC. - 172505
EISAI CO., LTD. - 158624
EISAI R&D MANAGEMENT CO., LTD. 158624
ELAZAR TAGANSKY - 180052
EL-FAR ELECTRONICS SYSTEMS 2000
LTD. - 174921
ELI LILLY AND COMPANY - 178103
EMBREX, INC. - 162856
ENZO LIFE SCIENCES, INC. - 195308 ,
195439
ERIC PELTIER - 183358
ESSILOR INTERNATIONAL
(COMPAGNIE GENERALE D'OPTIQUE)
- 182567
ETHICON, INC. - 182566
F. HOFFMANN-LA ROCHE AG - 188319
F. LLI CITTERIO S.P.A. - 170018
FABIO PERINI S.P.A. - 187568
FONDAZIONE CENTRO SAN
RAFFAELE DEL MONTE TABOR 150984
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V. - 177124
FUTURECHEM CO, LTD. - 183548
GALAXY BIOTECH, LLC - 178474
GEM PHARMACEUTICALS, LLC 182970
GENENTECH, INC. - 125168 , 145480 ,
148512
GENERAL DYNAMICS ORDNANCE
AND TACTICAL SYSTEMS - CANADA
INC. - 177385
GEN-ICHIRO SOMA - 174166
GENIUS METAL, INC. - 160248
GENNADY KATSNELSON - 183486
GENTEX CORPORATION - 180662
GIL HECHT - 170586
GIVEN IMAGING LTD. - 171677 , 172878
GLAXO GROUP LIMITED - 188282
GLAXOSMITHKLINE BIOLOGICALS
S.A. - 178568
April 28, 2011-‫כ"ד בניסן התשע"א‬
GRUNENTHAL GMBH - 181848
GUANGDONG ESQUEL TEXTILES CO.,
LTD. - 187205
HARSCO CORPORATION - 186896
HUAWEI TECHNOLOGIES CO, LTD. 178255
HUNTER DOUGLAS INC. - 188261
IBM CORPORATION - 172518 , 183950
ILLINOIS TOOL WORKS INC. - 182839
IMMUNEX CORPORATION - 196509
IMMUNOBIOLOGY LIMITED - 148153
IMMUNOMEDICS, INC. - 167587
IN MOTION INVESTMENT, LTD. 179413
INDIANA UNIVERSITY RESEARCH
AND TECHNOLOGY CORPORATION 183831
INDIVUMED GMBH - 181132
INGREDIA - 181682
INNATE PHARMA - 172679
INNOVA S.A. - 180687
INTERDIGITAL TECHNOLOGY
CORPORATION - 158729
IONIX PHARMACEUTICALS LIMITED 164129
ISCAR LTD. - 170586
ISCAR LTD. - 170586 , 181834
ISRAEL HADDAS - 180971
ITMAKESENSE LTD. - 186259
IUSA S.A. DE C.V. - 182374
JACOBUS PHARMACEUTICAL
COMPANY, INC. - 169889
JAGOTEC AG - 171494
JAN BEUTE - 184568
JANSSEN PHARMACEUTICA N.V. 164004
JANSSEN PHARMACEUTICA, N.V. 164002
JI KWANG INC. - 168694
JOHNSON MATTHEY PUBLIC LIMITED
COMPANY - 176197
JOSEPH OHAYON - 182612
JULIO CESAR GONZALEZ ALVAREZ 188437
432
KABUSHIKI KAISHA KOBE SEIKO
SHO (KOBE STEEL, LTD.) - 168555
KAMATICS CORPORATION - 182435
KANYA AG - 175794
KCI LICENSING, INC. - 185232
KOMET GROUP GMBH - 189964
KWALATA TRADING LIMITED 179413
LAICA S.P.A. - 178398
LEVI TOLMASOV - 181884
LG ELECTRONICS INC. - 179082
LG ELECTRONICS INC. - 179879 ,
181351
LTS LOHMANN THERAPIE-SYSTEME
AG - 168543
LUIS CARLOS TORRE SARMIENTO 188437
LUTRON ELECTRONICS CO., INC. 180704
MACLIP - 183358
MACROGENICS, INC. - 169604
MAGEN ECO ENERGY A.C.S. LTD. 183052
MARVELL HISPANIA, S.L. - 172141
MASAI MARKETING & TRADING AG 176727
MASTERMIND CO. LTD. - 193714
MB S.R.L. - 176813
MBDA FRANCE - 165576
MEGAPLAST S.A. - 180445
MERCK PATENT GMBH - 190537
MERCK SERONO S.A. - 173506
MERIDIAN MEDICAL
TECHNOLOGIES, INC. - 181118
MESSIER-BUGATTI - 170547
MICROSEMI CORP - ANALOG MIXED
SIGNAL GROUP LTD. - 184913
MICROSOFT CORPORATION - 153265
MILLIKEN & COMPANY - 181893
MINISTRY OF AGRICULTURE AND
RURAL DEVELOPMENT DEPT. - 169412
MOSAID TECHNOLOGIES
INCORPORATED - 160417
MOTOROLA, INC. - 173784
April 28, 2011-‫כ"ד בניסן התשע"א‬
MYELOS CORPORATION - 147093 ,
147094
N.R. SPUNTECH INDUSTRIES LTD. 200258
NAAN-DAN IRRIGATION SYSTEMS
LTD. - 151105
NEGEVTECH, LTD. - 187719
NIMBUS S.R.L. - 188429
NORTHWESTERN UNIVERSITY 179212
NOVARTIS AG - 166950 , 180678
NOVARTIS VACCINES AND
DIAGNOSTICS, INC. - 170719 , 184865
NOVO NORDISK A/S - 165608
NOVO NORDISK HEALTH CARE AG 165608
ONCOMUNE, LLC - 173943
ONDINE INTERNATIONAL LTD. 189551
ONO PHARMACEUTICAL CO., LTD. 163344 , 173973
P.&P. SAFETY BRAKING (2004) LTD 181696
PENNEL & FLIPO - 184000
PFIZER INC - 181322
PFIZER INC. - 176629
PLANUM VISION LTD. - 188349
PRC-DESOTO INTERNATIONAL, INC. 172109
PROCHON BIOTECH LTD. - 159920
PROCHON LTD. - 154209
PROTALIX LTD. - 177586
PROTEOTECH, INC. - 179160
PURDUE RESEARCH FOUNDATION 200933
PUTERMAN DISTRIBUTORS - 196213
QINETIQ LIMITED - 194527
Q-PIDT BV - 184568
QUALCOMM INCORPORATED - 167554
, 175172 , 175691
QUALCOMM INCORPORATED - 168802
, 204550
QUALCOMM INCORPORATED - 171916
433
, 205515
QUALCOMM INCORPORATED - 179803
, 180123 , 186404
R.P.E. S.r.l. - 188191
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD. - 166305
RAVEN BIOTECHNOLOGIES - 184803
RAYTHEON COMPANY - 175991 ,
180485
RAZ-PAT LTD. - 141640
RIJK ZWAAN ZAADTEELT EN
ZAADHANDEL B.V. - 160454
ROSETTA GENOMICS LTD. - 179285
ROTINOR GMBH - 182482
SAINT-GOBAIN GLASS FRANCE 184005
SANARIA INC - 168651
SANOFI-AVENTIS - 177422
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 172371
SARGENT MANUFACTURING
COMPANY - 188023
SCHERING-PLOUGH LTD. - 157231
SEOUL NATIONAL UNIVERSITY
INDUSTRY FOUNDATION - 184258
SERCONET LTD. - 160417
SHERWOOD SERVICES AG - 178902
SHEVET HA-LEVI TECHNOLOGICAL
LTD - 167530
SIC BREVETTI S.R.L. - 176559
SICPA HOLDING S.A. - 183350
SIDEM PHARMA S.A. - 181831
SILVERBROOK RESEARCH PTY. LTD.
- 146674 , 163488
SILVERBROOK RESEARCH PTY. LTD.
- 155492
SK TELECOM CO., LTD. - 171150
SLEEP DIAGNOSTICS PTY LTD. 188439
ST. JUDE MEDICAL, ATRIAL
FIBRILLATION DIVISION, INC. 189066
STATE OF ISRAEL, MINISTRY OF
AGRICULTURE, AGRICULTURAL
RESEARCH ORGANIZATION THE
April 28, 2011-‫כ"ד בניסן התשע"א‬
VOLCANI CENTER - 171969
STEPHEN L. BUCHANAN - 188947
STUCCHI S.P.A. - 189016
STUDIO MODERNA SA - 182057
SULZER MIXPAC AG - 192483
SUMITOMO CHEMICAL COMPANY,
LIMITED. - 175801 , 182544
SUVEN LIFE SCIENCES LIMITED 182439
SYMPHOGEN A/S - 180169
SYNGENTA PARTICIPATIONS AG 177723
TAIYO NIPPON SANSO CORPORATION
- 195704
TAKEDA PHARMACEUTICAL
COMPANY LIMITED - 174201
TELDOR WIRES AND CABLES LTD. 180507
TELIK, INC. - 152325
TEST ADVANTAGE, INC. - 170252
TETRONICS LIMITED - 184279
TEVA PHARMACEUTICAL
INDUSTRIES LTD. - 181298
THE ADMINISTRATORS OF THE
TULANE EDUCATIONAL FUND 160993
THE ASAN FOUNDATION OF - 183548
THE BOARD OF REGENTS OF THE
UNIVERSITY OF TEXAS SYSTEM 156361
THE BOC GROUP,INC. - 172505
THE DIRECTV GROUP, INC. - 168228
THE PROCTER & GAMBLE COMPANY
- 196628
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA - 169663 , 183993 ,
186181
THE REGENTS OF THE UNIVERSITY
OF MICHIGAN - 174870
THE TRUSTEES OF THE UNIVERSITY
OF PENNSYLVANIA - 166467
THERAVANCE, INC. - 162862
TORRE & TORRE INNOVACION, S.L. 188437
TOYAMA CHEMICAL CO., LTD. 163798
434
TUVIA SAGIV - 172889
TZONY SIEGAL - 183156
UAB RESEARCH FOUNDATION 196082
UHLMANN VISIOTEC GMBH - 172371
UNILEVER PLC - 180386 , 184654
UNITED STATES GYPSUM COMPANY
- 173641
UNITED STATES GYPSUM COMPANY
- 189724
UNIVAX, LLC - 173943
UNIVERSAL AVIONICS SYSTEMS
CORPORATION - 182003
UNIVERSITA DEGLI STUDI DI
PERUGIA - 172679
UNIVERSITY OF FLORIDA RESEARCH
FOUNDATION, INC. - 183993
UNIVERSITY OF MARYLAND
BIOTECHNOLOGY INSTITUTE - 204302
UNIVERSITY OF MARYLAND,
BALTIMORE - 137466 , 177612
UNIVERSITY OF MARYLAND,
BALTIMORE - 204302
UNIVERSITY OF SOUTH FLORIDA 176898
UNIVERSITY OF ZURICH - 188518
UOP LLC - 181926
URI PONGER - 172889
VENDEVIA GROUP, LLC - 173943
VERISITY LTD. - 155692
VERNALIS (R & D) LTD. - 164129
VERNALIS RESEARCH LIMITED 156713
VERTEX PHARMACEUTICALS
INCORPORATED - 166620
VICTAULIC COMPANY - 178978 ,
189604 , 191007
VLAAMSE INSTELLING VOOR
TECHNOLOGISCH ONDERZOEK
(VITO) - 183230
WARNER-LAMBERT COMPANY LLC 151568
WELLSTAT THERAPEUTICS
CORPORATION - 169332
April 28, 2011-‫כ"ד בניסן התשע"א‬
WISCONSIN ALUMNI RESEARCH
FOUNDATION - 181438
WISCONSIN ALUMNI RESEARCH
FOUNDATION - 195374
WORLDWIDE STRATEGY HOLDINGS
LIMITED - 160248
XEDA INTERNATIONAL - 187923
XOMA TECHNOLOGY - 145480
DEVELOPMENT CO. LTD. - 174826
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD. 169412
ZACH SYSTEM S.P.A. - 183745
ZAIDER KISUFIT HILA - 183491
ZUMEX, MAQUINAS Y ELEMENTOS,
S.A. - 174586
YALE UNIVERSITY - 176898
YALE UNIVERSITY - 183831
YEDA RESEARCH AND
DEVELOPMENT CO. LTD. - 154209
YEDA RESEARCH AND
435
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫מפתח ענייני‬
SUBJECT MATTER INDEX
A01D - 166794, 171969
A01H - 160454
A01N - 157231, 178568
A23B - 187923
A23C - 181682
A23G - 180386, 180687, 184654
A23N - 174586
A43B - 176727
A45D - 186259
A61B - 156376, 156378, 171677,
172878, 175187, 175190,
176559, 178902, 180674,
183156, 183388, 184568,
189066
A61C - 182612, 188947
A61F - 186181
A61K - 145480, 148153, 151568,
153464, 156361, 156532,
164129, 165446, 165608,
166467, 166950, 167849,
168651, 168694, 169412,
170873, 171494, 172679,
173943, 174201, 175285,
176898, 178474, 179215,
179815, 180678, 180852,
182647, 184865, 204302
A61L - 168543, 196628
A61M - 170618, 170620, 175439,
181118, 181884
A61N - 169667
A63B - 180662
B01D - 178398, 183230, 195704,
202313
B01F - 183486, 186896
B05B - 151105
B05C - 170547, 192483
B21D - 178978
B21F - 200258
B23B - 189964
436
B23Q - 181834
B26D - 187568
B28B - 173641, 189724
B29C - 184000
B29D - 180445
B32B - 181893, 182566
B41J - 193714
B42D - 183350
B60C - 185232
B62K - 182057
B62L - 181696
B63H - 182482
B64B - 188429
B65D - 196213
B65G - 175708
B81B - 188767
C01B - 169375
C02F - 162713,
C07C - 162862,
171058,
176629,
179160,
181926,
C07D - 156713,
164002,
167483,
174957,
177422,
179458,
182439,
195308
C07F - 152325,
C07H - 169540,
182970
C07K - 147093,
150984,
167587,
173506,
183831,
179212,
163798,
173973,
176707,
181831,
183548,
158624,
164004,
170349,
176197,
177518,
181322,
182544,
180971
169332,
175801,
177723,
181913,
183745
163344,
166620,
173110,
176767,
178103,
181848,
188174,
177945, 181298
174870, 181898,
147094,
160993,
169604,
174826,
184803,
150018,
162201,
170719,
177612,
184950,
April 28, 2011-‫כ"ד בניסן התשע"א‬
188282,
C08K - 176730
C08L - 172109
C09D - 169956
C09G - 179941
C11D - 203243,
203246
C12M - 183358
C12N - 125168,
154209,
174166,
180169,
195374,
C12P - 142393,
C12Q - 179285,
C21D - 166842
C22C - 160248
C23C - 168555
196509
203244, 203245,
137466,
159920,
177586,
181438,
196082
148512,
180531,
147902,
169663,
179413,
188518,
188319
195439
D05B - 187205
E01F - 194527
E02B - 180052
E04H - 172889
E05B - 167530
E05C - 188023
E06B - 184005, 188261
F16B - 175794
F16D - 182435
F16K - 188191
F16L - 189016, 189604, 191007
F17C - 186905
F21V - 188437
F23G - 184279
F24D - 176813
F24J - 183052
F27D - 190355
F41F - 165576
F41G - 181813
F41H - 170018
F42B - 177385
G01G - 141640
G01J - 175991
G01N - 162856,
172371,
200933
G01R - 163208
G01S - 179976
G02B - 182567,
G05B - 172505,
G06F - 146674,
169415,
183909,
G06Q - 182374,
G06T - 184258
G08B - 174921,
189719
G08G - 171150
G09G - 184913
G10L - 172518,
186404
167131, 169889,
181132, 190537,
182839, 189551
180704
153265, 155692,
170252, 183491,
183950
185337
188349, 188439,
177124, 181406,
H01B - 180507
H01H - 170586
H01L - 180715, 187719
H01S - 180485
H02M - 184358
H04B - 158729, 160417, 167554,
168228, 176728, 180123,
181351, 208120
H04J - 171916, 174229
H04L - 172141, 175691, 178255,
179026, 179082, 179803,
205515
H04M - 163488
H04N - 155492, 166305
H04W - 168802, 173784, 175172,
179879, 204550
H05H - 183993
G01C - 182003
437
April 28, 2011-‫כ"ד בניסן התשע"א‬
‫קודים למדינת המופיעים ביומן‬
COUNTRY CODES APPEARING IN THIS JOURNAL
Code
AR
AT
AU
BA
BE
BR
CA
CH
CN
CU
CZ
DE
DK
EC
EP
ES
FI
FR
GB
GE
GR
GT
HR
HU
IE
IL
IN
IT
JP
KR
LK
LU
438
Country or Organization
Argentina
Austria
Australia
Herzegovina
Belgium
Brazil
Canada
Switzerland
China
Cuba
Czech Republic
Germany
Denmark
Ecuador
European Patent Office
Spain
Finland
France
United Kingdom
Georgia
Greece
Guatemala
Croatia
Hungary
Ireland
Israel
India
Italy
Japan
Republic of Korea
Sri Lanka
Luxembourg
Code
MX
MY
NL
NO
NZ
PL
PT
RU
SE
SG
SI
SK
TH
TR
TW
UA
US
UY
UZ
WO
ZA
Country or Organization
Mexico
Malaysia
The Netherlands
Norway
New Zealand
Poland
Portugal
Russian Federation
Sweden
Singapore
Slovenia
Slovakia
Thailand
Turkey
Taiwan
Ukraine
United States of America
Uruguay
Uzbekistan
World Intellectual Property
Organization (W.I.P.O.)
South Africa
April 28, 2011-‫כ"ד בניסן התשע"א‬
LV
Latvia
‫ ירושלים‬,‫ משרד המשפטים‬,‫נערך ע"י רשות הפטנטים‬
EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM
439
April 28, 2011-‫כ"ד בניסן התשע"א‬